1 00:00:07,109 --> 00:00:08,377 >> OKAY, HI. 2 00:00:08,377 --> 00:00:10,980 I'D LIKE TO ASK AMY WILLIAMS TO 3 00:00:10,980 --> 00:00:12,615 HELP OPEN THE MEETING BEFORE WE 4 00:00:12,615 --> 00:00:15,584 GET STARTED WITH SOME OF OUR 5 00:00:15,584 --> 00:00:15,918 HOUSEKEEPING. 6 00:00:15,918 --> 00:00:16,252 >> SURE. 7 00:00:16,252 --> 00:00:17,653 THANKS SO MUCH, ANNIE. 8 00:00:17,653 --> 00:00:18,988 HI, EVERYONE. 9 00:00:18,988 --> 00:00:21,157 AS YOU ALL KNOW, I'M AMY 10 00:00:21,157 --> 00:00:22,591 WILLIAMS, THE DIRECTOR OF THE 11 00:00:22,591 --> 00:00:27,763 ADD VO KA OADVOCACY OFFICE AT TL 12 00:00:27,763 --> 00:00:28,164 CANCER INSTITUTE. 13 00:00:28,164 --> 00:00:29,365 AS I SAY AT THE TOP OF EACH OF 14 00:00:29,365 --> 00:00:30,699 THESE FSM ACA MEETINGS, THANK 15 00:00:30,699 --> 00:00:31,967 YOU SO MUCH FOR JOINING US TODAY 16 00:00:31,967 --> 00:00:33,736 AND FOR THE WORK THAT YOU DO IN 17 00:00:33,736 --> 00:00:38,174 ADVANCE OF THE MEETING WITH THE 18 00:00:38,174 --> 00:00:39,108 PREREAD AND THE BACKGROUND THAT 19 00:00:39,108 --> 00:00:39,642 WE SEND. 20 00:00:39,642 --> 00:00:41,277 I THINK WE HAVE A TERRIFIC 21 00:00:41,277 --> 00:00:43,913 COUPLE OF HOURS PLANNED FOR US 22 00:00:43,913 --> 00:00:44,446 TODAY. 23 00:00:44,446 --> 00:00:47,750 WE'RE GOING TO START OFF WITH A 24 00:00:47,750 --> 00:00:49,585 LITTLE BIT OF SCIENCE. 25 00:00:49,585 --> 00:00:50,920 WE HAVE TWO SCIENTIFIC ORIENTED 26 00:00:50,920 --> 00:00:52,354 PRESENTATIONS TODAY, ONE ABOUT 27 00:00:52,354 --> 00:00:54,290 CANCER GRAND CHALLENGES, WHICH I 28 00:00:54,290 --> 00:00:55,491 THINK ALMOST ALL OF YOU ARE 29 00:00:55,491 --> 00:00:57,593 FAMILIAR WITH, AND WE ACTUALLY 30 00:00:57,593 --> 00:00:59,528 HAVE SEVERAL NCRA MEMBERS WHO 31 00:00:59,528 --> 00:01:00,563 ARE PARTICIPATING IN THAT 32 00:01:00,563 --> 00:01:01,830 SCIENTIFIC INITIATIVE AND WE'LL 33 00:01:01,830 --> 00:01:03,265 HEAR A LITTLE BIT FROM THEM IN 34 00:01:03,265 --> 00:01:04,767 ADDITION TO OUR SCIENTIFIC 35 00:01:04,767 --> 00:01:06,435 LEADERSHIP. 36 00:01:06,435 --> 00:01:10,706 WE HAVE A LEG UPDATE AS ALWAYS 37 00:01:10,706 --> 00:01:12,808 AND WE'LL HAVE A PRESENTATION 38 00:01:12,808 --> 00:01:14,743 ALSO AROUND SURVIVORSHIP 39 00:01:14,743 --> 00:01:18,147 STANDARDS, AND THEN KIM WILL -- 40 00:01:18,147 --> 00:01:18,881 DR. RATHMELL, KIM, WILL BE 41 00:01:18,881 --> 00:01:20,216 JOINING US TO CLOSE OUT THE 42 00:01:20,216 --> 00:01:22,851 MEETING ACTUALLY. 43 00:01:22,851 --> 00:01:24,587 SHE HAD A MEETING DOWN AT THE 44 00:01:24,587 --> 00:01:25,621 WHITE HOUSE TODAY, IT WAS A 45 00:01:25,621 --> 00:01:26,889 CLINICAL TRIALS FORUM, SOME OF 46 00:01:26,889 --> 00:01:27,990 YOU MAY HAVE LISTEN TODAY THAT 47 00:01:27,990 --> 00:01:30,626 THIS MORNING. 48 00:01:30,626 --> 00:01:31,060 ED TO THAT 49 00:01:31,060 --> 00:01:32,261 THIS MORNING, SO THEEL BE 50 00:01:32,261 --> 00:01:35,531 JOSHE'LL BEJOINING US AT THE COF 51 00:01:35,531 --> 00:01:36,232 THAT EVENT. 52 00:01:36,232 --> 00:01:38,534 SO AS ALWAYS, THANK YOU FOR YOUR 53 00:01:38,534 --> 00:01:39,702 EXPERTISE, FOR ALWAYS SHARING 54 00:01:39,702 --> 00:01:40,936 THE COLLECTIVE PATIENT 55 00:01:40,936 --> 00:01:41,437 PERSPECTIVE. 56 00:01:41,437 --> 00:01:43,639 WE KNOW THAT ADVOCATES WEAR 57 00:01:43,639 --> 00:01:45,407 MANY, MANY HATS ON BEHAVE OF 58 00:01:45,407 --> 00:01:47,710 PATIENTS AND THIS IS JUST ONE OF 59 00:01:47,710 --> 00:01:48,143 THEM. 60 00:01:48,143 --> 00:01:49,144 SO THANK YOU SO MUCH FOR ALL 61 00:01:49,144 --> 00:01:53,816 THAT YOU DO, AND ANNIE, LET ME 62 00:01:53,816 --> 00:01:54,950 THANK YOU FOR CHAIRING TODAY'S 63 00:01:54,950 --> 00:01:55,818 MEETING AND FOR WALKING US 64 00:01:55,818 --> 00:01:59,221 THROUGH ALL OF OUR PRESENTAT 65 00:01:59,221 --> 00:01:59,555 PRESENTATIONS. 66 00:01:59,555 --> 00:02:00,856 I WILL TURN IT BACK OVER TO YOU. 67 00:02:00,856 --> 00:02:01,490 >> OKAY. 68 00:02:01,490 --> 00:02:03,259 THANK YOU SO MUCH, AMY. 69 00:02:03,259 --> 00:02:07,196 AND THANK YOU, EVERYBODY, FOR 70 00:02:07,196 --> 00:02:11,233 ATTENDING ON TIME AND ALL THE 71 00:02:11,233 --> 00:02:11,667 PREREAD WORK. 72 00:02:11,667 --> 00:02:15,504 DO WE HAVE QUORUM, AMY? 73 00:02:15,504 --> 00:02:17,039 >> YOU ARE TESTING MY QUICK 74 00:02:17,039 --> 00:02:17,673 COUNTING. 75 00:02:17,673 --> 00:02:18,107 YES. 76 00:02:18,107 --> 00:02:19,208 I BELIEVE THAT WE DO, YEP. 77 00:02:19,208 --> 00:02:20,542 >> OKAY. 78 00:02:20,542 --> 00:02:21,977 SO I NEED TO READ THE OPENING 79 00:02:21,977 --> 00:02:23,479 STATEMENT. 80 00:02:23,479 --> 00:02:24,913 AS COMMITTEE MEMBERS, I WANT TO 81 00:02:24,913 --> 00:02:27,549 REMIND YOU THAT YOU MUST ABSENT 82 00:02:27,549 --> 00:02:28,951 YOURSELVES DURING SPECIFIC 83 00:02:28,951 --> 00:02:30,719 DISCUSSIONS WHENEVER YOUR 84 00:02:30,719 --> 00:02:31,487 PARTICIPATION IN DELIBERATIONS 85 00:02:31,487 --> 00:02:33,656 ON A PARTICULAR PRODUCT, PROGRAM 86 00:02:33,656 --> 00:02:35,291 OR OTHER SPECIFIC MATTER WOULD 87 00:02:35,291 --> 00:02:36,825 CONSTITUTE A CONFLICT OF 88 00:02:36,825 --> 00:02:38,127 INTEREST OR CREATE THE 89 00:02:38,127 --> 00:02:39,662 APPEARANCE OF ONE. 90 00:02:39,662 --> 00:02:41,530 IT IS INCUMBENT UPON YOU TO 91 00:02:41,530 --> 00:02:43,265 ADVISE THE EXECUTIVE SECRETARY, 92 00:02:43,265 --> 00:02:45,901 AMY, AND ABSTAIN FROM ANY 93 00:02:45,901 --> 00:02:47,603 PARTICIPATION IN DISCUSSION OR 94 00:02:47,603 --> 00:02:48,570 ACTION REGARDING THAT MATTER. 95 00:02:48,570 --> 00:02:50,272 IN LIGHT OF THE CURRENT POLICIES 96 00:02:50,272 --> 00:02:51,473 GOVERNING CONFLICT OF INTEREST 97 00:02:51,473 --> 00:02:54,543 BASED ON FINANCIAL HOLDINGS OF 98 00:02:54,543 --> 00:02:55,644 SPECIAL GOVERNMENT EMPLOYEES, 99 00:02:55,644 --> 00:02:56,745 WHICH INCLUDE ALL MEMBERS OF 100 00:02:56,745 --> 00:02:58,280 THIS COMMITTEE, WE MUST DEPEND 101 00:02:58,280 --> 00:03:00,449 ON YOU TO VOLUNTARILY ABSENT 102 00:03:00,449 --> 00:03:01,784 YOURSELF DURING ANY AND ALL 103 00:03:01,784 --> 00:03:03,752 DISCUSSION OF MATTERS THAT COULD 104 00:03:03,752 --> 00:03:04,920 CONCEIVABLY IMPACT THE STATUS OF 105 00:03:04,920 --> 00:03:06,155 THOSE HOLDINGS. 106 00:03:06,155 --> 00:03:08,324 WE TRUST YOUR JUDGMENTS IN THESE 107 00:03:08,324 --> 00:03:09,625 INSTANCES. 108 00:03:09,625 --> 00:03:11,327 BY LAW, A QUORUM OF BOARD 109 00:03:11,327 --> 00:03:12,594 MEMBERS IS REQUIRED FOR EACH 110 00:03:12,594 --> 00:03:14,163 INSTANCE IN WHICH A VOTE OCCURS 111 00:03:14,163 --> 00:03:15,331 IN AN OPEN SESSION. 112 00:03:15,331 --> 00:03:17,199 DURING THIS MEETING, A MINIMUM 113 00:03:17,199 --> 00:03:18,500 OF EIGHT APPOINTED MEMBERS MUST 114 00:03:18,500 --> 00:03:20,703 BE PRESENT TO VOICE THEIR VOTES. 115 00:03:20,703 --> 00:03:22,204 NEW MEMBERS WHO ARE NOT CURRENT 116 00:03:22,204 --> 00:03:24,440 MEMBERS OF ANOTHER NCI ADVISORY 117 00:03:24,440 --> 00:03:28,010 BOARD ARE NOT VOTING UNTIL THEY 118 00:03:28,010 --> 00:03:29,445 HAVE BEEN CLEARED BY THE NCI 119 00:03:29,445 --> 00:03:31,246 ETHICS OFFICE AND OFFICE OF 120 00:03:31,246 --> 00:03:32,081 HUMAN RESOURCES. 121 00:03:32,081 --> 00:03:32,948 AND NOW THE PUBLIC COMMENT 122 00:03:32,948 --> 00:03:33,515 STATEMENT. 123 00:03:33,515 --> 00:03:35,117 MEMBERS OF THE PUBLIC WHO WISH 124 00:03:35,117 --> 00:03:36,752 TO EXPRESS VIEWS REGARDING ANY 125 00:03:36,752 --> 00:03:38,320 ITEMS DISCUSSED DURING THIS 126 00:03:38,320 --> 00:03:40,689 MEETING MAY DO SO BY WRITING 127 00:03:40,689 --> 00:03:42,257 MISS AMY WILLIAMS, EXECUTIVE 128 00:03:42,257 --> 00:03:43,892 SECRETARY, WITHIN 10 DAYS OF THE 129 00:03:43,892 --> 00:03:44,326 MEETING. 130 00:03:44,326 --> 00:03:45,728 ANY WRITTEN STATEMENTS BY 131 00:03:45,728 --> 00:03:47,062 MEMBERS OF THE PUBLIC WILL 132 00:03:47,062 --> 00:03:49,698 RECEIVE CAREFUL CONSIDERATION. 133 00:03:49,698 --> 00:03:51,433 AND SO AGAIN, I THANK YOU ALL 134 00:03:51,433 --> 00:03:52,101 FOR JOINING. 135 00:03:52,101 --> 00:03:53,602 I'M REALLY EXCITED ABOUT THE 136 00:03:53,602 --> 00:03:56,672 MEETING THAT WE HAVE AHEAD. 137 00:03:56,672 --> 00:03:59,641 I'M ESPECIALLY EXCITED TO 138 00:03:59,641 --> 00:04:01,043 INTRODUCE DR. ANDREW KURTZ, WHO 139 00:04:01,043 --> 00:04:03,779 IS THE PROGRAM DIRECTOR OF NCI 140 00:04:03,779 --> 00:04:05,514 CENTER FOR STRATEGIC SCIENTIFIC 141 00:04:05,514 --> 00:04:07,082 INITIATIVES, AND THE CO-LEAD FOR 142 00:04:07,082 --> 00:04:08,951 CANCER GRAND CHALLENGES. 143 00:04:08,951 --> 00:04:10,886 AS YOU MAY KNOW, CANCER GRAND 144 00:04:10,886 --> 00:04:13,322 CHALLENGES IS A PARTNERSHIP WITH 145 00:04:13,322 --> 00:04:15,958 NCI AND CANCER RESEARCH UK TO 146 00:04:15,958 --> 00:04:17,459 ADDRESS MAJOR UNRESOLVED 147 00:04:17,459 --> 00:04:18,660 QUESTIONS IN CANCER. 148 00:04:18,660 --> 00:04:23,899 I BELIEVE DR. SHARP LELESS TALKD 149 00:04:23,899 --> 00:04:25,667 TO US ABOUT IT BACK IN 2020 WHEN 150 00:04:25,667 --> 00:04:26,769 THINGS WERE STILL STARTING UP, 151 00:04:26,769 --> 00:04:28,003 AND I'M REALLY EXCITED THAT TWO 152 00:04:28,003 --> 00:04:31,473 OF OUR BOARD MEMBERS, YELAK BIRU 153 00:04:31,473 --> 00:04:33,308 AND JOYA DELGADO HARRIS, ARE 154 00:04:33,308 --> 00:04:34,343 ALSO RESEARCH ADVOCATE LEADERS 155 00:04:34,343 --> 00:04:36,145 WITHIN THE CANCER GRAND 156 00:04:36,145 --> 00:04:37,045 CHALLENGES, AND WE'LL GET A 157 00:04:37,045 --> 00:04:38,147 CHANCE TO HEAR FROM THEM AS 158 00:04:38,147 --> 00:04:39,648 WELL. 159 00:04:39,648 --> 00:04:41,950 SO DR. CURT, WHENEVER YOU'RE 160 00:04:41,950 --> 00:04:42,151 READY. 161 00:04:42,151 --> 00:04:47,556 THANK YOU FOR BEING WITH US. 162 00:04:47,556 --> 00:04:48,724 >> GREAT, AND THANK YOU SO MUCH. 163 00:04:48,724 --> 00:04:50,058 I REALLY WANT TO THANK THE 164 00:04:50,058 --> 00:04:51,160 MEMBERS OF THE COUNCIL FOR THIS 165 00:04:51,160 --> 00:04:52,261 INVITATION TO JOIN YOU TODAY. 166 00:04:52,261 --> 00:04:53,328 I WANT TO MENTION THAT I'M 167 00:04:53,328 --> 00:04:58,901 JOINED BY MY COLLEAGUE, TONY 168 00:04:58,901 --> 00:05:00,269 DICKHERBER WHO'S ALSO ON THE 169 00:05:00,269 --> 00:05:00,636 LINE. 170 00:05:00,636 --> 00:05:01,770 WE'VE WORKED CLOSELY ON THIS 171 00:05:01,770 --> 00:05:03,405 PROGRAM AND I HOPE HE'LL BE ABLE 172 00:05:03,405 --> 00:05:04,606 TO JOIN THE DISCUSSION AT THE 173 00:05:04,606 --> 00:05:06,241 END. 174 00:05:06,241 --> 00:05:08,811 SO I'M REALLY DELIGHTED TO HAVE 175 00:05:08,811 --> 00:05:10,412 A CHANCE TO TELL BUT CANCER 176 00:05:10,412 --> 00:05:12,247 GRAND CHALLENGES, WHICH AS YOU 177 00:05:12,247 --> 00:05:13,449 JUST HEARD IS ACTUALLY A 178 00:05:13,449 --> 00:05:14,450 PARTNERSHIP THAT WE RUN WITH 179 00:05:14,450 --> 00:05:18,353 CANCER RESEARCH UK, AND THEY 180 00:05:18,353 --> 00:05:19,455 ARE, IN FACT, A PRIVATE CHARITY 181 00:05:19,455 --> 00:05:20,556 IN THE UNITED KINGDOM. 182 00:05:20,556 --> 00:05:22,391 SO WHAT I'M HOPING TO DO IN THE 183 00:05:22,391 --> 00:05:25,961 NEXT FEW MINUTES IS JUST TO TELL 184 00:05:25,961 --> 00:05:27,095 YOU A LITTLE BIT ABOUT HOW THIS 185 00:05:27,095 --> 00:05:28,263 PROGRAM IS SET UP AND WHAT WE'RE 186 00:05:28,263 --> 00:05:30,265 TRYING TO ACCOMPLISH, AND THEN 187 00:05:30,265 --> 00:05:31,700 WHAT I HOPE IS THAT AFTER MY 188 00:05:31,700 --> 00:05:33,135 PART, YOU'LL HAVE A CHANCE TO 189 00:05:33,135 --> 00:05:35,504 HEAR SOME ADDITIONAL, I THINK, 190 00:05:35,504 --> 00:05:37,039 VERY IMPORTANT PERSPECTIVES FROM 191 00:05:37,039 --> 00:05:40,742 BOTH YELICK AND JOYA, BOTH OF 192 00:05:40,742 --> 00:05:42,277 WHOM HAVE BEEN VERY INTIMATELY 193 00:05:42,277 --> 00:05:44,046 INVOLVED IN THE PATIENT ADVOCACY 194 00:05:44,046 --> 00:05:46,448 EFFORTS AROUND CANCER GRAND 195 00:05:46,448 --> 00:05:50,385 CHALLENGES, AND I THINK WILL BE 196 00:05:50,385 --> 00:05:52,788 ABLE TO PROVIDE YOU SORT OF AN 197 00:05:52,788 --> 00:05:53,422 INSIDER'S VIEW OF THE 198 00:05:53,422 --> 00:05:54,256 OPPORTUNITIES THEY SEE WITH THIS 199 00:05:54,256 --> 00:06:00,596 PROGRAM. 200 00:06:00,596 --> 00:06:02,998 SO THIS IS SORT OF THE ROAD MAP 201 00:06:02,998 --> 00:06:05,801 FOR MY TALK TODAY. 202 00:06:05,801 --> 00:06:07,336 FIRST I WANTED TO GIVE YOU SORT 203 00:06:07,336 --> 00:06:09,505 OF A BRIEF BACKGROUND ON WHY 204 00:06:09,505 --> 00:06:11,473 CANCER GRAND CHALLENGES WAS 205 00:06:11,473 --> 00:06:14,009 CREATED IN THE FIRST PLACE, AND 206 00:06:14,009 --> 00:06:15,544 HOW IT ACTUALLY SORT OF BUILDS 207 00:06:15,544 --> 00:06:19,047 UPON ANOTHER NCI PROGRAM THAT 208 00:06:19,047 --> 00:06:20,782 PRECEDED IT A FEW YEARS EARLIER. 209 00:06:20,782 --> 00:06:23,085 I WILL ALSO SAY A FEW WORDS 210 00:06:23,085 --> 00:06:26,588 ABOUT WHAT WE ACTUALLY MEAN WHEN 211 00:06:26,588 --> 00:06:27,923 WE REFER TO SOMETHING AS A 212 00:06:27,923 --> 00:06:29,558 CANCER GRAND CHALLENGE AND THE 213 00:06:29,558 --> 00:06:30,626 CRITERIA THAT WE USE WHEN WE 214 00:06:30,626 --> 00:06:32,294 SELECT THE KIND OF RESEARCH 215 00:06:32,294 --> 00:06:33,929 PROBLEMS THAT WE THINK THIS 216 00:06:33,929 --> 00:06:34,997 PROGRAM REALLY OUGHT TO BE 217 00:06:34,997 --> 00:06:36,532 SUPPORTING. 218 00:06:36,532 --> 00:06:39,835 I'LL SAY A LITTLE BIT ABOUT THE 219 00:06:39,835 --> 00:06:41,036 PROJECTS THAT WE'VE FUNDED SINCE 220 00:06:41,036 --> 00:06:42,538 THE PROGRAM BEGAN. 221 00:06:42,538 --> 00:06:45,507 HOPEFULLY YOU ALL RECEIVED THE 222 00:06:45,507 --> 00:06:46,909 PREREADING MATERIAL FOR TODAY'S 223 00:06:46,909 --> 00:06:48,343 MEETING, WHICH INCLUDED SOME 224 00:06:48,343 --> 00:06:49,878 INFORMATION ON SOME OF THE MOST 225 00:06:49,878 --> 00:06:51,947 RECENT TEAMS THAT WE'VE FUNDED, 226 00:06:51,947 --> 00:06:53,282 BUT I'LL ALSO SAY JUST A FEW 227 00:06:53,282 --> 00:06:54,683 WORDS ABOUT SOME OF THE OTHER 228 00:06:54,683 --> 00:06:56,351 TEAMS THAT WERE FUNDED IN THE 229 00:06:56,351 --> 00:06:59,054 PRIOR ROUND. 230 00:06:59,054 --> 00:07:00,088 AND THEN OF PARTICULAR INTEREST 231 00:07:00,088 --> 00:07:02,124 TO THIS GROUP, I HOPE, I'LL SAY 232 00:07:02,124 --> 00:07:04,560 A FEW WORDS ABOUT HOW WE INVOLVE 233 00:07:04,560 --> 00:07:08,363 PATIENT ADVOCATES IN THE PROGRAM 234 00:07:08,363 --> 00:07:10,032 AND SHARE JUST ONE QUICK EXAMPLE 235 00:07:10,032 --> 00:07:11,099 OF HOW ONE OF ARE OUR FUNDED 236 00:07:11,099 --> 00:07:12,534 TEAMS HAS BEEN INVOLVED 237 00:07:12,534 --> 00:07:14,603 SPECIFICALLY IN PATIENT AND 238 00:07:14,603 --> 00:07:15,637 PUBLIC ENGAGEMENT, WHICH I HOPE 239 00:07:15,637 --> 00:07:18,974 THEN WILL BE A SORT OF 240 00:07:18,974 --> 00:07:20,075 JUMPING-OFF POINT FOR SOME 241 00:07:20,075 --> 00:07:20,876 ADDITIONAL DISCUSSION AND Q & A 242 00:07:20,876 --> 00:07:29,284 ABOUT THE PROGRAM. 243 00:07:29,284 --> 00:07:30,686 SO AS SOME OF YOU MAY KNOW, WAY 244 00:07:30,686 --> 00:07:34,089 BACK IN 2011, NCI ESTABLISHED A 245 00:07:34,089 --> 00:07:35,424 PROGRAM CALLED PROVOCATIVE 246 00:07:35,424 --> 00:07:35,824 QUESTIONS. 247 00:07:35,824 --> 00:07:38,226 SO THIS WAS A PROGRAM THAT WAS 248 00:07:38,226 --> 00:07:41,196 SPEARHEADED BY HAROLD VARMUS, 249 00:07:41,196 --> 00:07:42,264 AND THE GOAL OF THIS PROGRAM 250 00:07:42,264 --> 00:07:44,232 REALLY WAS TO STIMULATE RESEARCH 251 00:07:44,232 --> 00:07:46,969 IN AREAS THAT WERE EITHER 252 00:07:46,969 --> 00:07:49,838 PERPLEXING OR PERHAPS SEEMED 253 00:07:49,838 --> 00:07:51,840 PARADOXICAL OR PERHAPS FOR SOME 254 00:07:51,840 --> 00:07:53,542 OTHER REASON HADN'T RECEIVED 255 00:07:53,542 --> 00:07:55,611 WHAT WE CONSIDER TO BE ENOUGH 256 00:07:55,611 --> 00:07:56,478 ATTENTION. 257 00:07:56,478 --> 00:07:59,982 SO THE WAY THIS PROGRAM WAS RUN 258 00:07:59,982 --> 00:08:01,350 WAS THAT NEW RESEARCH QUESTIONS 259 00:08:01,350 --> 00:08:06,321 WOULD BE DEVELOPED PERIODICALLY 260 00:08:06,321 --> 00:08:07,522 BY GOING OUT AND ACTUALLY 261 00:08:07,522 --> 00:08:08,523 ENGAGING WITH THE CANCER 262 00:08:08,523 --> 00:08:09,157 RESEARCH COMMUNITY. 263 00:08:09,157 --> 00:08:10,826 AND THE WAY WE DID THAT WAS TO 264 00:08:10,826 --> 00:08:12,761 RUN A SERIES OF SMALL WORKSHOPS 265 00:08:12,761 --> 00:08:14,863 WITH MANY DIFFERENT RESEARCHERS 266 00:08:14,863 --> 00:08:16,398 IN THE EXTRAMURAL COMMUNITY, AND 267 00:08:16,398 --> 00:08:17,799 THEN AFTER A SERIES OF THOSE 268 00:08:17,799 --> 00:08:20,769 WORKSHOPS HAD BEEN HELD, SOME OF 269 00:08:20,769 --> 00:08:22,170 THE MOST INTERESTING IDEAS THAT 270 00:08:22,170 --> 00:08:23,939 EMERGED FROM THOSE GROUPS WOULD 271 00:08:23,939 --> 00:08:25,140 THEN BE ADVERTISED THROUGH 272 00:08:25,140 --> 00:08:26,408 FUNDING ANNOUNCEMENTS AND THEN 273 00:08:26,408 --> 00:08:29,845 WE WOULD SUPPORT R01 AND 274 00:08:29,845 --> 00:08:31,279 R21 AWARDS DO SOME RESEARCH IN 275 00:08:31,279 --> 00:08:32,147 THOSE AREAS. 276 00:08:32,147 --> 00:08:34,016 SO THESE AWARDS WERE IN THE 277 00:08:34,016 --> 00:08:38,153 RANGE OF ABOUT 300 TO $500,000 278 00:08:38,153 --> 00:08:39,354 EACH. 279 00:08:39,354 --> 00:08:40,789 THE PROJECTS WERE USUALLY, NOT 280 00:08:40,789 --> 00:08:42,658 ALWAYS, BUT USUALLY LED BY A 281 00:08:42,658 --> 00:08:45,160 SINGLE INVESTIGATOR, AND FOR 282 00:08:45,160 --> 00:08:47,029 ABOUT 10 YEARS OR SO, NCI 283 00:08:47,029 --> 00:08:49,197 SUPPORTED IN THE RANGE OF ABOUT 284 00:08:49,197 --> 00:08:51,733 35 TO 50 OF THESE AWARDS PER 285 00:08:51,733 --> 00:08:52,934 YEAR TO GO AFTER SOME OF THESE 286 00:08:52,934 --> 00:08:58,407 INTERESTING QUESTIONS. 287 00:08:58,407 --> 00:09:01,243 SO AROUND 2015, OUR FRIENDS AT 288 00:09:01,243 --> 00:09:05,313 CANCER RESEARCH UK STARTED 289 00:09:05,313 --> 00:09:07,049 THINKING ABOUT A SLIGHT 290 00:09:07,049 --> 00:09:08,450 VARIATION ON THIS FUNDING 291 00:09:08,450 --> 00:09:09,551 APPROACH, AND THEY ACTUALLY 292 00:09:09,551 --> 00:09:10,652 LAUNCHED AN INITIATIVE CALLED 293 00:09:10,652 --> 00:09:13,388 THE CRUK GRAND CHALLENGE. 294 00:09:13,388 --> 00:09:15,590 SO THE STRATEGY BEHIND THIS 295 00:09:15,590 --> 00:09:18,627 PROGRAM WAS TO COMBINE THIS 296 00:09:18,627 --> 00:09:22,030 COMMUNITY ENGAGEMENT AND PROBLEM 297 00:09:22,030 --> 00:09:24,633 DEVELOPMENT PROCESS OF THE 298 00:09:24,633 --> 00:09:26,068 PROVOCATIVE QUESTIONS INITIATIVE 299 00:09:26,068 --> 00:09:27,369 WITH A TEAM SCIENCE-BASED 300 00:09:27,369 --> 00:09:28,603 APPROACH IN WHICH THEY WERE 301 00:09:28,603 --> 00:09:31,339 PROPOSING TO GO AFTER PROBLEMS 302 00:09:31,339 --> 00:09:32,941 THAT WERE POTENTIALLY MUCH, MUCH 303 00:09:32,941 --> 00:09:33,942 BIGGER THAN THE ONES THAT COULD 304 00:09:33,942 --> 00:09:36,011 BE TACKLED BY INDIVIDUAL 305 00:09:36,011 --> 00:09:37,979 INVESTIGATORS. 306 00:09:37,979 --> 00:09:39,848 SO JUST TO KIND OF GIVE YOU A 307 00:09:39,848 --> 00:09:43,251 SENSE OF SCALE FOR THAT, THESE 308 00:09:43,251 --> 00:09:44,653 AWARDS WERE IN THE RANGE OF 309 00:09:44,653 --> 00:09:47,189 ABOUT 16 TO 20 MILLION POUNDS, 310 00:09:47,189 --> 00:09:48,490 WHICH IN U.S. CURRENCY IS KIND 311 00:09:48,490 --> 00:09:52,427 OF IN THE RANGE OF ABOUT 20 TO 312 00:09:52,427 --> 00:09:53,628 $25 MILLION, AND THESE TEAMS 313 00:09:53,628 --> 00:09:55,931 THAT CRUK WAS FUNDING WERE 314 00:09:55,931 --> 00:09:58,266 ANYWHERE FROM 10 TO 15 315 00:09:58,266 --> 00:09:59,201 INVESTIGATORS AT DIFFERENT 316 00:09:59,201 --> 00:10:01,403 INSTITUTIONS AROUND THE WORLD, 317 00:10:01,403 --> 00:10:05,874 AND BETWEEN 2017 AND 2019, CRUK 318 00:10:05,874 --> 00:10:07,542 FUNDED SEVEN OF THESE PROJECT 319 00:10:07,542 --> 00:10:09,811 TEAMS TO START ADDRESSING SOME 320 00:10:09,811 --> 00:10:11,680 MUCH BIGGER CHALLENGES IN CANCER 321 00:10:11,680 --> 00:10:13,982 RESEARCH. 322 00:10:13,982 --> 00:10:16,818 SO AS IT TURNED OUT, NCI HAD 323 00:10:16,818 --> 00:10:18,687 ALSO SORT OF BEEN THINKING ABOUT 324 00:10:18,687 --> 00:10:22,057 DOING SOMETHING SIMILAR, AND 325 00:10:22,057 --> 00:10:24,359 AROUND 2019, NCI AND CRUK SAT 326 00:10:24,359 --> 00:10:26,328 DOWN AND STARTED THINKING ABOUT 327 00:10:26,328 --> 00:10:27,429 THE POSSIBILITY OF WHETHER WE 328 00:10:27,429 --> 00:10:30,265 COULD ACTUALLY PARTNER TO RUN A 329 00:10:30,265 --> 00:10:32,334 JOINT GRAND CHALLENGE INITIATIVE 330 00:10:32,334 --> 00:10:34,002 TOGETHER, AND AS IT TURNS OUT, 331 00:10:34,002 --> 00:10:42,744 THAT'S EXACTLY WHAT WE DID. 332 00:10:42,744 --> 00:10:44,479 SO IN 2020, NCI AND CRUK 333 00:10:44,479 --> 00:10:48,617 PARTNERED TO EXPAND CRUK'S GRAND 334 00:10:48,617 --> 00:10:50,285 CHALLENGE INITIATIVE, AND TO 335 00:10:50,285 --> 00:10:51,586 DEVELOP THAT INTO A 336 00:10:51,586 --> 00:10:54,322 COLLABORATIVE FUNDING INITIATIVE 337 00:10:54,322 --> 00:10:56,324 THAT WE'VE SINCE REBRANDED AS 338 00:10:56,324 --> 00:10:57,292 CANCER GRAND CHALLENGES. 339 00:10:57,292 --> 00:10:58,927 SO THE GOAL OF THIS PROGRAM, 340 00:10:58,927 --> 00:11:01,429 AGAIN, IS TO SET VERY AMBITIOUS 341 00:11:01,429 --> 00:11:04,199 CHALLENGES IN CANCER RESEARCH, 342 00:11:04,199 --> 00:11:05,600 AND THEN PROVIDE LARGE AWARDS, 343 00:11:05,600 --> 00:11:07,569 UP TO $5 MILLION PER YEAR OVER 344 00:11:07,569 --> 00:11:10,639 FIVE YEARS, SO 25 MILLION TOTAL, 345 00:11:10,639 --> 00:11:13,942 IN ORDER TO SUPPORT 346 00:11:13,942 --> 00:11:14,776 MULTI-NATIONAL TEAMS TO ADDRESS 347 00:11:14,776 --> 00:11:18,280 THOSE CHALLENGES. 348 00:11:18,280 --> 00:11:21,483 SO THE INITIATIVE IS GUIDED BY 349 00:11:21,483 --> 00:11:23,318 AN INTERNATIONAL SCIENTIFIC 350 00:11:23,318 --> 00:11:25,053 COMMITTEE, WHICH WE RELY ON TO 351 00:11:25,053 --> 00:11:27,155 PROVIDE US ADVICE ON NOT ONLY 352 00:11:27,155 --> 00:11:29,658 THE CHALLENGES THAT WE SELECT, 353 00:11:29,658 --> 00:11:31,660 BUT ALSO THE TEAMS THAT WE FUND, 354 00:11:31,660 --> 00:11:34,462 AND WHICH WE INCORPORATE INPUTS 355 00:11:34,462 --> 00:11:36,231 FROM THE GLOBAL RESEARCH 356 00:11:36,231 --> 00:11:37,966 COMMUNITY TO ACTUALLY DEVELOP 357 00:11:37,966 --> 00:11:40,068 THOSE CHALLENGE IDEAS, AS WELL 358 00:11:40,068 --> 00:11:41,703 AS INPUTS FROM PEOPLE WHO ARE 359 00:11:41,703 --> 00:11:45,574 AFFECTED BY CANCER. 360 00:11:45,574 --> 00:11:47,175 SO FOR THE FIRST PHASE OF THE 361 00:11:47,175 --> 00:11:49,244 PARTNERSHIP, NCI AND CRUK AGREED 362 00:11:49,244 --> 00:11:50,612 TO CO-FUND THREE ROUNDS OF 363 00:11:50,612 --> 00:11:53,181 AWARDS WITH UP TO FOUR AWARDS 364 00:11:53,181 --> 00:11:56,318 PER ROUND, AND WE DO THAT -- THE 365 00:11:56,318 --> 00:11:58,887 NEW AWARDS, APPROXIMATELY EVERY 366 00:11:58,887 --> 00:12:03,792 TWO YEARS. 367 00:12:03,792 --> 00:12:06,328 SO WHAT EXACTLY DO WE MEAN WHEN 368 00:12:06,328 --> 00:12:08,396 WE SAY CANCER GRAND CHALLENGE? 369 00:12:08,396 --> 00:12:10,599 AND HOW ARE THESE PROBLEMS SORT 370 00:12:10,599 --> 00:12:12,567 OF DIFFERENT FROM THE OTHER 371 00:12:12,567 --> 00:12:14,870 RESEARCH THAT BOTH NCI AND CRUK 372 00:12:14,870 --> 00:12:18,139 FUND? 373 00:12:18,139 --> 00:12:20,208 SO TO BE FAIR, SOME OF THE 374 00:12:20,208 --> 00:12:21,943 CRITERIA DO OVERLAP WITH SOME OF 375 00:12:21,943 --> 00:12:23,511 OUR OTHER PROGRAMS, BUT SOME OF 376 00:12:23,511 --> 00:12:24,980 THESE ARE INTENTIONALLY UNIQUE 377 00:12:24,980 --> 00:12:26,781 JUST FOR THIS PROGRAM. 378 00:12:26,781 --> 00:12:28,083 SO FIRST AND FOREMOST, WE'RE 379 00:12:28,083 --> 00:12:31,253 INTERESTED IN ADDRESSING VERY 380 00:12:31,253 --> 00:12:32,487 IMPORTANT AND COMPLEX PROBLEMS 381 00:12:32,487 --> 00:12:35,423 IN CANCER RESEARCH, WHICH IF 382 00:12:35,423 --> 00:12:38,159 THEY WERE TO BE SOLVED, WOULD 383 00:12:38,159 --> 00:12:39,361 HAVE SIGNIFICANT BENEFIT FOR 384 00:12:39,361 --> 00:12:39,961 CANCER PATIENTS. 385 00:12:39,961 --> 00:12:41,529 SO THESE CAN BE PROBLEMS THAT 386 00:12:41,529 --> 00:12:43,632 ARE RELATED TO EITHER 387 00:12:43,632 --> 00:12:45,700 UNDERSTANDING, PREVENTING, 388 00:12:45,700 --> 00:12:48,336 DETECTING OR TREATING CANCER, 389 00:12:48,336 --> 00:12:50,505 AND THE WAY THE TEAMS GO AFTER 390 00:12:50,505 --> 00:12:51,706 THESE PROBLEMS CAN BE THROUGH A 391 00:12:51,706 --> 00:12:53,241 VARIETY OF APPROACHES, WHETHER 392 00:12:53,241 --> 00:12:55,543 THAT'S BASIC RESEARCH, 393 00:12:55,543 --> 00:12:57,078 TRANSLATIONAL CLINICAL OR 394 00:12:57,078 --> 00:12:58,914 POPULATION RESEARCH. 395 00:12:58,914 --> 00:13:01,549 SO WE INTENTIONALLY CAST A VERY 396 00:13:01,549 --> 00:13:02,884 BROAD NET IN TERMS OF THE TYPES 397 00:13:02,884 --> 00:13:06,688 OF RESEARCH THAT WE COULD FUND. 398 00:13:06,688 --> 00:13:09,090 CHALLENGES COULD BE NEW PROBLEMS 399 00:13:09,090 --> 00:13:11,960 THAT HAVE EMERGED FAIRLY 400 00:13:11,960 --> 00:13:14,195 RECENTLY FROM RECENT RESEARCH, 401 00:13:14,195 --> 00:13:16,097 OR IN SOME CASES THEY CAN 402 00:13:16,097 --> 00:13:17,432 ACTUALLY BE PERSISTENT PROBLEMS 403 00:13:17,432 --> 00:13:18,934 THAT HAVE EXISTED FOR MANY 404 00:13:18,934 --> 00:13:20,135 DECADES. 405 00:13:20,135 --> 00:13:22,237 BUT IN ALL CASES, WHAT WE'RE 406 00:13:22,237 --> 00:13:24,239 REALLY LOOKING FOR ARE PROBLEMS 407 00:13:24,239 --> 00:13:27,142 THAT ARE OF SUFFICIENT SCALE AND 408 00:13:27,142 --> 00:13:30,979 SCOPE THAT THEY REALLY DEMAND 409 00:13:30,979 --> 00:13:32,080 INTELLECTUAL INPUTS FROM 410 00:13:32,080 --> 00:13:33,982 MULTIPLE INVESTIGATORS. 411 00:13:33,982 --> 00:13:35,050 WE'RE REALLY LOOKING FOR THINGS 412 00:13:35,050 --> 00:13:37,085 THAT CAN ONLY BE TACKLED BY 413 00:13:37,085 --> 00:13:38,353 INTERNATIONAL MULTIDISCIPLINARY 414 00:13:38,353 --> 00:13:40,388 TEAMS. 415 00:13:40,388 --> 00:13:41,723 ALSO A VERY IMPORTANT CRITERION 416 00:13:41,723 --> 00:13:43,358 FOR THE THINGS WE SELECT IS THAT 417 00:13:43,358 --> 00:13:44,592 WE'RE REALLY LOOKING FOR 418 00:13:44,592 --> 00:13:47,262 PROBLEMS THAT ARE TIMELY. 419 00:13:47,262 --> 00:13:48,363 ESPECIALLY IN AREAS THAT WE 420 00:13:48,363 --> 00:13:51,633 THINK RESEARCHERS ARE POISED TO 421 00:13:51,633 --> 00:13:52,534 MAKE SIGNIFICANT PROBLEM IN THE 422 00:13:52,534 --> 00:13:54,302 NEAR TERM. 423 00:13:54,302 --> 00:13:55,704 AND IF YOU HAVE AN INTEREST IN 424 00:13:55,704 --> 00:13:57,672 LOOKING AT WHAT SOME OF ALL THE 425 00:13:57,672 --> 00:13:59,441 OTHER CHALLENGES HAVE BEEN IN 426 00:13:59,441 --> 00:14:01,076 PRIOR ROUNDS, YOU CAN GO TO THIS 427 00:14:01,076 --> 00:14:02,143 LINK ON THE SLIDE TO READ A 428 00:14:02,143 --> 00:14:03,345 LITTLE BIT MORE ABOUT PREVIOUS 429 00:14:03,345 --> 00:14:10,352 CHALLENGES. 430 00:14:10,352 --> 00:14:13,855 SO WE ACTUALLY FUNDED OUR FIRST 431 00:14:13,855 --> 00:14:15,290 AWARDS WAY BACK IN 2022, AND IN 432 00:14:15,290 --> 00:14:18,059 THE INTEREST OF TIME TODAY, I'M 433 00:14:18,059 --> 00:14:19,094 NOT GOING TO GO THROUGH ALL OF 434 00:14:19,094 --> 00:14:20,628 THESE BUT I JUST WANTED TO 435 00:14:20,628 --> 00:14:22,163 HIGHLIGHT A COUPLE TO GIVE YOU 436 00:14:22,163 --> 00:14:24,366 KIND OF A FLAVOR OF SOME OF THE 437 00:14:24,366 --> 00:14:26,968 KIND OF WORK THAT'S BEING DONE. 438 00:14:26,968 --> 00:14:29,704 THE FIRST ONE I'LL MENTION IS A 439 00:14:29,704 --> 00:14:32,307 PROJECT FROM TEAM EDYNAMIC, 440 00:14:32,307 --> 00:14:34,743 WHICH IS LED BY AN INVESTIGATOR 441 00:14:34,743 --> 00:14:37,946 NAMED PAUL MISCHEL WHO'S AT 442 00:14:37,946 --> 00:14:38,246 STANFORD. 443 00:14:38,246 --> 00:14:39,981 IN THIS PROJECT, THE TEAM IS 444 00:14:39,981 --> 00:14:41,950 STUDYING HOW SMALL CIRCULAR 445 00:14:41,950 --> 00:14:44,352 PIECES OF DNA, WHICH ARE CALLED 446 00:14:44,352 --> 00:14:47,655 EXTRA CHROMOSOMAL DNAs, OR 447 00:14:47,655 --> 00:14:49,190 ECDNAs FOR SHORT, ARE FORMED 448 00:14:49,190 --> 00:14:50,725 IN CANCER CELLS. 449 00:14:50,725 --> 00:14:53,361 SO THIS IS AN INTERESTING AREA. 450 00:14:53,361 --> 00:14:55,830 WE'VE KNOWN ABOUT THESE SMALL 451 00:14:55,830 --> 00:15:00,235 DNAs LITERALLY FOR DECADES, 452 00:15:00,235 --> 00:15:01,703 BUT ONLY RECENTLY WE'VE COME TO 453 00:15:01,703 --> 00:15:02,637 UNDERSTAND THAT THESE ARE 454 00:15:02,637 --> 00:15:05,040 ASSOCIATED WITH VERY AGGRESSIVE 455 00:15:05,040 --> 00:15:06,474 CANCERS AND APPEAR TO PLAY A 456 00:15:06,474 --> 00:15:09,544 VERY IMPORTANT ROLE IN CANCER 457 00:15:09,544 --> 00:15:10,545 PROGRESSION. 458 00:15:10,545 --> 00:15:12,614 SO THIS TEAM IS LOOKING TO 459 00:15:12,614 --> 00:15:14,883 UNDERSTAND HOW THESE ECDNAs 460 00:15:14,883 --> 00:15:16,418 ARE ABLE TO FORM IN CANCER AND 461 00:15:16,418 --> 00:15:18,920 HOW THEY DRIVE CANCER, WHICH WE 462 00:15:18,920 --> 00:15:20,588 BELIEVE IS GOING TO HAVE THE 463 00:15:20,588 --> 00:15:23,525 POTENTIAL TO INFORM SOME NEW 464 00:15:23,525 --> 00:15:24,826 TREATMENT STRATEGIES THAT WILL 465 00:15:24,826 --> 00:15:26,795 ACTUALLY BE APPLICABLE ACROSS A 466 00:15:26,795 --> 00:15:27,662 VARIETY OF DIFFERENT CANCER 467 00:15:27,662 --> 00:15:29,564 TYPES. 468 00:15:29,564 --> 00:15:31,066 THE OTHER PROJECT I'LL QUICKLY 469 00:15:31,066 --> 00:15:36,004 MENTION FROM THIS ROUND IS TEAM 470 00:15:36,004 --> 00:15:37,872 CANCAN, WHICH IS FOCUSED ON 471 00:15:37,872 --> 00:15:38,940 STUDYING CANCER CACHEXIA. 472 00:15:38,940 --> 00:15:42,544 AS MANY OF YOU WILL KNOW, CANCER 473 00:15:42,544 --> 00:15:44,112 CACHEXIA INVOLVES A DECLINE IN 474 00:15:44,112 --> 00:15:45,080 MUSCLE MASS AND PROGRESS YOU 475 00:15:45,080 --> 00:15:47,082 HAVE FUNCTIONAL IMPAIRMENT IN 476 00:15:47,082 --> 00:15:49,217 CANCER PATIENTS, SO THIS TEAM IS 477 00:15:49,217 --> 00:15:53,555 WORKING TO IDENTIFY SPECIFIC 478 00:15:53,555 --> 00:15:55,657 CLINICAL SUBTYPES OF CANCER 479 00:15:55,657 --> 00:15:57,826 CACHEXIA IN WHICH THEY'LL USE 480 00:15:57,826 --> 00:15:59,260 THAT INFORMATION TO DEVELOP NEW 481 00:15:59,260 --> 00:16:00,528 TREATMENTS FOR CACHEXIA THAT WE 482 00:16:00,528 --> 00:16:02,130 HOPE WILL BE BETTER TAILORED TO 483 00:16:02,130 --> 00:16:04,632 IMPROVE QUALITY OF LIFE AND LIFE 484 00:16:04,632 --> 00:16:07,035 EXPECTANCY, IN PARTICULAR CANCER 485 00:16:07,035 --> 00:16:10,939 TYPES AND INDIVIDUAL PATIENTS. 486 00:16:10,939 --> 00:16:11,806 SO I SHOULD MENTION THAT ALL OF 487 00:16:11,806 --> 00:16:14,542 THESE PROJECTS INVOLVE UPWARDS 488 00:16:14,542 --> 00:16:17,412 OF 10 TO 15 INVESTIGATORS AT 489 00:16:17,412 --> 00:16:19,047 VARIOUS INSTITUTIONS AROUND THE 490 00:16:19,047 --> 00:16:19,481 WORLD. 491 00:16:19,481 --> 00:16:21,182 THE PICTURES THAT ARE SHOWN HERE 492 00:16:21,182 --> 00:16:24,385 ARE OF THE TEAM LEADS THAT ARE 493 00:16:24,385 --> 00:16:26,254 RESPONSIBLE FOR LEADING EACH OF 494 00:16:26,254 --> 00:16:34,562 THESE INDIVIDUAL PROJECTS. 495 00:16:34,562 --> 00:16:36,331 SO I DO HOPE YOU HAD A CHANCE TO 496 00:16:36,331 --> 00:16:41,136 GLANCE, AT LOWE'S, AT LEASE, ATE 497 00:16:41,136 --> 00:16:43,338 PRE-READ MATERIAL FOR TODAY IF 498 00:16:43,338 --> 00:16:44,205 NOT READ IT CAREFULLY. 499 00:16:44,205 --> 00:16:45,240 THESE WERE THE TEAMS MENTIONED 500 00:16:45,240 --> 00:16:45,840 IN THAT ARTICLE. 501 00:16:45,840 --> 00:16:46,708 AGAIN IN THE INTEREST OF TIME, I 502 00:16:46,708 --> 00:16:47,909 WON'T GO THROUGH ALL OF THEM BUT 503 00:16:47,909 --> 00:16:51,679 I'LL JUST HIGHLIGHT A COUPLE. 504 00:16:51,679 --> 00:16:53,414 SO TEAM PROSPECT IS WORKING ON 505 00:16:53,414 --> 00:16:57,018 AN EXCITING PROJECT FOCUSED ON 506 00:16:57,018 --> 00:16:58,319 DETERMINING WHY THE INCIDENCE OF 507 00:16:58,319 --> 00:17:00,622 EARLY ONSET CANCERS IS RISING 508 00:17:00,622 --> 00:17:03,458 GLOBALLY. 509 00:17:03,458 --> 00:17:05,426 WHICH SOMEWHAT ALARMINGLY IS A 510 00:17:05,426 --> 00:17:06,861 PHENOMENON THAT'S HAPPENING FOR 511 00:17:06,861 --> 00:17:08,062 MULTIPLE DIFFERENT CANCER TYPES 512 00:17:08,062 --> 00:17:10,698 AND WE DON'T KNOW WHY. 513 00:17:10,698 --> 00:17:14,869 THIS PROJECT IS FOCUSED ON ONE 514 00:17:14,869 --> 00:17:16,271 OF THE MOST NOTABLE EXAMPLES OF 515 00:17:16,271 --> 00:17:18,006 THAT, WHICH IS EARLY ONSET 516 00:17:18,006 --> 00:17:19,774 COLORECTAL CANCER, AND IN THIS 517 00:17:19,774 --> 00:17:22,777 PROJECT, THEY'RE ATTEMPTING TO 518 00:17:22,777 --> 00:17:23,478 CHARACTERIZE THE MOLECULAR 519 00:17:23,478 --> 00:17:25,780 CHANGES THAT ARISE IN AN 520 00:17:25,780 --> 00:17:27,515 INDIVIDUAL DUE TO ALL THE 521 00:17:27,515 --> 00:17:29,184 VARIOUS ENVIRONMENTAL EXPOSURES 522 00:17:29,184 --> 00:17:32,453 ACROSS THAT INDIVIDUAL'S 523 00:17:32,453 --> 00:17:33,755 LIFETIME, AND HOW THOSE 524 00:17:33,755 --> 00:17:35,523 EXPOSURES, WE THINK, MAY BE 525 00:17:35,523 --> 00:17:36,624 ASSOCIATED WITH EARLY ONSET 526 00:17:36,624 --> 00:17:37,825 CANCER. 527 00:17:37,825 --> 00:17:39,460 THE OTHER ONE I'LL MENTION 528 00:17:39,460 --> 00:17:44,432 QUICKLY IS TEAM SAMBAI, LED BY 529 00:17:44,432 --> 00:17:46,334 MELISSA DAVIS AT THE MOREHOUSE 530 00:17:46,334 --> 00:17:46,768 SCHOOL OF MEDICINE. 531 00:17:46,768 --> 00:17:48,303 THIS TEAM IS ADDRESSING THE 532 00:17:48,303 --> 00:17:49,537 CHALLENGE ON UNDERSTANDING THE 533 00:17:49,537 --> 00:17:50,505 MECHANISMS THROUGH WHICH 534 00:17:50,505 --> 00:17:53,341 GENETICS, BIOLOGY AND SOCIAL 535 00:17:53,341 --> 00:17:55,977 DETERMINANTS AFFECT OUTCOMES IN 536 00:17:55,977 --> 00:17:56,911 DIVERSE POPULATIONS. 537 00:17:56,911 --> 00:17:57,946 SO THE APPROACH THEY'RE TAKING 538 00:17:57,946 --> 00:18:00,014 IN THIS PROJECT IS TO STUDY A 539 00:18:00,014 --> 00:18:03,184 VERY LARGE COHORT OF MORE THAN 540 00:18:03,184 --> 00:18:04,719 40,000 PATIENTS WITH PROSTATE, 541 00:18:04,719 --> 00:18:08,122 BREAST AND PANCREATIC CANCER, IN 542 00:18:08,122 --> 00:18:10,191 WHICH THEY'LL BE STUDYING NOT 543 00:18:10,191 --> 00:18:12,360 ONLY AFRICAN AMERICAN AND BLACK 544 00:18:12,360 --> 00:18:14,028 BRITISH POPULATIONS, BUT ALSO 545 00:18:14,028 --> 00:18:15,530 PARTICIPANTS FROM SIX OTHER 546 00:18:15,530 --> 00:18:18,833 AFRICAN COUNTRIES, IN WHICH THE 547 00:18:18,833 --> 00:18:19,934 OVERARCHING GOAL HERE IS TO 548 00:18:19,934 --> 00:18:28,109 START TO DECOU DEACON VO DECONVN 549 00:18:28,109 --> 00:18:29,777 START TO DEFINE THE UNDERLYING 550 00:18:29,777 --> 00:18:30,979 CAUSES OF DISPARATE HEALTH 551 00:18:30,979 --> 00:18:32,714 OUTCOMES IN THESE VARIOUS 552 00:18:32,714 --> 00:18:40,588 UNDERSERVED POPULATIONS. 553 00:18:40,588 --> 00:18:42,357 SO A MOMENT AGO, I MENTIONED TO 554 00:18:42,357 --> 00:18:45,526 YOU THAT NCI AND CRUK AGREED TO 555 00:18:45,526 --> 00:18:47,795 CO-FUND FOUR TEAMS PER ROUND, 556 00:18:47,795 --> 00:18:49,130 BUT WE'RE VERY EXCITED THAT WE 557 00:18:49,130 --> 00:18:50,665 ACTUALLY HAVE A FIFTH TEAM IN 558 00:18:50,665 --> 00:18:54,469 THIS ROUND WHICH IS SHOWN HERE, 559 00:18:54,469 --> 00:18:55,903 AND THIS TEAM WILL ACTUALLY BE 560 00:18:55,903 --> 00:18:59,507 FULLY FUNDED BY CRUK. 561 00:18:59,507 --> 00:19:02,243 SO AS A PRIVATE CHARITY, CRUK 562 00:19:02,243 --> 00:19:03,678 RELIES ON FUNDING SUPPORT FROM 563 00:19:03,678 --> 00:19:05,413 OTHER DONORS AND PARTNERS, SOME 564 00:19:05,413 --> 00:19:07,815 OF WHOM ARE SHOWN HERE ON THE 565 00:19:07,815 --> 00:19:09,017 SLIDE, AND SOME OF THESE 566 00:19:09,017 --> 00:19:11,786 PARTNERS HAVE ACTUALLY RALLIED 567 00:19:11,786 --> 00:19:12,987 SPECIFICALLY AROUND THE CANCER 568 00:19:12,987 --> 00:19:15,056 GRAND CHALLENGE INITIATIVE, 569 00:19:15,056 --> 00:19:17,692 WHICH IS ALLOWING CRUK THAT 570 00:19:17,692 --> 00:19:21,663 ADDITIONAL FUNDING SUPPORT TO 571 00:19:21,663 --> 00:19:22,430 FUND THIS TEAM. 572 00:19:22,430 --> 00:19:26,801 SO I SHOULD EMPHASIZE HERE THAT 573 00:19:26,801 --> 00:19:28,569 AS A U.S. FEDERAL AGENCY, NCI 574 00:19:28,569 --> 00:19:30,204 DOES NOT PARTICIPATE IN 575 00:19:30,204 --> 00:19:30,805 FUNDRAISING EFFORTS, ALTHOUGH 576 00:19:30,805 --> 00:19:36,344 THIS TEAM THAT WILL BE FUNDED BY 577 00:19:36,344 --> 00:19:37,545 CRUK IS STILL VERY MUCH 578 00:19:37,545 --> 00:19:40,481 CONSIDERED TO BE PART OF THE 579 00:19:40,481 --> 00:19:42,550 OVERALL GRAND CANCER CHALLENGE 580 00:19:42,550 --> 00:19:44,652 INITIATIVE AND WE'LL BE CLOSELY 581 00:19:44,652 --> 00:19:45,853 TRACKING THEIR RESEARCH 582 00:19:45,853 --> 00:19:46,921 DISCOVERIES SO WE CAN FOLD THAT 583 00:19:46,921 --> 00:19:48,056 INTO OUR GREATER UNDERSTANDING 584 00:19:48,056 --> 00:19:48,923 IN THIS PARTICULAR CHALLENGE 585 00:19:48,923 --> 00:19:55,029 AREA. 586 00:19:55,029 --> 00:19:57,131 THIS TEAM IS ADDRESSING A 587 00:19:57,131 --> 00:19:59,734 CHALLENGE ON DEVELOPING NEW 588 00:19:59,734 --> 00:20:02,036 THERAPIES PARTICULARLY TARGETING 589 00:20:02,036 --> 00:20:03,671 PEDIATRIC SOLID TUMORS USING 590 00:20:03,671 --> 00:20:07,408 DRUGS CALLED PROTACs, 591 00:20:07,408 --> 00:20:09,043 SPECIFICALLY DESIGNED TO TARGET 592 00:20:09,043 --> 00:20:10,211 AND ELIMINATE PROTEINS THAT 593 00:20:10,211 --> 00:20:19,787 DRIVE SOLID TUMORS IN CHILDREN. 594 00:20:19,787 --> 00:20:21,789 SO IN THE LAST COUPLE OF SLIDES 595 00:20:21,789 --> 00:20:23,091 AND FEW MINUTES, I WANT TO SAY 596 00:20:23,091 --> 00:20:25,927 JUST A FEW WORDS ABOUT HOW WE 597 00:20:25,927 --> 00:20:28,896 INVOLVE PATIENT ADVOCATES IN 598 00:20:28,896 --> 00:20:31,399 CANCER GRAND CHALLENGES, WHICH I 599 00:20:31,399 --> 00:20:32,600 SUSPECT IS OF PARTICULAR 600 00:20:32,600 --> 00:20:36,437 INTEREST TO THIS GROUP. 601 00:20:36,437 --> 00:20:37,038 SO ONE OF THE REQUIREMENTS IN 602 00:20:37,038 --> 00:20:39,707 ORDER TO RECEIVE FUNDING UNDER 603 00:20:39,707 --> 00:20:40,875 THIS PROGRAM IS THAT THE 604 00:20:40,875 --> 00:20:42,443 RESEARCH TEAMS MUST INVOLVE 605 00:20:42,443 --> 00:20:43,544 PATIENT ADVOCATES IN THEIR 606 00:20:43,544 --> 00:20:45,513 RESEARCH. 607 00:20:45,513 --> 00:20:46,681 AND IN FACT, WE SAY THAT THEY'RE 608 00:20:46,681 --> 00:20:48,683 REQUIRED TO RECRUIT AT LEAST ONE 609 00:20:48,683 --> 00:20:51,285 PATIENT ADVOCATE WITH A CLEARLY 610 00:20:51,285 --> 00:20:55,123 TEE FIDEFINED ROLE, ALTHOUGH INT 611 00:20:55,123 --> 00:20:56,124 YEARS, ALL OF THE TEAMS HAVE 612 00:20:56,124 --> 00:20:58,926 COME BACK TO US PROPOSING TO 613 00:20:58,926 --> 00:21:00,161 INVOLVE MULTIPLE PATIENT 614 00:21:00,161 --> 00:21:01,696 ADVOCATES, SOME OF WHOM ARE 615 00:21:01,696 --> 00:21:06,067 SHOWN HERE ON THE SLIDE. 616 00:21:06,067 --> 00:21:07,435 SO IN THE GUIDANCE THAT WE 617 00:21:07,435 --> 00:21:08,369 PROVIDE TO THE TEAMS, WE ASK 618 00:21:08,369 --> 00:21:10,438 THAT THE ADVOCATES SHOULD 619 00:21:10,438 --> 00:21:11,539 REPRESENT PEOPLE AFFECTED BY 620 00:21:11,539 --> 00:21:13,474 CANCER AS A GROUP AND NOT JUST 621 00:21:13,474 --> 00:21:15,676 PROVIDE THEIR INDIVIDUAL 622 00:21:15,676 --> 00:21:17,545 VIEWPOINTS OR THAT OF A 623 00:21:17,545 --> 00:21:18,746 PARTICULAR ADVOCACY 624 00:21:18,746 --> 00:21:20,181 ORGANIZATION, AND I AM SURE THE 625 00:21:20,181 --> 00:21:22,583 FOLKS ON THE CALL APPRECIATE 626 00:21:22,583 --> 00:21:24,085 SOME OF THE CHALLENGES AND 627 00:21:24,085 --> 00:21:25,319 OPPORTUNITIES IN DOING THAT MUCH 628 00:21:25,319 --> 00:21:26,954 BETTER THAN I DO. 629 00:21:26,954 --> 00:21:28,222 SOME OF THE OTHER GUIDANCE THAT 630 00:21:28,222 --> 00:21:31,759 WE PROVIDE IS THAT THE RESEARCH 631 00:21:31,759 --> 00:21:32,760 TEAMS SHOULD COLLABORATE VERY 632 00:21:32,760 --> 00:21:34,295 CLOSELY WITH THEIR ADVOCATES 633 00:21:34,295 --> 00:21:37,799 THROUGHOUT THE PROJECT IN SUCH A 634 00:21:37,799 --> 00:21:39,534 WAY THAT THAT INTERACTION REALLY 635 00:21:39,534 --> 00:21:40,535 ADDS VALUE TO THE PROJECT AND 636 00:21:40,535 --> 00:21:42,170 HELPS TO ADVANCE PROGRESS 637 00:21:42,170 --> 00:21:50,044 TOWARDS SOLVING THE CHALLENGE. 638 00:21:50,044 --> 00:21:51,245 SO JUST TO GET MAYBE A LITTLE 639 00:21:51,245 --> 00:21:52,346 BIT MORE ON THE WEEDS THERE IN 640 00:21:52,346 --> 00:21:54,749 TERMS OF WHAT THAT COULD LOOK 641 00:21:54,749 --> 00:21:56,384 LIKE, WE'VE ACTUALLY WORKED 642 00:21:56,384 --> 00:21:59,320 CLOSELY HERE AT THE NCI WITH OUR 643 00:21:59,320 --> 00:22:01,756 COUNTERPARTS AT CRUK TO 644 00:22:01,756 --> 00:22:03,491 ESTABLISH SOME DEFINITIONS FOR 645 00:22:03,491 --> 00:22:07,728 PATIENT ADVOCACY ACTIVITIES 646 00:22:07,728 --> 00:22:08,963 WHICH ALLOWS THE TEAMS TO 647 00:22:08,963 --> 00:22:10,164 DESCRIBE THEIR ACTIVITIES USING 648 00:22:10,164 --> 00:22:15,636 A COMMON TERMINOLOGY. 649 00:22:15,636 --> 00:22:16,671 I REALIZE SOME OF THESE 650 00:22:16,671 --> 00:22:17,939 DEFINITIONS MAY NOT NECESSARILY 651 00:22:17,939 --> 00:22:19,006 REFLECT HOW THESE TERMS ARE 652 00:22:19,006 --> 00:22:21,642 ALWAYS USED HERE IN THE U.S. OR 653 00:22:21,642 --> 00:22:23,978 PERHAPS IN OTHER LOCALES, BUT 654 00:22:23,978 --> 00:22:27,782 THE REAL INTENT HERE WAS TO 655 00:22:27,782 --> 00:22:28,883 HOPEFULLY AGREE ON A COMMON 656 00:22:28,883 --> 00:22:30,952 LEXICON THAT WE CAN USE ACROSS 657 00:22:30,952 --> 00:22:33,454 AN INTERNATIONAL COMMUNITY OF 658 00:22:33,454 --> 00:22:34,355 RESEARCHERS AND PATIENT 659 00:22:34,355 --> 00:22:35,423 ADVOCATES SO THAT EVERYONE IS 660 00:22:35,423 --> 00:22:36,724 REALLY SPEAKING THE SAME 661 00:22:36,724 --> 00:22:37,058 LANGUAGE. 662 00:22:37,058 --> 00:22:39,494 SO FOR THE PURPOSES OF CANCER 663 00:22:39,494 --> 00:22:41,329 GRAND CHALLENGES, WE USE THIS 664 00:22:41,329 --> 00:22:44,298 TERM INVOLVEMENT TO MEAN WHEN 665 00:22:44,298 --> 00:22:45,800 PATIENT ADVOCATES USE THEIR 666 00:22:45,800 --> 00:22:47,568 EXPERIENCES WITH CANCER TO HELP 667 00:22:47,568 --> 00:22:50,538 ACTUALLY SHAPE THE RESEARCH IN 668 00:22:50,538 --> 00:22:52,173 WHICH THE ADVOCATES HAVE A VOICE 669 00:22:52,173 --> 00:22:53,908 THAT'S THEN REFLECTED IN THE 670 00:22:53,908 --> 00:22:57,578 SCIENTIFIC STRATEGY. 671 00:22:57,578 --> 00:22:58,846 WE ALSO THEN USE THE TERM 672 00:22:58,846 --> 00:23:01,015 ENGAGEMENT TO MEAN WHEN PATIENT 673 00:23:01,015 --> 00:23:02,250 ADVOCATES ARE INVOLVED IN 674 00:23:02,250 --> 00:23:02,850 SHARING INFORMATION AND 675 00:23:02,850 --> 00:23:04,519 KNOWLEDGE ABOUT THE RESEARCH, 676 00:23:04,519 --> 00:23:06,053 EITHER WITH OTHER PATIENT 677 00:23:06,053 --> 00:23:09,223 ADVOCATES OR THE GENERAL PUBLIC 678 00:23:09,223 --> 00:23:10,958 OR OTHERS WHO ARE NOT DIRECTLY 679 00:23:10,958 --> 00:23:12,593 INVOLVED OR ASSOCIATED WITH THE 680 00:23:12,593 --> 00:23:14,462 RESEARCH. 681 00:23:14,462 --> 00:23:15,997 AND THEN WE DISTINGUISH BOTH OF 682 00:23:15,997 --> 00:23:18,833 THOSE ACTIVITIES FROM PATIENT 683 00:23:18,833 --> 00:23:20,067 PARTICIPATION, IN WHICH PATIENTS 684 00:23:20,067 --> 00:23:22,003 ARE EITHER PART OF A RESEARCH 685 00:23:22,003 --> 00:23:24,005 STUDY OR A CLINICAL TRIAL, BUT 686 00:23:24,005 --> 00:23:26,073 DON'T WORK DIRECTLY WITH THE 687 00:23:26,073 --> 00:23:27,174 RESEARCHERS ON THE ACTUAL 688 00:23:27,174 --> 00:23:36,250 PROJECT. 689 00:23:36,250 --> 00:23:37,118 SO ESTABLISHING THOSE COMMON 690 00:23:37,118 --> 00:23:38,185 DEFINITIONS HAS REALLY BEEN JUST 691 00:23:38,185 --> 00:23:39,086 ONE OF THE MANY ASPECTS THAT 692 00:23:39,086 --> 00:23:42,256 WE'VE HAD TO ADDRESS AS WE'VE 693 00:23:42,256 --> 00:23:43,024 WORKED TOGETHER WITH 694 00:23:43,024 --> 00:23:46,394 INTERNATIONAL PARTNERS TO REALLY 695 00:23:46,394 --> 00:23:47,628 EMBED ADVOCACY WITHIN THE 696 00:23:47,628 --> 00:23:49,830 OVERALL CANCER GRAND CHALLENGES 697 00:23:49,830 --> 00:23:51,232 INITIATIVE. 698 00:23:51,232 --> 00:23:52,633 TO HELP US WITH THAT, WE'VE 699 00:23:52,633 --> 00:23:53,467 ESTABLISHED THE GROUP SHOWN ON 700 00:23:53,467 --> 00:23:55,503 THIS SLIDE, WHICH IS THE CANCER 701 00:23:55,503 --> 00:23:57,505 GRAND CHALLENGES ADVOCACY PANEL. 702 00:23:57,505 --> 00:24:01,175 SO THIS IS A GROUP CHAIRED BY 703 00:24:01,175 --> 00:24:04,078 MARGARET GRAYSON IN THE UK AND 704 00:24:04,078 --> 00:24:06,113 THEY'VE REALLY BEEN INSTRUMENTAL 705 00:24:06,113 --> 00:24:06,981 IN HELPING TO LEAD THIS 706 00:24:06,981 --> 00:24:09,383 IMPORTANT PART OF THE PROGRAM. 707 00:24:09,383 --> 00:24:11,953 SO AS YOU CAN SEE FROM THE FOLKS 708 00:24:11,953 --> 00:24:14,188 ON THE SLIDE, WE NOW HAVE 709 00:24:14,188 --> 00:24:15,323 MEMBERS FROM VARIOUS COUNTRIES 710 00:24:15,323 --> 00:24:17,358 FROM AROUND THE WORLD, AND WE 711 00:24:17,358 --> 00:24:21,195 REALLY DO RELY HEAVILY ON THIS 712 00:24:21,195 --> 00:24:22,530 GROUP TO HELP US IDENTIFY BOTH 713 00:24:22,530 --> 00:24:26,867 SOME OF THE CHALLENGES, BUT ALSO 714 00:24:26,867 --> 00:24:28,035 THE OPPORTUNITIES THAT WE THINK 715 00:24:28,035 --> 00:24:29,837 THERE ARE IN TERMS OF HOW WE CAN 716 00:24:29,837 --> 00:24:30,938 APPROACH INVOLVING PATIENT 717 00:24:30,938 --> 00:24:34,308 ADVOCATES IN THE PROGRAM. 718 00:24:34,308 --> 00:24:37,044 SO THEY ASSIST US IN DOING A 719 00:24:37,044 --> 00:24:40,648 NUMBER OF THINGS. 720 00:24:40,648 --> 00:24:42,083 THIS IS JUST A BRIEF LIST OF 721 00:24:42,083 --> 00:24:43,384 SOME OF THE IMPORTANT THINGS 722 00:24:43,384 --> 00:24:44,585 THEY HELP US DO. 723 00:24:44,585 --> 00:24:45,786 SO THEY ASSIST THE PROGRAM TEAM 724 00:24:45,786 --> 00:24:48,222 IN DEVELOPING STRATEGIES FOR HOW 725 00:24:48,222 --> 00:24:51,158 WE INVOLVE PATIENT ADVOCATES IN 726 00:24:51,158 --> 00:24:52,259 CGC RESEARCH. 727 00:24:52,259 --> 00:24:54,595 THEY PROVIDE IMPORTANT FEEDBACK 728 00:24:54,595 --> 00:24:56,364 ON WHAT THE TEAMS PROPOSE TO US 729 00:24:56,364 --> 00:25:00,134 IN TERMS OF THEIR APPROACHES FOR 730 00:25:00,134 --> 00:25:01,202 INVOLVEMENT ENGAGEMENT, AND IN 731 00:25:01,202 --> 00:25:02,403 THAT WAY REALLY HELP TO SHAPE 732 00:25:02,403 --> 00:25:03,504 WHAT THE TEAMS ARE ABLE TO DO 733 00:25:03,504 --> 00:25:06,007 AND HOW THEY REFINE THOSE 734 00:25:06,007 --> 00:25:09,644 APPROACHES AND THEN THEY ALSO 735 00:25:09,644 --> 00:25:11,612 ENGAGE WITH PATIENT ADVOCATES ON 736 00:25:11,612 --> 00:25:12,413 FUNDED TEAMS THROUGHOUT THE 737 00:25:12,413 --> 00:25:13,547 PROJECTS TO REALLY HELP THEM 738 00:25:13,547 --> 00:25:15,850 CONTINUE TO REFINE AND ENHANCE 739 00:25:15,850 --> 00:25:22,256 THOSE PATIENT ADVOCACY EFFORTS. 740 00:25:22,256 --> 00:25:23,691 SO I THINK THIS LAST POINT IS 741 00:25:23,691 --> 00:25:24,458 REALLY IMPORTANT BECAUSE WHAT 742 00:25:24,458 --> 00:25:25,593 WE'VE SEEN, I THINK, OVER THE 743 00:25:25,593 --> 00:25:28,729 LAST COUPLE OF YEARS IS THAT THE 744 00:25:28,729 --> 00:25:31,232 TEAMS ARE ENGAGING IN PATIENT 745 00:25:31,232 --> 00:25:32,533 ADVOCACY IN DIFFERENT WAYS IN 746 00:25:32,533 --> 00:25:33,968 WHICH THERE'S SOME REALLY -- 747 00:25:33,968 --> 00:25:35,169 SOME GREAT OPPORTUNITIES FOR THE 748 00:25:35,169 --> 00:25:38,005 TEAMS TO LEARN FROM ONE ANOTHER, 749 00:25:38,005 --> 00:25:39,140 AND I THINK ONE OF THE IMPORTANT 750 00:25:39,140 --> 00:25:41,175 ROLES THAT THIS ADVOCACY PANEL 751 00:25:41,175 --> 00:25:43,044 PLAYS IS IN HELPING TO 752 00:25:43,044 --> 00:25:44,311 FACILITATE THAT AND THE WAYS 753 00:25:44,311 --> 00:25:46,013 THAT THEY'RE ABLE TO INTERACT 754 00:25:46,013 --> 00:25:47,982 ACROSS THE VARIOUS TEAMS AND IN 755 00:25:47,982 --> 00:25:50,484 SOME CASES SHARE BEST PRACTICES 756 00:25:50,484 --> 00:25:56,590 AND BOUNCE IDEAS OFF OF THEM. 757 00:25:56,590 --> 00:25:59,493 SO I JUST WANTED, BEFORE I 758 00:25:59,493 --> 00:26:01,028 CLOSE, TO MENTION ONE EXAMPLE OF 759 00:26:01,028 --> 00:26:03,064 A PATIENT ENGAGEMENT ACTIVITY BY 760 00:26:03,064 --> 00:26:05,399 ONE OF THE TEAMS THAT WAS FUNDED 761 00:26:05,399 --> 00:26:07,601 BY CRUK BACK IN 2019. 762 00:26:07,601 --> 00:26:11,338 THIS TEAM IS CALLED TEAM 763 00:26:11,338 --> 00:26:13,374 OPTIMISTICC, AND THE ACRONYM FOR 764 00:26:13,374 --> 00:26:14,341 THEIR TEAM STANDS FOR 765 00:26:14,341 --> 00:26:15,910 OPPORTUNITY TO INVESTIGATE THE 766 00:26:15,910 --> 00:26:16,777 MICROBIOME'S IMPACT ON SCIENCE 767 00:26:16,777 --> 00:26:19,046 AND TREATMENT IN COLORECTAL 768 00:26:19,046 --> 00:26:20,614 CANCER. 769 00:26:20,614 --> 00:26:21,916 SO I THINK IT'S REALLY 770 00:26:21,916 --> 00:26:23,117 INTERESTING WHAT THE PATIENT 771 00:26:23,117 --> 00:26:23,884 ADVOCATES HAVE DONE ON THIS 772 00:26:23,884 --> 00:26:24,418 TEAM. 773 00:26:24,418 --> 00:26:27,555 THEY HAVE SPEARHEADED AN EFFORT 774 00:26:27,555 --> 00:26:28,989 TO PRODUCE NINE EDUCATIONAL 775 00:26:28,989 --> 00:26:30,091 WEBINARS TO SHARE KNOWLEDGE 776 00:26:30,091 --> 00:26:33,561 ABOUT THIS RESEARCH IN WHICH 777 00:26:33,561 --> 00:26:34,862 THEY CONDUCTED A SERIES OF 778 00:26:34,862 --> 00:26:36,163 FORMAL CONVERSATIONS BETWEEN THE 779 00:26:36,163 --> 00:26:40,935 RESEARCHERS ON THE TEAM AND THE 780 00:26:40,935 --> 00:26:42,103 PATIENT ADVOCATES AND IN DOING 781 00:26:42,103 --> 00:26:43,537 THAT, THEY COVERED A NUMBER OF 782 00:26:43,537 --> 00:26:45,272 TOPICS OF POTENTIAL INTEREST TO 783 00:26:45,272 --> 00:26:46,407 EITHER OTHER PATIENT ADVOCATES 784 00:26:46,407 --> 00:26:48,809 OR IN SOME CASES THE GENERAL 785 00:26:48,809 --> 00:26:50,010 PUBLIC, THINGS LIKE HOW 786 00:26:50,010 --> 00:26:52,913 LIFESTYLE FACTORS SUCH AS DIET, 787 00:26:52,913 --> 00:26:55,449 ANTIBIOTIC USE CAN IMPACT THE 788 00:26:55,449 --> 00:26:56,450 MICROBIOME, POSSIBLE 789 00:26:56,450 --> 00:27:00,488 IMPLICATIONS FOR PREVENTION AND 790 00:27:00,488 --> 00:27:02,156 SCREENING OF COLORECTAL CANCER, 791 00:27:02,156 --> 00:27:03,991 AND HOW THIS RESEARCH, WE HOPE, 792 00:27:03,991 --> 00:27:05,626 MAY RESULT IN USING NOVEL 793 00:27:05,626 --> 00:27:07,728 TREATMENT STRATEGIES FOR 794 00:27:07,728 --> 00:27:09,363 COLORECTAL CANCER, INCLUDING 795 00:27:09,363 --> 00:27:11,398 VACCINES IN SOME CASES, AND IN 796 00:27:11,398 --> 00:27:13,968 OTHER CASES POTENTIALLY 797 00:27:13,968 --> 00:27:14,335 IMMUNOTHERAPY. 798 00:27:14,335 --> 00:27:16,237 SO FOR ME, ESPECIALLY AS A 799 00:27:16,237 --> 00:27:17,438 SCIENTIST BY TRAINING, I THOUGHT 800 00:27:17,438 --> 00:27:19,106 THIS WAS A REALLY GREAT EXAMPLE 801 00:27:19,106 --> 00:27:20,741 OF HOW THE PATIENT ADVOCATES ON 802 00:27:20,741 --> 00:27:22,843 THIS TEAM HAVE REALLY MADE THIS 803 00:27:22,843 --> 00:27:25,346 RESEARCH MORE IMPACTFUL BY 804 00:27:25,346 --> 00:27:27,782 MAKING IT MORE ACCESSIBLE TO A 805 00:27:27,782 --> 00:27:31,585 MUCH BROADER AUDIENCE. 806 00:27:31,585 --> 00:27:32,753 AND THERE ARE MANY OTHERS, THIS 807 00:27:32,753 --> 00:27:35,656 IS THE ONE I PICKED AND I HOPE 808 00:27:35,656 --> 00:27:37,158 YELICK AND JOYA MAY SHARE SOME 809 00:27:37,158 --> 00:27:42,897 OTHER EXAMPLES WITH US. 810 00:27:42,897 --> 00:27:45,065 SO I'M GOING TO CLOSE MY PART OF 811 00:27:45,065 --> 00:27:47,034 THE PRESENTATION HERE. 812 00:27:47,034 --> 00:27:51,005 I DO WANT TO ACKNOWLEDGE SOME OF 813 00:27:51,005 --> 00:27:52,339 THE MANY PEOPLE THAT IT TAKES TO 814 00:27:52,339 --> 00:27:53,607 MAKE A PARTNERSHIP LIKE THIS 815 00:27:53,607 --> 00:27:54,241 WORK. 816 00:27:54,241 --> 00:27:58,913 THERE'S A JOINT CRUK-NCI 817 00:27:58,913 --> 00:28:00,181 MANAGEMENT GROUP THAT'S 818 00:28:00,181 --> 00:28:01,248 RESPONSIBLE FOR THE OVERALL 819 00:28:01,248 --> 00:28:02,116 COORDINATION OF THE PROGRAM. 820 00:28:02,116 --> 00:28:03,684 ALSO THIS GROWING LIST OF BOTH 821 00:28:03,684 --> 00:28:07,154 NCI AND CRUK PROGRAM OFFICIALS 822 00:28:07,154 --> 00:28:08,823 AND PROGRAM SCIENTISTS WHO ARE 823 00:28:08,823 --> 00:28:10,558 KEEPING CAREFUL TABS ON HOW 824 00:28:10,558 --> 00:28:12,960 THESE PROJECTS ARE EVOLVING, AS 825 00:28:12,960 --> 00:28:15,796 WELL AS A VERY DEDICATED TEAM 826 00:28:15,796 --> 00:28:17,431 THAT TRACKS AND MANAGES HOW THE 827 00:28:17,431 --> 00:28:18,766 ACTUAL FUNDS ARE BEING SPENT, 828 00:28:18,766 --> 00:28:20,835 WHICH IT TURNS OUT IS NOT AN 829 00:28:20,835 --> 00:28:23,137 EASY ENDEAVOR WHEN YOU HAVE TWO 830 00:28:23,137 --> 00:28:25,472 DIFFERENT FUNDING ORGANIZATIONS 831 00:28:25,472 --> 00:28:26,874 INVOLVED. 832 00:28:26,874 --> 00:28:28,742 FINALLY, I WOULD BE REMISS IF I 833 00:28:28,742 --> 00:28:31,011 DID NOT THANK THE PEOPLE WHO ARE 834 00:28:31,011 --> 00:28:33,214 INVOLVE WOULD IN THE PATIENT 835 00:28:33,214 --> 00:28:34,415 ADVOCACY PIECE WHO I APOLOGIZE 836 00:28:34,415 --> 00:28:36,050 ARE NOT SHOWN ON THE SLIDE, BUT 837 00:28:36,050 --> 00:28:41,989 AT CRUK, ANDREA DELGADO GARCIA 838 00:28:41,989 --> 00:28:44,592 HAS DONE A FANTASTIC JOB LEADING 839 00:28:44,592 --> 00:28:49,296 THE ADVOCACY EFFORT ON OUR SIDE, 840 00:28:49,296 --> 00:28:50,731 LAURIE AND BREEZE RILEY HAVE 841 00:28:50,731 --> 00:28:52,166 DONE AN AMAZING JOB WORKING WITH 842 00:28:52,166 --> 00:28:54,235 OUR CRUK COUNTERPARTS TO MAKE 843 00:28:54,235 --> 00:28:55,436 SURE THAT WE DO THIS IN THE 844 00:28:55,436 --> 00:28:55,870 RIGHT WAY. 845 00:28:55,870 --> 00:28:57,204 SO I WANT TO ACKNOWLEDGE ALL OF 846 00:28:57,204 --> 00:28:58,706 THEM. 847 00:28:58,706 --> 00:29:00,474 SO I'M GOING TO STOP HERE, 848 00:29:00,474 --> 00:29:01,775 AGAIN, I REALLY WANT TO THANK 849 00:29:01,775 --> 00:29:03,878 YOU FOR THE INVITATION AND YOUR 850 00:29:03,878 --> 00:29:05,412 TIME TODAY, AND I LOOK FORWARD 851 00:29:05,412 --> 00:29:06,814 TO YOUR QUESTIONS AND THE 852 00:29:06,814 --> 00:29:07,581 DISCUSSION. 853 00:29:07,581 --> 00:29:12,753 SO THANK YOU. 854 00:29:12,753 --> 00:29:15,689 >> THANK YOU SO MUCH, DR. KURTZ, 855 00:29:15,689 --> 00:29:17,858 FOR SHARING THIS COMPREHENSIVE 856 00:29:17,858 --> 00:29:18,959 VIEW OF THE EXCITING WORK 857 00:29:18,959 --> 00:29:20,394 HAPPENING WITH THE CANCER GRAND 858 00:29:20,394 --> 00:29:20,728 CHALLENGES. 859 00:29:20,728 --> 00:29:24,665 AT THIS TIME, I'D LIKE TO INVITE 860 00:29:24,665 --> 00:29:31,472 YELICK AND JOYA TO JUST SHARE A 861 00:29:31,472 --> 00:29:32,373 LITTLE BIT ABOUT THEIR 862 00:29:32,373 --> 00:29:34,308 EXPERIENCES AND WHAT IT'S LIKE 863 00:29:34,308 --> 00:29:36,710 BEING ON THE ADVOCACY PANEL. 864 00:29:36,710 --> 00:29:41,548 I KNOW THAT FROM THE ADVOCATES I 865 00:29:41,548 --> 00:29:43,050 KNOW WHO ARE INVOLVED ON TEAM 866 00:29:43,050 --> 00:29:44,485 PROJECTS, THEY RAVE ABOUT WHAT A 867 00:29:44,485 --> 00:29:46,120 WONDERFUL EXPERIENCE IT IS, AND 868 00:29:46,120 --> 00:29:47,855 JUST A NOTE TO AMY, DO WE NEED 869 00:29:47,855 --> 00:29:50,824 TO CHANGE TO THE OFFICE OF 870 00:29:50,824 --> 00:29:51,892 ADVOCACY INVOLVEMENT, NOW THAT 871 00:29:51,892 --> 00:29:52,993 WE HAVE A NEW DEFINITION? 872 00:29:52,993 --> 00:29:55,095 BUT THAT'S FOR ANOTHER TIME. 873 00:29:55,095 --> 00:29:57,398 BUT JOYA OR YELICK, IF EITHER OF 874 00:29:57,398 --> 00:29:59,266 YOU WOULD LIKE TO TAKE A FEW 875 00:29:59,266 --> 00:30:00,334 MOMENTS TO SHARE, WE HAVE PLENTY 876 00:30:00,334 --> 00:30:03,337 OF TIME. 877 00:30:03,337 --> 00:30:05,706 >> I'LL START BECAUSE IF YELICK 878 00:30:05,706 --> 00:30:08,142 START I'LL END UP SAYING WHAT HE 879 00:30:08,142 --> 00:30:11,779 SAID. 880 00:30:11,779 --> 00:30:14,114 THIS HAS BEEN A FANTASTIC 881 00:30:14,114 --> 00:30:15,749 SPIRIT. 882 00:30:15,749 --> 00:30:16,884 YELAK AND I BOTH STARTED AT THE 883 00:30:16,884 --> 00:30:17,284 SAME TIME. 884 00:30:17,284 --> 00:30:18,285 I WAS THRILLED TO HAVE THE 885 00:30:18,285 --> 00:30:21,422 OPPORTUNITY. 886 00:30:21,422 --> 00:30:23,524 IT'S NOT LOST I'M SURE TO 887 00:30:23,524 --> 00:30:26,927 ANYBODY IN THIS GROUP -- ANY OF 888 00:30:26,927 --> 00:30:30,497 OUR MYRIAD ADVOCACY 889 00:30:30,497 --> 00:30:32,566 RELATIONSHIPS, WHAT I ENJOY 890 00:30:32,566 --> 00:30:34,234 ABOUT IT IS EXPOSURE TO MORE 891 00:30:34,234 --> 00:30:36,437 ADVOCATE, MORE PEOPLE FROM AN 892 00:30:36,437 --> 00:30:37,438 INTERNATIONAL PERSPECTIVE THAT 893 00:30:37,438 --> 00:30:41,008 WE CAN SHARE IDEAS AND LEARN 894 00:30:41,008 --> 00:30:41,508 FROM EACH OTHER. 895 00:30:41,508 --> 00:30:43,010 IT'S A PLEASURE TO WORK ON A 896 00:30:43,010 --> 00:30:44,878 TEAM THAT'S ACTUALLY HELPING TO 897 00:30:44,878 --> 00:30:46,413 ADVISE IF THAT'S THE RIGHT WORD 898 00:30:46,413 --> 00:30:47,414 OTHER SEASONED PATIENT 899 00:30:47,414 --> 00:30:48,582 ADVOCATES. 900 00:30:48,582 --> 00:30:50,017 SO LIKE ANDY DESCRIBED, EVERY 901 00:30:50,017 --> 00:30:51,986 TEAM HAS ADVOCATES AND THEY ARE 902 00:30:51,986 --> 00:30:53,754 STELLAR. 903 00:30:53,754 --> 00:30:57,825 THEY ARE PASSIONATE FOR WHATEVER 904 00:30:57,825 --> 00:31:00,227 REASONS AND ALL THE REASONS, AND 905 00:31:00,227 --> 00:31:05,566 THEY ARE NOT AFRAID OR 906 00:31:05,566 --> 00:31:06,767 INTIMIDATED TO SPEAK UP, THEY 907 00:31:06,767 --> 00:31:07,568 FEEL VERY MUCH INVOLVED WITH 908 00:31:07,568 --> 00:31:07,968 THEIR TEAM. 909 00:31:07,968 --> 00:31:11,939 I CAN'T SAY ENOUGH GOOD THINGS. 910 00:31:11,939 --> 00:31:13,474 I CAN'T THINK OF ANYTHING THAT'S 911 00:31:13,474 --> 00:31:15,209 NOT GOOD, IT'S JUST ALL VERY 912 00:31:15,209 --> 00:31:15,909 FAVORABLE EXPERIENCES. 913 00:31:15,909 --> 00:31:19,179 IT'S A PLEASURE TO BE ABLE TO BE 914 00:31:19,179 --> 00:31:20,280 PART OF THE TEAMS THAT ARE 915 00:31:20,280 --> 00:31:21,682 APPLYING FOR FUNDING IN TERMS OF 916 00:31:21,682 --> 00:31:24,418 ASSESSING THEIR APPLICATION AND 917 00:31:24,418 --> 00:31:26,720 THEIR PATIENT INVOLVEMENT, AND 918 00:31:26,720 --> 00:31:28,489 TO BE ABLE TO ADVISE THEM HOW 919 00:31:28,489 --> 00:31:29,790 THEY COULD DO BETTER, BUT TO SEE 920 00:31:29,790 --> 00:31:31,859 THE TEAMS THAT WERE SELECTED, TO 921 00:31:31,859 --> 00:31:35,295 HEAR FROM THE PIs AND ALL THE 922 00:31:35,295 --> 00:31:37,031 TEAM, THE PATIENT ADVOCATES, WAS 923 00:31:37,031 --> 00:31:38,565 THRILLING SO THE SUMMIT WE 924 00:31:38,565 --> 00:31:40,434 ATTENDED IN MARCH WAS JUST 925 00:31:40,434 --> 00:31:41,301 INVIGORATING AND REALLY LIKE ALL 926 00:31:41,301 --> 00:31:42,770 OF OUR INTERACTIONS, WHENEVER 927 00:31:42,770 --> 00:31:45,839 WE'RE TOGETHER, IT RECHARGES ME, 928 00:31:45,839 --> 00:31:48,008 IT HELPS US -- IT REMINDS US AS 929 00:31:48,008 --> 00:31:49,777 IF WE NEED TO BE REMINDED BUT IT 930 00:31:49,777 --> 00:31:52,179 DOES REMIND US OF WHY WE DO WHAT 931 00:31:52,179 --> 00:31:53,480 WE DO. 932 00:31:53,480 --> 00:31:57,651 I'M GLAD, ANDY, THAT YOU SHOUTED 933 00:31:57,651 --> 00:31:59,420 OUT THE PEOPLE THAT WE WORK WITH 934 00:31:59,420 --> 00:32:01,055 MOST CLOSELY AND INCLUDING THE 935 00:32:01,055 --> 00:32:02,589 TEAM HERE IN THE OFFICE OF 936 00:32:02,589 --> 00:32:03,257 ADVOCACY RELATIONS. 937 00:32:03,257 --> 00:32:06,093 SO IT JUST BEEN A PLEASURE. 938 00:32:06,093 --> 00:32:07,728 IT'S INSPIRING. 939 00:32:07,728 --> 00:32:10,898 AND IT MAKES YOU FEEL GOOD ABOUT 940 00:32:10,898 --> 00:32:12,132 WHAT YOU DO AND ABOUT THE 941 00:32:12,132 --> 00:32:13,534 RESEARCH THAT'S BEING CONDUCTED 942 00:32:13,534 --> 00:32:15,736 AND ABOUT THE IMPORTANCE OF 943 00:32:15,736 --> 00:32:17,271 INVOLVING ADVOCATES. 944 00:32:17,271 --> 00:32:20,140 SO IT'S ALL JUST UNDERSCORED BY 945 00:32:20,140 --> 00:32:20,774 THIS AFFILIATION. 946 00:32:20,774 --> 00:32:21,875 >> THANKS, JOYA. 947 00:32:21,875 --> 00:32:24,411 I FORGOT THAT WE MISSED YOU AND 948 00:32:24,411 --> 00:32:25,946 YELAK WHEN WE MET IN PERSON IN 949 00:32:25,946 --> 00:32:26,747 MARCH BECAUSE THIS IS WHERE YOU 950 00:32:26,747 --> 00:32:27,481 WERE. 951 00:32:27,481 --> 00:32:31,852 AND I SEE YOU, LEE, BUT I'D LIKE 952 00:32:31,852 --> 00:32:35,722 TO HEAR A LITTLE FROM YELAK. 953 00:32:35,722 --> 00:32:37,591 >> EVERYTHING JOYA SAID PLUS A 954 00:32:37,591 --> 00:32:38,992 COUPLE OF THINGS I REALLY WANT 955 00:32:38,992 --> 00:32:41,161 TO RE-HIGHLIGHT FROM WHAT 956 00:32:41,161 --> 00:32:43,931 DR. KURTZ SAID IS, THE CGC 957 00:32:43,931 --> 00:32:45,632 PATIENT ADVOCACY PANEL IS TRULY 958 00:32:45,632 --> 00:32:47,968 A REALLY GLOBAL ADVOCACY PANEL 959 00:32:47,968 --> 00:32:50,604 WITH VERY DIVERSE BACKGROUNDS. 960 00:32:50,604 --> 00:32:53,674 AND IT IS IMPORTANT TO ALSO NOTE 961 00:32:53,674 --> 00:32:57,177 AGAIN THAT WE ARE NOT -- OUR 962 00:32:57,177 --> 00:32:59,580 PARTICULAR CANCER OR OUR 963 00:32:59,580 --> 00:33:00,013 PARTICULAR ADVOCACY 964 00:33:00,013 --> 00:33:00,914 ORGANIZATION, BUT REALLY TO 965 00:33:00,914 --> 00:33:04,852 PROVIDE FEEDBACK AND INPUT AND 966 00:33:04,852 --> 00:33:10,424 WORKONICWORK ON THREE THINGS, HO 967 00:33:10,424 --> 00:33:11,959 CREATE A TRAINING PROGRAM AND 968 00:33:11,959 --> 00:33:14,495 TRAINING CURRICULUM FOR ALL 969 00:33:14,495 --> 00:33:15,362 ADVOCATES UPCOMING INTO THE 970 00:33:15,362 --> 00:33:15,929 PROGRAM. 971 00:33:15,929 --> 00:33:17,865 THE SECOND IS ENSURING PROJECT 972 00:33:17,865 --> 00:33:18,899 TEAMS THINK OF PATIENTS FIRST 973 00:33:18,899 --> 00:33:20,634 WHEN THEY'RE THINKING OF THEIR 974 00:33:20,634 --> 00:33:21,135 RESEARCH. 975 00:33:21,135 --> 00:33:23,370 AND THE LAST IS BE A RESOURCE TO 976 00:33:23,370 --> 00:33:26,673 THE SELECTED PROJECT ADVOCATE AS 977 00:33:26,673 --> 00:33:29,843 THEY GO THROUGH THE FIVE-YEAR 978 00:33:29,843 --> 00:33:30,177 PROGRAM. 979 00:33:30,177 --> 00:33:34,982 AS MENTIONED, IT IS A FIVE-YEAR 980 00:33:34,982 --> 00:33:36,483 PROGRAM AND THE UNIQUENESS OF 981 00:33:36,483 --> 00:33:37,951 THIS PROGRAM FOR ME IS THAT THE 982 00:33:37,951 --> 00:33:39,486 PROGRAM TEAM DOESN'T HAVE TO 983 00:33:39,486 --> 00:33:41,221 WORRY ABOUT WHERE NEXT YEAR'S 984 00:33:41,221 --> 00:33:42,990 FUNDING IS GOING TO COME FROM. 985 00:33:42,990 --> 00:33:45,292 THAT FIVE-YEAR IS GUARANTEED, 986 00:33:45,292 --> 00:33:47,394 AND IT REALLY ALLOWS THEM TO 987 00:33:47,394 --> 00:33:48,462 THINK BEYOND WHAT THEY WILL BE 988 00:33:48,462 --> 00:33:52,733 DOING THIS YEAR AND REALLY THINK 989 00:33:52,733 --> 00:33:54,168 AT A VERY GRAND LEVEL. 990 00:33:54,168 --> 00:33:58,238 IN MY OPINION, MARGARET AND 991 00:33:58,238 --> 00:34:00,541 ANDREA FROM UK AND FROM CANCER 992 00:34:00,541 --> 00:34:02,409 GRAND CHALLENGES HAVE DONE A 993 00:34:02,409 --> 00:34:05,913 FANTASTIC JOB OF ENSURING THAT 994 00:34:05,913 --> 00:34:07,981 WE REPRESENT NOT ONLY OURSELVES 995 00:34:07,981 --> 00:34:10,751 AND OUR COUNTRY AND OUR CANCERS, 996 00:34:10,751 --> 00:34:11,818 IF YOU WOULD, BUT ALSO IN 997 00:34:11,818 --> 00:34:14,788 GENERAL THE PATIENT -- AND THE 998 00:34:14,788 --> 00:34:16,123 PATIENTS THAT WE END UP SERVING. 999 00:34:16,123 --> 00:34:18,358 IT IS IN MY OPINION, AGAIN, AS 1000 00:34:18,358 --> 00:34:22,863 JOYA SAID, ONE OF THE MOST 1001 00:34:22,863 --> 00:34:23,830 SPECIAL PROGRAMS I HAVE BEEN 1002 00:34:23,830 --> 00:34:26,366 PART OF, AND I HAVE BEEN PART OF 1003 00:34:26,366 --> 00:34:27,801 ADVOCACY FOR A LONG TIME, BUT IT 1004 00:34:27,801 --> 00:34:29,603 HAS ALSO FORCED ME TO GROW, IF 1005 00:34:29,603 --> 00:34:32,839 YOU WOULD, AND LOOK AT ADVOCACY 1006 00:34:32,839 --> 00:34:34,041 VERY DIFFERENTLY AND UNIQUELY, 1007 00:34:34,041 --> 00:34:40,314 NOT ONLY BECAUSE I AM THERE 1008 00:34:40,314 --> 00:34:43,050 ADVOCATING FOR -- CANCERS BUT 1009 00:34:43,050 --> 00:34:44,051 REALLY BEING ABLE TO LOOK AT 1010 00:34:44,051 --> 00:34:46,286 THIS FROM A MULTI-STAKEHOLDER 1011 00:34:46,286 --> 00:34:48,589 PROBLEMS PERSPECTIVE. 1012 00:34:48,589 --> 00:34:50,857 I BELIEVE AVERAGE INSTITUTIONS 1013 00:34:50,857 --> 00:34:52,025 THAT ARE PART OF EACH OF THE 1014 00:34:52,025 --> 00:34:55,629 PROGRAMS AND THIS HAS MEMBERS 1015 00:34:55,629 --> 00:34:57,264 AND THE PROGRAM IS INITIATED IN 1016 00:34:57,264 --> 00:34:59,800 MANY DIFFERENT COUNTRIES, IN 1017 00:34:59,800 --> 00:35:03,503 FRANCE, INDIA, ITALY, UK, U.S., 1018 00:35:03,503 --> 00:35:04,404 GHANA, SOUTH AFRICA AND MANY 1019 00:35:04,404 --> 00:35:06,907 OTHERS. 1020 00:35:06,907 --> 00:35:08,909 SO ONE OF -- AND I'LL BE QUIET 1021 00:35:08,909 --> 00:35:11,945 NOW, THE GRATIFYING PORTIONS OF 1022 00:35:11,945 --> 00:35:16,116 THIS WAS THERE WAS A PROGRAM 1023 00:35:16,116 --> 00:35:19,286 THAT CAME INTO THE RFP PROCESS 1024 00:35:19,286 --> 00:35:22,322 AND IN OUR OPINION WAS NOT AS 1025 00:35:22,322 --> 00:35:22,723 PATIENT-CENTERED. 1026 00:35:22,723 --> 00:35:26,627 THE INVESTIGATORS TOOK OUR 1027 00:35:26,627 --> 00:35:27,628 FEEDBACK AND BY THE TIME THEY 1028 00:35:27,628 --> 00:35:29,162 SUBMITTED IT, IT WAS, IN MY 1029 00:35:29,162 --> 00:35:31,932 OPINION, ONE OF THE MOST 1030 00:35:31,932 --> 00:35:33,567 PATIENT-CENTERED, ONE OF THE 1031 00:35:33,567 --> 00:35:39,606 MOST ADVOCACY IN CURATING BOTH 1032 00:35:39,606 --> 00:35:41,141 INVOLVEMENT AND ENGAGEMENT 1033 00:35:41,141 --> 00:35:42,776 PERSPECTIVE AND THEY ENDED UP 1034 00:35:42,776 --> 00:35:43,877 ACTUALLY WINNING AND BEING 1035 00:35:43,877 --> 00:35:46,580 FUNDED AS A PROGRAM. 1036 00:35:46,580 --> 00:35:51,551 SO THE ADVOCACY TEAMS DO REAL 1037 00:35:51,551 --> 00:35:52,953 REALLY -- AND ARE GOING TO BE 1038 00:35:52,953 --> 00:35:54,288 RESOURCES THROUGHOUT THE 1039 00:35:54,288 --> 00:35:56,923 LIFECYCLE OF THAT PROJECT. 1040 00:35:56,923 --> 00:36:00,994 >> THANK YOU SO MUCH, JOYA AND 1041 00:36:00,994 --> 00:36:02,396 YELAK, THAT IS SO WONDERFUL TO 1042 00:36:02,396 --> 00:36:02,729 HEAR. 1043 00:36:02,729 --> 00:36:04,831 I THINK, TOO, ACROSS THE BOARD 1044 00:36:04,831 --> 00:36:06,767 THAT AS RESEARCH ADVOCATES, 1045 00:36:06,767 --> 00:36:08,335 WE'RE USED DIFFERENTLY, OR 1046 00:36:08,335 --> 00:36:09,102 INVOLVED DIFFERENTLY IN OUR 1047 00:36:09,102 --> 00:36:11,838 DIFFERENT SPACES AND HAVING, YOU 1048 00:36:11,838 --> 00:36:14,141 KNOW, THE BOARD TO GO BACK TO TO 1049 00:36:14,141 --> 00:36:15,442 HELP MAKE SURE THAT IT'S THE 1050 00:36:15,442 --> 00:36:17,544 BEST THAT IT CAN BE IS REALLY A 1051 00:36:17,544 --> 00:36:18,979 FASCINATING AND INTERESTING AND 1052 00:36:18,979 --> 00:36:20,881 REALLY HELPFUL CONCEPT. 1053 00:36:20,881 --> 00:36:24,117 THANK YOU FOR THE WORK THAT YOU 1054 00:36:24,117 --> 00:36:24,685 DO. 1055 00:36:24,685 --> 00:36:25,886 LEE, YOU'VE HAD YOUR HAND UP FOR 1056 00:36:25,886 --> 00:36:27,087 QUITE A WHILE, YOU'VE BEEN SO 1057 00:36:27,087 --> 00:36:27,321 PATIENT. 1058 00:36:27,321 --> 00:36:29,189 THANK YOU FOR WAITING. 1059 00:36:29,189 --> 00:36:30,824 >> THANKS FOR THE PRESENTATION. 1060 00:36:30,824 --> 00:36:34,661 AND THANKS FOR THIS PROGRAM, THE 1061 00:36:34,661 --> 00:36:35,295 CANCER GRAND CHALLENGE. 1062 00:36:35,295 --> 00:36:36,296 I THINK IT'S A GREAT PROGRAM. 1063 00:36:36,296 --> 00:36:37,931 SO I HAVE A PERSPECTIVE AS 1064 00:36:37,931 --> 00:36:40,901 ACTUALLY A TEAM MEMBER, SO WHEN 1065 00:36:40,901 --> 00:36:43,537 DR. KURTZ HAPPENED TO SHOW 1066 00:36:43,537 --> 00:36:44,738 PROJECT OPTIMISTIC IS THE TEAM 1067 00:36:44,738 --> 00:36:46,573 THAT I'VE BEEN ON FOR THE PAST 1068 00:36:46,573 --> 00:36:47,507 FIVE YEARS. 1069 00:36:47,507 --> 00:36:50,911 AND IN FACT, IF THEY'D SHOWN YOU 1070 00:36:50,911 --> 00:36:52,412 THAT WEBINAR, I HAD ONE OF THOSE 1071 00:36:52,412 --> 00:36:55,315 NINE WEBINAR SEGMENTS WORKING 1072 00:36:55,315 --> 00:36:59,019 WITH ONE OF THE RESEARCH THAT I 1073 00:36:59,019 --> 00:36:59,686 WAS WORKING WITH. 1074 00:36:59,686 --> 00:37:04,491 I LIKED THE PROJECT SO MUCH THAT 1075 00:37:04,491 --> 00:37:08,128 ACTUALLY IN I THINK THE 2021 1076 00:37:08,128 --> 00:37:09,529 CYCLE, I TEAMED UP WITH A 1077 00:37:09,529 --> 00:37:13,600 RESEARCHER WHO I KNOW FROM SWOG 1078 00:37:13,600 --> 00:37:15,802 AND WE SUBMITTED A PROPOSAL FOR 1079 00:37:15,802 --> 00:37:16,903 CACHEXIA, AND I SEE NOW THE 1080 00:37:16,903 --> 00:37:18,338 REASON THAT WE LOST IS BECAUSE 1081 00:37:18,338 --> 00:37:23,477 WE NAMED OUR PROJECT "NO MORE 1082 00:37:23,477 --> 00:37:24,578 CACHEXIA," NOT CANCAN. 1083 00:37:24,578 --> 00:37:26,246 SO HOW COULD YOU COMPARE THOSE 1084 00:37:26,246 --> 00:37:33,387 TWO THINGS? 1085 00:37:33,387 --> 00:37:36,123 ALSO THIS LAST CYCLE, I WORKED 1086 00:37:36,123 --> 00:37:40,927 ON A TEAM THAT WORKED ON 1087 00:37:40,927 --> 00:37:42,028 OPTIMISTICC WITH ME, WE DID NOT 1088 00:37:42,028 --> 00:37:44,431 GET ASKED TO SUBMIT A PROPOSAL 1089 00:37:44,431 --> 00:37:46,533 LIKE WE DID WITH CACHEXIA. 1090 00:37:46,533 --> 00:37:48,835 WE'RE ONE OF TWO CACHEXIA. 1091 00:37:48,835 --> 00:37:49,936 BUT SORT OF MY EXPERIENCE IS 1092 00:37:49,936 --> 00:37:53,373 THAT, YOU KNOW, ON THESE TEAMS, 1093 00:37:53,373 --> 00:37:57,411 THE PRE-CLINICAL WORK, THE BASIC 1094 00:37:57,411 --> 00:37:58,612 SCIENCE WORK, IT'S MORE 1095 00:37:58,612 --> 00:38:01,014 DIFFICULT FOR ADVOCATES TO 1096 00:38:01,014 --> 00:38:03,483 REALLY BECOME INVOLVED AND 1097 00:38:03,483 --> 00:38:04,651 ENGAGED IN THOSE ACTIVITIES. 1098 00:38:04,651 --> 00:38:06,720 IT'S MORE DIFFICULT FOR US 1099 00:38:06,720 --> 00:38:07,754 BECAUSE A LOT OF IT, YOU HAVE TO 1100 00:38:07,754 --> 00:38:09,823 BE THERE IN PERSON BECAUSE IT'S 1101 00:38:09,823 --> 00:38:11,158 LAB SCIENCE, YOU CAN'T -- IT'S 1102 00:38:11,158 --> 00:38:12,592 HARD TO DO THAT REMOTELY. 1103 00:38:12,592 --> 00:38:13,994 BUT ALSO A LOT OF THOSE 1104 00:38:13,994 --> 00:38:15,862 RESEARCHERS HAVE NO EXPERIENCE 1105 00:38:15,862 --> 00:38:17,397 WORKING WITH ADVOCATES. 1106 00:38:17,397 --> 00:38:20,901 SO WE ACTUALLY DID A SURVEY OF 1107 00:38:20,901 --> 00:38:24,538 THE OPTIMISTICC RESEARCHERS, AND 1108 00:38:24,538 --> 00:38:26,072 ABOUT 80% FELT THAT ADVOCATES 1109 00:38:26,072 --> 00:38:29,876 WERE REALLY HELPFUL AND HELPED 1110 00:38:29,876 --> 00:38:31,411 THE WORK AND THE SCIENCE, BUT I 1111 00:38:31,411 --> 00:38:35,148 THINK THAT OTHER 15, 20% REALLY 1112 00:38:35,148 --> 00:38:37,684 HAD NO EXPERIENCE WORKING WITH 1113 00:38:37,684 --> 00:38:39,119 ADVOCATES AND DIDN'T UNDERSTAND 1114 00:38:39,119 --> 00:38:40,754 THE BENEFIT WE COULD PROVIDE, 1115 00:38:40,754 --> 00:38:42,789 AND MAYBE FOR THEIR PARTICULAR 1116 00:38:42,789 --> 00:38:44,257 PART OF THE PROJECT, WE COULDN'T 1117 00:38:44,257 --> 00:38:45,358 PROVIDE A LOT OF BENEFIT JUST 1118 00:38:45,358 --> 00:38:46,126 BECAUSE OF THE NATURE OF THE 1119 00:38:46,126 --> 00:38:48,962 WORK. 1120 00:38:48,962 --> 00:38:50,430 BUT I THINK THE PROJECTS ARE 1121 00:38:50,430 --> 00:38:50,697 WONDERFUL. 1122 00:38:50,697 --> 00:38:51,965 I WOULD ENCOURAGE ANYONE WHO HAS 1123 00:38:51,965 --> 00:38:53,099 AN OPPORTUNITY TO PARTICIPATE IN 1124 00:38:53,099 --> 00:38:56,570 ONE OF THOSE TO DO SO. 1125 00:38:56,570 --> 00:38:57,871 ANOTHER THING, SO I ACTUALLY 1126 00:38:57,871 --> 00:39:01,174 ASKED TO BE ON THIS ADVOCATE 1127 00:39:01,174 --> 00:39:02,943 PANEL, BUT BECAUSE I WAS ON A 1128 00:39:02,943 --> 00:39:05,679 PROJECT ALREADY, I WAS TOLD I 1129 00:39:05,679 --> 00:39:08,281 COULD NOT BECOME A MEMBER OF THE 1130 00:39:08,281 --> 00:39:09,382 ADVOCACY PANEL. 1131 00:39:09,382 --> 00:39:11,251 SO I THOUGHT, WELL, WHAT BETTER 1132 00:39:11,251 --> 00:39:12,452 PERSON THAN SOMEONE WHO'S 1133 00:39:12,452 --> 00:39:13,553 ACTUALLY WORKING ON A PROJECT 1134 00:39:13,553 --> 00:39:15,222 WHO HAS EXPERIENCE WORKING ON 1135 00:39:15,222 --> 00:39:15,889 THE PROJECT? 1136 00:39:15,889 --> 00:39:17,958 BUT THAT WAS THEIR POLICY, SO I 1137 00:39:17,958 --> 00:39:19,593 DIDN'T GET INVOLVED IN THAT. 1138 00:39:19,593 --> 00:39:21,261 BUT OUR WORK IS ENDING THIS 1139 00:39:21,261 --> 00:39:21,828 YEAR. 1140 00:39:21,828 --> 00:39:24,431 WE'RE ON A NO-COST EXTENSION. 1141 00:39:24,431 --> 00:39:26,666 WE WERE OPERATING DURING THE 1142 00:39:26,666 --> 00:39:27,767 PANDEMIC SO WE DIDN'T SPEND A 1143 00:39:27,767 --> 00:39:29,836 LOT OF TRAVEL MONEY, SO WE HAD 1144 00:39:29,836 --> 00:39:32,706 EXTRA MONEY SO WE COULD HAVE A 1145 00:39:32,706 --> 00:39:34,007 NO-COST EXTENSION SO WE'RE GOING 1146 00:39:34,007 --> 00:39:36,843 TO BE GOING FOR THE REST OF THIS 1147 00:39:36,843 --> 00:39:38,044 YEAR, ADVOCATES HAVE BEEN 1148 00:39:38,044 --> 00:39:40,046 ROLLING OFF BECAUSE IT'S REALLY 1149 00:39:40,046 --> 00:39:42,983 JUST FINAL WRAP-UP WORK, WRITING 1150 00:39:42,983 --> 00:39:46,786 REPORTS, DOING DATA YO YO ANALY, 1151 00:39:46,786 --> 00:39:48,722 AND OUR WORK IS PRETTY MUCH 1152 00:39:48,722 --> 00:39:49,356 WRAPPED UP. 1153 00:39:49,356 --> 00:39:51,024 BUT I'VE BEEN DOING THIS FOR THE 1154 00:39:51,024 --> 00:39:51,658 PAST FIVE YEARS. 1155 00:39:51,658 --> 00:39:54,628 IF THIS WAS A CRUK PROJECT AT 1156 00:39:54,628 --> 00:39:55,929 THE TIME IT WAS BEFORE THE NCI 1157 00:39:55,929 --> 00:39:57,697 GOT INVOLVED, BUT IT WAS STILL 1158 00:39:57,697 --> 00:39:58,632 CANCER GRAND CHALLENGES. 1159 00:39:58,632 --> 00:40:00,567 SO I REALLY APPRECIATE THE 1160 00:40:00,567 --> 00:40:01,535 OPPORTUNITY TO WORK ON IT. 1161 00:40:01,535 --> 00:40:03,136 >> THANK YOU SO MUCH, LEE, FOR 1162 00:40:03,136 --> 00:40:05,539 THAT VERY COMPREHENSIVE SHARING 1163 00:40:05,539 --> 00:40:08,508 OF YOUR TEAM WORK. 1164 00:40:08,508 --> 00:40:09,709 IT SO VERY INTERESTING. 1165 00:40:09,709 --> 00:40:10,610 DR. CURT, DID YOU WANT TO 1166 00:40:10,610 --> 00:40:11,811 RESPOND TO ANY OF THAT? 1167 00:40:11,811 --> 00:40:13,680 >> I JUST WANT TO QUICKLY REACT 1168 00:40:13,680 --> 00:40:16,082 TO, I THINK, BOTH THE EXAMPLE 1169 00:40:16,082 --> 00:40:17,751 THAT YELAK GAVE AND SOME OF THE 1170 00:40:17,751 --> 00:40:21,054 COMMENTS LEE JUST MADE. 1171 00:40:21,054 --> 00:40:22,822 I THINK WHAT WE'VE SEEN OVER THE 1172 00:40:22,822 --> 00:40:26,960 LAST CYCLE IN PARTICULAR IS A 1173 00:40:26,960 --> 00:40:27,961 REAL APPRECIATION ON THE PART OF 1174 00:40:27,961 --> 00:40:30,363 THE RESEARCH TEAMS FOR THE 1175 00:40:30,363 --> 00:40:31,898 LEARNINGS THAT THEY'VE BEEN ABLE 1176 00:40:31,898 --> 00:40:36,169 TO GLEAN FROM THE PATIENT 1177 00:40:36,169 --> 00:40:37,170 ADVOCACY PANEL MEMBERS. 1178 00:40:37,170 --> 00:40:38,071 PARTICULARLY -- SO I DIDN'T GO 1179 00:40:38,071 --> 00:40:40,340 INTO ALL THESE DETAILS, BUT THE 1180 00:40:40,340 --> 00:40:42,475 WAY WE SOLICIT APPLICATIONS IS 1181 00:40:42,475 --> 00:40:43,176 IN TWO PHASES. 1182 00:40:43,176 --> 00:40:45,245 SO WE PUT OUT AN ANNOUNCEMENT OF 1183 00:40:45,245 --> 00:40:47,047 THE CHALLENGES AND WE ASKED THE 1184 00:40:47,047 --> 00:40:51,651 TEAMS SUBMIT TO US SO SORT OF A 1185 00:40:51,651 --> 00:40:52,752 SHORT APPLICATION ON THEIR IDEA, 1186 00:40:52,752 --> 00:40:55,522 AND THEN WE DOWN-SELECT TO A 1187 00:40:55,522 --> 00:40:57,357 GROUP OF FINALISTS, USUALLY 1188 00:40:57,357 --> 00:40:59,359 ABOUT A DOZEN OR SO, AND WE WORK 1189 00:40:59,359 --> 00:41:01,261 PRETTY CLOSELY WITH THOSE 1190 00:41:01,261 --> 00:41:02,262 FINALISTS AS THEY DEVELOP A FULL 1191 00:41:02,262 --> 00:41:02,862 APPLICATION. 1192 00:41:02,862 --> 00:41:04,331 SO IT'S DURING THAT FULL 1193 00:41:04,331 --> 00:41:08,668 APPLICATION DEVELOPMENT THAT WE 1194 00:41:08,668 --> 00:41:10,103 PROVIDE ADVICE AND FEEDBACK TO 1195 00:41:10,103 --> 00:41:11,638 THEM, AND THAT'S IN THIS LAST 1196 00:41:11,638 --> 00:41:12,872 ROUND, WHEN WE'VE REALLY BEEN 1197 00:41:12,872 --> 00:41:14,507 ABLE TO SHARE SOME INSIGHTS 1198 00:41:14,507 --> 00:41:16,042 AROUND SOME OF THE THINGS THAT 1199 00:41:16,042 --> 00:41:18,678 CAN BE EFFECTIVE IN THE PATIENT 1200 00:41:18,678 --> 00:41:19,579 ADVOCACY REALM. 1201 00:41:19,579 --> 00:41:21,982 TO YELAK'S POINT, I THINK IN 1202 00:41:21,982 --> 00:41:23,316 SOME CASES, THE DIFFERENCE 1203 00:41:23,316 --> 00:41:24,284 BETWEEN WHERE THEY STARTED AND 1204 00:41:24,284 --> 00:41:26,386 WHERE THEY ENDED UP WAS QUITE 1205 00:41:26,386 --> 00:41:28,021 SIGNIFICANT, AND THEY REALLY 1206 00:41:28,021 --> 00:41:31,558 APPRECIATED THAT. 1207 00:41:31,558 --> 00:41:32,659 >> THANK YOU SO MUCH. 1208 00:41:32,659 --> 00:41:37,864 THERE WAS A QUESTION IN THE CH 1209 00:41:37,864 --> 00:41:38,665 CHAT, KIRSTEN, DO YOU WANT TO 1210 00:41:38,665 --> 00:41:40,266 ASK YOUR QUESTION OR DO YOU WANT 1211 00:41:40,266 --> 00:41:41,034 ME TO READ IT? 1212 00:41:41,034 --> 00:41:41,968 >> I'M HAPPY TO ASK IT. 1213 00:41:41,968 --> 00:41:43,069 THANK YOU FOR THE OVERVIEW AND 1214 00:41:43,069 --> 00:41:43,970 THE EXAMPLES PROVIDED. 1215 00:41:43,970 --> 00:41:46,172 I WAS JUST TYPING IN THE CHAT AS 1216 00:41:46,172 --> 00:41:46,706 WELL. 1217 00:41:46,706 --> 00:41:48,675 I BELIEVE LONGEVITY HAS BEEN 1218 00:41:48,675 --> 00:41:52,412 INVOLVED IN THE CANCAN PROJECT. 1219 00:41:52,412 --> 00:41:53,847 I'LL JUST SAY FROM KIND OF THAT 1220 00:41:53,847 --> 00:41:54,948 FIRST INITIAL APPLICATION PHASE 1221 00:41:54,948 --> 00:41:56,483 AND I'M NO LONGER WITH LONGEVITY 1222 00:41:56,483 --> 00:41:58,785 SO I CAN'T -- THIS IS JUST MY 1223 00:41:58,785 --> 00:42:01,488 PAST EXPERIENCE, BUT LONGEVITY 1224 00:42:01,488 --> 00:42:02,989 WAS REALLY INVOLVED IN THAT 1225 00:42:02,989 --> 00:42:04,324 PROCESS, NOT ONLY AS AMY MOORE 1226 00:42:04,324 --> 00:42:05,558 WAS THE REPRESENTATIVE, I 1227 00:42:05,558 --> 00:42:06,459 BELIEVE, OR IS THE 1228 00:42:06,459 --> 00:42:08,662 REPRESENTATIVE, SO HER 1229 00:42:08,662 --> 00:42:09,663 EXPERIENCE HAS BEEN VOICED BUT 1230 00:42:09,663 --> 00:42:10,897 ALSO REACHING OUT TO OUR PATIENT 1231 00:42:10,897 --> 00:42:12,298 AND CAREGIVER COMMUNITIES TO GET 1232 00:42:12,298 --> 00:42:13,633 THEIR INPUT. 1233 00:42:13,633 --> 00:42:16,036 SO IT WAS A LEGIT PATIENT AND 1234 00:42:16,036 --> 00:42:21,541 CONTINUES TO BE ENGAGEMENT. 1235 00:42:21,541 --> 00:42:23,176 MY QUESTION IN THE CHAT WAS, CAN 1236 00:42:23,176 --> 00:42:27,147 AN INDIVIDUAL WHO'S PART OF A 1237 00:42:27,147 --> 00:42:28,682 PATIENT ADVOCACY ORGANIZATION, 1238 00:42:28,682 --> 00:42:30,450 CAN THEY BE ON THE CANCER GRAND 1239 00:42:30,450 --> 00:42:31,918 CHALLENGES TEAM, EXCUSE MY LACK 1240 00:42:31,918 --> 00:42:33,086 OF VOCABULARY RIGHT NOW. 1241 00:42:33,086 --> 00:42:35,722 ARE THEY ABLE TO -- IS THEIR 1242 00:42:35,722 --> 00:42:37,257 ORGANIZATION ALSO ABLE TO EITHER 1243 00:42:37,257 --> 00:42:41,461 BE A LEADING PARTNER IN AN 1244 00:42:41,461 --> 00:42:42,862 APPLICATION OR SOMEONE WHO'S NOT 1245 00:42:42,862 --> 00:42:44,597 RECEIVING FUNDING THROUGH IT BUT 1246 00:42:44,597 --> 00:42:46,399 HELP PAYING, IF THAT MAKES 1247 00:42:46,399 --> 00:42:48,068 SENSE. 1248 00:42:48,068 --> 00:42:49,803 >> YEAH, I THINK IT DOES. 1249 00:42:49,803 --> 00:42:50,870 I'M ACTUALLY GOING TO TAKE THIS 1250 00:42:50,870 --> 00:42:52,105 OPPORTUNITY TO LET MY COLLEAGUE 1251 00:42:52,105 --> 00:42:53,540 JOIN THE DISCUSSION, SO I'M NOT 1252 00:42:53,540 --> 00:42:54,340 HOGGING THE MIC. 1253 00:42:54,340 --> 00:42:55,709 BUT TONY, DO YOU WANT TO MAYBE 1254 00:42:55,709 --> 00:42:57,444 ADDRESS THAT ONE? 1255 00:42:57,444 --> 00:43:00,513 >> ACTUALLY I'M SURE ANDY CAN 1256 00:43:00,513 --> 00:43:01,781 HANDLE THIS MUCH MORE ELOQUENTLY 1257 00:43:01,781 --> 00:43:03,883 THAN I CAN, BUT IF I UNDERSTAND 1258 00:43:03,883 --> 00:43:05,185 ESSENTIALLY WHAT YOU'RE TRYING 1259 00:43:05,185 --> 00:43:09,456 TO ASK IS, IF THERE'S A TEAM 1260 00:43:09,456 --> 00:43:12,859 ACTUALLY -- 1261 00:43:12,859 --> 00:43:17,163 >> DID WE LOSE TONY? 1262 00:43:17,163 --> 00:43:18,331 >> I THINK WE MIGHT HAVE. 1263 00:43:18,331 --> 00:43:19,232 >> OKAY. 1264 00:43:19,232 --> 00:43:20,133 I'LL JUMP IN HERE. 1265 00:43:20,133 --> 00:43:24,003 SORRY ABOUT THAT. 1266 00:43:24,003 --> 00:43:26,072 >> -- AN ADVOCATE ALREADY 1267 00:43:26,072 --> 00:43:26,706 POSSIBLE SO -- 1268 00:43:26,706 --> 00:43:28,608 >> TONY, WE LOST YOU FOR MAYBE 1269 00:43:28,608 --> 00:43:30,477 ABOUT, I DON'T KNOW, 20, 1270 00:43:30,477 --> 00:43:30,977 30 SECONDS OR SO. 1271 00:43:30,977 --> 00:43:34,080 >> OH, NO. 1272 00:43:34,080 --> 00:43:36,916 I'M -- 1273 00:43:36,916 --> 00:43:38,384 >> I'M GOING TO SUGGEST THAT YOU 1274 00:43:38,384 --> 00:43:40,220 GO AHEAD AND ANSWER, ANDY. 1275 00:43:40,220 --> 00:43:41,087 >> I WILL. 1276 00:43:41,087 --> 00:43:42,188 >> THANKS, ANDY. 1277 00:43:42,188 --> 00:43:45,625 >> BE HAPPY TO. 1278 00:43:45,625 --> 00:43:46,793 SO THE FIRST THING -- 1279 00:43:46,793 --> 00:43:47,727 >> I'M SORRY. 1280 00:43:47,727 --> 00:43:49,062 >> TONY, YOU'RE CUTTING OUT SO 1281 00:43:49,062 --> 00:43:50,597 I'M GOING TO GO AHEAD AND FIELD 1282 00:43:50,597 --> 00:43:50,897 THIS ONE. 1283 00:43:50,897 --> 00:43:53,199 SO THE FIRST THING TO SAY MAYBE 1284 00:43:53,199 --> 00:43:55,168 IS THAT THE APPLICANTS IN TERMS 1285 00:43:55,168 --> 00:43:58,605 OF ELIGIBILITY ARE THE RESEARCH 1286 00:43:58,605 --> 00:44:00,039 INSTITUTION, SO THEY'RE THE LEAD 1287 00:44:00,039 --> 00:44:01,674 ON PUTTING THE APPLICATION 1288 00:44:01,674 --> 00:44:03,309 TOGETHER AND THEN THE 1289 00:44:03,309 --> 00:44:05,211 EXPECTATION IS THAT THEY WILL 1290 00:44:05,211 --> 00:44:06,880 ENGAGE WITH ADVOCATES TO JOIN 1291 00:44:06,880 --> 00:44:09,716 THAT TEAM AS PART OF THE OVERALL 1292 00:44:09,716 --> 00:44:13,019 APPLICATION THAT THEY WRITE. 1293 00:44:13,019 --> 00:44:15,421 THERE IS A POLICY THAT WE 1294 00:44:15,421 --> 00:44:17,624 GENERALLY DO NOT ALLOW THE SAME 1295 00:44:17,624 --> 00:44:20,260 ADVOCATE TO SERVE ON MULTIPLE 1296 00:44:20,260 --> 00:44:26,933 TEAMS. 1297 00:44:26,933 --> 00:44:27,767 SO AS LONG AS SOMEONE INVOLVED 1298 00:44:27,767 --> 00:44:30,537 IN THE ORGANIZATION, IT'S A 1299 00:44:30,537 --> 00:44:31,571 DIFFERENT PERSON THAN THE TEAM 1300 00:44:31,571 --> 00:44:32,972 THAT'S ALREADY STARTED, THERE'S 1301 00:44:32,972 --> 00:44:34,307 NO RESTRICTION ON THAT SAME 1302 00:44:34,307 --> 00:44:35,642 ORGANIZATION BECOMING INVOLVED. 1303 00:44:35,642 --> 00:44:36,609 DOES THAT ANSWER THE QUESTION 1304 00:44:36,609 --> 00:44:38,578 THAT YOU ASKED? 1305 00:44:38,578 --> 00:44:40,146 >> I THINK SO, YEAH. 1306 00:44:40,146 --> 00:44:41,915 I WAS WONDERING IF, FOR EXAMPLE, 1307 00:44:41,915 --> 00:44:43,316 LIKE ONE OF OUR COLLEAGUES HERE 1308 00:44:43,316 --> 00:44:44,851 WANTED TO BE PART OF A TEAM, IF 1309 00:44:44,851 --> 00:44:46,452 THEY WERE NOT ABLE TO, IF THERE 1310 00:44:46,452 --> 00:44:47,420 WAS CONFLICT OF INTEREST OR 1311 00:44:47,420 --> 00:44:47,854 ANYTHING LIKE THAT. 1312 00:44:47,854 --> 00:44:49,322 >> NO RESTRICTION AT ALL ON 1313 00:44:49,322 --> 00:44:49,656 THAT. 1314 00:44:49,656 --> 00:44:51,291 AND IF YOU HAVE OTHER QUESTIONS, 1315 00:44:51,291 --> 00:44:52,392 PLEASE DON'T HESITATE TO REACH 1316 00:44:52,392 --> 00:44:52,792 OUT. 1317 00:44:52,792 --> 00:44:58,464 HAPPY TO GO INTO MORE DETAILS. 1318 00:44:58,464 --> 00:44:59,766 >> MARTY, DID YOU HAVE A 1319 00:44:59,766 --> 00:45:00,033 QUESTION? 1320 00:45:00,033 --> 00:45:00,533 >> I DO. 1321 00:45:00,533 --> 00:45:02,468 THANKS FOR THE PRESENTATION, AND 1322 00:45:02,468 --> 00:45:03,970 YOU KNOW, I REALLY APPRECIATE 1323 00:45:03,970 --> 00:45:07,473 THE WORK THAT JOYA AND YELAK ARE 1324 00:45:07,473 --> 00:45:10,977 DOING AS PART OF THE PATIENT 1325 00:45:10,977 --> 00:45:16,649 ADVOCATE PANEL. 1326 00:45:16,649 --> 00:45:17,717 I WONDER IF THERE'S A THOUGHT 1327 00:45:17,717 --> 00:45:19,252 ABOUT EXTENDING THAT KIND OF 1328 00:45:19,252 --> 00:45:20,386 COLLABORATION TO THE PATIENT 1329 00:45:20,386 --> 00:45:20,954 ADVOCATES ON THE INDIVIDUAL 1330 00:45:20,954 --> 00:45:21,588 TEAMS THEMSELVES. 1331 00:45:21,588 --> 00:45:23,256 I KNOW THAT WHEN I WORKED ON A 1332 00:45:23,256 --> 00:45:25,525 PROJECT AS A PATIENT ADVOCATE, 1333 00:45:25,525 --> 00:45:27,460 SOMETIMES ACTUALLY TALKING TO 1334 00:45:27,460 --> 00:45:29,963 AND SPENDING TIME WITH PATIENT 1335 00:45:29,963 --> 00:45:32,365 ADVOCATES ON SEPARATE BUT 1336 00:45:32,365 --> 00:45:33,700 COMPARABLE PROJECTS KIND OF 1337 00:45:33,700 --> 00:45:35,034 ENERGIZES ME, BUT ALSO GIVES ME 1338 00:45:35,034 --> 00:45:37,537 SOME REALLY GOOD INFORMATION AND 1339 00:45:37,537 --> 00:45:38,938 IDEAS ON HOW TO BE MORE 1340 00:45:38,938 --> 00:45:39,839 EFFECTIVE. 1341 00:45:39,839 --> 00:45:41,941 SO WONDERING IF THERE'S ANY 1342 00:45:41,941 --> 00:45:44,010 POSSIBILITY OF THE PATIENT 1343 00:45:44,010 --> 00:45:45,245 ADVOCATES ON THE INDIVIDUAL 1344 00:45:45,245 --> 00:45:47,313 PROJECTS GETTING TOGETHER, 1345 00:45:47,313 --> 00:45:48,781 COLLABORATING AT ONE POINT OR 1346 00:45:48,781 --> 00:45:52,952 ANOTHER. 1347 00:45:52,952 --> 00:45:54,554 >> I'LL GIVE A QUICK RESPONSE TO 1348 00:45:54,554 --> 00:45:56,756 THAT AND HAPPY TO HEAR MORE FROM 1349 00:45:56,756 --> 00:45:57,690 YELAK AND JOYA. 1350 00:45:57,690 --> 00:45:58,858 ONE OF THE THINGS WE DO EACH 1351 00:45:58,858 --> 00:46:01,828 YEAR IS WE HOLD CANCER GRAND 1352 00:46:01,828 --> 00:46:03,162 CHALLENGES ANNUAL SUMMIT, WHICH 1353 00:46:03,162 --> 00:46:04,597 IS AN OPPORTUNITY FOR ALL THE 1354 00:46:04,597 --> 00:46:06,032 TEAMS TO COME TOGETHER AND 1355 00:46:06,032 --> 00:46:08,434 PRESENT ON THEIR RESEARCH, AS 1356 00:46:08,434 --> 00:46:10,737 WELL AS NETWORK AND JUST SHARE 1357 00:46:10,737 --> 00:46:13,840 AMONGST THEMSELVES SOME OF THE 1358 00:46:13,840 --> 00:46:15,375 THINGS THAT ARE HAPPENING WITH 1359 00:46:15,375 --> 00:46:16,276 THEIR TEAMS. 1360 00:46:16,276 --> 00:46:18,111 THE PATIENT ADVOCATES HAVE 1361 00:46:18,111 --> 00:46:19,245 REALLY USED THAT AS AN 1362 00:46:19,245 --> 00:46:20,146 OPPORTUNITY TO HAVE SOME OF 1363 00:46:20,146 --> 00:46:21,681 THEIR OWN DISCUSSIONS AROUND 1364 00:46:21,681 --> 00:46:22,982 WHAT THEY'RE DOING AND WHAT THEY 1365 00:46:22,982 --> 00:46:24,517 CAN LEARN FROM EACH OTHER, SO 1366 00:46:24,517 --> 00:46:26,853 THAT'S THEN I THINK A REALLY 1367 00:46:26,853 --> 00:46:28,288 RICH OPPORTUNITY FOR SOME 1368 00:46:28,288 --> 00:46:28,621 LEARNINGS. 1369 00:46:28,621 --> 00:46:30,056 THERE ARE SOME OTHER THINGS THAT 1370 00:46:30,056 --> 00:46:31,925 ARE ALSO HAPPENING IN THE 1371 00:46:31,925 --> 00:46:32,659 BACKGROUND. 1372 00:46:32,659 --> 00:46:34,994 WE'VE RECENTLY MADE SOME 1373 00:46:34,994 --> 00:46:37,330 ATTEMPTS TO DO SOME MORE 1374 00:46:37,330 --> 00:46:40,133 INFORMAL VIRTUAL MEETINGS THAT 1375 00:46:40,133 --> 00:46:41,501 INVOLVE PATIENT ADVOCATES FROM 1376 00:46:41,501 --> 00:46:43,469 ACROSS THE TEAMS TO DO EXACTLY 1377 00:46:43,469 --> 00:46:45,104 THE KIND OF THING AND HAVE 1378 00:46:45,104 --> 00:46:46,906 EXACTLY THE KIND OF INTERACTIONS 1379 00:46:46,906 --> 00:46:47,974 THAT YOU'RE TALKING ABOUT. 1380 00:46:47,974 --> 00:46:49,642 BUT I'M GOING TO STOP THERE AND 1381 00:46:49,642 --> 00:46:51,978 SEE IF YELAK OR JOYA WANT TO SAY 1382 00:46:51,978 --> 00:46:52,178 MORE. 1383 00:46:52,178 --> 00:46:53,713 >> SO ONE OF THE THINGS THAT 1384 00:46:53,713 --> 00:46:56,783 ANDREA STARTED RECENTLY IS OUR 1385 00:46:56,783 --> 00:46:57,684 QUARTERLY CHATS BETWEEN 1386 00:46:57,684 --> 00:46:59,018 ADVOCATES. 1387 00:46:59,018 --> 00:47:01,120 AND ALMOST LIKE A WORKING 1388 00:47:01,120 --> 00:47:04,190 SESSION EXPERIENCE SHARING 1389 00:47:04,190 --> 00:47:05,591 SESSION BETWEEN ADVOCATES. 1390 00:47:05,591 --> 00:47:08,695 WITHIN THE PROJECTS BUT ALSO 1391 00:47:08,695 --> 00:47:10,229 WITHIN THE CANCER GRAND 1392 00:47:10,229 --> 00:47:12,732 CHALLENGE ADVOCATES AT THE UPPER 1393 00:47:12,732 --> 00:47:13,066 LEVEL. 1394 00:47:13,066 --> 00:47:15,501 SO I THINK AS YOU KNOW, THE MORE 1395 00:47:15,501 --> 00:47:20,440 YOU KNOW PEOPLE, THE MORE YOU 1396 00:47:20,440 --> 00:47:27,013 WORK -- FOR EXAMPLE, SOME OF YOU 1397 00:47:27,013 --> 00:47:29,015 MAY NOT KNOW, BUT JOYA IS 1398 00:47:29,015 --> 00:47:30,817 EXCELLENT WITH SELFIES, FOR 1399 00:47:30,817 --> 00:47:32,185 EXAMPLE. 1400 00:47:32,185 --> 00:47:33,286 SO SOMEBODY AT TA LEVEL, YOU ARE 1401 00:47:33,286 --> 00:47:36,622 ABLE TO WORK MORE WITH THEM. 1402 00:47:36,622 --> 00:47:38,257 >> THAT'S MY CLAIM TO FAME, 1403 00:47:38,257 --> 00:47:41,527 APPARENTLY. 1404 00:47:41,527 --> 00:47:44,097 JUST TO PIGGY BACK OFF THAT, THE 1405 00:47:44,097 --> 00:47:45,331 CANCER ADVOCACY CAFE, I BELIEVE 1406 00:47:45,331 --> 00:47:48,034 IS WHAT IT'S CALLED, IS A NICE 1407 00:47:48,034 --> 00:47:50,036 OPPORTUNITY TO INTERACT WITH 1408 00:47:50,036 --> 00:47:51,571 ADVOCATES AND, OF COURSE, AS WAS 1409 00:47:51,571 --> 00:47:53,473 ALREADY MENTIONED, THE SUMMIT. 1410 00:47:53,473 --> 00:47:56,109 IT JUST RECHARGES YOU AND, LIKE 1411 00:47:56,109 --> 00:47:58,945 MARTY YOU SAID, IT'S A NICE WAY 1412 00:47:58,945 --> 00:47:59,946 TO -- IT'S AN EFFECTIVE WAY TO 1413 00:47:59,946 --> 00:48:01,414 GET TO KNOW PEOPLE AND TO SHARE 1414 00:48:01,414 --> 00:48:06,986 EXPERIENCES AND TO JUST GLEAN 1415 00:48:06,986 --> 00:48:08,087 INSIGHTS OFF OF EACH OTHER. 1416 00:48:08,087 --> 00:48:13,126 SO POINT TAKEN. 1417 00:48:13,126 --> 00:48:15,461 >> THAT'S FANTASTIC, THANK YOU. 1418 00:48:15,461 --> 00:48:16,329 NICOLE, YOU'VE BEEN WAITING 1419 00:48:16,329 --> 00:48:16,896 PATIENTLY. 1420 00:48:16,896 --> 00:48:17,563 >> HI. 1421 00:48:17,563 --> 00:48:22,702 I HAVE A QUESTION FOR FROM JOYA 1422 00:48:22,702 --> 00:48:24,604 AND YELAK'S PERSPECTIVE AS WELL 1423 00:48:24,604 --> 00:48:27,573 AS LEE'S BEING ON A PROJECT, 1424 00:48:27,573 --> 00:48:29,809 WHAT WOULD YOU SAY IS OR 1425 00:48:29,809 --> 00:48:32,612 ESTIMATE YOUR TIME COMMITMENT IS 1426 00:48:32,612 --> 00:48:35,982 AS YOUR INVOLVEMENT IN BOTH THE 1427 00:48:35,982 --> 00:48:37,083 PANEL AND IN THE PROJECT? 1428 00:48:37,083 --> 00:48:38,551 THESE ARE JUST SUCH LARGE 1429 00:48:38,551 --> 00:48:40,953 PROJECTS AND I WAS JUST CURIOUS, 1430 00:48:40,953 --> 00:48:41,788 ESPECIALLY HEARING ALL THE 1431 00:48:41,788 --> 00:48:42,822 DIFFERENT COMPONENTS WITH THE 1432 00:48:42,822 --> 00:48:45,258 SUMMIT AND THE TELECONFERENCES, 1433 00:48:45,258 --> 00:48:46,392 BECAUSE WE ALL WEAR A LOT OF 1434 00:48:46,392 --> 00:48:47,026 HATS. 1435 00:48:47,026 --> 00:48:48,661 JUST CURIOUS WHAT THE TIME 1436 00:48:48,661 --> 00:48:49,862 COMMITMENT IS FOR BEING 1437 00:48:49,862 --> 00:48:56,502 INVOLVED. 1438 00:48:56,502 --> 00:48:58,137 >> FROM MY PERSPECTIVE, PUTTING 1439 00:48:58,137 --> 00:48:59,639 TOGETHER THE PROPOSAL FOR THE 1440 00:48:59,639 --> 00:49:01,674 CACHEXIA PROJECT WHERE IT WAS 1441 00:49:01,674 --> 00:49:03,176 BASICALLY I WAS LEADING THE 1442 00:49:03,176 --> 00:49:04,610 ADVOCACY WORK, THAT WAS 1443 00:49:04,610 --> 00:49:05,378 INCREDIBLY TIME-CONSUMING, 1444 00:49:05,378 --> 00:49:06,479 BECAUSE WE COULDN'T TRAVEL TO 1445 00:49:06,479 --> 00:49:07,947 LONDON FOR THE PRESENTATION. 1446 00:49:07,947 --> 00:49:12,318 WE DID A ZOOM, PRE-RECORDED ZOOM 1447 00:49:12,318 --> 00:49:12,885 PRESENTATION. 1448 00:49:12,885 --> 00:49:14,754 ACTUALLY HAD A VIDEOGRAPHER COME 1449 00:49:14,754 --> 00:49:17,056 OUT TO MY HOUSE WITH A LIGHTING 1450 00:49:17,056 --> 00:49:18,291 PERSON, AND WE DID IT AT MY 1451 00:49:18,291 --> 00:49:20,960 HOUSE. 1452 00:49:20,960 --> 00:49:22,929 THAT REALLY TOOK A LOT OF TIME. 1453 00:49:22,929 --> 00:49:25,665 DAY TO DAY, THERE IS NOT AN 1454 00:49:25,665 --> 00:49:26,199 INCREDIBLE DEMAND. 1455 00:49:26,199 --> 00:49:31,404 WE HAVE MONTHLY MEETINGS FOR AN 1456 00:49:31,404 --> 00:49:32,505 HOUR, SO THERE'S THAT. 1457 00:49:32,505 --> 00:49:36,876 THEN WE HAVE OTHER SMALLER 1458 00:49:36,876 --> 00:49:37,877 MEETINGS, SMALLER GROUPS. 1459 00:49:37,877 --> 00:49:41,280 WE HAD WORK PACKAGES, SIX WORK 1460 00:49:41,280 --> 00:49:43,182 PACKAGES, SO YOU'RE ASSIGNED TO 1461 00:49:43,182 --> 00:49:44,617 A WORK PACKAGE AND YOU HAD A 1462 00:49:44,617 --> 00:49:46,052 TEAM MEETING AND THEN WORK 1463 00:49:46,052 --> 00:49:46,886 PACKAGE MEETINGS. 1464 00:49:46,886 --> 00:49:49,522 SO MAYBE TWO MEETINGS A MONTH, 1465 00:49:49,522 --> 00:49:52,959 REVIEWING DOCUMENTS, REVIEWING 1466 00:49:52,959 --> 00:49:53,426 PAPERS. 1467 00:49:53,426 --> 00:49:57,263 IT REALLY WAS NOT ODIOUS, IT 1468 00:49:57,263 --> 00:50:01,501 WASN'T OVERWHELMING. 1469 00:50:01,501 --> 00:50:03,669 >> FOR US, THE FIRST FOUR MONTHS 1470 00:50:03,669 --> 00:50:05,104 WAS, I THINK, THE MOST DEMANDING 1471 00:50:05,104 --> 00:50:07,273 FROM A TIMING PERSPECTIVE, 1472 00:50:07,273 --> 00:50:09,342 BECAUSE THAT WAS WHEN THE 1473 00:50:09,342 --> 00:50:12,979 PROPOSALS WERE BEING SUBMITTED, 1474 00:50:12,979 --> 00:50:14,147 WE WERE READING THROUGH THEM, WE 1475 00:50:14,147 --> 00:50:15,982 WERE PROVIDING COMMENTS, WE WERE 1476 00:50:15,982 --> 00:50:16,749 HAVING INTERNAL MEETINGS WITH 1477 00:50:16,749 --> 00:50:17,950 EACH OTHER TO PROVIDE COMMENTS 1478 00:50:17,950 --> 00:50:22,755 BACK TO THEM, AND THEN WE WERE 1479 00:50:22,755 --> 00:50:23,923 REVIEWING THE PROPOSALS THAT 1480 00:50:23,923 --> 00:50:26,192 WERE SUBMITTED. 1481 00:50:26,192 --> 00:50:30,463 AND THEN AS ANDY MENTIONED, THE 1482 00:50:30,463 --> 00:50:32,165 CONFERENCE HAPPENED IN THE 1483 00:50:32,165 --> 00:50:35,468 MARCH/APRIL TIME FRAME, SO FOR 1484 00:50:35,468 --> 00:50:37,737 ME AT LEAST, JANUARY, FEBRUARY, 1485 00:50:37,737 --> 00:50:38,905 MARCH, APRIL PROBABLY REQUIRED A 1486 00:50:38,905 --> 00:50:40,339 COUPLE OF HOURS A WEEK, BUT THEN 1487 00:50:40,339 --> 00:50:42,842 IT HAS FALLEN OFF FROM HOW MUCH 1488 00:50:42,842 --> 00:50:44,810 TIME IT IS REQUIRING. 1489 00:50:44,810 --> 00:50:45,678 >> AGREED. 1490 00:50:45,678 --> 00:50:48,014 I WAS TRYING TO TALLEY HOURS AND 1491 00:50:48,014 --> 00:50:49,549 I CAN'T GIVE YOU EXACTLY BUT I 1492 00:50:49,549 --> 00:50:52,018 THINK JUST WHAT YELAK SAID, IT 1493 00:50:52,018 --> 00:50:53,219 WAS CERTAINLY SOME HOURS ON THE 1494 00:50:53,219 --> 00:50:55,821 FRONT END BUT THEN IT KIND OF 1495 00:50:55,821 --> 00:50:57,823 TAPERED DOWN, BUT WHAT'S NICE IS 1496 00:50:57,823 --> 00:50:59,625 ANDREA DID A FANTASTIC JOB OF 1497 00:50:59,625 --> 00:51:01,260 HELPING US ORGANIZE OUR TIME, 1498 00:51:01,260 --> 00:51:03,596 JUST READING, JUST LIKE ALL THE 1499 00:51:03,596 --> 00:51:04,463 OTHER AFFILIATIONS WE ALL HAVE, 1500 00:51:04,463 --> 00:51:05,464 YOU KIND OF KNOW WHAT IT'S GOING 1501 00:51:05,464 --> 00:51:08,768 TO BE, BUT NOTHING WAS 1502 00:51:08,768 --> 00:51:10,002 OVERWHELMING, JUST WHEN YOU HAD 1503 00:51:10,002 --> 00:51:12,171 TO PUT A LITTLE MORE TIME VERSUS 1504 00:51:12,171 --> 00:51:13,839 IT WOULD KIND OF TAPER OFF. 1505 00:51:13,839 --> 00:51:15,441 >> THANK YOU. 1506 00:51:15,441 --> 00:51:16,475 >> IT WAS REASONABLE. 1507 00:51:16,475 --> 00:51:17,610 >> THANK YOU ALL SO MUCH. 1508 00:51:17,610 --> 00:51:21,214 AND VICKIE. 1509 00:51:21,214 --> 00:51:21,747 >> THANK YOU. 1510 00:51:21,747 --> 00:51:26,085 I THINK THIS IS WONDERFUL AND 1511 00:51:26,085 --> 00:51:29,922 THE WAY SOMETHING AS CRAFTY AND 1512 00:51:29,922 --> 00:51:32,191 HARD TO CRACK AS CANCER SHOULD 1513 00:51:32,191 --> 00:51:34,527 BE DONE IN TEAMS. 1514 00:51:34,527 --> 00:51:35,761 ONE OF THE QUESTIONS THAT I HAVE 1515 00:51:35,761 --> 00:51:38,831 GENERALLY, I LOVED HEARING ABOUT 1516 00:51:38,831 --> 00:51:40,900 THE KIND OF REFINEMENT OF 1517 00:51:40,900 --> 00:51:42,702 LANGUAGE, ABOUT LEE'S EXPERIENCE 1518 00:51:42,702 --> 00:51:45,571 OVER A LONGER PERIOD, AND EVEN 1519 00:51:45,571 --> 00:51:47,740 HAVING ADVOCATE CAFE. 1520 00:51:47,740 --> 00:51:49,775 IS SOMEONE ACTUALLY CAPTURING 1521 00:51:49,775 --> 00:51:54,180 THE LEARNINGS AS THE ROLE OF 1522 00:51:54,180 --> 00:51:56,882 ADVOCATES HAVE BECOME SO MUCH 1523 00:51:56,882 --> 00:51:59,018 MORE ENTRENCHED IN THE RESEARCH 1524 00:51:59,018 --> 00:52:01,654 PROCESS SO THAT EVERY TIME WE DO 1525 00:52:01,654 --> 00:52:03,823 SOMETHING NEW, WE DON'T HAVE TO 1526 00:52:03,823 --> 00:52:07,660 RE-LEARN THOSE STEPS, AND CAN 1527 00:52:07,660 --> 00:52:13,733 YOU TALK ABOUT THAT AT ALL? 1528 00:52:13,733 --> 00:52:15,134 >> I CAN START AND ANDY AND 1529 00:52:15,134 --> 00:52:16,002 OTHERS CAN CHIME IN. 1530 00:52:16,002 --> 00:52:17,403 ONE OF THE THINGS THAT I 1531 00:52:17,403 --> 00:52:19,238 VOLUNTEERED TO DO, AND WE ARE 1532 00:52:19,238 --> 00:52:21,540 THINKING THROUGH, IS CREATING A 1533 00:52:21,540 --> 00:52:23,476 WHITE PAPER THAT WILL END UP 1534 00:52:23,476 --> 00:52:24,343 PUBLISHING, SO OTHERS CAN 1535 00:52:24,343 --> 00:52:25,211 ACTUALLY USE THAT. 1536 00:52:25,211 --> 00:52:27,513 AND THEY DON'T HAVE TO RE-CREATE 1537 00:52:27,513 --> 00:52:29,815 THIS. 1538 00:52:29,815 --> 00:52:31,517 ALSO, A PATIENT ADVOCATE WHO'S 1539 00:52:31,517 --> 00:52:32,818 CONSIDERING MEMBERSHIP EITHER AT 1540 00:52:32,818 --> 00:52:35,855 A PROJECT LEVEL OR AT THE CANCER 1541 00:52:35,855 --> 00:52:37,356 GRAND CHALLENGE LEVEL, YOU WOULD 1542 00:52:37,356 --> 00:52:39,225 HAVE A BETTER UNDERSTANDING OF 1543 00:52:39,225 --> 00:52:41,961 WHAT IS REQUIRED OF YOU 1544 00:52:41,961 --> 00:52:43,696 THROUGHOUT YOUR TENURE, EITHER 1545 00:52:43,696 --> 00:52:47,833 THE FIVE-YEAR OR THE TWO OR 1546 00:52:47,833 --> 00:52:48,467 THREE-YEAR TENURE THERE. 1547 00:52:48,467 --> 00:52:51,871 SO THAT IS MY NEXT IMMEDIATE 1548 00:52:51,871 --> 00:52:57,643 NEXT STEPS, IF YOU WOULD. 1549 00:52:57,643 --> 00:52:59,045 >> WERE YOU GOING TO SAY 1550 00:52:59,045 --> 00:52:59,445 SOMETHING, AMY? 1551 00:52:59,445 --> 00:53:00,012 >> SURE. 1552 00:53:00,012 --> 00:53:01,714 I WAS ACTUALLY GOING TO DEFER TO 1553 00:53:01,714 --> 00:53:03,716 ANDY FIRST AND THEN I CAN SORT 1554 00:53:03,716 --> 00:53:04,583 OF CHIME IN. 1555 00:53:04,583 --> 00:53:06,085 >> I WAS JUST GOING TO MENTION 1556 00:53:06,085 --> 00:53:07,086 ONE THING. 1557 00:53:07,086 --> 00:53:08,254 SO LEE WILL KNOW THIS BETTER 1558 00:53:08,254 --> 00:53:10,156 THAN I DO, BUT ONE OF THE 1559 00:53:10,156 --> 00:53:11,857 PATIENT ADVOCATES ON THE 1560 00:53:11,857 --> 00:53:13,359 OPTIMISTICC TEAM NAMED LAURA 1561 00:53:13,359 --> 00:53:15,695 PORTER PUBLISHED A REALLY 1562 00:53:15,695 --> 00:53:17,897 TERRIFIC ARTICLE ON SORT OF SOME 1563 00:53:17,897 --> 00:53:19,732 GENERAL PERSPECTIVES ON PATIENT 1564 00:53:19,732 --> 00:53:22,535 ADVOCACY, WHICH I CAN ONLY 1565 00:53:22,535 --> 00:53:24,403 ASSUME WERE INFORMED BY HER 1566 00:53:24,403 --> 00:53:28,474 EXPERIENCE ON THE OT MYS OPTIMIC 1567 00:53:28,474 --> 00:53:28,674 TEAM. 1568 00:53:28,674 --> 00:53:31,010 I WAS TRYING TO PULL THAT UP 1569 00:53:31,010 --> 00:53:32,311 QUICKLY TO FIND THE LINK BUT I 1570 00:53:32,311 --> 00:53:33,813 HAVEN'T FOUND IT JUST YET. 1571 00:53:33,813 --> 00:53:34,914 I GUESS THE OTHER THING TO 1572 00:53:34,914 --> 00:53:35,915 MENTION IS THAT AT THE ANNUAL 1573 00:53:35,915 --> 00:53:38,617 SUMMIT THIS YEAR, AS I ALLUDED 1574 00:53:38,617 --> 00:53:40,219 TO, THERE WAS A RECOGNITION THAT 1575 00:53:40,219 --> 00:53:41,520 THERE ARE SOME PRETTY 1576 00:53:41,520 --> 00:53:43,622 SIGNIFICANT LEARNINGS THAT HAVE 1577 00:53:43,622 --> 00:53:45,024 HAPPENED JUST A COUPLE OF YEARS 1578 00:53:45,024 --> 00:53:46,425 INTO SOME OF THESE TEAMS THAT 1579 00:53:46,425 --> 00:53:48,694 REALLY NEED TO BE SHARED ACROSS 1580 00:53:48,694 --> 00:53:49,895 ALL THE TEAMS. 1581 00:53:49,895 --> 00:53:51,764 AND SO THERE IS AN EFFORT 1582 00:53:51,764 --> 00:53:53,366 UNDERWAY, I THINK, FOR THE 1583 00:53:53,366 --> 00:53:55,868 INTERNAL PROGRAM TEAM TO START 1584 00:53:55,868 --> 00:53:58,170 CAPTURING THESE THINGS IN SOME 1585 00:53:58,170 --> 00:53:59,538 NOTES AND I THINK WE HAVE SOME 1586 00:53:59,538 --> 00:54:01,841 MORE THINKING TO DO ABOUT HOW WE 1587 00:54:01,841 --> 00:54:03,476 MAKE SURE THOSE DON'T GET LOST, 1588 00:54:03,476 --> 00:54:05,144 BUT THAT IS HAPPENING IN THE 1589 00:54:05,144 --> 00:54:06,178 BACKGROUND, SO WE DON'T LOSE 1590 00:54:06,178 --> 00:54:09,148 THOSE VALUABLE INSIGHTS. 1591 00:54:09,148 --> 00:54:11,984 >> I WOULD JUST JUMP IN, ANDY, 1592 00:54:11,984 --> 00:54:14,687 I'M SORRY TO INTERRUPT YOU, AMY. 1593 00:54:14,687 --> 00:54:15,988 BUT THE WAY THAT ADVOCATES WOULD 1594 00:54:15,988 --> 00:54:16,856 LEARN AND GET THAT INFORMATION 1595 00:54:16,856 --> 00:54:19,225 AND SHARE THAT INFORMATION IS 1596 00:54:19,225 --> 00:54:20,760 PROBABLY A LITTLE BIT DIFFERENT 1597 00:54:20,760 --> 00:54:24,130 THAN THE WAY THAT THE RESEAR 1598 00:54:24,130 --> 00:54:24,897 RESEARCHERS WHO ARE NEEDING TO 1599 00:54:24,897 --> 00:54:26,298 WORK WITH ADVOCATES WOULD LEARN, 1600 00:54:26,298 --> 00:54:28,801 SO IT JUST PROBABLY NEEDS TO BE 1601 00:54:28,801 --> 00:54:31,170 A BIMODAL PROCESS FOR IF YOU 1602 00:54:31,170 --> 00:54:32,371 WANT RESEARCHERS TO LEARN ABOUT 1603 00:54:32,371 --> 00:54:33,939 IT, YOU ACTUALLY HAVE TO PUBLISH 1604 00:54:33,939 --> 00:54:35,741 IT IN A JOURNAL SO THAT THEY 1605 00:54:35,741 --> 00:54:37,710 HAVE THAT THERE AND ADVOCATES 1606 00:54:37,710 --> 00:54:42,381 PROBABLY NEED TO HAVE MORE 1607 00:54:42,381 --> 00:54:43,682 SESSIONS, I THINK, WHERE THEY 1608 00:54:43,682 --> 00:54:45,317 CAN LEARN FROM, SO I THINK BOTH 1609 00:54:45,317 --> 00:54:46,585 OF THOSE THINGS ARE REALLY COOL. 1610 00:54:46,585 --> 00:54:48,654 >> THAT'S REALLY GREAT -- 1611 00:54:48,654 --> 00:54:50,356 >> REALLY GOOD POINT. 1612 00:54:50,356 --> 00:54:52,158 POINT WELL TAKEN, VICKIE. 1613 00:54:52,158 --> 00:54:52,458 SORRY, ANDY. 1614 00:54:52,458 --> 00:54:56,629 >> NO, LAURA HAPPENS TO BE A 1615 00:54:56,629 --> 00:54:57,663 PHYSICIAN IN ADDITION TO BEING A 1616 00:54:57,663 --> 00:54:59,532 PATIENT ADVOCATE, WHICH IS 1617 00:54:59,532 --> 00:55:01,834 FANTASTIC, BUT AS YOU SAY, HOW 1618 00:55:01,834 --> 00:55:03,002 WE COMMUNICATE AND DISSEMINATE 1619 00:55:03,002 --> 00:55:04,203 THAT INFORMATION IS SOMETHING WE 1620 00:55:04,203 --> 00:55:05,738 NEED TO THINK CAREFULLY ABOUT, 1621 00:55:05,738 --> 00:55:06,372 SO REALLY APPRECIATE THAT 1622 00:55:06,372 --> 00:55:09,909 COMMENT. 1623 00:55:09,909 --> 00:55:10,943 >> ABSOLUTELY. 1624 00:55:10,943 --> 00:55:14,447 AND JUST SORT OF TO TIE A LOT OF 1625 00:55:14,447 --> 00:55:15,748 THE DIFFERENT DISCUSSION THREADS 1626 00:55:15,748 --> 00:55:17,583 TOGETHER, I THINK ONE OF THE 1627 00:55:17,583 --> 00:55:19,285 REASONS THE ADVOCACY OFFICE WAS 1628 00:55:19,285 --> 00:55:20,719 INTERESTED IN HAVING ANDY 1629 00:55:20,719 --> 00:55:21,921 PRESENT TODAY WAS BECAUSE THIS 1630 00:55:21,921 --> 00:55:24,857 IS SUCH A SORT OF NOVEL WAY THAT 1631 00:55:24,857 --> 00:55:28,794 ADVOCATES ARE ENGAGED, YOU KNOW, 1632 00:55:28,794 --> 00:55:30,329 FROM THE REQUIREMENT IN THE 1633 00:55:30,329 --> 00:55:32,665 APPLICATIONS, FROM THE STEP 1634 00:55:32,665 --> 00:55:33,999 WHERE THEY'RE ACTUALLY DEFINING 1635 00:55:33,999 --> 00:55:35,534 HOW ADVOCATES WILL BE ENGAGED 1636 00:55:35,534 --> 00:55:36,902 AND THEN ADVOCATES ARE REVIEWING 1637 00:55:36,902 --> 00:55:37,803 WHAT IS WRITTEN IN THAT M 1638 00:55:37,803 --> 00:55:39,205 ACATION, AND THEN POTENTIALLY 1639 00:55:39,205 --> 00:55:43,375 HELPING THEM REFINE AND REVISE 1640 00:55:43,375 --> 00:55:45,110 THAT, WITH -- SORT OF TO 1641 00:55:45,110 --> 00:55:45,978 EVERYONE'S POINT, WITH THIS 1642 00:55:45,978 --> 00:55:51,283 EVOLUTION COMES LEARNINGS. 1643 00:55:51,283 --> 00:55:53,252 THE ADVOCATES ARE REQUIRED TO BE 1644 00:55:53,252 --> 00:55:55,087 INVOLVED, THEY GET TO NETWORK 1645 00:55:55,087 --> 00:55:56,188 WITH EACH OTHER ACROSS TEAMS AND 1646 00:55:56,188 --> 00:55:57,490 THEY ALSO HAVE ONGOING 1647 00:55:57,490 --> 00:55:58,791 COMMUNICATION WITH A ADVOCATE 1648 00:55:58,791 --> 00:56:00,559 AND ADVISORY PANEL. 1649 00:56:00,559 --> 00:56:03,162 NOT ALL TEAM SCIENCES HAVE AN 1650 00:56:03,162 --> 00:56:04,463 ADVOCATE ADVISORY PANEL, SO I 1651 00:56:04,463 --> 00:56:06,065 JUST THINK ON MULTIPLE LEVELS, 1652 00:56:06,065 --> 00:56:09,468 IT'S A REALLY COOL WAY TO BRING 1653 00:56:09,468 --> 00:56:10,236 THE COLLECTIVE PATIENT 1654 00:56:10,236 --> 00:56:12,972 PERSPECTIVE TO THE SCIENCE. 1655 00:56:12,972 --> 00:56:15,107 AND SORT OF VICK EE, TO YOUR 1656 00:56:15,107 --> 00:56:15,708 POINTS, AND ONE OF THE THINGS 1657 00:56:15,708 --> 00:56:17,176 THAT I KNOW THE ADVOCACY OFFICE 1658 00:56:17,176 --> 00:56:18,844 HAS ENJOYED SEEING ARE THE MANY 1659 00:56:18,844 --> 00:56:22,414 DIFFERENT ACTIVITIES, NO TEAM IS 1660 00:56:22,414 --> 00:56:25,351 THE SAME, THE WAY THATTED A VO 1661 00:56:25,351 --> 00:56:27,286 CATS ENGAGE ON EACH TEAM IS 1662 00:56:27,286 --> 00:56:28,988 DIFFERENT AND FOR THE ADVOCACY 1663 00:56:28,988 --> 00:56:30,456 COMMUNITY AND FOR US TO BE ABLE 1664 00:56:30,456 --> 00:56:33,659 TO SEE ALL THE DIFFERENT 1665 00:56:33,659 --> 00:56:35,261 ACTIVITIES, SHARE THOSE 1666 00:56:35,261 --> 00:56:36,028 LEARNINGS WITH EACH OTHER, I 1667 00:56:36,028 --> 00:56:40,633 THINK IS VERY IMPORTANT. 1668 00:56:40,633 --> 00:56:44,970 I KNOW OUR PROGRAM STAFFER IS 1669 00:56:44,970 --> 00:56:46,505 MAKING SURE THIS STAYS FRONT AND 1670 00:56:46,505 --> 00:56:48,274 CENTER AND CONTINUES TO BE 1671 00:56:48,274 --> 00:56:52,511 SOMETHING THAT WE PROMOTE AND 1672 00:56:52,511 --> 00:56:56,982 SUPPORT THE EVOLUTION OF IT. 1673 00:56:56,982 --> 00:56:58,851 GO AHEAD, ANNIE. 1674 00:56:58,851 --> 00:57:01,020 >> AND THIS WHOLE THING ABOUT 1675 00:57:01,020 --> 00:57:03,289 HOW PEOPLE ARE USING THE 1676 00:57:03,289 --> 00:57:04,390 ADVOCATES AND DIFFERENT SCIENCE, 1677 00:57:04,390 --> 00:57:06,025 DIFFERENT RESEARCH MAY REQUIRE 1678 00:57:06,025 --> 00:57:08,227 DIFFERENT THINGS, RIGHT, AND 1679 00:57:08,227 --> 00:57:09,929 DIFFERENT RESEARCHERS MAY HAVE 1680 00:57:09,929 --> 00:57:11,030 DIFFERENT EXPERIENCE LEVELS AS 1681 00:57:11,030 --> 00:57:13,532 TO WHAT LEE WAS SAYING, WORKING 1682 00:57:13,532 --> 00:57:15,668 WITH ADVOCATES AND HOW ADVOCATES 1683 00:57:15,668 --> 00:57:17,436 CAN INFORM AND BRING INSIGHTS 1684 00:57:17,436 --> 00:57:18,637 TOLL THEIR WORK. 1685 00:57:18,637 --> 00:57:20,372 I WAS REALLY EXCITED TO HEAR 1686 00:57:20,372 --> 00:57:22,741 THAT THE ADVOCACY PANEL HELPS 1687 00:57:22,741 --> 00:57:26,879 THE APPLICANTS WITH FEEDBACK ON 1688 00:57:26,879 --> 00:57:28,747 HOW TO BETTER USE THEIR 1689 00:57:28,747 --> 00:57:32,284 ADVOCATES OR BETTER INVOLVE -- 1690 00:57:32,284 --> 00:57:34,186 I'M GOING TO GET USED TO THE NEW 1691 00:57:34,186 --> 00:57:35,921 TERMINOLOGY HERE, BETTER INVOLVE 1692 00:57:35,921 --> 00:57:37,957 ADVOCATES IN THE WORK, BUT I'M 1693 00:57:37,957 --> 00:57:38,857 WONDERING IF THERE'S OPPORTUNITY 1694 00:57:38,857 --> 00:57:43,662 HERE AT NCI FOR -- I KNOW THAT 1695 00:57:43,662 --> 00:57:47,666 LIKE WITH THE SPORES, I'M ON TWO 1696 00:57:47,666 --> 00:57:49,768 SPORES AND FROM WHAT I HEAR, 1697 00:57:49,768 --> 00:57:51,170 MANY OF THE SPORES ENGAGE OR 1698 00:57:51,170 --> 00:57:52,371 INVOLVE THEIR ADVOCATE IN 1699 00:57:52,371 --> 00:57:54,006 DIFFERENT WAYS, AND WHEN THERE 1700 00:57:54,006 --> 00:57:55,841 ARE APPLICATIONS OF THAT NATURE, 1701 00:57:55,841 --> 00:57:57,276 IF THERE'S OPPORTUNITY FOR OUR 1702 00:57:57,276 --> 00:57:59,778 BOARD OR SOMETHING SIMILAR TO 1703 00:57:59,778 --> 00:58:01,413 PROVIDE THAT FEEDBACK, AND HOW 1704 00:58:01,413 --> 00:58:05,351 TO REALLY ENGAGE OUR ADVOCATES 1705 00:58:05,351 --> 00:58:08,587 BETTER TO HELP WITH THE WORK. 1706 00:58:08,587 --> 00:58:10,356 BUT THAT PART REALLY GOT ME 1707 00:58:10,356 --> 00:58:11,657 EXCITED, THAT YOU GAVE FEEDBACK, 1708 00:58:11,657 --> 00:58:12,825 YOU SAW CHANGES AND THEN THE 1709 00:58:12,825 --> 00:58:16,128 APPLICATION LOOKED AMAZING. 1710 00:58:16,128 --> 00:58:17,763 WE'RE ABOUT OUT OF TIME, BUT 1711 00:58:17,763 --> 00:58:18,664 JOYA, IF IT'S QUICK. 1712 00:58:18,664 --> 00:58:19,698 >> IT'S QUICK. 1713 00:58:19,698 --> 00:58:21,567 JUST PROBABLY DOESN'T 1714 00:58:21,567 --> 00:58:23,202 NECESSARILY NEED TO BE SAID BUT 1715 00:58:23,202 --> 00:58:24,470 TO AMY'S POINT AND VICKIE'S 1716 00:58:24,470 --> 00:58:25,337 QUESTION, JUST BEFORE THIS CALL 1717 00:58:25,337 --> 00:58:30,175 I GOT OFF A CALL WITH ANDREA 1718 00:58:30,175 --> 00:58:32,011 DELGADO GARCIA, MYSELF AND SOME 1719 00:58:32,011 --> 00:58:33,512 OTHER ADVOCATES FOR A SUBGROUP 1720 00:58:33,512 --> 00:58:36,148 FOR TRAINING FOR -- ON PATIENT 1721 00:58:36,148 --> 00:58:36,749 ADVOCACY. 1722 00:58:36,749 --> 00:58:38,517 SO IT'S NICE TO BE ABLE TO SAY 1723 00:58:38,517 --> 00:58:40,052 OKAY, WE HAD THIS GROUP OF 1724 00:58:40,052 --> 00:58:41,253 PEOPLE, WE HAVE THESE 1725 00:58:41,253 --> 00:58:42,421 RESEARCHERS AND THESE PATIENT 1726 00:58:42,421 --> 00:58:43,756 ADVOCATES, HOW CAN WE PULL A 1727 00:58:43,756 --> 00:58:45,157 GROUP TOGETHER TO HELP DEVELOP A 1728 00:58:45,157 --> 00:58:46,558 TRAINING AND HOW DO WE UTILIZE 1729 00:58:46,558 --> 00:58:49,194 THIS EXPERTISE. 1730 00:58:49,194 --> 00:58:51,397 SO IT'S COMPRISED OF A NICE 1731 00:58:51,397 --> 00:58:52,998 GROUP OF US INCLUDING OUR 1732 00:58:52,998 --> 00:58:54,433 ADVOCACY PANEL MEMBERS AND SOME 1733 00:58:54,433 --> 00:58:56,201 FUTURE LEADERS FROM TWO 1734 00:58:56,201 --> 00:58:58,003 DIFFERENT TEAMS THAT ARE PART OF 1735 00:58:58,003 --> 00:59:02,341 THIS SUBGROUP, TO HELP CREATE 1736 00:59:02,341 --> 00:59:04,410 TRAINING, TO HELP RESEARCHERS 1737 00:59:04,410 --> 00:59:07,513 AND PATIENT ADVOCATES BETTER 1738 00:59:07,513 --> 00:59:09,214 UNDERSTAND WHAT IT MEANS TO BE 1739 00:59:09,214 --> 00:59:10,649 INVOLVED AND ENGAGED IN 1740 00:59:10,649 --> 00:59:11,083 ADVOCACY. 1741 00:59:11,083 --> 00:59:12,551 SO IT'S NICE TO BE ABLE TO 1742 00:59:12,551 --> 00:59:13,752 UTILIZE IN OTHER WAYS AS THE 1743 00:59:13,752 --> 00:59:14,887 NEED ARISES. 1744 00:59:14,887 --> 00:59:16,755 >> AND I'LL JUST COMMENT, 1745 00:59:16,755 --> 00:59:18,157 THERE'S A LOT OF WHAT TO DO OR 1746 00:59:18,157 --> 00:59:19,992 WHAT TO KNOW. 1747 00:59:19,992 --> 00:59:21,160 WHAT'S MISSION FOR ME IN A LOT 1748 00:59:21,160 --> 00:59:24,430 --WHAT'S MISSING FOR ME IN A LT 1749 00:59:24,430 --> 00:59:25,397 OF SPACES IS THE HOW. 1750 00:59:25,397 --> 00:59:27,166 IF YOU CAN GET THAT HOW IN THERE 1751 00:59:27,166 --> 00:59:31,170 MIGHT BE, YOU KNOW, EVEN MORE 1752 00:59:31,170 --> 00:59:31,437 IMPACTFUL. 1753 00:59:31,437 --> 00:59:33,138 >> I THINK THAT'S WHY THE 1754 00:59:33,138 --> 00:59:34,373 SHARING BETWEEN THE ADVOCATE 1755 00:59:34,373 --> 00:59:38,277 TEAMS, RIGHT, THE HOW IS ALWAYS 1756 00:59:38,277 --> 00:59:38,844 THE QUESTION. 1757 00:59:38,844 --> 00:59:41,346 >> IT'S NEBULOUS. 1758 00:59:41,346 --> 00:59:43,916 WELL, THANK YOU SO MUCH, ANDY, 1759 00:59:43,916 --> 00:59:45,784 AND TONY, FOR BEING HERE AND 1760 00:59:45,784 --> 00:59:48,721 SHARING, AND JOYA, YELAK AND 1761 00:59:48,721 --> 00:59:50,889 LEE, SHARING YOUR PERSONAL 1762 00:59:50,889 --> 00:59:51,890 EXPERIENCES BEING INVOLVED WITH 1763 00:59:51,890 --> 00:59:53,425 PATIENT ADVOCATES. 1764 00:59:53,425 --> 00:59:57,329 WE WERE -- THIS WAS VE A VERY 1765 00:59:57,329 --> 00:59:59,832 EXCITING DISCUSSION, AND NOW WE 1766 00:59:59,832 --> 01:00:02,367 HAVE -- I AM GOING TO INTRODUCE 1767 01:00:02,367 --> 01:00:06,038 MISS GIBBONS, WHO IS OUR -- HOLD 1768 01:00:06,038 --> 01:00:09,007 ON HERE -- DEPUTY DIRECTOR OF 1769 01:00:09,007 --> 01:00:10,409 NCI OFFICE OF GOVERNMENT AND 1770 01:00:10,409 --> 01:00:12,277 CONGRESSIONAL RELATIONS TO 1771 01:00:12,277 --> 01:00:14,012 DELIVER THE LEGISLATIVE REPORT. 1772 01:00:14,012 --> 01:00:16,081 THANK YOU SO MUCH FOR BEING WITH 1773 01:00:16,081 --> 01:00:16,849 US, HOLLY. 1774 01:00:16,849 --> 01:00:18,717 >> THANKS SO MUCH, ANNIE. 1775 01:00:18,717 --> 01:00:20,152 THANKS, EVERYONE, FOR HAVING ME. 1776 01:00:20,152 --> 01:00:22,421 WE CAN MOVE TO THE NEXT SLIDE. 1777 01:00:22,421 --> 01:00:24,356 SO TODAY, I'LL FOCUS THE BULK OF 1778 01:00:24,356 --> 01:00:26,425 MY UPDATE ON APPROPRIATIONS 1779 01:00:26,425 --> 01:00:29,261 ACTIVITY AND WHERE WE ARE IN THE 1780 01:00:29,261 --> 01:00:31,463 FY 2025 PROCESS. 1781 01:00:31,463 --> 01:00:34,166 I'LL HIGHLIGHT A FEW LEGISLATIVE 1782 01:00:34,166 --> 01:00:35,367 EFFORTS OF INTEREST WHICH ARE 1783 01:00:35,367 --> 01:00:37,336 COVERED IN MORE DETAIL IN YOUR 1784 01:00:37,336 --> 01:00:39,071 WRITTEN UPDATE, AND I'LL CLOSE 1785 01:00:39,071 --> 01:00:41,940 WITH SOME HIGHLIGHTS OF RECENT 1786 01:00:41,940 --> 01:00:42,674 CONGRESSIONAL ENGAGEMENT 1787 01:00:42,674 --> 01:00:43,876 INCLUDING FROM THE ADVOCACY 1788 01:00:43,876 --> 01:00:44,510 COMMUNITY. 1789 01:00:44,510 --> 01:00:48,480 SO TO RECAP, THE FY 24 1790 01:00:48,480 --> 01:00:49,348 APPROPRIATIONS WERE ENACTED 1791 01:00:49,348 --> 01:00:50,349 ABOUT HALFWAY INTO THE FISCAL 1792 01:00:50,349 --> 01:00:51,717 YEAR IN MARCH, AND WE WERE 1793 01:00:51,717 --> 01:00:53,285 ENCOURAGED TO SEE THAT CONGRESS 1794 01:00:53,285 --> 01:00:57,189 PROVIDED A BASE INCREASE FOR NCI 1795 01:00:57,189 --> 01:00:59,491 OF $120 MILLION. 1796 01:00:59,491 --> 01:01:00,459 THIS WAS PARTICULARLY 1797 01:01:00,459 --> 01:01:01,894 SIGNIFICANT AND A SHOW OF 1798 01:01:01,894 --> 01:01:03,095 BIPARTISAN SUPPORT IN THE FACE 1799 01:01:03,095 --> 01:01:05,597 OF VERY CHALLENGING BUDGET CUTS 1800 01:01:05,597 --> 01:01:07,866 WHICH WE DISCUSSED AT OUR LAST 1801 01:01:07,866 --> 01:01:08,100 MEETING. 1802 01:01:08,100 --> 01:01:09,067 ADDITIONALLY BECAUSE FY 23 WAS 1803 01:01:09,067 --> 01:01:10,602 THE LAST YEAR OF MANDATORY 1804 01:01:10,602 --> 01:01:12,471 FUNDING FOR THE CANCER MOONSHOT 1805 01:01:12,471 --> 01:01:14,306 AUTHORIZED UNDER THE 21ST 1806 01:01:14,306 --> 01:01:17,576 CENTURY CURES ACT, NCI'S OVERALL 1807 01:01:17,576 --> 01:01:19,778 BUDGET EXPERIENCE EXPERIENCED A 1808 01:01:19,778 --> 01:01:21,513 NET $96 MILLION BUDGET DECREASE. 1809 01:01:21,513 --> 01:01:24,983 SO THOSE CAPS ARE IN PLACE AGAIN 1810 01:01:24,983 --> 01:01:26,418 FOR 2025. 1811 01:01:26,418 --> 01:01:27,719 THEY ALLOW -- HOWEVER BECAUSE OF 1812 01:01:27,719 --> 01:01:29,922 DECISIONS MADE IN THE FY 24 1813 01:01:29,922 --> 01:01:31,423 PROCESS, THERE WILL BE EVEN 1814 01:01:31,423 --> 01:01:33,826 FEWER RESOURCES AVAILABLE FOR 1815 01:01:33,826 --> 01:01:35,260 NON-DEFENSE DISCRETIONARY FUNDS, 1816 01:01:35,260 --> 01:01:36,461 THE CATEGORY THAT NIH AND NCI 1817 01:01:36,461 --> 01:01:37,696 ARE A PART. 1818 01:01:37,696 --> 01:01:39,998 SO FOR FY 25, IT WILL BE EQUALLY 1819 01:01:39,998 --> 01:01:42,701 IF NOT MORE CHALLENGING FOR 1820 01:01:42,701 --> 01:01:45,103 APPROPRIATORS TO NAVIGATE. 1821 01:01:45,103 --> 01:01:47,239 THIS IS JUST MY REGULAR REMINDER 1822 01:01:47,239 --> 01:01:48,473 OF WHERE WE ARE IN THE CURRENT 1823 01:01:48,473 --> 01:01:49,675 PROCESS. 1824 01:01:49,675 --> 01:01:53,045 FOR FY 25, WHICH WILL BEGIN ON 1825 01:01:53,045 --> 01:01:53,946 OCTOBER 1ST, WE'RE RIGHT IN THE 1826 01:01:53,946 --> 01:01:55,113 MIDDLE OF THE APPROPRIATIONS 1827 01:01:55,113 --> 01:01:56,882 PROCESS. 1828 01:01:56,882 --> 01:01:58,183 THE SUBCOMMITTEES ARE WORKING ON 1829 01:01:58,183 --> 01:01:59,818 THEIR BILLS, WHICH I'LL TALK 1830 01:01:59,818 --> 01:02:01,687 ABOUT MORE IN A MOMENT. 1831 01:02:01,687 --> 01:02:03,088 AND SINCE WE MET LAST, THERE'S 1832 01:02:03,088 --> 01:02:05,290 BEEN A SIGNIFICANT LEADERSHIP 1833 01:02:05,290 --> 01:02:07,092 TRANSITION IN THE HOUSE. 1834 01:02:07,092 --> 01:02:09,962 FORMER APPROPRIATIONS CHAIR OF 1835 01:02:09,962 --> 01:02:11,230 TEXAS IS RETIRING FROM CONGRESS 1836 01:02:11,230 --> 01:02:12,931 AND RETIRED FROM HER POST AS 1837 01:02:12,931 --> 01:02:14,766 CHAIR OF THE FULL HOUSE 1838 01:02:14,766 --> 01:02:15,400 APPROPRIATIONS COMMITTEE AHEAD 1839 01:02:15,400 --> 01:02:18,136 OF THE FY '25 PROCESS. 1840 01:02:18,136 --> 01:02:21,773 CONGRESSMAN TOM CO COLE OF OKLAA 1841 01:02:21,773 --> 01:02:22,875 PICTURED HERE WAS ELECTED TO 1842 01:02:22,875 --> 01:02:23,709 THIS POSITION. 1843 01:02:23,709 --> 01:02:24,710 FORMER CHAIR AND RANK MEMBER OF 1844 01:02:24,710 --> 01:02:26,545 THE LABOR HHS SUBCOMMITTEE AND 1845 01:02:26,545 --> 01:02:28,080 IS STRONG ADVOCATE FOR THE 1846 01:02:28,080 --> 01:02:29,414 IMPORTANCE OF INVESTMENT IN 1847 01:02:29,414 --> 01:02:30,582 BIOMEDICAL RESEARCH INCLUDING 1848 01:02:30,582 --> 01:02:34,419 CANCER RESEARCH. 1849 01:02:34,419 --> 01:02:36,188 SO FOR MANY YEARS, CONGRESSMAN 1850 01:02:36,188 --> 01:02:37,823 COLE HAS ADVOCATED FOR SUSTAINED 1851 01:02:37,823 --> 01:02:39,224 INVESTMENTS IN BIOMEDICAL 1852 01:02:39,224 --> 01:02:39,858 RESEARCH. 1853 01:02:39,858 --> 01:02:40,959 HE'S ALSO EMPHASIZED THE 1854 01:02:40,959 --> 01:02:43,061 IMPORTANCE OF THESE INVESTMENTS 1855 01:02:43,061 --> 01:02:43,795 FOR NATIONAL SECURITY. 1856 01:02:43,795 --> 01:02:46,331 HE'S QUOTED HERE IN 2017, 1857 01:02:46,331 --> 01:02:47,733 SEVERAL YEARS AHEAD OF THE 1858 01:02:47,733 --> 01:02:51,203 COVID-19 PANDEMIC, STRESSING THE 1859 01:02:51,203 --> 01:02:52,204 ROLE THE SUSTAINED INVESTMENTS 1860 01:02:52,204 --> 01:02:53,505 PLAY IN PANDEMIC PREPAREDNESS. 1861 01:02:53,505 --> 01:02:54,773 SO IT WILL BE INTERESTING TO SEE 1862 01:02:54,773 --> 01:02:56,341 THE APPROACH HE TAKES AS CHAIR 1863 01:02:56,341 --> 01:02:57,743 AND THE INPUT HE HAS IN THE 1864 01:02:57,743 --> 01:02:59,845 FINAL PROPOSALS FOR NIH AND 1865 01:02:59,845 --> 01:03:01,813 OTHER BIOMEDICAL RESEARCH 1866 01:03:01,813 --> 01:03:05,851 INVESTMENTS. 1867 01:03:05,851 --> 01:03:09,688 SO JUST THIS MORNING, CHAIR OF 1868 01:03:09,688 --> 01:03:13,191 THE HOUSE LABOR HHS COMMITTEE 1869 01:03:13,191 --> 01:03:15,260 RELEASED AN INITIAL 25 BILL 1870 01:03:15,260 --> 01:03:20,098 AHEAD OF A SUBCOMMITTEE MARKUP 1871 01:03:20,098 --> 01:03:21,934 SCHEDULED TOMORROW. 1872 01:03:21,934 --> 01:03:23,869 THIS ECHOES HIS LONG-STANDING 1873 01:03:23,869 --> 01:03:25,037 SUPPORT FOR BIOMEDICAL RESEARCH. 1874 01:03:25,037 --> 01:03:26,838 THE BILL ADDRESSES MANY OTHER 1875 01:03:26,838 --> 01:03:27,506 GOP PRIORITIES. 1876 01:03:27,506 --> 01:03:29,675 IT INCLUDES SEVERAL CONTENTIOUS 1877 01:03:29,675 --> 01:03:31,643 POLICY RIDERS AND IT IS NOT A 1878 01:03:31,643 --> 01:03:32,511 BIPARTISAN PROPOSAL. 1879 01:03:32,511 --> 01:03:35,147 IT'S EXPECTED TO MOVE OUT OF THE 1880 01:03:35,147 --> 01:03:35,914 SUBCOMMITTEE TOMORROW ALONG 1881 01:03:35,914 --> 01:03:37,549 PARTY LINES, WITHOUT DEMOCRATIC 1882 01:03:37,549 --> 01:03:38,650 SUPPORT. 1883 01:03:38,650 --> 01:03:40,585 A FEW OTHER KEY TAKEAWAYS AND 1884 01:03:40,585 --> 01:03:42,454 THINGS TO KEEP IN MIND, AGAIN, 1885 01:03:42,454 --> 01:03:45,624 THE HOUSE LABOR HHS BILL IS 1886 01:03:45,624 --> 01:03:47,426 WRITTEN TO A TOP LINE LEVEL THAT 1887 01:03:47,426 --> 01:03:49,995 IS ACTUALLY BELOW FY 24 ENACTED 1888 01:03:49,995 --> 01:03:50,562 LEVELS. 1889 01:03:50,562 --> 01:03:52,965 FOR EXAMPLE, THE PROPOSED 1890 01:03:52,965 --> 01:03:55,467 DISCRETIONARY TOTAL FOR 1891 01:03:55,467 --> 01:03:56,201 DEPARTMENT OF HEALTH AND HUMAN 1892 01:03:56,201 --> 01:03:58,170 SERVICES WITHIN THE BILL IS 7% 1893 01:03:58,170 --> 01:03:59,972 BELOW THE FY 24 ENACTED LEVEL. 1894 01:03:59,972 --> 01:04:02,808 SO WITHIN THE HOUSE PROPOSAL, IT 1895 01:04:02,808 --> 01:04:04,443 PROPOSES ROUGHLY FLAT FUNDING 1896 01:04:04,443 --> 01:04:06,778 FOR NIH AT APPROXIMATELY 1897 01:04:06,778 --> 01:04:08,580 $48 BILLION. 1898 01:04:08,580 --> 01:04:12,084 IT PROPOSES $7.875 BILLION FOR 1899 01:04:12,084 --> 01:04:13,852 NCI, AND THIS DOES REPRESENT A 1900 01:04:13,852 --> 01:04:17,122 PROPOSED INCREASE FOR NCI OF 1901 01:04:17,122 --> 01:04:19,091 APPROXIMATELY $655 MILLION. 1902 01:04:19,091 --> 01:04:20,859 HOWEVER, THE PROPOSED INCREASE 1903 01:04:20,859 --> 01:04:22,894 IS A RESULT OF PROPOSED 1904 01:04:22,894 --> 01:04:24,663 RESTRUCTURING WITHIN NIH, WHICH 1905 01:04:24,663 --> 01:04:26,498 I'LL COME BACK TO LATER, AND 1906 01:04:26,498 --> 01:04:27,933 IT'S UNCLEAR WHETHER THE SENATE 1907 01:04:27,933 --> 01:04:32,504 WILL SUPPORT THIS APPROACH. 1908 01:04:32,504 --> 01:04:33,839 SO MOVING OVER TO THE SENATE 1909 01:04:33,839 --> 01:04:35,774 SIDE, THE LABOR HHS 1910 01:04:35,774 --> 01:04:36,475 APPROPRIATION SUBCOMMITTEE HELD 1911 01:04:36,475 --> 01:04:38,410 A HEARING ON MAY 23RD TO 1912 01:04:38,410 --> 01:04:41,146 CONSIDER THE PRESIDENT'S FY 25 1913 01:04:41,146 --> 01:04:42,614 NIH BUDGET REQUEST. 1914 01:04:42,614 --> 01:04:44,016 FIVE INSTITUTE AND CENTER 1915 01:04:44,016 --> 01:04:45,450 DIRECTORS ACCOMPANIED 1916 01:04:45,450 --> 01:04:49,054 DR. BERTAGNOLLI. 1917 01:04:49,054 --> 01:04:51,156 INCLUDING DID RATHMELL 1918 01:04:51,156 --> 01:04:52,024 REPRESENTING NCI AS WELL AS 1919 01:04:52,024 --> 01:04:53,558 CORRECTORS OF THE NATIONAL 1920 01:04:53,558 --> 01:04:54,893 INSTITUTE ON DRUG ABUSE, THE 1921 01:04:54,893 --> 01:04:56,495 NATIONAL INSTITUTE ON AGING, THE 1922 01:04:56,495 --> 01:04:57,896 NATIONAL INSTITUTE ON ALLERGY 1923 01:04:57,896 --> 01:04:59,531 AND INFECTIOUS DISEASE, AND THE 1924 01:04:59,531 --> 01:05:02,267 NATIONAL HEART, LUNG AND BLOOD 1925 01:05:02,267 --> 01:05:04,369 INSTITUTE. 1926 01:05:04,369 --> 01:05:06,238 IT WAS THE FIRST APPROPRIATIONS 1927 01:05:06,238 --> 01:05:11,143 HEARING FOR DR. BERTAGNOLLI, DR, 1928 01:05:11,143 --> 01:05:13,345 AND OVERALL IT WAS A POSITIVE 1929 01:05:13,345 --> 01:05:14,346 AND BIPARTISAN HEARING WITH 1930 01:05:14,346 --> 01:05:15,847 SENATORS FROM BOTH PARTIES 1931 01:05:15,847 --> 01:05:16,948 EMPHASIZING THE IMPORTANCE OF 1932 01:05:16,948 --> 01:05:18,450 BIOMEDICAL RESEARCH AND RAISING 1933 01:05:18,450 --> 01:05:19,351 QUESTIONS FOCUSED ON SPECIFIC 1934 01:05:19,351 --> 01:05:21,753 AREAS OF INTEREST, INCLUDING 1935 01:05:21,753 --> 01:05:23,422 ACCESS TO CANCER CLINICAL TRIALS 1936 01:05:23,422 --> 01:05:26,591 IN RURAL AREAS, ALZHEIMER'S 1937 01:05:26,591 --> 01:05:28,226 RESEARCH, OPIOID RESEARCH, LONG 1938 01:05:28,226 --> 01:05:30,662 COVID AND MORE. 1939 01:05:30,662 --> 01:05:32,097 SO HERE'S THE CONGRESSIONAL 1940 01:05:32,097 --> 01:05:33,665 CALENDAR AND WHAT TO EXPECT IN 1941 01:05:33,665 --> 01:05:35,167 THE COMING MONTHS. 1942 01:05:35,167 --> 01:05:36,768 I FLAGGED SEVERAL DATES WITH 1943 01:05:36,768 --> 01:05:38,303 SPECIFIC RELEVANCE TO THE 1944 01:05:38,303 --> 01:05:39,938 APPROPRIATIONS PROCESS. 1945 01:05:39,938 --> 01:05:41,907 TOMORROW, AGAIN, JUNE 27TH, THE 1946 01:05:41,907 --> 01:05:43,975 HOUSE LABOR HHS APPROPRIATIONS 1947 01:05:43,975 --> 01:05:45,410 SUBCOMMITTEE WILL MARK UP ITS 1948 01:05:45,410 --> 01:05:45,977 BILL. 1949 01:05:45,977 --> 01:05:47,379 THE SENATE PLANS TO BEGIN 1950 01:05:47,379 --> 01:05:49,881 MARKING UP BILLS THE WEEK OF 1951 01:05:49,881 --> 01:05:50,148 JULY 8TH. 1952 01:05:50,148 --> 01:05:51,750 THE FULL HOUSE APPROPRIATIONS 1953 01:05:51,750 --> 01:05:53,051 COMMITTEE IS SCHEDULED TO MARK 1954 01:05:53,051 --> 01:05:55,554 UP THE LABOR HHS BILL ON 1955 01:05:55,554 --> 01:05:56,988 JULY 10TH. 1956 01:05:56,988 --> 01:05:58,190 AND THE FINAL HOUSE BILL IS 1957 01:05:58,190 --> 01:05:59,424 CURRENTLY SCHEDULED FOR A FLOOR 1958 01:05:59,424 --> 01:06:01,793 VOTE THE WEEK OF JULY 29TH. 1959 01:06:01,793 --> 01:06:03,228 ALL OF THIS ACTIVITY WILL BE 1960 01:06:03,228 --> 01:06:05,097 FOLLOWED BY THE AUGUST RECESS. 1961 01:06:05,097 --> 01:06:07,499 CONGRESS WILL BE BACK FOR A BUSY 1962 01:06:07,499 --> 01:06:08,667 SEPTEMBER, WHERE WE EXPECT TO 1963 01:06:08,667 --> 01:06:11,303 SEE CONTINUED APPROPRIATIONS 1964 01:06:11,303 --> 01:06:12,637 ACTIVITY AND THE CLOSE OF THE 1965 01:06:12,637 --> 01:06:14,372 FISCAL YEAR ON SEPTEMBER 30TH. 1966 01:06:14,372 --> 01:06:16,842 HOWEVER, IT'S UNLIKELY THAT FY 1967 01:06:16,842 --> 01:06:18,310 25 APPROPRIATIONS WILL BE 1968 01:06:18,310 --> 01:06:19,845 ENACTED ON TIME AND WE DO EXPECT 1969 01:06:19,845 --> 01:06:21,746 TO SEE A CONTINUING RESOLUTION 1970 01:06:21,746 --> 01:06:23,882 THAT WILL CARRY US PAST THE 1971 01:06:23,882 --> 01:06:25,884 NOVEMBER ELECTION AND INTO THE 1972 01:06:25,884 --> 01:06:26,985 LAME DUCK SESSION OF CONGRESS 1973 01:06:26,985 --> 01:06:29,020 WHICH BEGINS ON NOVEMBER 12TH. 1974 01:06:29,020 --> 01:06:30,889 AND THE LAME DUCK SESSION RUNS 1975 01:06:30,889 --> 01:06:31,990 UNTIL THE NEW CONGRESS IS SWORN 1976 01:06:31,990 --> 01:06:38,997 IN ON JANUARY 3RD OF 2025. 1977 01:06:38,997 --> 01:06:40,432 SO THIS IS JUST A QUICK VISUAL 1978 01:06:40,432 --> 01:06:42,934 OF TRENDS OVER TIME DURING LAME 1979 01:06:42,934 --> 01:06:43,735 DUCK SESSIONS OF CONGRESS AND 1980 01:06:43,735 --> 01:06:45,337 YOU CAN COME BACK TO IT FOR A 1981 01:06:45,337 --> 01:06:46,338 CLOSER LOOK. 1982 01:06:46,338 --> 01:06:48,173 BLUE MEANS BILLS WERE ENACTED 1983 01:06:48,173 --> 01:06:49,274 BEFORE THE LAME DUCK SESSION, 1984 01:06:49,274 --> 01:06:50,575 ORANGE MEANS THEY WERE ENACTED 1985 01:06:50,575 --> 01:06:52,677 DURING AND GREEN WERE ENACTED 1986 01:06:52,677 --> 01:06:53,778 AFTER THE LAME DUCK SESSION. 1987 01:06:53,778 --> 01:06:56,915 SO YOU'LL SEE HERE IN 2020 AND 1988 01:06:56,915 --> 01:06:58,483 2022, ALL OF THE APPROPRIATIONS 1989 01:06:58,483 --> 01:06:59,784 BILLS WERE ENACTED DURING THE 1990 01:06:59,784 --> 01:07:04,156 LAME DUCK SESSION. 1991 01:07:04,156 --> 01:07:08,860 SO JUST TO RECAP, WE DO EXPECT A 1992 01:07:08,860 --> 01:07:12,697 CR UNTIL AFTER THE ELECTION, AND 1993 01:07:12,697 --> 01:07:14,432 THE LAST TWO LAME DUCK SESSIONS 1994 01:07:14,432 --> 01:07:16,168 CONGRESS DID ENACT 1995 01:07:16,168 --> 01:07:17,035 APPROPRIATIONS BILLS. 1996 01:07:17,035 --> 01:07:19,237 IN 2016 AND 2018, HOWEVER, MANY 1997 01:07:19,237 --> 01:07:20,672 BILLS WERE ENACTED AFTER THE 1998 01:07:20,672 --> 01:07:21,973 LAME DUCK SESSION. 1999 01:07:21,973 --> 01:07:23,041 AND SO WE'LL HAVE TO WAIT AND 2000 01:07:23,041 --> 01:07:25,710 SEE WHAT HAPPENS IN NOVEMBER AND 2001 01:07:25,710 --> 01:07:28,647 DECEMBER. 2002 01:07:28,647 --> 01:07:30,015 I'M GOING TO SHIFT TO BIT TO 2003 01:07:30,015 --> 01:07:31,583 FOCUS ON A LESS SPECULATIVE 2004 01:07:31,583 --> 01:07:32,350 TOPIC. 2005 01:07:32,350 --> 01:07:33,985 WE'LL HIGHLIGHT SOME RECENT 2006 01:07:33,985 --> 01:07:35,320 CONGRESSIONAL ENGAGEMENT. 2007 01:07:35,320 --> 01:07:38,823 LAST MONTH NCI'S DR. SANYA 2008 01:07:38,823 --> 01:07:39,691 SPRINGFIELD, DIRECTOR OF NCI'S 2009 01:07:39,691 --> 01:07:41,560 CENTER TO REDUCE CANCER HEALTH 2010 01:07:41,560 --> 01:07:42,427 DISPARITIES, SPOKE AT A 2011 01:07:42,427 --> 01:07:43,962 CONGRESSIONAL BRIEFING HOSTED BY 2012 01:07:43,962 --> 01:07:44,729 THE AMERICAN ASSOCIATION FOR 2013 01:07:44,729 --> 01:07:47,032 CANCER RESEARCH TO HIGHLIGHT THE 2014 01:07:47,032 --> 01:07:49,301 RELEASE OF THE AAC REPUBLICAN 2015 01:07:49,301 --> 01:07:52,270 SER DISPARITIES PROGRESS REPORT. 2016 01:07:52,270 --> 01:07:54,806 NCI ALSO HOSTED CONGRESSIONAL 2017 01:07:54,806 --> 01:07:56,675 STAFF FOR A VISIT FOCUSED ON 2018 01:07:56,675 --> 01:07:57,609 CHILDHOOD CANCER RESEARCH. 2019 01:07:57,609 --> 01:07:59,277 STAFF MET WITH EXTRAMURAL 2020 01:07:59,277 --> 01:08:01,346 PROGRAM LEADERS, NCI PEDIATRIC 2021 01:08:01,346 --> 01:08:03,215 ONCOLOGY BRANCH LEADERSHIP, AND 2022 01:08:03,215 --> 01:08:05,183 TOURED TWO PEDIATRIC ONCOLOGY 2023 01:08:05,183 --> 01:08:06,618 BRANCH LABS AND MET WITH TWO 2024 01:08:06,618 --> 01:08:07,052 PATIENTS. 2025 01:08:07,052 --> 01:08:10,222 THEY ALSO VISITED THE CHILDREN'S 2026 01:08:10,222 --> 01:08:11,189 INN AT NIH WHERE CHILDREN AND 2027 01:08:11,189 --> 01:08:12,958 THEIR FAMILIES STAY ON THE NIH 2028 01:08:12,958 --> 01:08:14,059 CAMPUS AS THEY PARTICIPATE IN 2029 01:08:14,059 --> 01:08:16,828 NIH STUDIES AT THE CLINICAL 2030 01:08:16,828 --> 01:08:18,530 CENTER. 2031 01:08:18,530 --> 01:08:18,930 DR. RATHMELLED THE 2032 01:08:18,930 --> 01:08:26,738 GROUP AT RATHMELL JOINED THEGRO. 2033 01:08:26,738 --> 01:08:27,739 DR. RATHMELL HAS CONTINUED TO 2034 01:08:27,739 --> 01:08:28,840 MEET WITH MEMBERS OF CONGRESS. 2035 01:08:28,840 --> 01:08:30,041 SHE'S PICTURED HERE IN THE TOP 2036 01:08:30,041 --> 01:08:33,445 LEFT WITH DR. BERTAGNOLLI AND 2037 01:08:33,445 --> 01:08:35,647 CONGRESSWOMAN ROSA DELAURO OF 2038 01:08:35,647 --> 01:08:37,716 CONNECTICUT WHO SERVES AS 2039 01:08:37,716 --> 01:08:39,684 RANKING MEMBER. 2040 01:08:39,684 --> 01:08:41,219 BELOW THAT, THE CHAIRMAN OF THE 2041 01:08:41,219 --> 01:08:45,991 LABOR HHS SUBCOMMITTEE, 2042 01:08:45,991 --> 01:08:49,828 CONGRESSMAN ADERHOLT FROM 2043 01:08:49,828 --> 01:08:53,231 ALABAMA, AND SENATOR TAMMY 2044 01:08:53,231 --> 01:08:53,698 BALDWIN OF WISCONSIN. 2045 01:08:53,698 --> 01:08:56,167 TO THE RIGHT SHE'S PICTURED WITH 2046 01:08:56,167 --> 01:08:59,504 CONGRESSMAN JOE MORELLE, AND AS 2047 01:08:59,504 --> 01:09:02,107 HE REFERENCES AFTER A TWEET, HE 2048 01:09:02,107 --> 01:09:04,843 HAS A DEEPLY PERSONAL CONNECTION 2049 01:09:04,843 --> 01:09:07,245 TO CANCER AS HE LOST HIS 2050 01:09:07,245 --> 01:09:09,114 DAUGHTER TO BREAST CANCER WHEN 2051 01:09:09,114 --> 01:09:10,649 SHE WAS ONLY 31 YEARS OLD. 2052 01:09:10,649 --> 01:09:12,384 IN THE INTEREST OF TIME, I'LL 2053 01:09:12,384 --> 01:09:13,718 MOVE THROUGH THE NEXT FEW SLIDES 2054 01:09:13,718 --> 01:09:15,553 FAIRLY QUICKLY. 2055 01:09:15,553 --> 01:09:16,655 AGAIN MORE INFORMATION IS 2056 01:09:16,655 --> 01:09:18,823 INCLUDED IN YOUR WRITTEN UPDATE. 2057 01:09:18,823 --> 01:09:20,292 THERE ARE SEVERAL LEGISLATIVE 2058 01:09:20,292 --> 01:09:24,429 PROPOSALS PENDING IN ONGOING 2059 01:09:24,429 --> 01:09:25,297 CONGRESSIONAL COMMITTEE ACTIVITY 2060 01:09:25,297 --> 01:09:27,098 FOCUSED ON ISSUES INCLUDING 2061 01:09:27,098 --> 01:09:29,434 TELEHEALTH EXTENSIONS, DRUG 2062 01:09:29,434 --> 01:09:30,135 SHORTAGES, OPPORTUNITIES TO 2063 01:09:30,135 --> 01:09:31,703 IMPROVE ACCESS TO AND CONDUCT OF 2064 01:09:31,703 --> 01:09:33,938 CLINICAL TRIALS, AND THE ROLE OF 2065 01:09:33,938 --> 01:09:35,473 ARTIFICIAL INTELLIGENCE BOTH IN 2066 01:09:35,473 --> 01:09:37,776 BIOMEDICAL RESEARCH AND IN OTHER 2067 01:09:37,776 --> 01:09:39,311 SECTORS, AS WELL AS POTENTIAL 2068 01:09:39,311 --> 01:09:41,379 LEGISLATION FOCUSED ON NIH'S 2069 01:09:41,379 --> 01:09:45,884 STRUCTURE AND OPERATIONS. 2070 01:09:45,884 --> 01:09:49,154 SO THERE HAS BEEN BICAMERAL 2071 01:09:49,154 --> 01:09:50,789 INTEREST AMONG REPUBLICAN 2072 01:09:50,789 --> 01:09:59,664 MEMBERS OF CONGRESS TO -- 2073 01:09:59,664 --> 01:10:02,500 SENATOR BILL CASSIDY OF 2074 01:10:02,500 --> 01:10:03,068 LOUISIANA RELEASED A PUBLIC 2075 01:10:03,068 --> 01:10:04,369 REQUEST FOR INFORMATION ON 2076 01:10:04,369 --> 01:10:05,470 POLICIES CONGRESS COULD CONSIDER 2077 01:10:05,470 --> 01:10:07,639 TO MODERNIZE NIH. 2078 01:10:07,639 --> 01:10:10,275 IN HIS WORDS, SO THAT IT IS MORE 2079 01:10:10,275 --> 01:10:11,576 TRANSPARENT, NIMBLE AND 2080 01:10:11,576 --> 01:10:12,210 FORWARD-THINKING. 2081 01:10:12,210 --> 01:10:14,112 LAST MONTH HE RELEASED A WHITE 2082 01:10:14,112 --> 01:10:15,480 PAPER PICTURED HERE SUMMARIZING 2083 01:10:15,480 --> 01:10:17,148 PUBLIC COMMENTS AND OUTLINING 2084 01:10:17,148 --> 01:10:18,383 PROPOSED POLICY CHANGES TO 2085 01:10:18,383 --> 01:10:21,219 ADDRESS SEVERAL AREAS, INCLUDING 2086 01:10:21,219 --> 01:10:23,188 RESEARCH PRIORITIZATION AND 2087 01:10:23,188 --> 01:10:24,823 PORTFOLIO BALANCE, SUSTAINING 2088 01:10:24,823 --> 01:10:27,025 U.S. COMPETITIVE ADVANTAGE, AND 2089 01:10:27,025 --> 01:10:29,761 OPPORTUNITIES TO STREAMLINE PEER 2090 01:10:29,761 --> 01:10:32,530 REVIEW. 2091 01:10:32,530 --> 01:10:34,466 IN THE HOUSE EARLIER THIS MONTH 2092 01:10:34,466 --> 01:10:36,034 ON JUNE 14TH, THE HOUSE 2093 01:10:36,034 --> 01:10:37,969 COMMITTEE ON ENERGY AND COMMERCE 2094 01:10:37,969 --> 01:10:44,109 CHAIR CATHY MACK MORRIS RODGERS 2095 01:10:44,109 --> 01:10:50,148 RELEASED A FRAMEWORK FOR NIH 2096 01:10:50,148 --> 01:10:51,116 REFORM, EMPHASIZING THAT THE 2097 01:10:51,116 --> 01:10:52,450 FRAMEWORK IS A STARTING POINT 2098 01:10:52,450 --> 01:10:53,151 FOR DISCUSSION. 2099 01:10:53,151 --> 01:10:56,087 THE FRAMEWORK PROPOSES SEVERAL 2100 01:10:56,087 --> 01:10:57,956 STRUCTURAL AND POLICY REFORMS 2101 01:10:57,956 --> 01:11:00,358 INCLUDING CONSOLIDATING NIH'S 27 2102 01:11:00,358 --> 01:11:03,428 INSTITUTES AND CENTERS OR ICs 2103 01:11:03,428 --> 01:11:05,597 INTO 15 NEW ICs WITH THE GOAL 2104 01:11:05,597 --> 01:11:07,031 AS THE CONGRESSMAN STATES TO 2105 01:11:07,031 --> 01:11:08,700 BETTER ALIGN THE MISSIONS OF 2106 01:11:08,700 --> 01:11:11,736 EACH INSTITUTE AND CENTER. 2107 01:11:11,736 --> 01:11:13,171 NOTABLY, NCI, THE NATIONAL 2108 01:11:13,171 --> 01:11:15,140 INSTITUTE ON MENTAL HEALTH, AND 2109 01:11:15,140 --> 01:11:15,940 THE NATIONAL INSTITUTE ON AGING 2110 01:11:15,940 --> 01:11:19,511 WOULD NOT BE RESTRUCTURED. 2111 01:11:19,511 --> 01:11:21,379 SO THE INITIAL HOUSE LABOR HHS 2112 01:11:21,379 --> 01:11:23,314 APPROPRIATIONS BILL THAT 2113 01:11:23,314 --> 01:11:25,650 REPRESENTATIVE ADERHOLT RELEASED 2114 01:11:25,650 --> 01:11:27,318 THIS MORNING MIRRORS 2115 01:11:27,318 --> 01:11:29,954 CONSOLIDATION FROM ICs FROM 27 2116 01:11:29,954 --> 01:11:31,623 TO 15 AND JUST AS THE FRAMEWORK 2117 01:11:31,623 --> 01:11:32,457 IS A STARTING POINT FOR 2118 01:11:32,457 --> 01:11:33,658 DISCUSSION, THE APPROPRIATIONS 2119 01:11:33,658 --> 01:11:35,627 SUBCOMMITTEE PROPOSALS IN EACH 2120 01:11:35,627 --> 01:11:36,795 CHAMBER ARE TYPICALLY A STARTING 2121 01:11:36,795 --> 01:11:38,696 POINT FOR NEGOTIATIONS SO WE'LL 2122 01:11:38,696 --> 01:11:39,964 NEED TO WAIT AND SEE HOW THE 2123 01:11:39,964 --> 01:11:41,599 PROCESS PLAYS OUT, BOTH WITHIN 2124 01:11:41,599 --> 01:11:42,801 THE ENERGY AND COMMERCE 2125 01:11:42,801 --> 01:11:44,102 COMMITTEE AND WITHIN THE 2126 01:11:44,102 --> 01:11:48,907 APPROPRIATIONS COMMITTEES. 2127 01:11:48,907 --> 01:11:50,208 ADDITIONALLY ON THE HOUSE SIDE, 2128 01:11:50,208 --> 01:11:51,876 A BIPARTISAN EFFORT CONTINUES TO 2129 01:11:51,876 --> 01:11:53,478 EXPLORE OPPORTUNITIES TO EXPAND 2130 01:11:53,478 --> 01:11:55,480 UPON THE 21ST CENTURY CURES ACT, 2131 01:11:55,480 --> 01:11:56,548 WHICH ORIGINALLY AUTHORIZED 2132 01:11:56,548 --> 01:11:58,216 FUNDS FOR THE CANCER MOONSHOT AN 2133 01:11:58,216 --> 01:12:00,084 SEVERAL OTHER RESEARCH EFFORTS 2134 01:12:00,084 --> 01:12:01,853 AT NIH SUCH AS THE ALL-OF-US 2135 01:12:01,853 --> 01:12:02,921 RESEARCH PROGRAM AND THE BRAIN 2136 01:12:02,921 --> 01:12:04,689 INITIATIVE. 2137 01:12:04,689 --> 01:12:07,926 REPRESENTATIVE DIANA DEGETTE, 2138 01:12:07,926 --> 01:12:09,327 DEMOCRAT OF COLORADO WAS 2139 01:12:09,327 --> 01:12:11,496 ORIGINAL LEAD SPONSOR OF 21ST 2140 01:12:11,496 --> 01:12:13,832 CENTURY CURES AND OF A RECENT 2141 01:12:13,832 --> 01:12:14,699 CURES 2.0 PROPOSAL. 2142 01:12:14,699 --> 01:12:16,134 SHE'S PARTNERING WITH 2143 01:12:16,134 --> 01:12:21,072 REPRESENTATIVE LARRY BUCSHON, 2144 01:12:21,072 --> 01:12:21,940 INDIANA, INCLUDING THE 2145 01:12:21,940 --> 01:12:23,575 ESTABLISHMENT OF ARPA-H AND 2146 01:12:23,575 --> 01:12:25,677 SEVERAL FDA-FOCUSED PROVISIONS 2147 01:12:25,677 --> 01:12:26,644 WERE ACCOMPLISHED THROUGH OTHER 2148 01:12:26,644 --> 01:12:28,413 LEGISLATIVE AND EXECUTIVE 2149 01:12:28,413 --> 01:12:30,849 ACTIONS, SO CONGRESSWOMAN 2150 01:12:30,849 --> 01:12:34,319 DEGETTE AND CONGRESSMAN BUCSHON 2151 01:12:34,319 --> 01:12:37,388 ARE SPEAKING INPUT ON POLICIES 2152 01:12:37,388 --> 01:12:40,425 TO MOVE THE SECTORS FORWARD. 2153 01:12:40,425 --> 01:12:42,560 SO EARLIER I HIGHLIGHTED SEVERAL 2154 01:12:42,560 --> 01:12:43,962 EXAMPLES OF NCI'S ENGAGEMENT 2155 01:12:43,962 --> 01:12:45,730 WITH MEMBERS OF CONGRESS AND 2156 01:12:45,730 --> 01:12:46,064 THEIR STAFF. 2157 01:12:46,064 --> 01:12:47,832 AND I ALSO WANT TO TAKE A MOMENT 2158 01:12:47,832 --> 01:12:50,134 TO ACKNOWLEDGE THE BROADER 2159 01:12:50,134 --> 01:12:50,668 COMMUNITIES ENGAGEMENT AND 2160 01:12:50,668 --> 01:12:51,803 OUTREACH TO ENSURE THAT CONGRESS 2161 01:12:51,803 --> 01:12:53,104 IS AWARE OF THE IMPORTANT 2162 01:12:53,104 --> 01:12:54,739 RESEARCH EFFORTS UNDERWAY ACROSS 2163 01:12:54,739 --> 01:12:56,307 THE COUNTRY THAT ARE ENABLED BY 2164 01:12:56,307 --> 01:12:57,942 THEIR INVESTMENTS IN NIH AND 2165 01:12:57,942 --> 01:12:59,043 NCI. 2166 01:12:59,043 --> 01:13:00,778 HERE YOU'LL SEE THE ASSOCIATION 2167 01:13:00,778 --> 01:13:02,647 OF AMERICAN CANCER INSTITUTES 2168 01:13:02,647 --> 01:13:03,882 AND THE AMERICAN ASSOCIATION FOR 2169 01:13:03,882 --> 01:13:05,283 CANCER RESEARCH HOSTED THEIR 2170 01:13:05,283 --> 01:13:11,556 ANNUAL HILL DAY IN MAY. 2171 01:13:11,556 --> 01:13:12,557 ADDITIONALLY DR. RATHMELL 2172 01:13:12,557 --> 01:13:14,392 HAPPENED TO RUN INTO ASCO 2173 01:13:14,392 --> 01:13:15,293 COLLEAGUES IN APRIL WHILE THEY 2174 01:13:15,293 --> 01:13:16,494 WERE AT THEIR HILL DAY AND SHE 2175 01:13:16,494 --> 01:13:19,030 WAS ON THE HILL TO MEET WITH 2176 01:13:19,030 --> 01:13:21,966 REPRESENTATIVE MORELLI. 2177 01:13:21,966 --> 01:13:23,968 SHE ALSO -- JUST WANTED TO 2178 01:13:23,968 --> 01:13:25,270 EMPHASIZE THAT WE REALLY DO 2179 01:13:25,270 --> 01:13:26,905 APPRECIATE THE ADVOCACY 2180 01:13:26,905 --> 01:13:29,107 COMMUNITY'S ENGAGEMENT WITH NCI 2181 01:13:29,107 --> 01:13:30,975 AND WITH CONGRESS. 2182 01:13:30,975 --> 01:13:32,076 THANK YOU, I WILL END THERE AND 2183 01:13:32,076 --> 01:13:33,044 I HOPE YOU HAVE A LITTLE BIT OF 2184 01:13:33,044 --> 01:13:34,379 TIME FOR QUESTIONS. 2185 01:13:34,379 --> 01:13:36,114 MY CONTACT INFORMATION IS ON THE 2186 01:13:36,114 --> 01:13:37,448 NEXT SLIDE, SO PLEASE FEEL FREE 2187 01:13:37,448 --> 01:13:38,550 TO REACH OUT ANY TIME IF THERE 2188 01:13:38,550 --> 01:13:39,918 ARE QUESTIONS WE DON'T GET TO 2189 01:13:39,918 --> 01:13:45,690 TODAY. 2190 01:13:45,690 --> 01:13:49,394 >> THANK YOU SO MUCH, HOLLY, AS 2191 01:13:49,394 --> 01:13:51,796 ALWAYS FOR JUST COMPREHENSIVELY 2192 01:13:51,796 --> 01:13:55,133 PRESENTING TO US ALL THE 2193 01:13:55,133 --> 01:13:56,868 COMPLEXITY OF BUDGETING AND THE 2194 01:13:56,868 --> 01:13:58,636 DISCUSSIONS HAPPENING UP ON THE 2195 01:13:58,636 --> 01:14:00,238 HILL, ESPECIALLY THINGS THAT ARE 2196 01:14:00,238 --> 01:14:02,540 HAPPENING JUST THIS MORNING. 2197 01:14:02,540 --> 01:14:06,711 IT'S REALLY GREAT TO HEAR THAT. 2198 01:14:06,711 --> 01:14:10,715 SO ARE WE ANTICIPATING THAT FY 2199 01:14:10,715 --> 01:14:12,517 2025 BUDGET WILL GET COMPLETED 2200 01:14:12,517 --> 01:14:14,485 OR ARE WE LOOKING FOR ANOTHER 2201 01:14:14,485 --> 01:14:16,888 ROUND OF CONTINUING RESOLUTIONS? 2202 01:14:16,888 --> 01:14:19,824 >> WE WILL CERTAINLY AT LEAST 2203 01:14:19,824 --> 01:14:22,226 SEE THAT FIRST CONTINUING 2204 01:14:22,226 --> 01:14:24,862 RESOLUTION TO CARRY US AFTER THE 2205 01:14:24,862 --> 01:14:25,396 ELECTION. 2206 01:14:25,396 --> 01:14:26,631 CONGRESSMAN COLE, CHAIR OF THE 2207 01:14:26,631 --> 01:14:28,066 HOUSE APPROPRIATIONS COMMITTEE, 2208 01:14:28,066 --> 01:14:29,667 HAS ALREADY STATED THAT THAT IS 2209 01:14:29,667 --> 01:14:31,436 HIS PLAN, AND SO I THINK IT'S 2210 01:14:31,436 --> 01:14:32,971 SAFE TO SAY THAT WE WILL AT 2211 01:14:32,971 --> 01:14:36,240 LEAST HAVE ONE, BUT I THINK IT'S 2212 01:14:36,240 --> 01:14:38,543 LIKELY THAT WE MAY HAVE MORE 2213 01:14:38,543 --> 01:14:39,577 EITHER BRINGING US THROUGH THE 2214 01:14:39,577 --> 01:14:41,512 END OF THE LAME DUCK SESSION OR, 2215 01:14:41,512 --> 01:14:42,714 IF THEY'RE NOT ABLE TO COMPLETE 2216 01:14:42,714 --> 01:14:43,615 THEIR WORK, INTO THE NEW 2217 01:14:43,615 --> 01:14:44,916 CONGRESS. 2218 01:14:44,916 --> 01:14:45,984 >> THANKS. 2219 01:14:45,984 --> 01:14:48,786 AND MARTY, YOU HAVE A QUESTION? 2220 01:14:48,786 --> 01:14:50,054 >> YES, I DO. 2221 01:14:50,054 --> 01:14:51,356 THANKS SO MUCH FOR THAT REPORT. 2222 01:14:51,356 --> 01:14:53,658 THAT WAS REALLY INTERESTING. 2223 01:14:53,658 --> 01:14:59,230 MY QUESTION IS ABOUT CATHY 2224 01:14:59,230 --> 01:15:03,301 MCMORRIS RODGERS' PLAN TO 2225 01:15:03,301 --> 01:15:04,135 RESTRUCTURE, AND YOU MENTIONED 2226 01:15:04,135 --> 01:15:05,269 THAT WAS IN CONJUNCTION WITH 2227 01:15:05,269 --> 01:15:06,504 ANOTHER CONGRESSPERSON. 2228 01:15:06,504 --> 01:15:09,540 IS THAT A BIPARTISAN APPROACH OR 2229 01:15:09,540 --> 01:15:09,974 IS IT NOT? 2230 01:15:09,974 --> 01:15:12,577 >> NO, IT'S NOT A BIPARTISAN 2231 01:15:12,577 --> 01:15:12,844 APPROACH. 2232 01:15:12,844 --> 01:15:15,780 IT WAS ANNOUNCED IN PARTNERSHIP 2233 01:15:15,780 --> 01:15:17,081 WITH CONGRESSMAN ADERHOLT WHO IS 2234 01:15:17,081 --> 01:15:18,750 THE CHAIR OF OUR APPROPRIATIONS 2235 01:15:18,750 --> 01:15:20,618 SUBCOMMITTEE, AND SO THAT'S WHY 2236 01:15:20,618 --> 01:15:22,286 YOU'LL SEE AT LEAST STRUCTURALLY 2237 01:15:22,286 --> 01:15:24,889 A LOT OF THOSE PROPOSALS FOR 2238 01:15:24,889 --> 01:15:25,790 CONSOLIDATING INSTITUTES AND 2239 01:15:25,790 --> 01:15:27,325 CENTERS ARE REFLECTED IN 2240 01:15:27,325 --> 01:15:29,794 CONGRESSMAN ADERHOLT'S PROPOSAL 2241 01:15:29,794 --> 01:15:32,997 THAT WAS RELEASED THIS MORNING 2242 01:15:32,997 --> 01:15:35,633 FOR FY 25. 2243 01:15:35,633 --> 01:15:37,402 SO THIS WAS A REPUBLICAN 2244 01:15:37,402 --> 01:15:38,169 PROPOSAL FROM THE REPUBLICAN 2245 01:15:38,169 --> 01:15:39,570 CHAIR OF ENERGY AND COMMERCE, 2246 01:15:39,570 --> 01:15:41,272 REPUBLICAN CHAIR OF LABOR HHS 2247 01:15:41,272 --> 01:15:42,006 SUBCOMMITTEE AND THEIR 2248 01:15:42,006 --> 01:15:43,875 COLLEAGUES HAVE HAD INPUT, AND 2249 01:15:43,875 --> 01:15:45,076 NOW THEY'RE SOLICITING PUBLIC 2250 01:15:45,076 --> 01:15:48,379 INPUT AS WELL, BUT IT IS NOT -- 2251 01:15:48,379 --> 01:15:50,548 SO FAR IT IS NOT A BIPARTISAN 2252 01:15:50,548 --> 01:15:51,549 APPROACH, SO WE'LL SEE HOW 2253 01:15:51,549 --> 01:15:52,583 THINGS MOVE FORWARD. 2254 01:15:52,583 --> 01:15:54,452 >> THANK YOU. 2255 01:15:54,452 --> 01:15:56,521 >> YOU'RE WELCOME. 2256 01:15:56,521 --> 01:15:58,256 >> AND THANK YOU AGAIN, HOLLY. 2257 01:15:58,256 --> 01:16:01,025 IF THERE ARE NO FURTHER 2258 01:16:01,025 --> 01:16:02,560 QUESTIONS, I SEE THAT 2259 01:16:02,560 --> 01:16:04,295 DR. RATHMELL WAS ABLE TO JOIN US 2260 01:16:04,295 --> 01:16:06,597 EARLY AND IN THE INTEREST OF THE 2261 01:16:06,597 --> 01:16:08,232 BEST USE OF HER TIME, WE'RE 2262 01:16:08,232 --> 01:16:09,000 SCHEDULED FOR A BREAK. 2263 01:16:09,000 --> 01:16:10,635 IT WAS SUPPOSED TO BE 15 2264 01:16:10,635 --> 01:16:11,102 MINUTES. 2265 01:16:11,102 --> 01:16:13,271 DO WE THINK WE CAN DO IT IN 10, 2266 01:16:13,271 --> 01:16:13,738 GROUP? 2267 01:16:13,738 --> 01:16:14,639 10 MINUTES? 2268 01:16:14,639 --> 01:16:15,339 OKAY. 2269 01:16:15,339 --> 01:16:20,411 SO LET'S BE BACK AT EXACTLY 1:4D 2270 01:16:20,411 --> 01:16:21,846 THEN WE CAN HAVE THE REST OF OUR 2271 01:16:21,846 --> 01:16:22,714 SESSION. 2272 01:16:22,714 --> 01:16:24,449 THANK YOU SO MUCH, EVERYBODY, 2273 01:16:24,449 --> 01:16:30,361 AND WE'LL SEE YOU IN ABOUT 10 MINUTES. 2274 01:16:30,361 --> 01:16:31,796 THANK YOU FOR TAKING A QUICK 2275 01:16:31,796 --> 01:16:32,230 BREAK, EVERYONE. 2276 01:16:32,230 --> 01:16:33,564 I WILL NOW CALL THE MEETING BACK 2277 01:16:33,564 --> 01:16:38,236 TO ORDER. 2278 01:16:38,236 --> 01:16:39,237 THANK YOU FOR BEING BRIEF. 2279 01:16:39,237 --> 01:16:42,640 NEXT UP, WE HAVE A PRESENTATION 2280 01:16:42,640 --> 01:16:45,910 ON SURVIVORSHIP PLANNING, AND WE 2281 01:16:45,910 --> 01:16:48,579 HAVE DR. MICHELLE MOLLICA, 2282 01:16:48,579 --> 01:16:49,881 DEPUTY DIRECTOR OF NCI'S OFFICE 2283 01:16:49,881 --> 01:16:51,516 OF CANCER SURVIVORSHIP, TO GIVE 2284 01:16:51,516 --> 01:16:52,283 US HER PRESENTATION. 2285 01:16:52,283 --> 01:16:53,818 THANK YOU SO MUCH FOR SPENDING 2286 01:16:53,818 --> 01:16:55,453 TIME WITH US TODAY, MICHELLE. 2287 01:16:55,453 --> 01:16:57,555 >> THANK YOU VERY MUCH FOR THE 2288 01:16:57,555 --> 01:16:58,423 INVITATION, AND IT'S A PLEASURE 2289 01:16:58,423 --> 01:17:01,726 TO BE HERE WITH YOU ALL TODAY. 2290 01:17:01,726 --> 01:17:07,432 SO I WILL BE TALKING A BIT ABOUT 2291 01:17:07,432 --> 01:17:09,067 A NEWLY DEVELOPED SET OF 2292 01:17:09,067 --> 01:17:12,470 NATIONAL STANDARD FOR CANCER 2293 01:17:12,470 --> 01:17:14,539 SURVIVORSHIP CARE. 2294 01:17:14,539 --> 01:17:15,873 IN TODAY'S TALK, I'M JUST GOING 2295 01:17:15,873 --> 01:17:18,309 TO START BY PROVIDING A BIT OF 2296 01:17:18,309 --> 01:17:20,511 BACKGROUND INCLUDING SOME 2297 01:17:20,511 --> 01:17:21,679 PREVIOUS EFFORTS WE'VE 2298 01:17:21,679 --> 01:17:24,015 UNDERTAKEN IN SURVIVORSHIP CARE 2299 01:17:24,015 --> 01:17:25,550 ACROSS THE LAST FEW DECADES. 2300 01:17:25,550 --> 01:17:29,253 I'LL TALK ABOUT THE PROCESS FOR 2301 01:17:29,253 --> 01:17:36,194 DEVELOPING THESE NA NATIONAL 2302 01:17:36,194 --> 01:17:37,195 STANDARDS, I'LL PROVIDE AN 2303 01:17:37,195 --> 01:17:38,162 OVERVIEW AND TALK ABOUT NEXT 2304 01:17:38,162 --> 01:17:38,396 STEPS. 2305 01:17:38,396 --> 01:17:40,164 SO I WILL START JUST BY 2306 01:17:40,164 --> 01:17:41,165 CENTERING US ALL ON THE 2307 01:17:41,165 --> 01:17:43,134 DEFINITION OF CANCER SURVIVORS. 2308 01:17:43,134 --> 01:17:46,104 SO THE NCI RECOGNIZES ANY 2309 01:17:46,104 --> 01:17:47,805 INDIVIDUAL AS A CANCER SURVIVOR 2310 01:17:47,805 --> 01:17:48,673 FROM THE TIME OF DIAGNOSIS 2311 01:17:48,673 --> 01:17:52,610 THROUGH THE BALANCE OF LIFE. 2312 01:17:52,610 --> 01:17:54,545 COLLECTIVELY, THERE ARE OVER 2313 01:17:54,545 --> 01:17:55,279 18 MILLION CANCER SURVIVORS IN 2314 01:17:55,279 --> 01:17:57,248 THE U.S., LIVING BOTH WITH AND 2315 01:17:57,248 --> 01:18:03,321 AFTER A CANCER DIAGNOSIS. 2316 01:18:03,321 --> 01:18:05,323 WE KNOW THAT CANCER SURVIVORSHIP 2317 01:18:05,323 --> 01:18:05,990 CARE IS COMPLEX. 2318 01:18:05,990 --> 01:18:07,558 THESE ARE A FEW OF THE MANY 2319 01:18:07,558 --> 01:18:08,726 RECOMMENDATIONS FOR CANCER 2320 01:18:08,726 --> 01:18:10,495 SURVIVORS, AND I DON'T NEED TO 2321 01:18:10,495 --> 01:18:12,363 TELL ALL OF YOU HOW COMPLEX 2322 01:18:12,363 --> 01:18:13,664 SURVIVORSHIP CARE IS, BUT IT 2323 01:18:13,664 --> 01:18:14,999 INCLUDES THINGS LIKE PREVENTION 2324 01:18:14,999 --> 01:18:19,737 AND SURVEILLANCE FOR RECURRENCE, 2325 01:18:19,737 --> 01:18:20,938 SURVEILLANCE AND MANAGEMENT OF 2326 01:18:20,938 --> 01:18:22,440 PHYSICAL EFFECTS, PSYCHOSOCIAL 2327 01:18:22,440 --> 01:18:24,542 EFFECTS, PROMOTING HEALTHY 2328 01:18:24,542 --> 01:18:25,543 LIFESTYLE BEHAVIORS LIKE 2329 01:18:25,543 --> 01:18:27,078 PHYSICAL ACTIVITY AND NUTRITION, 2330 01:18:27,078 --> 01:18:29,280 IDENTIFYING AND MANAGING 2331 01:18:29,280 --> 01:18:30,281 COMORBIDITIES, SCREENING FOR 2332 01:18:30,281 --> 01:18:31,949 SUBSEQUENT CANCERS, MONITORING 2333 01:18:31,949 --> 01:18:33,885 MENTAL WELL-BEING, AS WELL AS 2334 01:18:33,885 --> 01:18:35,753 COORDINATING CARE OFTEN AMONG 2335 01:18:35,753 --> 01:18:41,792 AMONG MULTIPLE PROVIDERS. 2336 01:18:41,792 --> 01:18:43,094 THERE HAVE BEEN SEVERAL PREVIOUS 2337 01:18:43,094 --> 01:18:45,096 EFFORTS TO INFORM SURVIVORSHIP 2338 01:18:45,096 --> 01:18:46,731 CARE OR THE DELIVERY OF QUALITY 2339 01:18:46,731 --> 01:18:48,065 CARE AFTER A CANCER DIAGNOSIS. 2340 01:18:48,065 --> 01:18:54,071 WE HAVE SEVERAL SURVIVORSHIP 2341 01:18:54,071 --> 01:18:54,939 GUIDELINES, THE NATIONAL 2342 01:18:54,939 --> 01:18:56,207 COALITION, THE NCC NHAS A 2343 01:18:56,207 --> 01:18:58,042 GENERAL SET OF SURVIVORSHIP 2344 01:18:58,042 --> 01:19:00,244 GUIDELINES, AS WELL AS SOME 2345 01:19:00,244 --> 01:19:02,547 CANCER-SPECIFIC GUIDELINES IN 2346 01:19:02,547 --> 01:19:04,448 BREAST AND COLORECTAL CANCER. 2347 01:19:04,448 --> 01:19:07,818 WE ALSO HAVE CHILDREN'S LATE AND 2348 01:19:07,818 --> 01:19:09,353 LONG-TERM GUIDELINES FROM THE 2349 01:19:09,353 --> 01:19:12,890 CHILDREN'S ONCOLOGY GROUP, THE 2350 01:19:12,890 --> 01:19:13,858 LIVESTRONG ESSENTIAL ELEMENTS 2351 01:19:13,858 --> 01:19:16,827 WAS AN EFFORT IN 2011 TO DEFINE 2352 01:19:16,827 --> 01:19:17,862 POST-TREATMENT SURVIVORSHIP 2353 01:19:17,862 --> 01:19:19,230 CARE, AND WHAT YOU SEE ON THE 2354 01:19:19,230 --> 01:19:22,667 RIGHT-HAND SIDE IS THE QUALITY 2355 01:19:22,667 --> 01:19:24,302 OF SURVIVORSHIP CARE FRAMEWORK. 2356 01:19:24,302 --> 01:19:26,537 ONE OF OUR COLLEAGUES LED THE 2357 01:19:26,537 --> 01:19:28,806 DEVELOPMENT OF THIS WITH SEVERAL 2358 01:19:28,806 --> 01:19:29,707 NCI COLLEAGUES, AND THIS WAS 2359 01:19:29,707 --> 01:19:31,108 REALLY JUST TO DEFINE THE KEY 2360 01:19:31,108 --> 01:19:33,544 COMPONENTS OF SURVIVORSHIP CARE. 2361 01:19:33,544 --> 01:19:34,879 AND THEN MANY OF YOU MAY BE 2362 01:19:34,879 --> 01:19:37,148 FAMILIAR WITH THE COMMISSION ON 2363 01:19:37,148 --> 01:19:38,583 CANCER STANDARDS AT COMMISSION 2364 01:19:38,583 --> 01:19:40,585 ON CANCER ACCREDITED 2365 01:19:40,585 --> 01:19:41,919 INSTITUTIONS, AND WE HAVE A 2366 01:19:41,919 --> 01:19:44,989 SPECIFIC SURVIVORSHIP STANDARD 2367 01:19:44,989 --> 01:19:46,857 THAT WAS RECENTLY UPDATED IN 2368 01:19:46,857 --> 01:19:47,058 2019. 2369 01:19:47,058 --> 01:19:49,060 IT PREVIOUSLY REQUIRED A 2370 01:19:49,060 --> 01:19:51,229 SURVIVORSHIP CARE PLAN, SO A 2371 01:19:51,229 --> 01:19:53,431 SUMMARY OF TREATMENT AND CANCER 2372 01:19:53,431 --> 01:19:54,599 HISTORY AS WELL AS FOLLOW-UP 2373 01:19:54,599 --> 01:19:56,834 CARE GUIDELINES OR 2374 01:19:56,834 --> 01:19:58,703 RECOMMENDATIONS. 2375 01:19:58,703 --> 01:20:01,239 IT WAS UPDATED TO FOCUS MORE ON 2376 01:20:01,239 --> 01:20:02,673 SURVIVORSHIP CARE PROGRAMS AND 2377 01:20:02,673 --> 01:20:05,309 REQUIRED A SURVIVORSHIP CARE 2378 01:20:05,309 --> 01:20:08,813 COORDINATOR AT EACH COC 2379 01:20:08,813 --> 01:20:10,481 ACCREDITED SITE, AS WELL AS AT 2380 01:20:10,481 --> 01:20:12,016 LEAST THREE PROGRAMS OR SERVICES 2381 01:20:12,016 --> 01:20:13,651 FOR SURVIVORS, SO A LITTLE BIT 2382 01:20:13,651 --> 01:20:15,386 MORE FLEXIBILITY. 2383 01:20:15,386 --> 01:20:16,754 AND YOU CAN GO AHEAD AND GO TO 2384 01:20:16,754 --> 01:20:22,994 THE NEXT SLIDE. 2385 01:20:22,994 --> 01:20:24,929 BUT OVERALL, SURVIVOR SHIP CARE 2386 01:20:24,929 --> 01:20:27,398 IN THE U.S. IS VARIABLE AND 2387 01:20:27,398 --> 01:20:28,266 OFTEN SUBOPTIMAL. 2388 01:20:28,266 --> 01:20:31,435 SO ALTHOUGH WE HAVE SURVIVORSHIP 2389 01:20:31,435 --> 01:20:32,837 GUIDELINES, THEY EXIST BUT ARE 2390 01:20:32,837 --> 01:20:34,405 NOT SYSTEMATICALLY IMPLEMENTED. 2391 01:20:34,405 --> 01:20:36,173 THE DELIVERY OF SURVIVORSHIP 2392 01:20:36,173 --> 01:20:37,575 CARE OFTEN VARIES GREATLY BASED 2393 01:20:37,575 --> 01:20:40,111 ON WHERE THE SURVIVOR LIVES, THE 2394 01:20:40,111 --> 01:20:42,079 RESOURCES OF THE HEALTH SYSTEM, 2395 01:20:42,079 --> 01:20:44,048 PROVIDER PREFERENCES AND 2396 01:20:44,048 --> 01:20:45,583 RESOURCES OF THE PROVIDER, AND 2397 01:20:45,583 --> 01:20:47,785 THE LACK OF CONSISTENT 2398 01:20:47,785 --> 01:20:49,420 SURVIVORSHIP CARE OFTEN LEADS TO 2399 01:20:49,420 --> 01:20:52,356 SURVIVORS WITH UNMET NEEDS, WITH 2400 01:20:52,356 --> 01:20:54,492 POOR HEALTH OUTCOMES AND WITH 2401 01:20:54,492 --> 01:21:01,165 ISSUES ACCESSING QUALITY CARE. 2402 01:21:01,165 --> 01:21:02,133 SO THE GOAL OF THIS PROJECT WAS 2403 01:21:02,133 --> 01:21:03,734 TO DEVELOP A SET OF NATIONAL 2404 01:21:03,734 --> 01:21:04,802 STANDARDS FOR SURVIVORSHIP CARE, 2405 01:21:04,802 --> 01:21:06,637 AND THAT INCLUDES ESSENTIAL 2406 01:21:06,637 --> 01:21:08,939 HEALTH SYSTEM PROCESSES AND 2407 01:21:08,939 --> 01:21:10,941 POLICY COMPONENTS, AS WELL AS 2408 01:21:10,941 --> 01:21:12,910 THE ASSESSMENT OF THE QUALITY OF 2409 01:21:12,910 --> 01:21:14,879 SURVIVOR SHSHIP CARE. 2410 01:21:14,879 --> 01:21:16,247 AND I JUST WANTED TO DEFINE WHAT 2411 01:21:16,247 --> 01:21:17,782 WE MEAN WHEN WE SAY A STANDARD, 2412 01:21:17,782 --> 01:21:19,083 SO YOU'VE HEARD ME SAY 2413 01:21:19,083 --> 01:21:21,619 GUIDELINES A FEW TIMES, SO 2414 01:21:21,619 --> 01:21:22,720 GUIDELINES OR CLINICAL 2415 01:21:22,720 --> 01:21:23,721 GUIDELINES ARE RECOMMENDATIONS 2416 01:21:23,721 --> 01:21:26,757 BASED ON THE EVIDENCE THAT 2417 01:21:26,757 --> 01:21:31,028 PROVIDERS SHOULD PROVIDE TO GIVE 2418 01:21:31,028 --> 01:21:31,829 OPTIMAL PATIENT CARE, SO 2419 01:21:31,829 --> 01:21:33,264 SPECIFIC SETS OF RECOMMENDATIONS 2420 01:21:33,264 --> 01:21:34,565 FOR THAT INDIVIDUAL. 2421 01:21:34,565 --> 01:21:35,900 WHEN WE TALK ABOUT STANDARDS, 2422 01:21:35,900 --> 01:21:36,767 WE'RE TALKING ABOUT 2423 01:21:36,767 --> 01:21:38,102 RECOMMENDATIONS FOR THE HEALTH 2424 01:21:38,102 --> 01:21:39,403 SYSTEM THAT APPLY TO THE 2425 01:21:39,403 --> 01:21:40,504 PATIENTS THEY SERVE OR THE 2426 01:21:40,504 --> 01:21:44,875 SURVIVORS THEY SERVE. 2427 01:21:44,875 --> 01:21:46,344 SO I MENTIONED THREE DISTINCT 2428 01:21:46,344 --> 01:21:47,878 AREAS IN OUR STANDARDS. 2429 01:21:47,878 --> 01:21:53,584 AND I JUST WANT WANT TO DEFINE E 2430 01:21:53,584 --> 01:21:54,585 FOR YOU HERE. 2431 01:21:54,585 --> 01:21:55,653 HEALTH SYSTEM POLICY ARE 2432 01:21:55,653 --> 01:21:56,754 PRINCIPLES AND PROCEDURES THAT 2433 01:21:56,754 --> 01:21:57,788 GUIDE AN ORGANIZATION'S CAPACITY 2434 01:21:57,788 --> 01:21:59,090 AND STRUCTURE TO PROVIDE 2435 01:21:59,090 --> 01:22:00,324 SURVIVORSHIP CARE. 2436 01:22:00,324 --> 01:22:02,493 PROCESSES ARE THE CAPACITY TO 2437 01:22:02,493 --> 01:22:04,495 DELIVER CARE THROUGH ITS 2438 01:22:04,495 --> 01:22:05,896 EMBEDDED PRACTICES AND 2439 01:22:05,896 --> 01:22:06,330 PROCEDURES. 2440 01:22:06,330 --> 01:22:07,865 AND ASSESSMENT AND EVALUATION IS 2441 01:22:07,865 --> 01:22:09,433 MEASURING THE IMPACT OF 2442 01:22:09,433 --> 01:22:10,267 SURVIVORSHIP CARE WITHIN AN 2443 01:22:10,267 --> 01:22:16,173 ORGANIZATION. 2444 01:22:16,173 --> 01:22:17,475 I WANT TO ACKNOWLEDGE THAT THIS 2445 01:22:17,475 --> 01:22:19,510 PROJECT WAS UNDERTAKEN AS PART 2446 01:22:19,510 --> 01:22:21,545 OF THE BIDEN CANCER MOONSHOT AND 2447 01:22:21,545 --> 01:22:23,381 PART OF THE CANCER CABINET, 2448 01:22:23,381 --> 01:22:25,816 WHICH WAS AN ALL OF GOVERNMENT 2449 01:22:25,816 --> 01:22:27,585 APPROACH TO TACKLING ISSUES 2450 01:22:27,585 --> 01:22:31,389 RELATED TO CANCER, AND THE 2451 01:22:31,389 --> 01:22:33,257 CANCER CABINET CREATED A 2452 01:22:33,257 --> 01:22:34,158 SUPPORTING PATIENTS AND 2453 01:22:34,158 --> 01:22:36,360 CAREGIVERS TASK FORCE, AND THIS 2454 01:22:36,360 --> 01:22:37,328 WORK CAME OUT OF THAT. 2455 01:22:37,328 --> 01:22:39,563 SO WE ARE PART OF A SURVIVORSHIP 2456 01:22:39,563 --> 01:22:40,631 WORKING GROUP, AND YOU CAN SEE 2457 01:22:40,631 --> 01:22:42,733 THAT I WAS ONE OF THE CO-CHAIRS 2458 01:22:42,733 --> 01:22:44,969 ALONG WITH TWO COLLEAGUES AT THE 2459 01:22:44,969 --> 01:22:47,171 VETERANS AFFAIRS OR THE VA, WHO 2460 01:22:47,171 --> 01:22:50,207 ARE LEADING THE COMPREHENSIVE 2461 01:22:50,207 --> 01:22:52,743 SURVIVORSHIP PROGRAM WITHIN THE 2462 01:22:52,743 --> 01:22:53,477 VA SYSTEM. 2463 01:22:53,477 --> 01:22:54,779 AND I WANT TO ACKNOWLEDGE THAT 2464 01:22:54,779 --> 01:22:56,981 THERE ARE SEVERAL WORKING GROUP 2465 01:22:56,981 --> 01:22:58,716 MEMBERS FROM ACROSS THE 2466 01:22:58,716 --> 01:23:01,252 GOVERNMENT AGENCIES, INCLUDING 2467 01:23:01,252 --> 01:23:06,323 CDC, THE VA, USDA, CMS, FDA, AND 2468 01:23:06,323 --> 01:23:07,758 DEPARTMENT OF DEFENSE AS WELL AS 2469 01:23:07,758 --> 01:23:14,899 NCI. 2470 01:23:14,899 --> 01:23:16,567 SO OUR PROCESS FOR THIS IS WE 2471 01:23:16,567 --> 01:23:18,102 FIRST DID A LANDSCAPE REVIEW OF 2472 01:23:18,102 --> 01:23:19,069 ALL OF THE AVAILABLE INFORMATION 2473 01:23:19,069 --> 01:23:20,604 ON SURVIVORSHIP CARE, AND THAT 2474 01:23:20,604 --> 01:23:22,506 INCLUDES GUIDELINES, FRAME 2475 01:23:22,506 --> 01:23:25,109 WORKS, CANCER CONTROL PLANS, 2476 01:23:25,109 --> 01:23:27,845 INTERNATIONAL WORK, AND RELEVANT 2477 01:23:27,845 --> 01:23:28,279 LITERATURE. 2478 01:23:28,279 --> 01:23:30,347 AND WE IDENTIFIED POSSIBLE 2479 01:23:30,347 --> 01:23:31,348 INDICATORS IN EACH OF THOSE 2480 01:23:31,348 --> 01:23:33,350 THREE GROUPS, SO HEALTH SYSTEM 2481 01:23:33,350 --> 01:23:36,787 POLICIES, PR PROCESSES AND 2482 01:23:36,787 --> 01:23:37,655 ASSESSMENT AND EVALUATION. 2483 01:23:37,655 --> 01:23:38,856 WE THEN HELD THREE SUBJECT 2484 01:23:38,856 --> 01:23:40,090 MATTER EXPERT CONSENSUS 2485 01:23:40,090 --> 01:23:40,858 MEETINGS. 2486 01:23:40,858 --> 01:23:42,626 THOSE WERE VIRTUAL MEETINGS THAT 2487 01:23:42,626 --> 01:23:44,395 HAD SURVIVORSHIP SUBJECT MATTER 2488 01:23:44,395 --> 01:23:45,830 EXPERTS IN ATTENDANCE, AND THEY 2489 01:23:45,830 --> 01:23:47,698 WERE ALSO OPEN TO THE PUBLIC TO 2490 01:23:47,698 --> 01:23:48,999 SUBMIT PUBLIC COMMENT AND TO 2491 01:23:48,999 --> 01:23:50,534 COMMENT ON THOSE. 2492 01:23:50,534 --> 01:23:52,336 I'LL SHOW YOU THE LIST OF OUR 2493 01:23:52,336 --> 01:23:54,205 SUBJECT MATTER EXPERTS IN JUST A 2494 01:23:54,205 --> 01:23:55,506 SECOND, BUT ONE OF THE KEY 2495 01:23:55,506 --> 01:23:58,275 THINGS THAT WE TRIED TO DO WAS 2496 01:23:58,275 --> 01:24:01,011 INVOLVE SURVIVOR ADVOCATES AND 2497 01:24:01,011 --> 01:24:01,712 ADVOCACY GROUPS AS MUCH AS 2498 01:24:01,712 --> 01:24:02,980 POSSIBLE. 2499 01:24:02,980 --> 01:24:04,849 BECAUSE WE FEEL LIKE THAT IS ONE 2500 01:24:04,849 --> 01:24:08,052 OF THE MOST IMPORTANT STEPS IN 2501 01:24:08,052 --> 01:24:09,153 DEVELOPING STANDARDS THAT HEALTH 2502 01:24:09,153 --> 01:24:09,920 SYSTEMS SHOULD FOLLOW. 2503 01:24:09,920 --> 01:24:12,957 WE THEN CAME UP WITH A LIST OF 2504 01:24:12,957 --> 01:24:15,259 THE INDICATORS UNDER EACH OF 2505 01:24:15,259 --> 01:24:17,461 THOSE THREE AREAS OF POLICIES, 2506 01:24:17,461 --> 01:24:20,164 PROCESSES AND ASSESSMENT AND 2507 01:24:20,164 --> 01:24:22,366 EVALUATION, AND FINALIZED THE 2508 01:24:22,366 --> 01:24:24,001 STANDARDS IN COLLABORATION WITH 2509 01:24:24,001 --> 01:24:25,002 OUR SUBJECT MATTER EXPERTS. 2510 01:24:25,002 --> 01:24:26,937 WE'RE IN THE PROCESS OF PILOT 2511 01:24:26,937 --> 01:24:29,206 TESTING THOSE STANDARDS FOR 2512 01:24:29,206 --> 01:24:29,874 FEASIBILITY, I'LL TALK ABOUT 2513 01:24:29,874 --> 01:24:32,243 THAT IN JUST A SECOND, AND THEN 2514 01:24:32,243 --> 01:24:33,444 WORKING ON SOME FUTURE 2515 01:24:33,444 --> 01:24:34,545 DISSEMINATION AND EVALUATION 2516 01:24:34,545 --> 01:24:42,186 EFFORTS. 2517 01:24:42,186 --> 01:24:43,721 I HAVE TWO SLIDES THAT SHOW YOU 2518 01:24:43,721 --> 01:24:45,189 THE SUBJECT MATTER EXPERTS. 2519 01:24:45,189 --> 01:24:51,295 I WANT TO POINT OUT THAT SHELLEY 2520 01:24:51,295 --> 01:24:53,531 NASSO, NATIONAL COALIT COALITIOR 2521 01:24:53,531 --> 01:24:54,965 CANCER SURVIVORSHIP WAS ONE OF 2522 01:24:54,965 --> 01:24:58,135 OUR EXPERTS. 2523 01:24:58,135 --> 01:25:06,076 THEN MOLLY MAHER, AND A CANCER 2524 01:25:06,076 --> 01:25:06,477 SURVIVOR ADVOCATE. 2525 01:25:06,477 --> 01:25:07,845 IN ADDITION TO THAT, WE HAD A 2526 01:25:07,845 --> 01:25:09,213 VARIED AND MULTIDISCIPLINARY 2527 01:25:09,213 --> 01:25:10,147 TEAM OF SUBJECT MATTER EXPERTS 2528 01:25:10,147 --> 01:25:12,316 THAT SPANNED EVERYTHING FROM 2529 01:25:12,316 --> 01:25:13,784 SOCIAL WORK TO ONCOLOGY 2530 01:25:13,784 --> 01:25:15,219 PROVIDERS TO PRIMARY CARE. 2531 01:25:15,219 --> 01:25:17,721 WE REALLY TRIED TO REACH FAR AND 2532 01:25:17,721 --> 01:25:21,525 WIDE AND USE SORT OF A SNOWBALL 2533 01:25:21,525 --> 01:25:22,359 METHOD TO BE ABLE TO IDENTIFY 2534 01:25:22,359 --> 01:25:23,327 THE RIGHT PEOPLE AT THE TABLE, 2535 01:25:23,327 --> 01:25:25,329 AND WE WERE LUCKY THAT WE HAD 2536 01:25:25,329 --> 01:25:30,367 DIVERSE PERSPECTIVES. 2537 01:25:30,367 --> 01:25:32,002 SO ON THE NEXT THREE SLIDES, I'M 2538 01:25:32,002 --> 01:25:33,871 GOING TO SHOW YOU WHAT WE CAME 2539 01:25:33,871 --> 01:25:35,639 UP WITH FOR THE NATIONAL 2540 01:25:35,639 --> 01:25:36,340 STANDARDS FOR SURVIVORSHIP CARE. 2541 01:25:36,340 --> 01:25:40,277 SO HOW WE LAID THESE OUT WAS WE 2542 01:25:40,277 --> 01:25:43,647 IDENTIFIED 10 INDICATORS IN EACH 2543 01:25:43,647 --> 01:25:45,215 AREA FOR HEALTH SYSTEM POLICY 2544 01:25:45,215 --> 01:25:46,550 PROCESSES AND ASSESSMENT AND 2545 01:25:46,550 --> 01:25:47,651 EVALUATION. 2546 01:25:47,651 --> 01:25:50,621 WE HAVE A WEBSITE WITH ALL OF 2547 01:25:50,621 --> 01:25:52,056 THIS INFORMATION SO I DON'T WANT 2548 01:25:52,056 --> 01:25:53,490 TO READ THESE ALL FOR YOU, BUT I 2549 01:25:53,490 --> 01:25:57,461 WILL JUST SAY THAT WE 2550 01:25:57,461 --> 01:25:58,128 HIGHLIGHTED EVIDENCE-BASED CARE 2551 01:25:58,128 --> 01:25:59,763 THAT HEALTH SYSTEMS SHOULD BE 2552 01:25:59,763 --> 01:26:01,832 PROVIDING FOR SURVIVORS. 2553 01:26:01,832 --> 01:26:05,703 SO IN HEALTH SYSTEM POLICY, WE 2554 01:26:05,703 --> 01:26:06,370 INCLUDED THAT THE ORGANIZATION 2555 01:26:06,370 --> 01:26:07,771 HAS A POLICY THAT INCLUDES 2556 01:26:07,771 --> 01:26:10,641 ESTABLISHMENT OF A SURVIVORSHIP 2557 01:26:10,641 --> 01:26:12,009 PROGRAM, BUT IT GOES ALL THE WAY 2558 01:26:12,009 --> 01:26:13,310 DOWN IF YOU LOOK AT THE END, 2559 01:26:13,310 --> 01:26:14,745 SUBJECT MATTER EXPERTS FELT 2560 01:26:14,745 --> 01:26:16,747 REALLY STRONGLY ABOUT HAVING A 2561 01:26:16,747 --> 01:26:18,949 BUSINESS CASE OR A PLAN 2562 01:26:18,949 --> 01:26:20,718 INCLUDING A BUDGET AND FUNDING 2563 01:26:20,718 --> 01:26:23,854 ALLOCATED FOR SURVIVORSHIP CARE 2564 01:26:23,854 --> 01:26:25,456 TO BE ABLE TO POINT TO THE 2565 01:26:25,456 --> 01:26:26,357 SUSTAINABILITY FOR SURVIVORSHIP 2566 01:26:26,357 --> 01:26:29,159 CARE. 2567 01:26:29,159 --> 01:26:32,896 IN THE AREA OF PROCESSES, THE 2568 01:26:32,896 --> 01:26:34,064 INDICATORS INCLUDE THAT CANCER 2569 01:26:34,064 --> 01:26:37,334 SURVIVORS ARE PROVIDED WITH 2570 01:26:37,334 --> 01:26:39,103 ACCESS TO A SURVIVORSHIP PROGRAM 2571 01:26:39,103 --> 01:26:41,105 THAT THEY ARE ASSESSED AT 2572 01:26:41,105 --> 01:26:42,206 MULTIPLE TIME POINT FOR THINGS 2573 01:26:42,206 --> 01:26:45,042 LIKE PHYSICAL EFFECTS, EMOTIONAL 2574 01:26:45,042 --> 01:26:48,512 AND PSYCH LODGE CAL EFFECTS ALL 2575 01:26:48,512 --> 01:26:50,214 THE WAY DOWN TO ASSESSING FOR 2576 01:26:50,214 --> 01:26:52,182 FINANCIAL HARDSHIP OR TOXICITY 2577 01:26:52,182 --> 01:26:53,417 AND CONCERNS REGARDING INSURANCE 2578 01:26:53,417 --> 01:26:54,718 COVERAGE AND BEING ENGAGED IN 2579 01:26:54,718 --> 01:26:56,854 THE CARE PLANNING PROCESS, 2580 01:26:56,854 --> 01:26:57,955 ESPECIALLY THROUGHOUT THE 2581 01:26:57,955 --> 01:27:02,526 CONTINUUM OF CARE AS A SURVIVOR. 2582 01:27:02,526 --> 01:27:04,762 AND IN THE AREA OF HEALTH SYSTEM 2583 01:27:04,762 --> 01:27:07,264 EVALUATION AND ASSESSMENT THAT 2584 01:27:07,264 --> 01:27:08,499 THE ORGANIZATION HAS A PROCESS 2585 01:27:08,499 --> 01:27:11,268 TO COLLECT DATA ON THINGS LIKE 2586 01:27:11,268 --> 01:27:12,670 SURVIVORS PATIENT-REPORTED 2587 01:27:12,670 --> 01:27:13,671 OUTCOMES, QUALITY OF LIFE, 2588 01:27:13,671 --> 01:27:15,973 RETURN TO WORK AND PARTICIPATION 2589 01:27:15,973 --> 01:27:18,876 IN PAID AND UNPAID WORK AND 2590 01:27:18,876 --> 01:27:19,176 SCHOOL. 2591 01:27:19,176 --> 01:27:21,378 LU SEE THAT IT INCLUDES THINGS 2592 01:27:21,378 --> 01:27:23,781 LIKE SURVIVAL RATES, RATE OF 2593 01:27:23,781 --> 01:27:25,082 OCCURRENCE, RATE OF SEQUENCE 2594 01:27:25,082 --> 01:27:25,315 CANCERS. 2595 01:27:25,315 --> 01:27:27,017 THESE ARE THINGS THAT SUBJECT 2596 01:27:27,017 --> 01:27:28,118 MATTER EXPERTS FELT REALLY 2597 01:27:28,118 --> 01:27:29,653 STRONGLY WERE IMPORTANT AND 2598 01:27:29,653 --> 01:27:31,221 ASPIRATIONAL, BUT MOST HEALTH 2599 01:27:31,221 --> 01:27:35,059 SYSTEMS ARE NOT ADEQUATELY AND 2600 01:27:35,059 --> 01:27:35,926 SYSTEMATICALLY COLLECTING THIS 2601 01:27:35,926 --> 01:27:37,594 INFORMATION SO IT DEFINITELY IS 2602 01:27:37,594 --> 01:27:39,163 GOING TO TAKE A BIG LIFT FOR 2603 01:27:39,163 --> 01:27:41,031 HEALTH SYSTEMS TO BE ABLE TO DO 2604 01:27:41,031 --> 01:27:41,432 THIS. 2605 01:27:41,432 --> 01:27:44,768 I ALSO WANT TO POINT OUT THAT WE 2606 01:27:44,768 --> 01:27:46,303 INCLUDED CAREGIVERS' EXPERIENCE 2607 01:27:46,303 --> 01:27:47,838 AND UNMET NEEDS BECAUSE WE FEEL 2608 01:27:47,838 --> 01:27:49,273 THAT CAREGIVERS AND CARE 2609 01:27:49,273 --> 01:27:53,243 PARTNERS ARE IMPORTANT, AND KEY 2610 01:27:53,243 --> 01:27:55,012 STAKEHOLDERS IN THE SURVIVORSHIP 2611 01:27:55,012 --> 01:27:56,213 CARE QUALITY, AND THEN THE 2612 01:27:56,213 --> 01:27:57,915 NUMBER OF HEALTH PROFESSIONALS 2613 01:27:57,915 --> 01:27:59,883 TRAINED TO PROVIDE SURVIVORSHIP 2614 01:27:59,883 --> 01:28:03,520 CARE. 2615 01:28:03,520 --> 01:28:04,822 SO SOME OF OUR NEXT STEPS I 2616 01:28:04,822 --> 01:28:06,924 MENTIONED PILOT TESTING THE 2617 01:28:06,924 --> 01:28:09,226 STANDARDS, AND THIS IS WHERE WE 2618 01:28:09,226 --> 01:28:11,962 ARE CURRENTLY IN THE PROCESS. 2619 01:28:11,962 --> 01:28:14,098 THE VA DOES HAVE A COMPREHENSIVE 2620 01:28:14,098 --> 01:28:14,832 SURVIVORSHIP PROGRAM THAT THEY 2621 01:28:14,832 --> 01:28:18,001 ARE CURRENTLY FINALIZING TO WORK 2622 01:28:18,001 --> 01:28:19,870 ACROSS ALL VA SITES. 2623 01:28:19,870 --> 01:28:21,305 THEY ARE USING THESE STANDARDS 2624 01:28:21,305 --> 01:28:22,673 TO INFORM THE DEVELOPMENT OF 2625 01:28:22,673 --> 01:28:23,540 THEIR PROGRAM. 2626 01:28:23,540 --> 01:28:25,743 WE ALSO HOPE THAT HEALTH SYSTEMS 2627 01:28:25,743 --> 01:28:27,177 WILL ADAPT THE NATIONAL 2628 01:28:27,177 --> 01:28:28,545 STANDARDS TO THEIR SPECIFIC 2629 01:28:28,545 --> 01:28:31,548 CANCER SURVIVOR POPULATIONS AND 2630 01:28:31,548 --> 01:28:32,316 HEALTH SYSTEM NEEDS. 2631 01:28:32,316 --> 01:28:34,585 THE STANDARDS ARE AVAILABLE ON 2632 01:28:34,585 --> 01:28:35,853 OUR OFFICE OF CANCER 2633 01:28:35,853 --> 01:28:37,654 SURVIVORSHIP WEBSITE TO 2634 01:28:37,654 --> 01:28:38,722 HEALTHCARE ORGANIZATIONS SO THEY 2635 01:28:38,722 --> 01:28:41,058 CAN ASSESS EITHER EXISTING 2636 01:28:41,058 --> 01:28:43,127 PROGRAMS THAT THEY HAVE OR USE 2637 01:28:43,127 --> 01:28:45,529 TO INFORM THE DEVELOPMENT OF NEW 2638 01:28:45,529 --> 01:28:45,963 PROGRAMS. 2639 01:28:45,963 --> 01:28:50,467 AND WE RECENTLY PUBLISHED A 2640 01:28:50,467 --> 01:28:51,602 SUPPLEMENT NOTICE FOR 2641 01:28:51,602 --> 01:28:53,904 SUPPLEMENTS FOR CURRENTLY FUNDED 2642 01:28:53,904 --> 01:28:55,539 GRANTS FOCUSED ON ASSESSING AND 2643 01:28:55,539 --> 01:28:56,473 ENHANCING SURVIVORSHIP CARE. 2644 01:28:56,473 --> 01:28:58,776 THE GOAL HERE WAS TO HAVE HEALTH 2645 01:28:58,776 --> 01:29:00,310 SYSTEMS AND PROGRAMS ASSESS 2646 01:29:00,310 --> 01:29:02,212 ALIGNMENT WITH THE STANDARDS AND 2647 01:29:02,212 --> 01:29:03,413 IDENTIFY GAP AREAS WHERE THEY 2648 01:29:03,413 --> 01:29:04,948 CAN IMPROVE THEIR CARE. 2649 01:29:04,948 --> 01:29:07,918 WE'RE ALSO WORKING ON DEVELOPING 2650 01:29:07,918 --> 01:29:11,889 A TOOLKIT SO THAT HEALTH SYSTEMS 2651 01:29:11,889 --> 01:29:13,557 CAN USE RESOURCES AND HAVE 2652 01:29:13,557 --> 01:29:14,625 GUIDANCE IN IMPLEMENTING THE 2653 01:29:14,625 --> 01:29:16,093 STANDARDS AND WE HAVE A 2654 01:29:16,093 --> 01:29:17,661 CHECKLIST TOOL TO ASSESS 2655 01:29:17,661 --> 01:29:18,962 ALIGNMENT AND THEN THERE'S LOTS 2656 01:29:18,962 --> 01:29:20,831 OF ROOM IN THE AREA OF ADVANCING 2657 01:29:20,831 --> 01:29:23,500 RESEARCH AND POLICY, SO 2658 01:29:23,500 --> 01:29:24,701 EVALUATING SURVIVOR AND HEALTH 2659 01:29:24,701 --> 01:29:26,003 SYSTEM OUTCOMES RELATED TO 2660 01:29:26,003 --> 01:29:30,140 IMPLEMENTING THE STANDARDS, WE 2661 01:29:30,140 --> 01:29:31,441 HAVE LOTS OF WORK TO DO IN TERMS 2662 01:29:31,441 --> 01:29:33,644 OF GUIDING REIMBURSEMENT FOR 2663 01:29:33,644 --> 01:29:34,578 SURVIVORSHIP SERVICES AND 2664 01:29:34,578 --> 01:29:36,513 CREATING RESOURCES TO DO THAT, 2665 01:29:36,513 --> 01:29:38,182 AS WELL AS ALIGNING THE 2666 01:29:38,182 --> 01:29:40,184 STANDARDS WITH THE COC 2667 01:29:40,184 --> 01:29:40,651 SURVIVORSHIP STANDARD. 2668 01:29:40,651 --> 01:29:43,253 YOU'LL NOTICE THAT SOME OF 2669 01:29:43,253 --> 01:29:44,354 THE -- THE COC REQUIREMENTS 2670 01:29:44,354 --> 01:29:47,191 WOULD BE MET THROUGH 2671 01:29:47,191 --> 01:29:48,458 IMPLEMENTING THE STANDARDS, SO 2672 01:29:48,458 --> 01:29:50,994 WE HOPE TO ALIGN AND NOT MAKE 2673 01:29:50,994 --> 01:29:54,064 THEM DUPLICATIVE OR ONEROUS FOR 2674 01:29:54,064 --> 01:29:58,869 HEALTH SYSTEMS TO IMPLEMENT. 2675 01:29:58,869 --> 01:30:00,137 WE HAVE LOTS MORE RESOURCES ON 2676 01:30:00,137 --> 01:30:01,572 OUR OFFICE OF CANCER 2677 01:30:01,572 --> 01:30:02,306 SURVIVORSHIP WEBSITE. 2678 01:30:02,306 --> 01:30:06,009 HAPPY TO SHARE THESE AFTER THE 2679 01:30:06,009 --> 01:30:07,578 MEETING AS WELL AND THAT 2680 01:30:07,578 --> 01:30:09,780 INCLUDES THINGS LIKE Q & A 2681 01:30:09,780 --> 01:30:11,248 VIDEOS, WE HAVE ALL OF THE 2682 01:30:11,248 --> 01:30:12,416 VIDEOS FROM THE SUBJECT MATTER 2683 01:30:12,416 --> 01:30:14,017 EXPERT MEETINGS AND THERE WAS A 2684 01:30:14,017 --> 01:30:17,221 REALLY RICH DISCUSSION AMONG THE 2685 01:30:17,221 --> 01:30:17,955 EXPERTS AND LOTS MORE 2686 01:30:17,955 --> 01:30:21,124 INFORMATION. 2687 01:30:21,124 --> 01:30:22,826 AND I'LL END JUST BY SAYING THAT 2688 01:30:22,826 --> 01:30:24,595 IT IS NATIONAL CANCER SURVIVORS 2689 01:30:24,595 --> 01:30:26,797 MONTH AND WE'VE DONE SEVERAL 2690 01:30:26,797 --> 01:30:29,733 DIFFERENT THINGS TO TRY TO 2691 01:30:29,733 --> 01:30:31,335 HIGHLIGHT THE IMPORTANCE OF 2692 01:30:31,335 --> 01:30:33,070 SURVIVOR VOICES AND PERSPECTIVES 2693 01:30:33,070 --> 01:30:36,373 FROM SURVIVORS AND ADVOCATE. 2694 01:30:36,373 --> 01:30:42,012 WE HAD A RECENT WEBINAR THAT 2695 01:30:42,012 --> 01:30:44,514 FEATURED A PANEL OF FOUR CANCER 2696 01:30:44,514 --> 01:30:45,716 SURVIVOR ADVOCATES. 2697 01:30:45,716 --> 01:30:46,750 DR. RATHMELL WAS GRACIOUS ENOUGH 2698 01:30:46,750 --> 01:30:47,651 TO PROVIDE THE INTRO FOR THAT 2699 01:30:47,651 --> 01:30:48,285 WEBINAR. 2700 01:30:48,285 --> 01:30:50,153 WE WERE VERY THANKFUL FOR THAT. 2701 01:30:50,153 --> 01:30:52,556 WE HAVE NEW CANCER SURVIVOR 2702 01:30:52,556 --> 01:30:53,857 STORIES AND MS. ELLIS IS ONE OF 2703 01:30:53,857 --> 01:30:55,926 OUR FEATURED CANCER SURVIVORS ON 2704 01:30:55,926 --> 01:30:57,094 THE SURVIVOR STORIES. 2705 01:30:57,094 --> 01:31:00,063 IT IS ONE OF OUR MOST VISITED 2706 01:31:00,063 --> 01:31:02,599 PAGES ON OUR OCS WEBSITE, AND WE 2707 01:31:02,599 --> 01:31:04,735 HAVE SEVERAL SPECIAL TOPIC 2708 01:31:04,735 --> 01:31:05,435 AREAS. 2709 01:31:05,435 --> 01:31:07,004 WE HIGHLIGHT FOCUS AREAS IN 2710 01:31:07,004 --> 01:31:08,872 RESEARCH THAT WERE FOCUSED ON, 2711 01:31:08,872 --> 01:31:10,440 INCLUDING THE STANDARDS BUT ALSO 2712 01:31:10,440 --> 01:31:12,109 FOCUSED ON HEALTH EQUITY AND 2713 01:31:12,109 --> 01:31:14,177 HEALTH DISPARITIES IN 2714 01:31:14,177 --> 01:31:15,445 SURVIVORSHIP, AND PRIMARY CARE 2715 01:31:15,445 --> 01:31:19,182 IN CANCER SURVIVORSHIP. 2716 01:31:19,182 --> 01:31:20,384 I WILL STOP THERE AND I'M VERY 2717 01:31:20,384 --> 01:31:21,551 HAPPY TO TAKE YOUR QUESTIONS. 2718 01:31:21,551 --> 01:31:22,986 THANK YOU SO MUCH FOR THE 2719 01:31:22,986 --> 01:31:23,620 OPPORTUNITY TO PRESENT TO YOU 2720 01:31:23,620 --> 01:31:33,697 TODAY. 2721 01:31:33,697 --> 01:31:35,966 >> THANK YOU SO MUCH, 2722 01:31:35,966 --> 01:31:36,300 DR. MOLLICA. 2723 01:31:36,300 --> 01:31:37,668 FOR THOSE OF US LUCKY ENOUGH TO 2724 01:31:37,668 --> 01:31:38,735 BE HERE, IT IS A VERY IMPORTANT 2725 01:31:38,735 --> 01:31:39,069 TOPIC. 2726 01:31:39,069 --> 01:31:40,003 LEE, YOU HAVE YOUR HAND UP. 2727 01:31:40,003 --> 01:31:40,504 >> YES. 2728 01:31:40,504 --> 01:31:41,838 THANK YOU VERY MUCH, 2729 01:31:41,838 --> 01:31:43,340 DR. MOLLICA, FOR ALL YOU DO FOR 2730 01:31:43,340 --> 01:31:45,008 US SURVIVORS. 2731 01:31:45,008 --> 01:31:46,910 I THINK ONE OF THE PRIMARY 2732 01:31:46,910 --> 01:31:50,314 ISSUES IS THAT TRANSITION FROM 2733 01:31:50,314 --> 01:31:52,616 CANCER CARE INTO PRIMARY CARE. 2734 01:31:52,616 --> 01:31:56,253 AND A LOT OF US DON'T HAVE A 2735 01:31:56,253 --> 01:31:58,455 HEALTH SYSTEM PRIMARY CARE TYPE 2736 01:31:58,455 --> 01:31:59,222 OF A DOCTOR. 2737 01:31:59,222 --> 01:32:00,624 ONE OF THE THINGS I LIKED ABOUT 2738 01:32:00,624 --> 01:32:03,193 THE OLD SURVIVORSHIP CARE PLANS, 2739 01:32:03,193 --> 01:32:04,628 I LOOKED AT IT AS A PASSPORT. 2740 01:32:04,628 --> 01:32:07,130 SO WHENEVER YOU GO TO A NEW 2741 01:32:07,130 --> 01:32:08,765 DOCTOR, YOU HAVE THAT 2742 01:32:08,765 --> 01:32:10,000 INFORMATION WITH YOU, YOU COULD 2743 01:32:10,000 --> 01:32:12,336 GIVE TO THEM. 2744 01:32:12,336 --> 01:32:13,971 FOR EXAMPLE, MY PRIMARY CARE 2745 01:32:13,971 --> 01:32:15,172 PHYSICIAN IS FINALLY GOING TO 2746 01:32:15,172 --> 01:32:15,539 RETIRE. 2747 01:32:15,539 --> 01:32:18,241 I'VE GOT TO GET A NEW ONE. 2748 01:32:18,241 --> 01:32:19,676 THE ONE I HAVE KNOWS WHAT I WENT 2749 01:32:19,676 --> 01:32:20,577 THROUGH, THE NEW ONE IS NOT 2750 01:32:20,577 --> 01:32:22,646 GOING TO KNOW THAT. 2751 01:32:22,646 --> 01:32:26,483 SO I THINK SURVIVORSHIP CARE 2752 01:32:26,483 --> 01:32:28,118 PLANS WERE IMPORTANT AND USEFUL 2753 01:32:28,118 --> 01:32:29,386 FOR SURVIVORS, EVEN THOUGH I 2754 01:32:29,386 --> 01:32:30,587 UNDERSTAND OVERALL SURVIVAL WAS 2755 01:32:30,587 --> 01:32:32,322 NOT AFFECTED BY THAT, IT WAS NOT 2756 01:32:32,322 --> 01:32:33,557 IMPROVED BY THAT, BUT I THINK 2757 01:32:33,557 --> 01:32:38,395 IT'S A QUALITY OF LIFE MEASURE, 2758 01:32:38,395 --> 01:32:39,930 SURVIVORSHIP CARE PLANS ARE 2759 01:32:39,930 --> 01:32:40,364 IMPORTANT. 2760 01:32:40,364 --> 01:32:43,600 BUT THAT TRANSITION IS 2761 01:32:43,600 --> 01:32:45,769 DIFFICULT, AND WE NEED TO COME 2762 01:32:45,769 --> 01:32:47,070 UP WITH SOME SORT OF A WAY 2763 01:32:47,070 --> 01:32:48,372 WHETHER WE'RE URBAN, RURAL, NO 2764 01:32:48,372 --> 01:32:49,306 MATTER WHERE WE LIVE, WE CAN 2765 01:32:49,306 --> 01:32:51,808 MAKE THAT TRANSITION. 2766 01:32:51,808 --> 01:32:55,412 AND KEEP INFORMING PEOPLE WHAT 2767 01:32:55,412 --> 01:32:57,280 WE'VE HAD, WHAT THE SIDE EFFECTS 2768 01:32:57,280 --> 01:32:58,849 MIGHT BE FOR PEOPLE THAT DON'T 2769 01:32:58,849 --> 01:32:59,282 DEAL WITH THIS. 2770 01:32:59,282 --> 01:33:00,083 >> ABSOLUTELY. 2771 01:33:00,083 --> 01:33:02,152 THANK YOU FOR THAT POINT. 2772 01:33:02,152 --> 01:33:03,787 IT IS SO IMPORTANT. 2773 01:33:03,787 --> 01:33:05,922 TRANSITION IS ACTUALLY BUILT IN 2774 01:33:05,922 --> 01:33:07,557 AS ONE OF THE INDICATORS IN THAT 2775 01:33:07,557 --> 01:33:12,262 HEALTH SYSTEM PROCESS OR POLICY 2776 01:33:12,262 --> 01:33:13,296 THAN THE STANDARDS, SO 2777 01:33:13,296 --> 01:33:14,164 DEFINITELY IMPORTANT. 2778 01:33:14,164 --> 01:33:15,699 I WILL ALSO SAY THAT WE 2779 01:33:15,699 --> 01:33:16,833 RECOGNIZE THE ISSUES IN PRIMARY 2780 01:33:16,833 --> 01:33:17,034 CARE. 2781 01:33:17,034 --> 01:33:18,702 WE HAD A RECENT REQUEST FOR 2782 01:33:18,702 --> 01:33:20,904 APPLICATIONS FOCUSED ON SYSTEM 2783 01:33:20,904 --> 01:33:22,906 LEVEL INTERVENTIONS, SO IT'S 2784 01:33:22,906 --> 01:33:24,408 NOT -- THE ONUS IS NOT ON YOU AS 2785 01:33:24,408 --> 01:33:25,842 A SURVIVOR TO TAKE THAT 2786 01:33:25,842 --> 01:33:27,177 INFORMATION TO YOUR PRIMARY CARE 2787 01:33:27,177 --> 01:33:28,545 PROVIDER AND EDUCATE THEM, BUT 2788 01:33:28,545 --> 01:33:30,080 RATHER THAT THEY ARE EDUCATED AS 2789 01:33:30,080 --> 01:33:30,747 A SYSTEM. 2790 01:33:30,747 --> 01:33:32,749 BUT WE HAVE A LOT OF WORK TO DO. 2791 01:33:32,749 --> 01:33:34,184 SO I COMPLETELY AGREE WITH YOU 2792 01:33:34,184 --> 01:33:35,385 AND IT'S SOMETHING WE TALK ABOUT 2793 01:33:35,385 --> 01:33:40,657 REGULARLY. 2794 01:33:40,657 --> 01:33:44,494 >> AND HOW DO WE COPE IN THE 2795 01:33:44,494 --> 01:33:45,595 MEANTIME, EVERY DAY, WITH WHAT 2796 01:33:45,595 --> 01:33:46,363 WE'VE BEEN THROUGH. 2797 01:33:46,363 --> 01:33:48,598 OVER TIME THINGS WILL IMPROVE, 2798 01:33:48,598 --> 01:33:49,733 BUT DO YOU HAVE RECOMMENDATIONS 2799 01:33:49,733 --> 01:33:52,436 OR MAYBE COME UP WITH SOME 2800 01:33:52,436 --> 01:33:53,537 INTERMEDIATE GOAL, SHORT TERM 2801 01:33:53,537 --> 01:33:55,772 GOALS THAT WILL HELP US OUT 2802 01:33:55,772 --> 01:33:57,874 STARTING TOMORROW? 2803 01:33:57,874 --> 01:34:00,143 >> IT'S A GREAT QUESTION, AND 2804 01:34:00,143 --> 01:34:04,181 IT'S SOMETHING THAT WE TALK 2805 01:34:04,181 --> 01:34:06,416 ABOUT BUT YOU THINK WE CAN DO 2806 01:34:06,416 --> 01:34:06,950 MORE WORK TO HELP. 2807 01:34:06,950 --> 01:34:07,551 THANK YOU. 2808 01:34:07,551 --> 01:34:10,187 >> KRISTEN, YOU HAD A QUESTION? 2809 01:34:10,187 --> 01:34:13,657 >> YEAH, HI. 2810 01:34:13,657 --> 01:34:17,394 I'LL ALSO ADD THAT I HAD A 2811 01:34:17,394 --> 01:34:18,695 BEAUTIFUL SURVIVORSHIP CARE PLAN 2812 01:34:18,695 --> 01:34:20,297 AND I HAD THE MOST THOROUGH 2813 01:34:20,297 --> 01:34:23,934 PHYSICAL AFTER SURGERY, AND IT 2814 01:34:23,934 --> 01:34:25,435 WAS WONDERFUL AND I WAS REALLY 2815 01:34:25,435 --> 01:34:27,671 EXCITED BECAUSE I WAS ALL JAZZED 2816 01:34:27,671 --> 01:34:29,806 ABOUT SURVIVORSHIP BUT NO ONE 2817 01:34:29,806 --> 01:34:31,741 EVER LOOKED AT THE DOCUMENT 2818 01:34:31,741 --> 01:34:33,176 INCLUDING MYSELF, IT'S A PAPER 2819 01:34:33,176 --> 01:34:34,177 DOCUMENT, IT'S SOMEWHERE 2820 01:34:34,177 --> 01:34:35,679 UPSTAIRS, IT'S BEEN ON ME TO DO 2821 01:34:35,679 --> 01:34:36,446 FOLLOW-UP SCREENINGS AND ALL 2822 01:34:36,446 --> 01:34:36,913 THAT. 2823 01:34:36,913 --> 01:34:40,016 I HAVE A WONDERFUL PRIMARY CARE 2824 01:34:40,016 --> 01:34:41,551 DOCTOR WHO'S AMAZING AND I GO TO 2825 01:34:41,551 --> 01:34:43,220 HER FOR EVERYTHING AND I'M LUCKY 2826 01:34:43,220 --> 01:34:44,321 TO HAVE THAT BUT SHE NEVER EVEN 2827 01:34:44,321 --> 01:34:45,088 SAW THE DOCUMENT. 2828 01:34:45,088 --> 01:34:46,289 SO I'M EXCITED THAT THINGS ARE 2829 01:34:46,289 --> 01:34:49,392 CONTINUING TO MOVE FORWARD, SO 2830 01:34:49,392 --> 01:34:54,865 PEOPLE CAN -- THE BURDEN IS ON 2831 01:34:54,865 --> 01:34:56,833 THEM TO FOLLOW THROUGH ON 2832 01:34:56,833 --> 01:34:57,534 SURVIVORSHIP ISSUES. 2833 01:34:57,534 --> 01:34:58,702 BUT MY QUESTION IS, WHICH I PUT 2834 01:34:58,702 --> 01:35:00,604 IN THE CHAT, IS THE VA DOING 2835 01:35:00,604 --> 01:35:02,339 ANY -- DO THEY HAVE ANY 2836 01:35:02,339 --> 01:35:03,607 INCENTIVES, I KNOW YOU HAVE THE 2837 01:35:03,607 --> 01:35:06,877 REIMBURSEMENT RESOURCES COMING, 2838 01:35:06,877 --> 01:35:08,678 BUT I PERSONALLY FEEL LIKE IF 2839 01:35:08,678 --> 01:35:09,779 YOU PAY PEOPLE TO DO THINGS OR 2840 01:35:09,779 --> 01:35:13,917 IF THERE ARE INCENTIVES OTHER 2841 01:35:13,917 --> 01:35:15,418 PENALTIES, THAT'S REALLY HOW YOU 2842 01:35:15,418 --> 01:35:16,720 CREATE CHANGE, SO JUGS WONDER IF 2843 01:35:16,720 --> 01:35:17,821 THAT'S PART OF THE MODEL NOW 2844 01:35:17,821 --> 01:35:18,021 OR -- 2845 01:35:18,021 --> 01:35:19,723 >> SO THAT'S ALWAYS THE GOAL. 2846 01:35:19,723 --> 01:35:21,825 WE DON'T -- WE OURSELVES AT NCI 2847 01:35:21,825 --> 01:35:22,893 DON'T INFLUENCE THINGS LIKE 2848 01:35:22,893 --> 01:35:25,428 PAYMENT OR REIMBURSEMENT SO I 2849 01:35:25,428 --> 01:35:26,897 WANT TO JUST PUT THAT OUT THERE. 2850 01:35:26,897 --> 01:35:30,167 I WILL JUST SAY THAT THE VA IS 2851 01:35:30,167 --> 01:35:32,636 STARTING WITH A WHAT THEY CALL A 2852 01:35:32,636 --> 01:35:34,704 MINIMALLY VIABLE PRODUCT WHICH 2853 01:35:34,704 --> 01:35:35,805 MEANS THEY'RE STARTING SMALL AND 2854 01:35:35,805 --> 01:35:38,642 THEY'RE HOPING TO BE ABLE TO 2855 01:35:38,642 --> 01:35:40,310 ROLL IT OUT BUT BECAUSE IT'S A 2856 01:35:40,310 --> 01:35:40,977 COMPREHENSIVE SYSTEM WITH 2857 01:35:40,977 --> 01:35:41,912 PRIMARY CARE, I DO THINK THAT 2858 01:35:41,912 --> 01:35:43,613 THERE WILL BE BETTER INCENTIVES 2859 01:35:43,613 --> 01:35:46,917 AND TRANSITIONS IN CARE TO BE 2860 01:35:46,917 --> 01:35:47,884 ABLE TO DO THAT, SO THAT IS 2861 01:35:47,884 --> 01:35:50,187 SOMETHING THAT THEY'RE LOOKING 2862 01:35:50,187 --> 01:35:55,258 INTO. 2863 01:35:55,258 --> 01:35:56,927 >> YES, HI, EVERYONE. 2864 01:35:56,927 --> 01:35:58,562 AGAIN, LIKE KRISTEN I'M EXCITED 2865 01:35:58,562 --> 01:35:59,196 TO SEE THIS. 2866 01:35:59,196 --> 01:36:01,798 I DID NOT HAVE A CANCER CARE 2867 01:36:01,798 --> 01:36:01,998 PLAN. 2868 01:36:01,998 --> 01:36:04,201 I DON'T KNOW IF IT WAS BECAUSE I 2869 01:36:04,201 --> 01:36:07,237 WAS GOING INTO SURVIVORSHIP IN 2870 01:36:07,237 --> 01:36:10,840 2007 OR NOT, BUT I ALSO WORK 2871 01:36:10,840 --> 01:36:13,009 WITH SHELLEY DOING CANCER CARE 2872 01:36:13,009 --> 01:36:14,778 PLAN BACK IN 2016, SO IT'S 2873 01:36:14,778 --> 01:36:16,713 REALLY EXCITING TO SEE THIS 2874 01:36:16,713 --> 01:36:18,782 MOVEMENT, ESPECIALLY ALONG THE 2875 01:36:18,782 --> 01:36:20,650 POTENTIAL TO HAVE REIMBURSEMENT 2876 01:36:20,650 --> 01:36:21,618 BECAUSE I KNOW THAT WAS A MAJOR 2877 01:36:21,618 --> 01:36:22,152 ISSUE. 2878 01:36:22,152 --> 01:36:23,420 THIS IS KIND OF PIGGY BACKING 2879 01:36:23,420 --> 01:36:27,157 OFF OF THE OTHER QUESTION BUT I 2880 01:36:27,157 --> 01:36:28,491 ALSO USED TO WORK FOR THE 2881 01:36:28,491 --> 01:36:30,794 SOCIETY OF IMMUNOTHERAPY IN 2882 01:36:30,794 --> 01:36:33,863 CANCER AND WE PARTNERED WITH 2883 01:36:33,863 --> 01:36:35,165 ICCC, JUST MANAGING CARE IN THE 2884 01:36:35,165 --> 01:36:36,333 COMMUNITY SETTING WAS BEING ABLE 2885 01:36:36,333 --> 01:36:38,201 TO UNDERSTAND AND RECOGNIZE 2886 01:36:38,201 --> 01:36:39,135 ADVERSE EVENTS WHEN THEY WERE 2887 01:36:39,135 --> 01:36:40,870 COMING UP, SO I KNOW THERE IS A 2888 01:36:40,870 --> 01:36:41,972 TOOLKIT BUT I'M WONDERING IF 2889 01:36:41,972 --> 01:36:44,074 THERE IS KIND OF A PROACTIVE 2890 01:36:44,074 --> 01:36:46,343 EDUCATION AND ENGAGEMENT 2891 01:36:46,343 --> 01:36:47,711 STRATEGY FOR COMMUNITY 2892 01:36:47,711 --> 01:36:48,812 PRACTITIONERS SO THAT THEY WILL 2893 01:36:48,812 --> 01:36:51,114 BE MOTIVATED AND FEEL 2894 01:36:51,114 --> 01:36:52,449 COMFORTABLE WORKING ON THESE 2895 01:36:52,449 --> 01:36:54,985 CARE PLANS GOING OUT AND 2896 01:36:54,985 --> 01:36:55,986 SPECIFICALLY AND SOMEWHAT 2897 01:36:55,986 --> 01:36:58,822 SELFISHLY IF THERE IS ANYTHING 2898 01:36:58,822 --> 01:37:03,059 RELATED TO IMMUNOONCOLOGY 2899 01:37:03,059 --> 01:37:04,127 BECAUSE AGAIN I WAS ON A 2900 01:37:04,127 --> 01:37:05,996 CLINICAL TRIAL IN 2007, I WAS 2901 01:37:05,996 --> 01:37:08,365 TREATED AT A MAJOR NCI 2902 01:37:08,365 --> 01:37:09,466 DESIGNATED CENTER, AND I GO BACK 2903 01:37:09,466 --> 01:37:10,533 JUST BECAUSE I'M VERY CLOSE WITH 2904 01:37:10,533 --> 01:37:12,869 MY TEAM, BUT THE GUIDANCE IS, 2905 01:37:12,869 --> 01:37:14,471 YOU KNOW, YOU MADE IT, JUST GO 2906 01:37:14,471 --> 01:37:20,844 LIVE YOUR LIFE. 2907 01:37:20,844 --> 01:37:23,580 THAT DOESN'T MAKE ME FEEL COME 2908 01:37:23,580 --> 01:37:25,181 FORTDABLE TO SAY COME BACK IF 2909 01:37:25,181 --> 01:37:28,218 THERE'S A PROBLEM. 2910 01:37:28,218 --> 01:37:30,086 I PRESENTED AT STAGE THREE 2911 01:37:30,086 --> 01:37:30,587 MELANOMA. 2912 01:37:30,587 --> 01:37:32,022 YOU DON'T KNOW WHEN THERE'S A 2913 01:37:32,022 --> 01:37:32,622 PROBLEM AND SOMETIMES BY THE 2914 01:37:32,622 --> 01:37:34,424 TIME YOU KNOW, IT'S TOO LATE, SO 2915 01:37:34,424 --> 01:37:37,594 JUST WONDERING WHAT IF ANY, AND 2916 01:37:37,594 --> 01:37:39,329 IF IT'S POSSIBLE TO HAVE SOME 2917 01:37:39,329 --> 01:37:41,731 KIND OF GUIDANCE, TO HELP FOLKS 2918 01:37:41,731 --> 01:37:45,402 WHO MIGHT BE ON THE VERGE OF 2919 01:37:45,402 --> 01:37:46,536 RECURRING COMING IN EARLIER. 2920 01:37:46,536 --> 01:37:48,471 >> YOU ASK AMAZING QUESTIONS. 2921 01:37:48,471 --> 01:37:51,508 I'LL ANSWER THE FIRST QUESTION 2922 01:37:51,508 --> 01:37:52,375 ABOUT COMMUNITY RESOURCES. 2923 01:37:52,375 --> 01:37:54,644 SO WE DESIGNED THESE 2924 01:37:54,644 --> 01:37:57,180 SPECIFICALLY TO NOT BE ONLY 2925 01:37:57,180 --> 01:37:58,982 APPLICABLE FOR CANCER CENTERS OR 2926 01:37:58,982 --> 01:38:00,183 LARGE ACADEMIC MEDICAL CENTERS. 2927 01:38:00,183 --> 01:38:04,688 WE REALLY WANTED HEALTH CYST EMS 2928 01:38:04,688 --> 01:38:06,289 TO BE ABLE TO TAILOR THIS TO THE 2929 01:38:06,289 --> 01:38:07,390 RESOURCES THEY HAVE SO THEY 2930 01:38:07,390 --> 01:38:08,224 COULD EASILY IMPLEMENT. 2931 01:38:08,224 --> 01:38:09,526 SO WE'RE WORKING ON SOME 2932 01:38:09,526 --> 01:38:11,928 COMMUNITY RESOURCES AND ACCC IS 2933 01:38:11,928 --> 01:38:12,896 DEFINITELY A GROUP THAT WE'LL 2934 01:38:12,896 --> 01:38:14,030 ENGAGE WITH ALONG THE WAY, SO I 2935 01:38:14,030 --> 01:38:17,434 THINK THAT THAT'S A GREAT 2936 01:38:17,434 --> 01:38:17,734 SUGGESTION. 2937 01:38:17,734 --> 01:38:20,403 THEN YOU ASKED ABOUT 2938 01:38:20,403 --> 01:38:20,737 IMMUNOTHERAPY. 2939 01:38:20,737 --> 01:38:22,539 SO I WOULD JUST SAY THAT WE 2940 01:38:22,539 --> 01:38:24,941 TALKED A LOT ABOUT WHAT 2941 01:38:24,941 --> 01:38:27,243 POPULATIONS THIS WILL SERVE, AND 2942 01:38:27,243 --> 01:38:29,179 I THINK THAT THERE IS A NEED FOR 2943 01:38:29,179 --> 01:38:30,613 SURVIVORSHIP CARE IN SOME OF THE 2944 01:38:30,613 --> 01:38:34,217 NEWER TARGETED THERAPIES AND 2945 01:38:34,217 --> 01:38:35,085 BIOTHERAPIES, SO WE HAVE A LOT 2946 01:38:35,085 --> 01:38:36,453 OF WORK TO DO, BUT THESE 2947 01:38:36,453 --> 01:38:38,855 STANDARDS WOULD APPLY TO THOSE 2948 01:38:38,855 --> 01:38:39,322 PATIENTS AS WELL. 2949 01:38:39,322 --> 01:38:41,057 SO I THINK WE HAVE SOME WORK TO 2950 01:38:41,057 --> 01:38:42,258 DO. 2951 01:38:42,258 --> 01:38:44,561 >> THANK YOU. 2952 01:38:44,561 --> 01:38:45,829 >> BOB, YOU'RE NEXT. 2953 01:38:45,829 --> 01:38:46,930 >> SURE. 2954 01:38:46,930 --> 01:38:48,565 I'VE BEEN A SURVIVOR LONG ENOUGH 2955 01:38:48,565 --> 01:38:52,035 THAT I'VE SEEN THE INTEREST IN 2956 01:38:52,035 --> 01:38:54,003 SURVIVORSHIP PLANS KIND OF WAX 2957 01:38:54,003 --> 01:38:55,638 AND WANE THROUGH THE YEARS, AND 2958 01:38:55,638 --> 01:38:59,209 I'VE SEEN IT SOMETIMES SYSTEMS 2959 01:38:59,209 --> 01:39:00,543 AND HOSPITALS GIVE LIP SERVICE 2960 01:39:00,543 --> 01:39:02,278 TO IT AND THEY SAY WE DO IT, BUT 2961 01:39:02,278 --> 01:39:04,647 WHAT CAN WE AS ADVOCATES DO IN 2962 01:39:04,647 --> 01:39:08,351 OUR OWN COMMUNITIES TO REALLY 2963 01:39:08,351 --> 01:39:09,919 MAKE SURE IT'S REALLY EMBEDDED 2964 01:39:09,919 --> 01:39:11,287 AS PART OF THE TREATMENT 2965 01:39:11,287 --> 01:39:12,255 CULTURE, THAT THIS IS REALLY 2966 01:39:12,255 --> 01:39:13,056 IMPORTANT TO US? 2967 01:39:13,056 --> 01:39:14,324 >> ABSOLUTELY. 2968 01:39:14,324 --> 01:39:16,393 AND I BELIEVE YOU HAVE A CANCER 2969 01:39:16,393 --> 01:39:17,761 SURVIVOR STORY ON OUR WEBSITE AS 2970 01:39:17,761 --> 01:39:19,529 WELL, SO THANK YOU FOR DOING 2971 01:39:19,529 --> 01:39:19,729 THAT. 2972 01:39:19,729 --> 01:39:20,230 >> YES, I DO. 2973 01:39:20,230 --> 01:39:22,198 >> SO I WILL JUST SAY, YOU'VE 2974 01:39:22,198 --> 01:39:23,833 ALL BROUGHT UP SURVIVORSHIP CARE 2975 01:39:23,833 --> 01:39:25,468 PLANS, AND I DON'T THINK THAT 2976 01:39:25,468 --> 01:39:27,737 IT'S NOT THAT IT'S EFFECTIVE, 2977 01:39:27,737 --> 01:39:29,272 BUT I THINK KRISTEN SAID THIS, 2978 01:39:29,272 --> 01:39:30,807 OFTEN PROVIDERS FOCUS ONLY ON 2979 01:39:30,807 --> 01:39:33,443 SORT OF THE PIECE OF PAPER AND 2980 01:39:33,443 --> 01:39:34,811 HERE YOU GO AND NOT ON THE 2981 01:39:34,811 --> 01:39:37,547 PROCESS OF CARE AND SO I THINK 2982 01:39:37,547 --> 01:39:39,315 THAT PROVIDERS AND SURVIVORS CAN 2983 01:39:39,315 --> 01:39:42,385 FOCUS ON THAT DISCUSSION. 2984 01:39:42,385 --> 01:39:43,753 WHAT SHOULD I DO, WHAT SHOULD I 2985 01:39:43,753 --> 01:39:44,954 EXPECT OF MY PROVIDERS, WHAT 2986 01:39:44,954 --> 01:39:47,323 SHOULD I EXPECT OF MY HEALTH 2987 01:39:47,323 --> 01:39:47,657 SYSTEMS. 2988 01:39:47,657 --> 01:39:50,059 SO EDUCATING YOUR FELLOW 2989 01:39:50,059 --> 01:39:52,996 SURVIVORS ABOUT WHAT TO ASK FOR 2990 01:39:52,996 --> 01:39:54,964 IN TERMS OF CONTINUING CARE AND 2991 01:39:54,964 --> 01:39:55,865 SURVIVORSHIP CARE INSTEAD OF 2992 01:39:55,865 --> 01:39:57,167 JUST FOCUSING ON DO I HAVE A 2993 01:39:57,167 --> 01:39:59,702 PIECE OF PAPER OR NOT REALLY 2994 01:39:59,702 --> 01:40:03,106 MORE ABOUT THE PROCESS OF CARE 2995 01:40:03,106 --> 01:40:03,873 AND COMMUNICATION AND DISCUSSION 2996 01:40:03,873 --> 01:40:05,175 WITH YOUR DIFFERENT PROVIDERS, 2997 01:40:05,175 --> 01:40:06,776 AND THAT'S ON THE RESPONSIBILITY 2998 01:40:06,776 --> 01:40:09,546 OF THE HEALTHCARE SYSTEM AND 2999 01:40:09,546 --> 01:40:12,282 PROVIDER, AND IT ALSO DOES OFTEN 3000 01:40:12,282 --> 01:40:13,383 FALL ON THE SURVIVOR 3001 01:40:13,383 --> 01:40:14,651 UNFORTUNATELY, BUT WE NEED TO BE 3002 01:40:14,651 --> 01:40:15,618 BETTER PREPARED TO BE ABLE TO DO 3003 01:40:15,618 --> 01:40:17,387 THAT. 3004 01:40:17,387 --> 01:40:21,090 >> THANK YOU. 3005 01:40:21,090 --> 01:40:23,560 >> WE HAVE TIME FOR ONE MORE. 3006 01:40:23,560 --> 01:40:24,761 MARTY, IF YOU CAN GO AHEAD AND 3007 01:40:24,761 --> 01:40:25,662 ASK YOUR QUESTION. 3008 01:40:25,662 --> 01:40:26,095 >> SURE. 3009 01:40:26,095 --> 01:40:26,529 THANK YOU. 3010 01:40:26,529 --> 01:40:28,431 I'LL TRY TO BE QUICK. 3011 01:40:28,431 --> 01:40:31,734 SO THIS IS SO IMPORTANT, WHAT 3012 01:40:31,734 --> 01:40:32,836 YOU'RE DOING. 3013 01:40:32,836 --> 01:40:35,004 AND I HEAR FROM TOO MANY PEOPLE 3014 01:40:35,004 --> 01:40:37,841 IN MY SUPPORT GROUPS THAT WHEN 3015 01:40:37,841 --> 01:40:39,342 THEY'RE TREATED FOR THEIR 3016 01:40:39,342 --> 01:40:42,212 CANCER, THEY'RE THEN KIND OF LET 3017 01:40:42,212 --> 01:40:42,846 OUT THE DOOR. 3018 01:40:42,846 --> 01:40:44,781 WELL, WE'VE TAKEN CARE OF YOUR 3019 01:40:44,781 --> 01:40:46,216 CANCER, YOU'RE ON YOUR OWN NOW. 3020 01:40:46,216 --> 01:40:49,385 HAVING THIS COMPREHENSIVE 3021 01:40:49,385 --> 01:40:51,721 FRAMEWORK FOR FOLLOW-UP IS 3022 01:40:51,721 --> 01:40:54,691 REALLY, REALLY SIGNIFICANT. 3023 01:40:54,691 --> 01:40:58,194 IT SEEMS TO PUT THE PRIMARY 3024 01:40:58,194 --> 01:41:01,531 RESPONSIBILITY ON THE HEALTHCARE 3025 01:41:01,531 --> 01:41:04,501 SYSTEM FOR SURVIVORSHIP CARE AND 3026 01:41:04,501 --> 01:41:11,374 YET AS NOTED BY SOME OF THE 3027 01:41:11,374 --> 01:41:13,476 PARTICIPANTS, IT GOES BEYOND 3028 01:41:13,476 --> 01:41:14,310 TRADITIONAL HEALTHCARE. 3029 01:41:14,310 --> 01:41:17,914 SO YOU HAVE ISSUES AROUND DIET, 3030 01:41:17,914 --> 01:41:19,782 YOU HAVE ISSUES AROUND -- AND 3031 01:41:19,782 --> 01:41:23,253 THE NEED FOR EX-A EXERCISE, YOUE 3032 01:41:23,253 --> 01:41:24,888 FINANCIAL TOXICITY, YOU HAVE 3033 01:41:24,888 --> 01:41:26,055 WORKPLACE ACCOMMODATION ISSUES, 3034 01:41:26,055 --> 01:41:26,523 ET CETERA, ET CETERA. 3035 01:41:26,523 --> 01:41:28,358 SO MY QUESTION IS, WHAT ARE YOU 3036 01:41:28,358 --> 01:41:30,226 FINDING IN TERMS OF BARRIERS, IN 3037 01:41:30,226 --> 01:41:35,331 TERMS OF REACHING OUT TO THESE 3038 01:41:35,331 --> 01:41:38,067 EXTERNAL NOT HEALTHCARE 3039 01:41:38,067 --> 01:41:39,802 ORGANIZATIONS TO GET THEM TO 3040 01:41:39,802 --> 01:41:42,605 PARTICIPATE IN THE SURVIVORSHIP 3041 01:41:42,605 --> 01:41:44,207 APPROACH AND WHAT ARE YOU DOING 3042 01:41:44,207 --> 01:41:45,975 TO OVERCOME THOSE? 3043 01:41:45,975 --> 01:41:49,012 WHAT WORKS IN TERMS OF THAT 3044 01:41:49,012 --> 01:41:50,680 OUTREACH? 3045 01:41:50,680 --> 01:41:51,915 >> THAT'S A GREAT QUESTION. 3046 01:41:51,915 --> 01:41:52,315 THANK YOU SO MUCH. 3047 01:41:52,315 --> 01:41:53,917 SO WE ARE IN THE VERY EARLY 3048 01:41:53,917 --> 01:41:55,351 STAGES OF PILOT TESTING THESE 3049 01:41:55,351 --> 01:41:56,719 STANDARDS, SO I THINK THOSE 3050 01:41:56,719 --> 01:41:59,455 QUESTIONS ARE TO COME, BUT THERE 3051 01:41:59,455 --> 01:42:00,657 ARE MANY NON-PROFIT 3052 01:42:00,657 --> 01:42:01,491 ORGANIZATIONS THAT ARE OFFERING 3053 01:42:01,491 --> 01:42:03,626 THAT TYPE OF SUPPORTIVE CARE IN 3054 01:42:03,626 --> 01:42:03,993 DIFFERENT AREAS. 3055 01:42:03,993 --> 01:42:05,795 AND I THINK WE NEED TO BETTER 3056 01:42:05,795 --> 01:42:07,463 ROUTE OUR SURVIVORS TO THAT 3057 01:42:07,463 --> 01:42:08,598 THROUGH OUR HEALTH SYSTEMS. 3058 01:42:08,598 --> 01:42:14,537 SO I THINK PLEASE STAY TUNED 3059 01:42:14,537 --> 01:42:15,505 BECAUSE OUR HOPE IS TO BE ABLE 3060 01:42:15,505 --> 01:42:16,739 TO BRIDGE THAT GAP. 3061 01:42:16,739 --> 01:42:18,474 >> THANK YOU SO MUCH. 3062 01:42:18,474 --> 01:42:19,976 >> THANKS, AND JUST IF I COULD 3063 01:42:19,976 --> 01:42:22,378 ADD REALLY QUICKLY, I'M 3064 01:42:22,378 --> 01:42:25,181 PRIVILEGED ENOUGH TO BE IN 3065 01:42:25,181 --> 01:42:30,553 SURVIVORSHIP FSURVIVORSHIP FOR M 3066 01:42:30,553 --> 01:42:32,922 AND I JUST LOVE THE FOCUS ON 3067 01:42:32,922 --> 01:42:34,657 LIVING INSTEAD OF THE CANCER, 3068 01:42:34,657 --> 01:42:36,426 BUT I DO HAVE MY SURVIVORSHIP 3069 01:42:36,426 --> 01:42:39,228 PLANS THAT I TAKE TO MY PRIMARY 3070 01:42:39,228 --> 01:42:41,731 CARE WHICH HAVE CHANGED QUITE A 3071 01:42:41,731 --> 01:42:46,135 BIT, BUT I DO WANT TO NOTE IF 3072 01:42:46,135 --> 01:42:47,003 THERE'S MISSING INFORMATION, 3073 01:42:47,003 --> 01:42:48,271 THEY'RE NOT GOING TO HAVE, AND I 3074 01:42:48,271 --> 01:42:54,744 HAD TO GET TSH O -- ONE OF MY 3075 01:42:54,744 --> 01:42:57,113 PROVIDERS DIDN'T BRIEF BELIEVE I 3076 01:42:57,113 --> 01:43:02,185 DIDN'T HAVE A GALLBLADDER, AND 3077 01:43:02,185 --> 01:43:04,621 AT THE TIME I DIDN'T THINK THAT, 3078 01:43:04,621 --> 01:43:07,123 WELL, LET ME JUST GO GET MY 3079 01:43:07,123 --> 01:43:08,658 SURGICAL REPORT INSTEAD OF 3080 01:43:08,658 --> 01:43:11,294 HAVING TO JUST HAVE THE EXPENSE 3081 01:43:11,294 --> 01:43:12,195 OF ANOTHER ULTRASOUND. 3082 01:43:12,195 --> 01:43:15,131 BUT IT'S REALLY -- SOME PEOPLE 3083 01:43:15,131 --> 01:43:17,867 DON'T EVEN KNOW WHAT THEY'D HAD 3084 01:43:17,867 --> 01:43:20,903 OR WHAT IS COMING UP. 3085 01:43:20,903 --> 01:43:23,640 SO THE PLAN FOR WHEN THE SYSTEM 3086 01:43:23,640 --> 01:43:25,808 ISN'T READY FOR US, IT'S JUST 3087 01:43:25,808 --> 01:43:28,211 STILL AN IMPORTANT PIECE OF 3088 01:43:28,211 --> 01:43:32,015 MOVING ON TO THE NEXT PHASE. 3089 01:43:32,015 --> 01:43:33,983 BUT AMY, WE HAD A COUPLE MORE 3090 01:43:33,983 --> 01:43:34,784 QUESTIONS COMING THROUGH. 3091 01:43:34,784 --> 01:43:37,320 HOW DO YOU WANT TO HANDLE THAT? 3092 01:43:37,320 --> 01:43:41,424 >> I'M LOOKING IN THE CHAT NOW 3093 01:43:41,424 --> 01:43:43,292 TOO. 3094 01:43:43,292 --> 01:43:44,594 WHY DON'T WE JUST KEEP DOING 3095 01:43:44,594 --> 01:43:47,630 THAT AND YOU CAN KEEP MOVING ON, 3096 01:43:47,630 --> 01:43:47,830 ANNIE. 3097 01:43:47,830 --> 01:43:49,365 >> I KNOW DR. RATHMELL JOINED US 3098 01:43:49,365 --> 01:43:50,733 A LITTLE BIT EARLY BUT WE STILL 3099 01:43:50,733 --> 01:43:52,301 HAVE TIME FOR THE DISCUSSION, I 3100 01:43:52,301 --> 01:43:53,503 DON'T WANT TO CUT IT OFF WHEN 3101 01:43:53,503 --> 01:43:56,072 PEOPLE HAVE THINGS TO SAY, BUT 3102 01:43:56,072 --> 01:43:57,640 LEE, YOU HAD YOUR HAND UP 3103 01:43:57,640 --> 01:43:58,174 EARLIER. 3104 01:43:58,174 --> 01:43:59,709 WE'LL DO LEE AND THEN WE'LL DO 3105 01:43:59,709 --> 01:44:00,276 BRITTANY. 3106 01:44:00,276 --> 01:44:02,211 >> WE DID LEE IN THE CHAT. 3107 01:44:02,211 --> 01:44:03,312 HE WAS MENTIONING -- 3108 01:44:03,312 --> 01:44:05,381 >> THAT'S TAKEN CARE OF? 3109 01:44:05,381 --> 01:44:05,581 OKAY. 3110 01:44:05,581 --> 01:44:05,948 >> THAT'S FINE. 3111 01:44:05,948 --> 01:44:07,083 >> AND THEN BRITTANY, DID YOU 3112 01:44:07,083 --> 01:44:09,052 WANT TO GO AHEAD AND ASK YOUR 3113 01:44:09,052 --> 01:44:09,318 QUESTION? 3114 01:44:09,318 --> 01:44:10,053 >> OH, SURE. 3115 01:44:10,053 --> 01:44:11,988 I JUST HAD A CLARIFICATION 3116 01:44:11,988 --> 01:44:13,723 QUESTION MAYBE, YOU KNOW, I 3117 01:44:13,723 --> 01:44:16,025 HEARD THE FOCUS ON THE VA PILOT, 3118 01:44:16,025 --> 01:44:17,326 WHICH IS GREAT, BUT MY COMMENT 3119 01:44:17,326 --> 01:44:18,528 IN THE CHAT AND QUESTION IF YOU 3120 01:44:18,528 --> 01:44:19,929 COULD SHARE A LITTLE BIT MORE 3121 01:44:19,929 --> 01:44:22,098 ABOUT INTENTIONS TO PILOT MORE 3122 01:44:22,098 --> 01:44:24,267 BROADLY, WE RECOGNIZE THE VA 3123 01:44:24,267 --> 01:44:26,803 POPULATION AS NOT NECESSARILY 3124 01:44:26,803 --> 01:44:27,570 REFLECTIVE OF THE GENERAL 3125 01:44:27,570 --> 01:44:28,938 POPULATION, IT TENDS TO BE 3126 01:44:28,938 --> 01:44:31,507 OLDER, IT'S NOT QUITE AS 3127 01:44:31,507 --> 01:44:32,842 RACIALLY AND ETHNICALLY DIVERSE, 3128 01:44:32,842 --> 01:44:34,310 ET CETERA, SO JUST CONCERNS 3129 01:44:34,310 --> 01:44:36,312 WITH, YOU KNOW, TAKING LEARNINGS 3130 01:44:36,312 --> 01:44:37,880 FROM THE PILOT THAT MAY NOT BE 3131 01:44:37,880 --> 01:44:38,948 GENERALIZABLE TO THE LARGER 3132 01:44:38,948 --> 01:44:40,616 PATIENT POPULATION AND HOW YOU 3133 01:44:40,616 --> 01:44:42,351 ALL ARE KIND OF APPROACHING 3134 01:44:42,351 --> 01:44:45,088 FOCUSING ON OTHER PILOTS AND 3135 01:44:45,088 --> 01:44:47,056 OTHER SITES. 3136 01:44:47,056 --> 01:44:48,291 >> THANKS VERY MUCH, BRITTANY. 3137 01:44:48,291 --> 01:44:49,392 SO I'LL ANSWER THAT VERY QUICKLY 3138 01:44:49,392 --> 01:44:53,463 ONLY TO SAY THAT THE VA WAS SORT 3139 01:44:53,463 --> 01:44:56,632 OF A NATURAL PARTNER IN THE 3140 01:44:56,632 --> 01:44:57,333 GOVERNMENT -- ALL OF GOVERNMENT 3141 01:44:57,333 --> 01:44:58,634 APPROACH WITH THE CANCER CABINET 3142 01:44:58,634 --> 01:45:02,171 SO IT'S JUST ONE SITE. 3143 01:45:02,171 --> 01:45:04,073 THE GRANT SUPPLEMENT NOTICE THAT 3144 01:45:04,073 --> 01:45:06,476 WE RECENTLY FIELDED, WE GOT A 3145 01:45:06,476 --> 01:45:08,010 GREAT RESPONSE FROM AND THAT 3146 01:45:08,010 --> 01:45:09,846 INCLUDED CANCER CENTERS, THAT 3147 01:45:09,846 --> 01:45:10,713 INCLUDED COMMUNITY SITES, SO 3148 01:45:10,713 --> 01:45:13,783 WE'RE REALLY EXCITED TO BE ABLE 3149 01:45:13,783 --> 01:45:16,686 TO FUND SUPPLEMENTS OR GRANT 3150 01:45:16,686 --> 01:45:18,254 FUNDING TO BE ABLE TO ASSESS 3151 01:45:18,254 --> 01:45:19,989 ALIGNMENT AND IDENTIFY GAPS. 3152 01:45:19,989 --> 01:45:22,158 SO OUR GOAL IS NOT TO FOCUS ONLY 3153 01:45:22,158 --> 01:45:24,026 ON THE VA SYSTEM, SO THAT'S AN 3154 01:45:24,026 --> 01:45:28,197 EXCELLENT POINT. 3155 01:45:28,197 --> 01:45:29,932 >> DO WE HAVE ANY OTHER 3156 01:45:29,932 --> 01:45:33,603 QUESTIONS FOR DR. MOLLICA? 3157 01:45:33,603 --> 01:45:34,170 OKAY. 3158 01:45:34,170 --> 01:45:35,471 HEARING NONE, THANK YOU SO MUCH 3159 01:45:35,471 --> 01:45:37,106 FOR SPENDING TIME WITH US AND 3160 01:45:37,106 --> 01:45:40,710 SHARING YOUR EXCITING WORK. 3161 01:45:40,710 --> 01:45:42,678 AS YOU COULD HEAR, WE'RE VERY, 3162 01:45:42,678 --> 01:45:44,447 VERY ENTHUSIASTIC AND INTERESTED 3163 01:45:44,447 --> 01:45:45,448 ABOUT WHAT IS GOING TO BE 3164 01:45:45,448 --> 01:45:46,582 HAPPENING IN THAT AREA. 3165 01:45:46,582 --> 01:45:51,287 SO THANK YOU VERY MUCH. 3166 01:45:51,287 --> 01:45:51,721 OKAY. 3167 01:45:51,721 --> 01:45:55,191 NOW FOR THE MAIN EVENT, I WOULD 3168 01:45:55,191 --> 01:45:56,726 LIKE TO JUST THANK DR. RATHMELL 3169 01:45:56,726 --> 01:45:58,594 FOR TAKING TIME OUT OF HER BUSY 3170 01:45:58,594 --> 01:46:01,597 DAY TO GIVE US AN UPDATE, AND 3171 01:46:01,597 --> 01:46:02,398 THANK YOU AGAIN FOR BEING WITH 3172 01:46:02,398 --> 01:46:03,599 US. 3173 01:46:03,599 --> 01:46:04,700 >> THANK YOU. 3174 01:46:04,700 --> 01:46:06,669 I'M GLAD TO BE HERE. 3175 01:46:06,669 --> 01:46:09,705 THANK YOU FOR ACCOMMODATING MY 3176 01:46:09,705 --> 01:46:12,241 LITTLE BIT CRAZY SCHEDULE TODAY. 3177 01:46:12,241 --> 01:46:13,876 IT'S KIND OF FUN TO BE AT THE 3178 01:46:13,876 --> 01:46:15,478 END, SO I HOPE THIS GOES REALLY 3179 01:46:15,478 --> 01:46:16,913 WELL. 3180 01:46:16,913 --> 01:46:18,047 I WANT TO JUST LET YOU KNOW 3181 01:46:18,047 --> 01:46:20,349 WHERE I WAS TODAY. 3182 01:46:20,349 --> 01:46:21,617 THE WHITE HOUSE DECIDED TO 3183 01:46:21,617 --> 01:46:23,586 CONVENE A GROUP TOGETHER TO TALK 3184 01:46:23,586 --> 01:46:25,755 ABOUT HOW WE TRANSFORM CLINICAL 3185 01:46:25,755 --> 01:46:26,322 TRIALS. 3186 01:46:26,322 --> 01:46:28,191 HOW DO WE BRING CLINICAL 3187 01:46:28,191 --> 01:46:29,492 RESEARCH INTO THE MAINSTREAM AND 3188 01:46:29,492 --> 01:46:33,196 HOW DO WE MAKE IT BE A PART OF 3189 01:46:33,196 --> 01:46:36,165 CARE , THAT CLINICAL RESEARCH IS 3190 01:46:36,165 --> 01:46:37,200 CARE, AND I THINK THIS IS 3191 01:46:37,200 --> 01:46:38,000 SOMETHING THAT WE WILL TALK 3192 01:46:38,000 --> 01:46:41,504 ABOUT MORE IN THIS GROUP BECAUSE 3193 01:46:41,504 --> 01:46:42,939 I THINK YOUR VOICES ARE REALLY 3194 01:46:42,939 --> 01:46:44,307 IMPORTANT IN THIS DISCUSSION. 3195 01:46:44,307 --> 01:46:46,342 IT WAS WELL REPRESENTED BY 3196 01:46:46,342 --> 01:46:47,677 ADVOCACY GROUPS, CANCER REALLY 3197 01:46:47,677 --> 01:46:51,781 DOMINATED THE ROOM BUT IT WAS 3198 01:46:51,781 --> 01:46:52,715 REPRESENTED TO ALL. 3199 01:46:52,715 --> 01:46:55,551 FUN FACT, IT RAN RIGHT UP UNTIL 3200 01:46:55,551 --> 01:46:56,886 I NEEDED TO COME TO THIS SO I 3201 01:46:56,886 --> 01:46:59,255 SAID I NEED A CONFERENCE ROOM 3202 01:46:59,255 --> 01:47:00,489 WHERE I COULD HAVE A MEETING SO 3203 01:47:00,489 --> 01:47:02,458 I THOUGHT I'D GET SOME DRAP 3204 01:47:02,458 --> 01:47:03,426 GOVERNMENT ROOM BUT THOSE MUST 3205 01:47:03,426 --> 01:47:04,961 BE ALL TAKEN BECAUSE THEY PUT ME 3206 01:47:04,961 --> 01:47:06,929 IN THIS HISTORIC SECRETARY OF 3207 01:47:06,929 --> 01:47:10,766 WAR ROOM. 3208 01:47:10,766 --> 01:47:13,836 SO -- ANYWAY, I JUST HAD TO 3209 01:47:13,836 --> 01:47:14,170 SHARE. 3210 01:47:14,170 --> 01:47:16,372 I'M IN A CRAZY FANCY LITTLE 3211 01:47:16,372 --> 01:47:21,377 HISTORIC ROOM. 3212 01:47:21,377 --> 01:47:27,617 SO LET'S GET STARTED. 3213 01:47:27,617 --> 01:47:30,152 SO TODAY, WHAT WE'LL TALK ABOUT 3214 01:47:30,152 --> 01:47:32,889 IS RECENT NEWS AND UPDATES AND 3215 01:47:32,889 --> 01:47:34,190 THEN MOVE INTO BUDGET. 3216 01:47:34,190 --> 01:47:35,725 YOU ALREADY HEARD FROM HOLLY A 3217 01:47:35,725 --> 01:47:38,761 LITTLE BIT ABOUT WHERE CONGRESS 3218 01:47:38,761 --> 01:47:41,297 IS LOOKING TOWARD IN OUR BUDGET 3219 01:47:41,297 --> 01:47:45,468 DISCUSSIONS. 3220 01:47:45,468 --> 01:47:47,570 SO HOT OFF THE PRESSES, AND THEN 3221 01:47:47,570 --> 01:47:48,738 REALLY WANT TO SPEND A MINUTE 3222 01:47:48,738 --> 01:47:49,705 LOOKING AT OUR RESEARCH AND 3223 01:47:49,705 --> 01:47:50,273 PROGRAM HIGHLIGHTS. 3224 01:47:50,273 --> 01:47:51,807 EVEN THOUGH IT FEELS LIKE NOT 3225 01:47:51,807 --> 01:47:54,410 THAT LONG AGO WHEN I MET WITH 3226 01:47:54,410 --> 01:47:58,681 YOU, I THINK IT WAS IN FEBRUARY, 3227 01:47:58,681 --> 01:48:00,750 SO MUCH HAS HAPPENED, AND I 3228 01:48:00,750 --> 01:48:02,184 THINK IT'S JUST VITALLY 3229 01:48:02,184 --> 01:48:05,488 IMPORTANT THAT IT'S APPARENT 3230 01:48:05,488 --> 01:48:07,123 THAT THE PROGRESS IS JUST 3231 01:48:07,123 --> 01:48:08,024 CONTINUING UNABATED. 3232 01:48:08,024 --> 01:48:09,191 AND THEN WE WILL HAVE SOME TIME 3233 01:48:09,191 --> 01:48:13,562 FOR ADDITIONAL QUESTIONS. 3234 01:48:13,562 --> 01:48:15,164 BEFORE I LAUNCH IN, I JUST WANT 3235 01:48:15,164 --> 01:48:16,966 TO SAY THIS IS SURVIVORSHIP 3236 01:48:16,966 --> 01:48:21,470 MONTH AND THE PRESENTATION RIGHT 3237 01:48:21,470 --> 01:48:25,274 BEFORE IS SO APT AND JUST TOP OF 3238 01:48:25,274 --> 01:48:29,545 MIND IS HOW WE MOVE FROM THE 3239 01:48:29,545 --> 01:48:33,249 SPACE OF WE'VE TAKEN CARE OF THE 3240 01:48:33,249 --> 01:48:34,417 CANCER, CONGRATULATIONS, TO THAT 3241 01:48:34,417 --> 01:48:35,318 IS ONE PART OF YOUR HEALTH 3242 01:48:35,318 --> 01:48:38,054 SYSTEM AND NOW SURVIVORSHIP 3243 01:48:38,054 --> 01:48:40,456 PLAYS A MAJOR ROLE GOING ONWARD. 3244 01:48:40,456 --> 01:48:41,524 AND I PARTICULARLY LIKE THE 3245 01:48:41,524 --> 01:48:44,927 COMMENT IN THE CHAT FROM LEE 3246 01:48:44,927 --> 01:48:46,028 THAT CINCINNATI WAS INCLUDING 3247 01:48:46,028 --> 01:48:48,297 PRIMARY CARE AS A CLOSE PART OF 3248 01:48:48,297 --> 01:48:50,399 THE CANCER CENTER. 3249 01:48:50,399 --> 01:48:51,367 SO ABSOLUTELY IMPORTANT. 3250 01:48:51,367 --> 01:48:51,834 OKAY. 3251 01:48:51,834 --> 01:48:57,306 NEXT SLIDE. 3252 01:48:57,306 --> 01:48:59,809 SO FIRST I HAVE TO THANK SEVERAL 3253 01:48:59,809 --> 01:49:03,646 OF YOU WHO ARE ENDING THE TERM 3254 01:49:03,646 --> 01:49:08,551 ON THE NCRA, SO EVERYONE ON THIS 3255 01:49:08,551 --> 01:49:10,619 SLIDE BECAME A MEMBER OF THE 3256 01:49:10,619 --> 01:49:14,256 NCRA IN 2020, AND SO JOINED JUST 3257 01:49:14,256 --> 01:49:15,891 IN TIME FOR THE PANDEMIC SO I'M 3258 01:49:15,891 --> 01:49:18,094 SURE I'VE HAD MORE THAN YOUR 3259 01:49:18,094 --> 01:49:21,931 SHARE OF THESE WEBEX VERSIONS OF 3260 01:49:21,931 --> 01:49:24,533 THE NCRA, BUT REALLY WANT TO 3261 01:49:24,533 --> 01:49:27,937 THANK EVERYONE SO I'LL JUST -- I 3262 01:49:27,937 --> 01:49:32,074 THINK EVERYONE IS ON TODAY, BUT 3263 01:49:32,074 --> 01:49:33,042 KRISTEN SANTIAGO, JACQUELINE 3264 01:49:33,042 --> 01:49:36,779 SMITH, KEVIN STEMBERGER, NICOLE 3265 01:49:36,779 --> 01:49:37,713 WILLMARTH AND YELAK BIRU, THANK 3266 01:49:37,713 --> 01:49:40,049 YOU VERY MUCH FOR THE TIME AND 3267 01:49:40,049 --> 01:49:41,450 COMMITMENT AND JUST KNOW THAT 3268 01:49:41,450 --> 01:49:44,820 EVEN WHEN YOU ROTATE OFF OF 3269 01:49:44,820 --> 01:49:46,322 BOARDS HERE WITH THE NCI, WE 3270 01:49:46,322 --> 01:49:48,190 TEND TO KEEP YOU A LITTLE BIT ON 3271 01:49:48,190 --> 01:49:49,091 SPEED-DIAL. 3272 01:49:49,091 --> 01:49:51,827 SO YOU'LL STILL BE PART OF THE 3273 01:49:51,827 --> 01:49:52,695 NCI FAMILY. 3274 01:49:52,695 --> 01:49:57,299 SO THANKS VERY MUCH. 3275 01:49:57,299 --> 01:49:57,600 OKAY. 3276 01:49:57,600 --> 01:49:59,335 SO MOVING ON TO THE NEXT NEWS 3277 01:49:59,335 --> 01:50:03,973 AND UPDATES. 3278 01:50:03,973 --> 01:50:05,174 SPEAKING OF BOARD MEMBERSHIP, I 3279 01:50:05,174 --> 01:50:06,976 WANT TO LET YOU KNOW ABOUT ONE 3280 01:50:06,976 --> 01:50:10,146 THING THAT WE'LL BE DOING COMING 3281 01:50:10,146 --> 01:50:11,881 UP FORWARD. 3282 01:50:11,881 --> 01:50:14,183 SO AS I JUST MENTIONED, WE HAVE 3283 01:50:14,183 --> 01:50:15,518 HAD SEVERAL PEOPLE ROTATING OFF. 3284 01:50:15,518 --> 01:50:18,154 THERE WILL BE NEW MEMBERS 3285 01:50:18,154 --> 01:50:21,690 JOINING, AND ONE ASPECT OF BOARD 3286 01:50:21,690 --> 01:50:23,526 MEMBERSHIP THAT I'VE HEARD FROM 3287 01:50:23,526 --> 01:50:28,230 SEVERAL OF THE BOARDS BUT ALSO 3288 01:50:28,230 --> 01:50:30,533 LEARN IN TALKING WITH ANNIE 3289 01:50:30,533 --> 01:50:32,068 ELLIS WAS THAT OUR ORIENTATION 3290 01:50:32,068 --> 01:50:33,936 IS FAIRLY NARROW AND SPECIFIC. 3291 01:50:33,936 --> 01:50:35,137 IT'S ENOUGH TO ALLOW YOU TO DO 3292 01:50:35,137 --> 01:50:37,206 THE WORK THAT WE'RE ASKING FOR 3293 01:50:37,206 --> 01:50:38,674 BUT IT'S NOT AS COMPREHENSIVE AS 3294 01:50:38,674 --> 01:50:40,843 IT COULD BE. 3295 01:50:40,843 --> 01:50:43,145 TO GIVE FOLKS A REALLY BROAD 3296 01:50:43,145 --> 01:50:44,980 PICTURE OF WHAT GOES ON AT THE 3297 01:50:44,980 --> 01:50:47,516 NCI AND WHERE THE WORK IS 3298 01:50:47,516 --> 01:50:49,819 HAPPENING AND WHAT IT IS THAT WE 3299 01:50:49,819 --> 01:50:52,221 ARE DOING OR ARE ABLE TO DO. 3300 01:50:52,221 --> 01:50:54,056 SO WE ARE IN THE PROCESS OF 3301 01:50:54,056 --> 01:50:55,925 PLANNING AND ORIENTATION FOR NCI 3302 01:50:55,925 --> 01:50:56,692 ADVISORY BOARD MEMBERS. 3303 01:50:56,692 --> 01:50:58,894 THERE ARE SIX BOARDS, SO THIS 3304 01:50:58,894 --> 01:51:01,097 BEING ONE OF THEM. 3305 01:51:01,097 --> 01:51:03,065 AND PLANNING TO CROSS FERTILIZE 3306 01:51:03,065 --> 01:51:04,867 IN THOSE BOARDS BY BRINGING THE 3307 01:51:04,867 --> 01:51:06,802 INCOMING BOARD MEMBERS TOGETHER 3308 01:51:06,802 --> 01:51:08,404 FOR AN IN-PERSON ORIENTATION. 3309 01:51:08,404 --> 01:51:11,373 SO MORE DETAILS TO COME, AND WE 3310 01:51:11,373 --> 01:51:13,309 MAY PING FOLKS TO FIND OUT WHAT 3311 01:51:13,309 --> 01:51:14,677 WOULD BE THE MOST RELEVANT 3312 01:51:14,677 --> 01:51:18,380 INFORMATION TO PUT INTO AN 3313 01:51:18,380 --> 01:51:19,248 IN-PERSON ORIENTATION. 3314 01:51:19,248 --> 01:51:20,349 VERY EXCITED TO DO THIS, BECAUSE 3315 01:51:20,349 --> 01:51:22,751 I THINK IT WILL HELP OUR BOARDS 3316 01:51:22,751 --> 01:51:30,526 REALLY BE MEATY. 3317 01:51:30,526 --> 01:51:32,261 SO I'D LIKE TO INTRODUCE THE 3318 01:51:32,261 --> 01:51:34,063 FACT THAT THE WORK HERE IS OF 3319 01:51:34,063 --> 01:51:36,799 THE HIGHEST CALIBER, JUST 3320 01:51:36,799 --> 01:51:39,135 POINTING TO SOME RECENT 3321 01:51:39,135 --> 01:51:40,436 INTRAMURAL ACCOMPLISHMENTS. 3322 01:51:40,436 --> 01:51:41,871 AS YOU KNOW, THE NCI CONSISTS OF 3323 01:51:41,871 --> 01:51:43,739 INVESTIGATORS AND SCIENTISTS AND 3324 01:51:43,739 --> 01:51:44,773 CLINICIANS WHO ARE IN MARYLAND 3325 01:51:44,773 --> 01:51:46,475 AND THAT'S SORT OF THE NCI 3326 01:51:46,475 --> 01:51:47,910 PROPERLY, AND THEN WE FUND 3327 01:51:47,910 --> 01:51:51,413 INVESTIGATORS ALL AROUND THE 3328 01:51:51,413 --> 01:51:53,582 COUNTRY AND THE SCALE OF THAT IS 3329 01:51:53,582 --> 01:51:55,584 REALLY MASSIVE. 3330 01:51:55,584 --> 01:51:57,753 IN OUR MAIN CAMPUS, WE HAVE 3331 01:51:57,753 --> 01:51:58,954 OUTSTANDING INVESTIGATORS AND 3332 01:51:58,954 --> 01:52:02,558 JUST TO PUT SOME FACES TO WHO 3333 01:52:02,558 --> 01:52:05,327 THESE FOLKS ARE AND WHY THEIR 3334 01:52:05,327 --> 01:52:08,030 NAMES BECOME HOUSEHOLD NAMES. 3335 01:52:08,030 --> 01:52:09,565 SO ELECTED TO THE NATIONAL 3336 01:52:09,565 --> 01:52:10,232 ACADEMY OF SCIENCES. 3337 01:52:10,232 --> 01:52:11,867 THIS IS ONE OF THE HIGHEST 3338 01:52:11,867 --> 01:52:14,703 HONORS THAT A SCIENTIST CAN 3339 01:52:14,703 --> 01:52:15,004 ACHIEVE. 3340 01:52:15,004 --> 01:52:17,273 WE HAD THREE ELECTED MEMBERS 3341 01:52:17,273 --> 01:52:18,140 THIS YEAR. 3342 01:52:18,140 --> 01:52:25,714 STEVE ROSENBERG, GIORGIO 3343 01:52:25,714 --> 01:52:27,783 TRINCHIERI AND DESCRAN WOLIN. 3344 01:52:27,783 --> 01:52:28,984 THE AMERICAN SOCIETY FOR 3345 01:52:28,984 --> 01:52:29,652 CLINICAL INVESTIGATION IS AN 3346 01:52:29,652 --> 01:52:30,519 ORGANIZATION FOR PHYSICIAN 3347 01:52:30,519 --> 01:52:32,054 SCIENTISTS THAT RECOGNIZES THOSE 3348 01:52:32,054 --> 01:52:33,489 WHO ARE MAKING REMARKABLE 3349 01:52:33,489 --> 01:52:35,291 CONTRIBUTIONS AT EARLY STAGES IN 3350 01:52:35,291 --> 01:52:37,526 THEIR CAREERS. 3351 01:52:37,526 --> 01:52:40,930 THESE HAVE TO BE ELECTED BEFORE 3352 01:52:40,930 --> 01:52:45,201 THEY'RE 50, SO JUNG-MIN LEE AND 3353 01:52:45,201 --> 01:52:47,836 DOUG STEWART WERE BOTH ELECTED. 3354 01:52:47,836 --> 01:52:48,904 THEN THE ASSOCIATION OF AMERICAN 3355 01:52:48,904 --> 01:52:52,775 PHYSICIANS IS ANOTHER FOR 3356 01:52:52,775 --> 01:52:56,045 PHYSICIAN SCIENTISTS, ANOTHER 3357 01:52:56,045 --> 01:52:57,046 VERY PRESTIGIOUS MARK OF A 3358 01:52:57,046 --> 01:52:59,348 CAREER THAT HAS IMPACTED HUMAN 3359 01:52:59,348 --> 01:53:03,052 HEALTH, AND ELAINE JAFFE AND 3360 01:53:03,052 --> 01:53:05,254 YVES POMMIER WERE BOTH ELECTED 3361 01:53:05,254 --> 01:53:09,425 THIS YEAR. 3362 01:53:09,425 --> 01:53:10,426 SO AMONG OTHER THINGS THAT I 3363 01:53:10,426 --> 01:53:13,362 LOOK AT NOW SIX MONTHS IN THIS 3364 01:53:13,362 --> 01:53:15,231 ROLE AND CAN SEE SOME OF THE 3365 01:53:15,231 --> 01:53:18,033 SCOPE AND SCALE OF THE NCI WAS 3366 01:53:18,033 --> 01:53:22,238 SINCE I SAW YOU LAST WAS THE 3367 01:53:22,238 --> 01:53:25,608 AACR AND ASCO MEETINGS, TWO OF 3368 01:53:25,608 --> 01:53:26,842 THE MAJOR PROFESSIONAL SOCIETIES 3369 01:53:26,842 --> 01:53:27,209 FOR CANCER. 3370 01:53:27,209 --> 01:53:28,410 OF COURSE THERE ARE MANY OTHERS, 3371 01:53:28,410 --> 01:53:32,381 BUT THESE ARE TWO OF THE LARGEST 3372 01:53:32,381 --> 01:53:37,620 AMERICAN SOCIETIES. 3373 01:53:37,620 --> 01:53:40,656 THE FOOT PRINT OF NCI-FUNDED 3374 01:53:40,656 --> 01:53:44,326 INVESTIGATORS AND NCI PERSONNEL 3375 01:53:44,326 --> 01:53:46,695 WAS VERY, VERY NOTABLE. 3376 01:53:46,695 --> 01:53:50,499 WE HAD WINNERS OF SOME OF THE 3377 01:53:50,499 --> 01:53:51,166 MAJOR AWARDS. 3378 01:53:51,166 --> 01:53:53,002 FOR EXAMPLE, STEVE ROSENBERG 3379 01:53:53,002 --> 01:53:54,603 AGAIN WON THE LIFETIME 3380 01:53:54,603 --> 01:53:55,738 ACHIEVEMENT AWARD FOR CANCER 3381 01:53:55,738 --> 01:53:56,105 RESEARCH. 3382 01:53:56,105 --> 01:53:57,873 HIS NAME IS PROBABLY WELL-KNOWN 3383 01:53:57,873 --> 01:54:00,376 TO UP THAT HE'S PIONEERED SOME 3384 01:54:00,376 --> 01:54:02,911 OF THIS WORK THAT'S NOW LED TO 3385 01:54:02,911 --> 01:54:06,382 THE CAR-T-CELL IMMUNOTHERAPY FOR 3386 01:54:06,382 --> 01:54:09,418 STEM CELLS THAT REALLY HAS 3387 01:54:09,418 --> 01:54:10,286 TRANSFORMED THE WAY WE THINK 3388 01:54:10,286 --> 01:54:11,620 ABOUT CANCER. 3389 01:54:11,620 --> 01:54:13,922 AND ASCO GIVES AWAY A 3390 01:54:13,922 --> 01:54:14,356 HUMANITARIAN AWARD. 3391 01:54:14,356 --> 01:54:17,593 THIS IS AN AWARD THAT'S REALLY 3392 01:54:17,593 --> 01:54:19,028 RECOGNIZED AS SOMEONE WHO HAS 3393 01:54:19,028 --> 01:54:21,897 GONE ABOVE AND BEYOND TO ADVANCE 3394 01:54:21,897 --> 01:54:24,366 THE CARE OF PATIENTS WITH 3395 01:54:24,366 --> 01:54:24,600 CANCER. 3396 01:54:24,600 --> 01:54:26,902 IT DOESN'T HAVE TO BE IN THE 3397 01:54:26,902 --> 01:54:27,870 GLOBAL COMMUNITY BUT THEY 3398 01:54:27,870 --> 01:54:29,038 HAPPENED TO CHOOSE OUR DIRECTOR 3399 01:54:29,038 --> 01:54:34,243 OF NCI CENTER FOR GLOBAL HEALTH, 3400 01:54:34,243 --> 01:54:35,711 DR. SATISH GO PAL, WHO HAS 3401 01:54:35,711 --> 01:54:37,579 REALLY COMMITTED HIS LIFE TO 3402 01:54:37,579 --> 01:54:38,647 IMPROVING THE STATE OF CANCER. 3403 01:54:38,647 --> 01:54:43,952 SO IN MY PRESENTATIONS AT AACR 3404 01:54:43,952 --> 01:54:45,888 AND ASCO, I GOT TO MEET AND TALK 3405 01:54:45,888 --> 01:54:47,556 TO LOTS OF FOLKS, I THOUGHT I 3406 01:54:47,556 --> 01:54:49,825 WOULD JUST SHARE SO THAT YOU 3407 01:54:49,825 --> 01:54:50,826 KNOW WHAT WAS IN MY HEAD AT THE 3408 01:54:50,826 --> 01:54:53,996 TIME THAT I WAS TALKING TO THEM. 3409 01:54:53,996 --> 01:54:57,299 THE AACR, THE MAJOR THEME OF 3410 01:54:57,299 --> 01:55:02,004 THAT CONVERSATION WAS TO TALK 3411 01:55:02,004 --> 01:55:05,407 ABOUT A SHIFT IN THINKING. 3412 01:55:05,407 --> 01:55:06,809 I'M FROM NASHVILLE AS YOU ALL 3413 01:55:06,809 --> 01:55:09,244 KNOW, I'M A FAN OF TAYLOR SWIFT 3414 01:55:09,244 --> 01:55:15,184 AND WE USE THE TECHNOLOGY OF THE 3415 01:55:15,184 --> 01:55:16,618 ERAS, THE EVOLUTION OF CANCER 3416 01:55:16,618 --> 01:55:18,654 VIRGINIA BEACH AND THE EVOLUTION 3417 01:55:18,654 --> 01:55:20,222 OF SCIENTIFIC THINKING FROM TOP 3418 01:55:20,222 --> 01:55:22,391 DOWN SORT OF SILOED TYPE OF 3419 01:55:22,391 --> 01:55:27,763 THINKING TO MORE RECENTLY A VERY 3420 01:55:27,763 --> 01:55:29,631 MULTIDISCIPLINARY COLLABORATIVE, 3421 01:55:29,631 --> 01:55:30,499 RECOGNIZING THAT THERE'S VALUE 3422 01:55:30,499 --> 01:55:35,003 IN PARTNERSHIP, AND NOW TO WHAT 3423 01:55:35,003 --> 01:55:39,174 WE ARE CALLING A 360, WHICH IS 3424 01:55:39,174 --> 01:55:41,443 ENGAGING EVERY VOICE. 3425 01:55:41,443 --> 01:55:42,845 I TALKED TO YOU BEFORE ABOUT THE 3426 01:55:42,845 --> 01:55:43,879 NATIONAL CANCER PLAN AND ONE OF 3427 01:55:43,879 --> 01:55:46,181 THE PIVOTAL GOALS BEING ENGAGING 3428 01:55:46,181 --> 01:55:48,917 EVERY PERSON, AND IT COMES 3429 01:55:48,917 --> 01:55:50,119 BECAUSE OF SOCIAL MEDIA, IT 3430 01:55:50,119 --> 01:55:52,121 COMES BECAUSE OF CHANGES IN THE 3431 01:55:52,121 --> 01:55:55,691 WAY WE THINK ABOUT DATA, AI, AND 3432 01:55:55,691 --> 01:55:56,825 TOOLS THAT ALLOW US TO THINK 3433 01:55:56,825 --> 01:56:00,429 MORE BROADLY THAN EVER BEFORE, 3434 01:56:00,429 --> 01:56:02,631 BECAUSE OUR SOCIETY IS MOVING 3435 01:56:02,631 --> 01:56:05,134 TOWARD INCLUDING VOICES THAT HAD 3436 01:56:05,134 --> 01:56:06,802 NOT PREVIOUSLY BEEN ENGAGED, AND 3437 01:56:06,802 --> 01:56:08,404 I'M TRULY EXCITED ABOUT WHAT 3438 01:56:08,404 --> 01:56:09,705 THAT CAN MEAN FOR CANCER CARE. 3439 01:56:09,705 --> 01:56:16,612 SO ESPECIALLY TO THIS BOARD, 3440 01:56:16,612 --> 01:56:18,147 EVERYONE'S VOICE IS IMPORTANT IN 3441 01:56:18,147 --> 01:56:21,216 MAKING DECISIONS AND SETTING 3442 01:56:21,216 --> 01:56:22,618 PRIORITIES AROUND THE CANCER 3443 01:56:22,618 --> 01:56:24,052 ARENA. 3444 01:56:24,052 --> 01:56:26,088 AND AT ASCO, THE FOCUS THERE IS 3445 01:56:26,088 --> 01:56:28,223 A LITTLE BIT MORE TOWARD 3446 01:56:28,223 --> 01:56:30,859 CLINICAL RESEARCH AND SO WE 3447 01:56:30,859 --> 01:56:33,829 REALLY EMPHASIZED THAT INHERENT 3448 01:56:33,829 --> 01:56:36,465 NEED TO MOVE CLINICAL RESEARCH 3449 01:56:36,465 --> 01:56:38,534 FORWARD FASTER. 3450 01:56:38,534 --> 01:56:41,403 AND THE IDEA THERE IS THAT WE 3451 01:56:41,403 --> 01:56:44,339 CANNOT AFFORD THE TIME THAT IT 3452 01:56:44,339 --> 01:56:46,875 MIGHT TAKE FOR A CLINICAL 3453 01:56:46,875 --> 01:56:48,944 RESEARCH IDEA TO TAKE LITERALLY 3454 01:56:48,944 --> 01:56:51,280 YEARS BEFORE IT BECOMES A 3455 01:56:51,280 --> 01:56:53,582 PROTOCOL YEARS MORE TO ACCRUE TO 3456 01:56:53,582 --> 01:56:57,453 PATIENTS, YEARS MORE TO BE 3457 01:56:57,453 --> 01:56:57,953 REVIEWED. 3458 01:56:57,953 --> 01:57:00,389 SO THAT THAT'S TIME THAT'S NOT 3459 01:57:00,389 --> 01:57:01,123 ACCEPTABLE. 3460 01:57:01,123 --> 01:57:04,193 SOME PIECES OF IT JUST DO TAKE 3461 01:57:04,193 --> 01:57:05,194 TIME, BUT THERE ARE PIECES THAT 3462 01:57:05,194 --> 01:57:06,462 WE CAN ACCELERATE. 3463 01:57:06,462 --> 01:57:08,864 THERE ARE DIFFERENT WAYS THAT WE 3464 01:57:08,864 --> 01:57:10,032 CAN GET CLINICAL RESEARCH INTO 3465 01:57:10,032 --> 01:57:12,601 THE HANDS OF PATIENTS WHO ARE 3466 01:57:12,601 --> 01:57:13,802 DESIROUS OF IT. 3467 01:57:13,802 --> 01:57:16,205 THAT WAS A GOOD SETUP FOR THE 3468 01:57:16,205 --> 01:57:17,206 EVENTS TODAY WHERE WE WERE 3469 01:57:17,206 --> 01:57:20,409 REALLY TALKING ABOUT HOW DO WE 3470 01:57:20,409 --> 01:57:22,878 MOVE FROM CLINICAL RESEARCH IS 3471 01:57:22,878 --> 01:57:25,013 SOMETHING THAT YOU HOLD OUT TO 3472 01:57:25,013 --> 01:57:27,850 UNTIL THE LAST MINUTE, BUT 3473 01:57:27,850 --> 01:57:29,518 CLINICAL RESEARCH IS HOW WE CARE 3474 01:57:29,518 --> 01:57:31,487 FOR PATIENTS. 3475 01:57:31,487 --> 01:57:34,523 IT IS A PART OF THE STANDARD OF 3476 01:57:34,523 --> 01:57:36,959 CARE, BECAUSE WE ARE NOT DONE, 3477 01:57:36,959 --> 01:57:39,394 AND WE ARE STILL LEARNING, AND 3478 01:57:39,394 --> 01:57:43,098 WE CAN ENGAGE OUR PUBLIC MORE IF 3479 01:57:43,098 --> 01:57:46,368 WE'RE MOVING MORE TO CLINICAL 3480 01:57:46,368 --> 01:57:47,703 TRIAL SPACE THAT IS A PART OF 3481 01:57:47,703 --> 01:57:53,175 EVERYDAY LIFE. 3482 01:57:53,175 --> 01:57:54,610 SO A COUPLE OF OTHER THINGS THAT 3483 01:57:54,610 --> 01:57:55,611 ARE COMING SOON. 3484 01:57:55,611 --> 01:57:58,680 THIS ONE PARTICULARLY RELEVANT 3485 01:57:58,680 --> 01:58:03,485 TO THE NCRA IS A SORT OF A 3486 01:58:03,485 --> 01:58:05,220 REORGANIZATION OF BRINGING THREE 3487 01:58:05,220 --> 01:58:07,022 OF OUR OFFICES TOGETHER INTO A 3488 01:58:07,022 --> 01:58:09,191 CENTER FOR EXTERNAL AFFAIRS. 3489 01:58:09,191 --> 01:58:10,359 SO ONE OF THOSE OFFICES IS THE 3490 01:58:10,359 --> 01:58:12,794 OFFICE OF ADVOCACY RELATIONS. 3491 01:58:12,794 --> 01:58:15,731 YOU ALL KNOW AMY WILLIAMS, SHE 3492 01:58:15,731 --> 01:58:17,366 IS OUR ESTEEMED LEADER OF THE 3493 01:58:17,366 --> 01:58:19,468 OFFICE OF ADVOCACY RELATIONS, 3494 01:58:19,468 --> 01:58:21,937 BUT WE HAVE TWO OTHER OFFICES 3495 01:58:21,937 --> 01:58:26,341 THAT YOU KNOW, BUT MAY NOT KNOW 3496 01:58:26,341 --> 01:58:27,342 AS WELL. 3497 01:58:27,342 --> 01:58:28,544 THE OFFICE OF GOVERNMENT AND 3498 01:58:28,544 --> 01:58:31,046 CONGRESSIONAL RELATIONS, THAT'S 3499 01:58:31,046 --> 01:58:36,518 MK HALL HOLOHAN AND HOLLY GIBBO 3500 01:58:36,518 --> 01:58:37,619 YOU HEARD FROM TODAY WHO FOCUS 3501 01:58:37,619 --> 01:58:38,954 ON OUR RELATIONSHIP WITH 3502 01:58:38,954 --> 01:58:39,588 OBVIOUSLY GOVERNMENT AND 3503 01:58:39,588 --> 01:58:40,756 CONGRESS, AND OUR OFFICE OF 3504 01:58:40,756 --> 01:58:42,124 COMMUNICATIONS AND PUBLIC 3505 01:58:42,124 --> 01:58:42,357 LIAISON. 3506 01:58:42,357 --> 01:58:44,259 SO THIS IS OUR COMMUNICATIONS 3507 01:58:44,259 --> 01:58:46,962 BRANCH. 3508 01:58:46,962 --> 01:58:48,931 SO ALL OF THESE GROUPS TOGETHER 3509 01:58:48,931 --> 01:58:50,499 CAN BE ELEVATED AND MADE MORE 3510 01:58:50,499 --> 01:58:51,900 POWERFUL BY BRINGING THEM 3511 01:58:51,900 --> 01:58:52,501 TOGETHER. 3512 01:58:52,501 --> 01:58:54,636 SO THE IDEA IS TO CREATE THEM 3513 01:58:54,636 --> 01:58:55,637 TOGETHER AS A CENTER. 3514 01:58:55,637 --> 01:58:59,007 THIS WILL, I THINK, EMPOWER EACH 3515 01:58:59,007 --> 01:59:02,010 TO BE ABLE TO BE MORE EFFECTIVE, 3516 01:59:02,010 --> 01:59:03,946 AND LOOKING FORWARD TO THIS 3517 01:59:03,946 --> 01:59:06,248 STRATEGIC REALIGNMENT TO BRING 3518 01:59:06,248 --> 01:59:08,884 COHESION SO THAT WE ARE BEING 3519 01:59:08,884 --> 01:59:10,652 ABLE TO LEAN DIRECTLY INTO 3520 01:59:10,652 --> 01:59:11,787 COMMUNICATIONS WHEN ADVOCACY 3521 01:59:11,787 --> 01:59:14,056 NEEDS THAT, AND THAT WE CAN 3522 01:59:14,056 --> 01:59:15,991 COMMUNICATE BETTER INTO WHERE 3523 01:59:15,991 --> 01:59:18,460 WE'RE WORKING IN GOVERNMENT AND 3524 01:59:18,460 --> 01:59:20,562 CONGRESSIONAL RELATIONS AS WELL. 3525 01:59:20,562 --> 01:59:22,731 BECAUSE THEY'RE ALL VERY 3526 01:59:22,731 --> 01:59:24,933 CONNECTED AND CAN WORK ACROSS 3527 01:59:24,933 --> 01:59:28,537 THESE BOUNDARIES VERY 3528 01:59:28,537 --> 01:59:31,506 EFFECTIVELY. 3529 01:59:31,506 --> 01:59:32,574 COUPLE OF OTHER BIG THINGS YOU 3530 01:59:32,574 --> 01:59:34,109 SHOULD KNOW ABOUT AS MEMBERS OF 3531 01:59:34,109 --> 01:59:35,010 THE NCAR BOARD. 3532 01:59:35,010 --> 01:59:38,046 SO WE HAVE A NEW LEADERSHIP 3533 01:59:38,046 --> 01:59:39,815 MEMBER, WELL, NOT QUITE YET, 3534 01:59:39,815 --> 01:59:40,849 IT'S STILL JUNE. 3535 01:59:40,849 --> 01:59:43,118 NOT UNTIL JUNE 30TH. 3536 01:59:43,118 --> 01:59:45,087 SO WARREN KIBBE WILL BE JOINING 3537 01:59:45,087 --> 01:59:46,888 US AS A NEW DEPUTY DIRECTOR FOR 3538 01:59:46,888 --> 01:59:47,756 DAY A SCIENCE. 3539 01:59:47,756 --> 01:59:50,125 HIS FOCUS WILL BE ON STRATEGIES 3540 01:59:50,125 --> 01:59:52,561 FOR A.I. INITIATIVES, WHICH OF 3541 01:59:52,561 --> 01:59:54,029 COURSE COME UP IN EVERY VENUE 3542 01:59:54,029 --> 01:59:55,230 AND EVERY TALK. 3543 01:59:55,230 --> 01:59:56,765 DATA HARMONIZATION, REALLY 3544 01:59:56,765 --> 01:59:59,001 ESSENTIAL THAT WE UTILIZE ALL OF 3545 01:59:59,001 --> 02:00:00,969 THE DATA TO THE MOST BENEFIT 3546 02:00:00,969 --> 02:00:02,704 THAT IT CAN BE POSSIBLE. 3547 02:00:02,704 --> 02:00:05,474 AGAIN, ANOTHER TENET OF THE 3548 02:00:05,474 --> 02:00:07,409 NATIONAL CANCER PLAN, WORKING ON 3549 02:00:07,409 --> 02:00:08,944 COMMON DATA ELEMENTS, USING A 3550 02:00:08,944 --> 02:00:10,712 COMMON LANGUAGE WHEN WE PUT DATA 3551 02:00:10,712 --> 02:00:13,148 TOGETHER SO THAT WE CAN MORE 3552 02:00:13,148 --> 02:00:16,318 EASILY MOVE DATA AND ANALYZE 3553 02:00:16,318 --> 02:00:17,452 DATA. 3554 02:00:17,452 --> 02:00:19,855 CODING ALGORITHMS, AND ALSO A 3555 02:00:19,855 --> 02:00:21,056 DIGITAL TRANSFORMATION OF 3556 02:00:21,056 --> 02:00:22,024 EVERYTHING ABOUT HOW WE WORK. 3557 02:00:22,024 --> 02:00:23,659 SO VERY EXCITED TO HAVE HIM COME 3558 02:00:23,659 --> 02:00:25,127 AND JOIN US AND HE'LL BE HERE 3559 02:00:25,127 --> 02:00:26,228 SOON, I'M SURE YOU WILL HEAR 3560 02:00:26,228 --> 02:00:30,499 FROM HIM IN THIS VENUE. 3561 02:00:30,499 --> 02:00:32,234 AND THEN ROUNDING OUT THE TEAM, 3562 02:00:32,234 --> 02:00:35,904 WE ALSO BROUGHT ON DR. SHAALAN 3563 02:00:35,904 --> 02:00:38,106 BEG, HE'S AN NCI SENIOR ADVISOR 3564 02:00:38,106 --> 02:00:40,409 FOR CLINICAL RESEARCH. 3565 02:00:40,409 --> 02:00:43,712 HE IS A CLINICAL INVESTIGATOR 3566 02:00:43,712 --> 02:00:45,681 AND IS CHARGED WITH, AGAIN, THE 3567 02:00:45,681 --> 02:00:48,116 THEME OF THE DAY WOULD BE HOW DO 3568 02:00:48,116 --> 02:00:50,385 WE ACCELERATE CLINICAL RESEARCH. 3569 02:00:50,385 --> 02:00:53,689 HOW DO WE DEMOCRATIZE CLINICAL 3570 02:00:53,689 --> 02:00:55,691 RESEARCH, HOW DO WE DISTRIBUTE 3571 02:00:55,691 --> 02:00:57,125 IT INTO COMMUNITIES, AND HOW DO 3572 02:00:57,125 --> 02:00:59,227 WE GET THE ANSWERS THAT WE NEED 3573 02:00:59,227 --> 02:01:01,630 IN A TIMELY WAY MOST 3574 02:01:01,630 --> 02:01:02,297 EFFICIENTLY. 3575 02:01:02,297 --> 02:01:04,566 SO HE HAS SOME UNIQUE EXPERIENCE 3576 02:01:04,566 --> 02:01:07,969 IN THIS REGARD, AND HAS REALLY 3577 02:01:07,969 --> 02:01:09,705 JOINED US SORT OF RUNNING OUT OF 3578 02:01:09,705 --> 02:01:11,540 THE GATE. 3579 02:01:11,540 --> 02:01:12,941 SO THE REFERENCE ON THE RIGHT IS 3580 02:01:12,941 --> 02:01:16,211 TO A CANCER CURRENTS BLOG THAT 3581 02:01:16,211 --> 02:01:18,213 WE WROTE TOGETHER TO HIGHLIGHT 3582 02:01:18,213 --> 02:01:19,681 WHERE THERE ARE EFFORTS THAT WE 3583 02:01:19,681 --> 02:01:20,515 CAN REALLY MAKE A BIG 3584 02:01:20,515 --> 02:01:25,987 DIFFERENCE. 3585 02:01:25,987 --> 02:01:28,657 AND THEN LEADERSHIP IS NOT IN 3586 02:01:28,657 --> 02:01:30,826 JUST NAMING DEPUTIES AND SENIOR 3587 02:01:30,826 --> 02:01:31,526 ADVISORS, ET CETERA. 3588 02:01:31,526 --> 02:01:33,528 IT'S IN REALLY SORT OF BUILDING 3589 02:01:33,528 --> 02:01:36,131 OUR LEADERSHIP AND OUR 3590 02:01:36,131 --> 02:01:36,798 LEADERSHIP CAPACITY AND OUR LEAD 3591 02:01:36,798 --> 02:01:38,667 ARE SHIP COMMUNICATION ACROSS 3592 02:01:38,667 --> 02:01:39,367 THE CONTINUUM. 3593 02:01:39,367 --> 02:01:42,738 THIS IS TAKING PLACE IN LOTS OF 3594 02:01:42,738 --> 02:01:44,606 DIFFERENT COMPONENTS OF THE NCI. 3595 02:01:44,606 --> 02:01:47,642 I JUST WANT TO POINT TODAY TO 3596 02:01:47,642 --> 02:01:49,978 TWO INITIATIVES THAT ARE VERY 3597 02:01:49,978 --> 02:01:52,981 FRESH AND RECENT ANNOUNCED SINCE 3598 02:01:52,981 --> 02:01:54,483 THE LAST TIME WE WERE TOGETHER, 3599 02:01:54,483 --> 02:01:56,151 IS THE CANCER EQUITY LEADERS. 3600 02:01:56,151 --> 02:01:57,352 YOU MAY HAVE SEEN SOME 3601 02:01:57,352 --> 02:01:57,853 ANNOUNCEMENT ABOUT THIS. 3602 02:01:57,853 --> 02:02:00,222 IT WAS ANNOUNCED AT AACR, AND 3603 02:02:00,222 --> 02:02:01,556 THERE'S BEEN QUITE A LOT OF NEWS 3604 02:02:01,556 --> 02:02:04,392 ABOUT IT, WHICH IS THESE 3605 02:02:04,392 --> 02:02:06,261 INDIVIDUALS ARE CANCER LEADERS, 3606 02:02:06,261 --> 02:02:08,597 LOTS OF THEM ARE CANCER CENTER 3607 02:02:08,597 --> 02:02:09,798 DIRECTORS. 3608 02:02:09,798 --> 02:02:11,333 ALL FROM MINORITY GROUPS, ALL 3609 02:02:11,333 --> 02:02:14,202 VERY COMMITTED TO PAVING THE WAY 3610 02:02:14,202 --> 02:02:17,305 FOR THE NEXT GENERATION. 3611 02:02:17,305 --> 02:02:19,374 REDUCING BARRIERS AND SILOS. 3612 02:02:19,374 --> 02:02:20,542 LOOKING FOR WAYS THAT WE CAN 3613 02:02:20,542 --> 02:02:22,477 PROVIDE THE BEST CARE TO EVERY 3614 02:02:22,477 --> 02:02:25,313 PATIENT AND REALLY COMMITTED TO 3615 02:02:25,313 --> 02:02:27,516 SERVING AS ROLE MODELS. 3616 02:02:27,516 --> 02:02:30,252 SO THIS GROUP WILL BE AN 3617 02:02:30,252 --> 02:02:32,788 IMPORTANT GROUP THAT WE'LL LEAN 3618 02:02:32,788 --> 02:02:37,159 ON AS WE MOVE FORWARD. 3619 02:02:37,159 --> 02:02:42,097 SEPARATELY, WE HAD OUR FIRST 3620 02:02:42,097 --> 02:02:43,632 BLACK IN CANCER CONFERENCE LAST 3621 02:02:43,632 --> 02:02:44,866 FRIDAY ON CAMPUS. 3622 02:02:44,866 --> 02:02:47,269 THIS IS A REALLY EXCITING 3623 02:02:47,269 --> 02:02:49,671 GRASSROOTS EFFORT THAT STARTED 3624 02:02:49,671 --> 02:02:51,540 FROM SOME POSTDOCTORAL FELLOWS 3625 02:02:51,540 --> 02:02:52,974 WHO RECOGNIZED THAT THEY JUST 3626 02:02:52,974 --> 02:02:55,076 DIDN'T HAVE ACCESS TO A 3627 02:02:55,076 --> 02:02:55,377 COMMUNITY. 3628 02:02:55,377 --> 02:03:00,348 IT STARTED AS A SOCIAL MEDIA 3629 02:03:00,348 --> 02:03:09,324 TYPE OF ACTIVITY, A HASHTAG, 3630 02:03:09,324 --> 02:03:09,958 BLACKINCANCER, AND MOVED ON TO 3631 02:03:09,958 --> 02:03:11,359 BECOME A MOVEMENT, AND BROUGHT 3632 02:03:11,359 --> 02:03:12,928 AN AMAZING ARRAY OF SPEAKERS 3633 02:03:12,928 --> 02:03:15,330 TOGETHER AND THE FIRST OF REALLY 3634 02:03:15,330 --> 02:03:19,467 BUILDING A COMMUNITY IN THE 3635 02:03:19,467 --> 02:03:20,035 CANCER ARENA. 3636 02:03:20,035 --> 02:03:21,803 I WAS VERY HONORED TO HAVE THE 3637 02:03:21,803 --> 02:03:22,404 OPPORTUNITY TO TALK TO THIS 3638 02:03:22,404 --> 02:03:24,105 GROUP, AND WITH THEIR THEME, 3639 02:03:24,105 --> 02:03:26,074 LIFTING AS WE CLIMB, S SO REALLY 3640 02:03:26,074 --> 02:03:27,976 TRYING TO BUILD LEADERS IN ALL 3641 02:03:27,976 --> 02:03:34,616 VENUES. 3642 02:03:34,616 --> 02:03:37,752 AND IT'S ALSO ABOUT HOW WE 3643 02:03:37,752 --> 02:03:38,587 COMMUNICATE, SO THERE'S A NAME 3644 02:03:38,587 --> 02:03:39,721 CHANGE THAT'S COMING SOON TO OUR 3645 02:03:39,721 --> 02:03:42,557 CENTER TO REDUCE CANCER HEALTH 3646 02:03:42,557 --> 02:03:46,361 DISPARITIES, FORMERLY KNOWN AS 3647 02:03:46,361 --> 02:03:46,561 CRCHD. 3648 02:03:46,561 --> 02:03:48,864 THE WORK OF THAT CENTER WON'T 3649 02:03:48,864 --> 02:03:50,398 CHANGE, BUT THE NAME WILL. 3650 02:03:50,398 --> 02:03:51,633 AND SO WE'RE ALREADY STARTING TO 3651 02:03:51,633 --> 02:03:54,469 CALL IT THE CENTER FOR CANCER 3652 02:03:54,469 --> 02:03:57,305 HEALTH EQUITY, AND I THINK IF 3653 02:03:57,305 --> 02:03:58,506 YOU LOOK AT THE NAMES FOR JUST A 3654 02:03:58,506 --> 02:04:02,277 MINUTE, YOU CAN SEE THE POWER 3655 02:04:02,277 --> 02:04:07,515 AND THE DIFFERENCE FROM A TITLE 3656 02:04:07,515 --> 02:04:09,150 THAT IS GENERALLY NEGATIVE AND 3657 02:04:09,150 --> 02:04:14,022 JUST SUGGESTS TO REDUCE BUT NOT 3658 02:04:14,022 --> 02:04:15,123 FULLY ADDRESS TO ONE THAT IS 3659 02:04:15,123 --> 02:04:17,092 VERY POSITIVE. 3660 02:04:17,092 --> 02:04:20,462 AND HELPS US FOCUS ON THE HEALTH 3661 02:04:20,462 --> 02:04:21,363 EQUITY THAT WE ALL VERY MUCH 3662 02:04:21,363 --> 02:04:23,565 WANT TO ACHIEVE, SO I HAVE TO 3663 02:04:23,565 --> 02:04:27,535 GIVE BIG KUDOS TO SONYA 3664 02:04:27,535 --> 02:04:28,703 SPRINGFIELD AND HER TEAM TO TAKE 3665 02:04:28,703 --> 02:04:29,938 ON THE INITIATIVE TO SAY WE 3666 02:04:29,938 --> 02:04:31,539 SHOULD USE A NAME THAT IS 3667 02:04:31,539 --> 02:04:32,607 MEANINGFUL. 3668 02:04:32,607 --> 02:04:33,575 SO THANK YOU FOR THAT, AND THAT 3669 02:04:33,575 --> 02:04:37,746 WILL BE COMING SOON. 3670 02:04:37,746 --> 02:04:39,814 BUDGET. 3671 02:04:39,814 --> 02:04:41,483 SO YOU CAN GO RIGHT ON IN TO THE 3672 02:04:41,483 --> 02:04:41,716 BUDGET. 3673 02:04:41,716 --> 02:04:43,251 SO YOU ALREADY HEARD SOME OF 3674 02:04:43,251 --> 02:04:45,854 THIS SO I'LL GO THROUGH FAIRLY 3675 02:04:45,854 --> 02:04:47,222 QUICKLY BUT HAPPY TO TAKE 3676 02:04:47,222 --> 02:04:47,656 QUESTIONS ABOUT IT. 3677 02:04:47,656 --> 02:04:49,090 YOU CAN SEE HERE WHERE WE ARE 3678 02:04:49,090 --> 02:04:49,991 WITH OUR BUDGET. 3679 02:04:49,991 --> 02:04:53,929 LAST YEAR'S BUDGET, THERE ON THE 3680 02:04:53,929 --> 02:04:57,098 FAR RIGHT COLUMN, WAS 3681 02:04:57,098 --> 02:04:58,099 $7.3 BILLION IN TOTAL. 3682 02:04:58,099 --> 02:05:02,137 THAT INCLUDED CARES ACT FUNDING. 3683 02:05:02,137 --> 02:05:04,139 IN 2024, IT WAS 7.22. 3684 02:05:04,139 --> 02:05:05,373 SO WE DID HAVE AN INCREASE IN 3685 02:05:05,373 --> 02:05:08,877 OUR BASE, BUT THAT WAS OFFSET BY 3686 02:05:08,877 --> 02:05:10,045 A DECREASE IN MOONSHOT MONEY 3687 02:05:10,045 --> 02:05:11,346 THAT WAS COMING IN, SO ACTUALLY 3688 02:05:11,346 --> 02:05:12,447 IT WAS OUR FIRST DECREASE THAT 3689 02:05:12,447 --> 02:05:13,748 WE HAD SEEN IN MANY YEARS. 3690 02:05:13,748 --> 02:05:15,483 WE DON'T KNOW WHAT WILL COME 3691 02:05:15,483 --> 02:05:21,890 LATER, BUT YOU HEARD FROM HOLLY 3692 02:05:21,890 --> 02:05:23,191 GIBBONS WHAT THE FIRST PASS IS 3693 02:05:23,191 --> 02:05:24,826 STARTING TO COME IN AT. 3694 02:05:24,826 --> 02:05:26,594 THE COLUMN ON THE LEFT OR IN THE 3695 02:05:26,594 --> 02:05:29,030 MIDDLE, I GUESS, IS OUR 3696 02:05:29,030 --> 02:05:32,867 PROFESSIONAL JUDGMENT BUDGET. 3697 02:05:32,867 --> 02:05:34,703 SO ALTHOUGH $7 BILLION IS A LOT 3698 02:05:34,703 --> 02:05:37,472 OF MONEY, I IT HAS NOT BEEN A 3699 02:05:37,472 --> 02:05:38,573 NUMBER THAT'S BEEN KEEPING UP 3700 02:05:38,573 --> 02:05:41,009 WITH EITHER INFLATION OR THE 3701 02:05:41,009 --> 02:05:42,777 CAPACITY THAT'S NECESSARY TO BE 3702 02:05:42,777 --> 02:05:44,512 ABLE TO DO THE KIND OF WORK THAT 3703 02:05:44,512 --> 02:05:50,285 WE ARE EXPECTING IS NEEDED. 3704 02:05:50,285 --> 02:05:52,988 SO WHEN WE PUT TOGETHER A 3705 02:05:52,988 --> 02:05:54,422 PROFESSIONAL JUDGMENT BUDGET, WE 3706 02:05:54,422 --> 02:05:56,591 MAKE AN ESTIMATE WHAT WOULD THIS 3707 02:05:56,591 --> 02:05:57,492 ACTUALLY COST. 3708 02:05:57,492 --> 02:05:58,927 SO IN 2023 WE WERE OFF BUT 3709 02:05:58,927 --> 02:06:01,463 CLOSE, OUR PROFESSIONAL JUDGMENT 3710 02:06:01,463 --> 02:06:02,397 WAS $7.7 BILLION, AND YOU CAN 3711 02:06:02,397 --> 02:06:04,032 SEE, IT'S ONLY INCREASED. 3712 02:06:04,032 --> 02:06:06,868 AND SO WE ARE WIDENING OUR GAP 3713 02:06:06,868 --> 02:06:09,204 OF WHAT WE CAN AND CAN'T DO, AND 3714 02:06:09,204 --> 02:06:10,872 IN TERMS OF OUR BUDGET. 3715 02:06:10,872 --> 02:06:19,047 SO IT IS IMPORTANT TO KNOW HOW 3716 02:06:19,047 --> 02:06:21,916 TIGHT IT IS BECOMING WITH A 3717 02:06:21,916 --> 02:06:22,817 BUDGET THAT'S STAYING 3718 02:06:22,817 --> 02:06:26,788 ESSENTIALLY FLAT. 3719 02:06:26,788 --> 02:06:28,723 SO I ALSO WANT TO MAKE SURE YOU 3720 02:06:28,723 --> 02:06:32,160 KNOW WHERE WE ENDED UP WITH OUR 3721 02:06:32,160 --> 02:06:33,928 PAYLINES. 3722 02:06:33,928 --> 02:06:35,663 SO FIRST JUST BY WAY OF 3723 02:06:35,663 --> 02:06:37,966 DEFINITION, THE PAYLINE IS THE 3724 02:06:37,966 --> 02:06:42,037 LEVEL AT WHICH WE PAY GRANTS 3725 02:06:42,037 --> 02:06:42,437 WITHOUT QUESTION. 3726 02:06:42,437 --> 02:06:43,605 OUR FINAL FUNDING RATE IS ALWAYS 3727 02:06:43,605 --> 02:06:45,140 A LITTLE BIT HIGHER BECAUSE 3728 02:06:45,140 --> 02:06:48,109 THERE ARE SPECIAL PROGRAMS THAT 3729 02:06:48,109 --> 02:06:50,378 BRING SOME OTHER GRANTS IN AND 3730 02:06:50,378 --> 02:06:51,446 THERE ARE A FEW OTHER 3731 02:06:51,446 --> 02:06:52,113 MECHANISMS. 3732 02:06:52,113 --> 02:06:54,115 SO IT WILL BE A SMIDGEON HIGHER 3733 02:06:54,115 --> 02:06:55,417 THAN THIS NUMBER. 3734 02:06:55,417 --> 02:06:57,085 THIS IS THE NO QUESTIONS ASKED, 3735 02:06:57,085 --> 02:06:58,753 YOUR GRANT GOT THIS SCORE, THIS 3736 02:06:58,753 --> 02:07:00,789 IS WHAT WE'LL -- WHERE WE'RE 3737 02:07:00,789 --> 02:07:03,892 PAY. 3738 02:07:03,892 --> 02:07:07,695 SO WHETHER WE DIDN'T HAVE OUR WR 3739 02:07:07,695 --> 02:07:09,097 BUDGET WHEN WE TALKED LAST, WE 3740 02:07:09,097 --> 02:07:10,398 WERE HOLDING AN INTERIM PAYLINE 3741 02:07:10,398 --> 02:07:12,000 WHERE WE WERE ESTIMATING THAT 3742 02:07:12,000 --> 02:07:13,735 WE'D BE ABLE TO GET AWAY WITH AT 3743 02:07:13,735 --> 02:07:15,403 LEAST 9% AS OUR PAYLINE AND WE 3744 02:07:15,403 --> 02:07:18,006 WERE HOLDING 14% FOR AN EARLY 3745 02:07:18,006 --> 02:07:19,307 STAGE INVESTIGATOR, SO AN 3746 02:07:19,307 --> 02:07:20,775 INVESTIGATOR WITHIN THE FIRST 10 3747 02:07:20,775 --> 02:07:25,413 YEARS OUT OF THEIR PH.D., A AND% 3748 02:07:25,413 --> 02:07:26,414 FOR R21 GRANTS. 3749 02:07:26,414 --> 02:07:28,583 NOW KNOWING OUR BUDGET, WE WERE 3750 02:07:28,583 --> 02:07:30,518 ABLE TO MAKE IT MOVE TO 10, SO 3751 02:07:30,518 --> 02:07:34,189 WE NOW ARE PAYING AT THE TENTH 3752 02:07:34,189 --> 02:07:36,224 PERCENTILE FOR R01s. 3753 02:07:36,224 --> 02:07:37,892 WE DID DO ONE THING WHICH WAS TO 3754 02:07:37,892 --> 02:07:39,327 REALLY PUSH THE FUNDING FOR THE 3755 02:07:39,327 --> 02:07:40,195 EARLY STAGE INVESTIGATOR AND 3756 02:07:40,195 --> 02:07:42,097 MOVED IT UP TO 17%. 3757 02:07:42,097 --> 02:07:44,466 SO THERE'S BASICALLY A 3758 02:07:44,466 --> 02:07:45,834 7 PERCENTILE POINT HANDICAP FOR 3759 02:07:45,834 --> 02:07:51,873 AN EARLY STAGE INVESTIGATOR. 3760 02:07:51,873 --> 02:07:53,174 SO MY REFERENCE THERE TO THE 3761 02:07:53,174 --> 02:07:54,742 BOTTOM LINE BLOG, YOU CAN READ 3762 02:07:54,742 --> 02:07:55,743 SOME OF THE THOUGHTS THAT WENT 3763 02:07:55,743 --> 02:08:02,317 INTO THAT DECISION-MAKING. 3764 02:08:02,317 --> 02:08:03,284 THIS TELLS THE STORY A LITTLE 3765 02:08:03,284 --> 02:08:04,352 BIT MORE CLEARLY. 3766 02:08:04,352 --> 02:08:05,520 FIRST THE DARKER LINE ON THE 3767 02:08:05,520 --> 02:08:07,722 BOTTOM IS THE FUNDING -- THE 3768 02:08:07,722 --> 02:08:10,258 PAYLINE FOR R01s FOR 3769 02:08:10,258 --> 02:08:12,360 ESTABLISHED INVESTIGATORS. 3770 02:08:12,360 --> 02:08:14,229 AND YOU CAN SEE IT HOVERED 3771 02:08:14,229 --> 02:08:14,762 AROUND 10. 3772 02:08:14,762 --> 02:08:15,997 WE WERE REALLY MAKING SOME 3773 02:08:15,997 --> 02:08:16,998 STRONG GAINS. 3774 02:08:16,998 --> 02:08:19,334 THIS WAS INITIATED UNDER 3775 02:08:19,334 --> 02:08:20,001 DR. SHARPLESS, YOU PROBABLY 3776 02:08:20,001 --> 02:08:22,270 HEARD FROM HIM, REALLY PUSHING 3777 02:08:22,270 --> 02:08:23,738 TO TRYING TO GET THAT PAYLINE TO 3778 02:08:23,738 --> 02:08:26,674 A NUMBER THAT'S MORE LIKE 15, 3779 02:08:26,674 --> 02:08:29,444 WHICH IS -- AND WE'VE GOTTEN UP 3780 02:08:29,444 --> 02:08:33,081 TO 12, SO WE ARE BACK AT 10, AND 3781 02:08:33,081 --> 02:08:34,282 STILL TRYING TO FIGURE OUT HOW 3782 02:08:34,282 --> 02:08:36,451 WE CAN GET IT IN FUTURE YEARS UP 3783 02:08:36,451 --> 02:08:37,385 A LITTLE BIT MORE. 3784 02:08:37,385 --> 02:08:39,687 BUT YOU CAN SEE THAT WE'VE ALSO 3785 02:08:39,687 --> 02:08:43,057 BEEN CONSISTENTLY TRYING TO 3786 02:08:43,057 --> 02:08:45,193 ENCOURAGE EARLY STAGE 3787 02:08:45,193 --> 02:08:46,528 INVESTIGATORS TO GET THAT FIRST 3788 02:08:46,528 --> 02:08:52,200 GRANT AND TO BEGIN THEIR 3789 02:08:52,200 --> 02:08:54,736 INDEPENDENT CAREERS, SO THE 3790 02:08:54,736 --> 02:08:55,436 LIGHT BLUE LINE IS THE 3791 02:08:55,436 --> 02:08:56,738 DIFFERENTIAL FUNDING PAYLINE FOR 3792 02:08:56,738 --> 02:08:59,574 EARLY STAGE INVESTIGATORS, AND 3793 02:08:59,574 --> 02:09:01,276 YOU CAN SEE THAT GAP THIS YEAR. 3794 02:09:01,276 --> 02:09:03,344 SO THE PAYLINE WAS 17 LAST YEAR. 3795 02:09:03,344 --> 02:09:04,979 THAT'S WHERE WE CAME UP WITH 17, 3796 02:09:04,979 --> 02:09:09,817 WAS TRYING TO HOLD IT AT WHERE 3797 02:09:09,817 --> 02:09:11,152 IT HAD PEAKED, SO SENDING A 3798 02:09:11,152 --> 02:09:12,921 STRONG SIGNAL TO THOSE IN THEIR 3799 02:09:12,921 --> 02:09:17,859 EARLY CAREERS THAT THEY ARE VERY 3800 02:09:17,859 --> 02:09:18,760 IMPORTANT TO US, THEY ARE OUR 3801 02:09:18,760 --> 02:09:19,961 NEXT GENERATION AND IT'S REALLY 3802 02:09:19,961 --> 02:09:21,296 ESSENTIAL THAT WE PRIORITIZE THE 3803 02:09:21,296 --> 02:09:31,172 WORK THAT THEY'RE BRINGING. 3804 02:09:31,172 --> 02:09:32,574 SO I ALSO WANT TO BRING A 3805 02:09:32,574 --> 02:09:33,675 REVISIT TO THE NATIONAL CANCER 3806 02:09:33,675 --> 02:09:34,609 PLAN. 3807 02:09:34,609 --> 02:09:35,376 SO THE NATIONAL CANCER PLAN, 3808 02:09:35,376 --> 02:09:37,145 AGAIN, AS I MENTIONED THE LAST 3809 02:09:37,145 --> 02:09:39,781 TIME WE TALKED, CONSISTS OF 3810 02:09:39,781 --> 02:09:40,782 EIGHT GOALS. 3811 02:09:40,782 --> 02:09:42,116 I SPENT A LOT OF TIME WITH THAT. 3812 02:09:42,116 --> 02:09:44,953 THIS IS EARLY ON, ABOUT THE TIME 3813 02:09:44,953 --> 02:09:48,823 THAT I MET WITH YOU LAST, AND 3814 02:09:48,823 --> 02:09:50,491 END OF KIND OF THINKING OF IT AS 3815 02:09:50,491 --> 02:09:51,392 THOSE EIGHT GOALS INTO TWO 3816 02:09:51,392 --> 02:09:52,894 DIFFERENT GROUPS. 3817 02:09:52,894 --> 02:09:57,966 ONE, ON THE RIGHT, HEALTH 16 3818 02:09:57,966 --> 02:09:59,167 CENTRIC GOALS, SO PREVENTING 3819 02:09:59,167 --> 02:10:00,768 CANCER, EARLY DETECTION OF 3820 02:10:00,768 --> 02:10:02,170 CANCER, DEVELOPING EFFECTIVE 3821 02:10:02,170 --> 02:10:03,705 THERAPIES, AND THEN FINALLY, 3822 02:10:03,705 --> 02:10:06,007 DELIVERING OPTIMAL CARE. 3823 02:10:06,007 --> 02:10:07,609 THAT INCLUDES SURVIVORSHIP, THAT 3824 02:10:07,609 --> 02:10:09,777 INCLUDES THE CARE THROUGHOUT THE 3825 02:10:09,777 --> 02:10:12,947 CARE EXPERIENCE, AND YOU CAN SEE 3826 02:10:12,947 --> 02:10:15,250 HOW THAT REALLY TAKES EVERY 3827 02:10:15,250 --> 02:10:17,585 POINT AT WHICH A PATIENT IS A 3828 02:10:17,585 --> 02:10:20,221 PART OF THIS CANCER CONTINUUM. 3829 02:10:20,221 --> 02:10:21,623 AND SO WHAT ARE THE OTHER FOUR 3830 02:10:21,623 --> 02:10:22,390 GOALS? 3831 02:10:22,390 --> 02:10:23,891 SO THE OTHER FOUR GOALS, I SEE 3832 02:10:23,891 --> 02:10:25,760 THOSE AS EMPOWERING GOALS. 3833 02:10:25,760 --> 02:10:27,762 IF THEY ARE APPLIED CORRECTLY, 3834 02:10:27,762 --> 02:10:28,529 THEY CAN ACCELERATE THE WORK 3835 02:10:28,529 --> 02:10:29,964 THAT WE'RE DOING IN PREVENTION 3836 02:10:29,964 --> 02:10:31,933 IN EARLY DETECTION, IN 3837 02:10:31,933 --> 02:10:33,568 DEVELOPING EFFECTIVE THERAPIES, 3838 02:10:33,568 --> 02:10:36,938 AND IN DELIVERING OPTIMAL CARE, 3839 02:10:36,938 --> 02:10:40,875 BECAUSE THOSE GOALS ARE FOCUSING 3840 02:10:40,875 --> 02:10:45,446 ON MAXIMIZING DATA UTILITY, 3841 02:10:45,446 --> 02:10:46,848 ELIMINATING INEQUITIES, ENGAGING 3842 02:10:46,848 --> 02:10:49,984 THE WORKFORCE AND BUILDING AN 3843 02:10:49,984 --> 02:10:51,486 OPTIMAL WORKFORCE, AND THEN 3844 02:10:51,486 --> 02:10:52,420 FINALLY, THE ONE THAT I STILL 3845 02:10:52,420 --> 02:10:54,422 FIND AS MY FAVORITE IS ENGAGING 3846 02:10:54,422 --> 02:10:56,658 EVERY PERSON. 3847 02:10:56,658 --> 02:10:57,859 I'VE ALSO HEARD A LOT OF 3848 02:10:57,859 --> 02:10:59,127 QUESTIONS ABOUT WHERE IS 3849 02:10:59,127 --> 02:11:00,328 DISCOVERY SCIENCE HERE? 3850 02:11:00,328 --> 02:11:01,562 AND DISCOVERY SCIENCE IS THE 3851 02:11:01,562 --> 02:11:04,198 FUEL BEHIND ALL OF THOSE AND SO 3852 02:11:04,198 --> 02:11:06,067 THIS GRAPHICAL REPRESENTATION 3853 02:11:06,067 --> 02:11:07,402 SHOWS HOW DISCOVERY SCIENCE IS A 3854 02:11:07,402 --> 02:11:12,907 CORE PART OF EVERY PIECE OF THE 3855 02:11:12,907 --> 02:11:13,908 GOALS, AND WHEN THEY WORK 3856 02:11:13,908 --> 02:11:14,709 TOGETHER IS WHERE THERE'S SOME 3857 02:11:14,709 --> 02:11:16,277 OF THE MOST POWER TO GET TO THAT 3858 02:11:16,277 --> 02:11:17,679 POINT THAT ARE INDICATED THERE 3859 02:11:17,679 --> 02:11:19,547 ON THE RIGHT, ON THE ORANGE, AND 3860 02:11:19,547 --> 02:11:23,718 ARE ALSO THE GOALS OF THE CANCER 3861 02:11:23,718 --> 02:11:24,752 MOONSHOT, IMPROVED HEALTH 3862 02:11:24,752 --> 02:11:26,154 OUTCOMES FOR EVERYONE AND 3863 02:11:26,154 --> 02:11:28,022 REDUCING CANCER MORTALITY BY 50% 3864 02:11:28,022 --> 02:11:28,456 BY 2047. 3865 02:11:28,456 --> 02:11:29,957 SO WE'VE BEEN TRYING TO 3866 02:11:29,957 --> 02:11:32,160 COMMUNICATE ABOUT THE NATIONAL 3867 02:11:32,160 --> 02:11:34,228 CANCER PLAN EARLY AND OFTEN AND 3868 02:11:34,228 --> 02:11:35,663 QUITE CONTINUOUSLY BECAUSE IT 3869 02:11:35,663 --> 02:11:38,032 CAN BE A REALLY POWERFUL ROAD 3870 02:11:38,032 --> 02:11:44,138 MAP, IS WHAT I HAVE FOUND. 3871 02:11:44,138 --> 02:11:46,407 IN A TIGHT BUDGET TIME FOCUSING 3872 02:11:46,407 --> 02:11:48,276 ON TRYING TO MOVE THINGS 3873 02:11:48,276 --> 02:11:51,012 FORWARD, I HAVE FOUND THAT 3874 02:11:51,012 --> 02:11:53,314 HAVING A SET OF VALUES CAN 3875 02:11:53,314 --> 02:11:56,117 REALLY BE VERY IMPORTANT FOR ME. 3876 02:11:56,117 --> 02:11:57,852 AND SO THE VALUES THAT I HAVE 3877 02:11:57,852 --> 02:12:00,154 BEEN PUTTING FRONT AND CENTER 3878 02:12:00,154 --> 02:12:01,856 AND DECISIONS THAT WE'VE NEEDED 3879 02:12:01,856 --> 02:12:03,591 TO MAKE ARE, NUMBER ONE, TALENT 3880 02:12:03,591 --> 02:12:04,225 DEVELOPMENT. 3881 02:12:04,225 --> 02:12:07,695 SO THAT SHOWS IN THE PAYLINE 3882 02:12:07,695 --> 02:12:08,896 ADJUSTMENT THAT WE DID TO MOVE 3883 02:12:08,896 --> 02:12:10,965 THAT TO 17%. 3884 02:12:10,965 --> 02:12:14,135 IN THE BUDGET DECISIONS, WE ALSO 3885 02:12:14,135 --> 02:12:18,373 HELD TIGHT ON OUR TRAINING 3886 02:12:18,373 --> 02:12:20,541 BRANCH, SO THE TRAINING BRANCH 3887 02:12:20,541 --> 02:12:21,976 ALSO DIDN'T RECEIVE A FURTHER 3888 02:12:21,976 --> 02:12:24,712 CUT. 3889 02:12:24,712 --> 02:12:26,381 OTHER VALUE, CREATIVITY AND 3890 02:12:26,381 --> 02:12:29,117 INNOVATION, AND ENABLING EVERY 3891 02:12:29,117 --> 02:12:32,687 GROUP TO INFUSE CREATIVITY AND 3892 02:12:32,687 --> 02:12:33,287 INNOVATION INTO THE WORK THAT 3893 02:12:33,287 --> 02:12:33,888 THEY DO. 3894 02:12:33,888 --> 02:12:35,623 EMPOWERMENT, SO LOOKING FOR 3895 02:12:35,623 --> 02:12:37,759 VOICES, AND GIVING THEM POWER, 3896 02:12:37,759 --> 02:12:39,761 AND FISCAL RESPONSIBILITY, WHICH 3897 02:12:39,761 --> 02:12:41,496 JUST HAS TO BE A PART OF WHAT WE 3898 02:12:41,496 --> 02:12:48,336 DO IN A TIGHT BUDGET CLIMATE. 3899 02:12:48,336 --> 02:12:49,871 AND THEN RESEARCH AND PROGRAM 3900 02:12:49,871 --> 02:12:50,638 HIGHLIGHT. 3901 02:12:50,638 --> 02:12:53,708 SO THIS IS WHERE I JUST WANT TO 3902 02:12:53,708 --> 02:12:55,977 SHOW SOME EXCITING ADVANCES IN 3903 02:12:55,977 --> 02:12:57,612 SOME KEY AREAS AND WHERE WE'RE 3904 02:12:57,612 --> 02:13:00,982 REALLY TRA TRANSFORMING CLINICAL 3905 02:13:00,982 --> 02:13:01,582 RESEARCH. 3906 02:13:01,582 --> 02:13:03,785 SO HERE IS JUST A LIST TO GIVE 3907 02:13:03,785 --> 02:13:05,319 YOU SORT OF SOME SENSE. 3908 02:13:05,319 --> 02:13:06,687 THE FIRST ONE I JUST WANT TO 3909 02:13:06,687 --> 02:13:08,656 POINT TO IS IN THIS REALM OF 3910 02:13:08,656 --> 02:13:09,857 CLINICAL RESEARCH, WHERE WE'RE 3911 02:13:09,857 --> 02:13:11,259 TALKING ABOUT CAN WE DO IT 3912 02:13:11,259 --> 02:13:15,296 FASTER, CAN WE GET IT INTO MORE 3913 02:13:15,296 --> 02:13:16,731 PLACES, WE DIDN'T REALLY HAVE 3914 02:13:16,731 --> 02:13:19,333 GOOD DATA ON HOW MANY PATIENT IN 3915 02:13:19,333 --> 02:13:20,535 THE CANCER COMMUNITY WERE 3916 02:13:20,535 --> 02:13:23,104 PARTICIPATING IN CLINICAL 3917 02:13:23,104 --> 02:13:25,072 RESEARCH. 3918 02:13:25,072 --> 02:13:26,174 AND THIS PAPER THAT JUST CAME 3919 02:13:26,174 --> 02:13:27,608 OUT SUGGESTS THAT THE WIDELY 3920 02:13:27,608 --> 02:13:35,082 TAUGHTED NUTAUGTOUTED NUMBER OFT 3921 02:13:35,082 --> 02:13:36,818 CORRECT, IT'S ACTUALLY QUITE 3922 02:13:36,818 --> 02:13:38,152 HIGHER, IT'S ACTUALLY 7%. 3923 02:13:38,152 --> 02:13:40,855 NOW I THINK 7% IS NOT THE NUMBER 3924 02:13:40,855 --> 02:13:42,256 WE NEED TO LAND AT AT THE END, 3925 02:13:42,256 --> 02:13:44,091 BUT IT'S GOOD TO KNOW, AND IT'S 3926 02:13:44,091 --> 02:13:45,193 IMPORTANT TO KNOW WHERE PEOPLE 3927 02:13:45,193 --> 02:13:46,561 ARE PARTICIPATING IN CLINICAL 3928 02:13:46,561 --> 02:13:49,964 TRIALS AND THIS PAPER IS TO SOME 3929 02:13:49,964 --> 02:13:51,265 LEVEL OF GRANULARITY IN LOOKING 3930 02:13:51,265 --> 02:13:52,600 AT WHERE PEOPLE ARE FINDING 3931 02:13:52,600 --> 02:13:55,636 CLINICAL RESEARCH. 3932 02:13:55,636 --> 02:13:57,905 SEVERAL OTHER IMPORTANT STUDIES 3933 02:13:57,905 --> 02:13:59,941 THAT RECENTLY CAME TO FRUITION, 3934 02:13:59,941 --> 02:14:02,076 ONE LOOKING AT A URINE TEST TO 3935 02:14:02,076 --> 02:14:03,377 IDENTIFY HIGH RISK PROSTATE 3936 02:14:03,377 --> 02:14:04,912 CANCERS, TO AVOID SOME OF THE 3937 02:14:04,912 --> 02:14:06,013 UNNECESSARY BIOPSIES THAT HAVE 3938 02:14:06,013 --> 02:14:07,748 BEEN A PART OF PROSTATE CANCER 3939 02:14:07,748 --> 02:14:08,382 CARE. 3940 02:14:08,382 --> 02:14:10,351 ONE REALLY LOOKING AT CHILDHOOD 3941 02:14:10,351 --> 02:14:11,319 CANCER SURVIVORS. 3942 02:14:11,319 --> 02:14:13,154 THIS IS A BIG PART OF 3943 02:14:13,154 --> 02:14:14,355 UNDERSTANDING SURVIVORSHIP, WHAT 3944 02:14:14,355 --> 02:14:16,324 DOES THAT MEAN FOR YOUR BODY, 3945 02:14:16,324 --> 02:14:21,429 HAVING UNDERGONE THIS TREATMENT. 3946 02:14:21,429 --> 02:14:22,597 THEY MAY, IN FACT, AFFECT 3947 02:14:22,597 --> 02:14:24,265 INDICATORS OF AGE. 3948 02:14:24,265 --> 02:14:26,167 AND THEN ALSO LOOKING AT 3949 02:14:26,167 --> 02:14:28,836 BIOMATERIALS THAT COULD ENHANCE 3950 02:14:28,836 --> 02:14:30,238 CANCER VACCINES, THOSE BEING A 3951 02:14:30,238 --> 02:14:32,640 REALLY EXCITING PART OF THE 3952 02:14:32,640 --> 02:14:33,708 EXPERIMENTAL THERAPEUTICS 3953 02:14:33,708 --> 02:14:39,614 PIPELINE. 3954 02:14:39,614 --> 02:14:42,016 SO BACK WHEN I INTRODUCED 3955 02:14:42,016 --> 02:14:43,117 DR. KIBBE, I HAD TO SAY THAT 3956 02:14:43,117 --> 02:14:45,386 A.I. IS PE PERMEATING EVERYWHER, 3957 02:14:45,386 --> 02:14:46,587 AND HERE ARE JUST A COUPLE OF 3958 02:14:46,587 --> 02:14:47,021 EXAMPLES. 3959 02:14:47,021 --> 02:14:48,523 THESE ARE TWO STUDIES THAT WERE 3960 02:14:48,523 --> 02:14:49,190 PUBLISHED JUST IN THE LAST 3961 02:14:49,190 --> 02:14:51,592 COUPLE OF MONTHS THAT USED 3962 02:14:51,592 --> 02:14:56,163 A.I.-DRIVEN TOOLS TO ASSESS 3963 02:14:56,163 --> 02:14:58,432 PATIENT READINESS OR LIKELY 3964 02:14:58,432 --> 02:15:06,607 RESPONSIVENESS TO T, THE FIRST D 3965 02:15:06,607 --> 02:15:07,909 PERCEPTION, PREDICTING WHO WOULD 3966 02:15:07,909 --> 02:15:09,110 RESPOND BEST TO CERTAIN 3967 02:15:09,110 --> 02:15:11,212 THERAPIES, AND THEN A SECOND 3968 02:15:11,212 --> 02:15:13,447 STUDY CALLED LORIS LOOKED 3969 02:15:13,447 --> 02:15:15,316 SPECIFICALLY AT IMMUNOTHERAPY. 3970 02:15:15,316 --> 02:15:16,517 ALLOWING PATIENTS TO BE ABLE TO 3971 02:15:16,517 --> 02:15:21,322 HAVE MORE CONFIDENCE ABOUT -- 3972 02:15:21,322 --> 02:15:22,924 AND THEIR PROVIDERS TO HAVE MORE 3973 02:15:22,924 --> 02:15:23,591 CONFIDENCE ABOUT WHETHER A 3974 02:15:23,591 --> 02:15:24,458 TREATMENT IS THE RIGHT OPTION 3975 02:15:24,458 --> 02:15:25,192 FOR THEM. 3976 02:15:25,192 --> 02:15:26,527 BECAUSE YOU WANT THE OPTION THAT 3977 02:15:26,527 --> 02:15:29,263 HAS THE BEST CHANCE TO BE 3978 02:15:29,263 --> 02:15:34,936 SUCCESSFUL. 3979 02:15:34,936 --> 02:15:38,639 THEN THIS IS BACK TO THE 360 3980 02:15:38,639 --> 02:15:40,241 ERA, HOW DO WE TRANSFORM 3981 02:15:40,241 --> 02:15:41,442 CLINICAL RESEARCH IN A WAY THAT 3982 02:15:41,442 --> 02:15:42,743 ALLOWS US TO GET CLINICAL 3983 02:15:42,743 --> 02:15:44,278 STUDIES INTO A MUCH BROADER 3984 02:15:44,278 --> 02:15:45,146 POPULATION. 3985 02:15:45,146 --> 02:15:46,881 SO FIRST IS UTILIZING 3986 02:15:46,881 --> 02:15:48,082 DECENTRALIZED CLINICAL TRIAL 3987 02:15:48,082 --> 02:15:50,251 DESIGNS, AND WE'RE WORKING VERY 3988 02:15:50,251 --> 02:15:52,553 ACTIVELY ON WAYS THAT WE CAN 3989 02:15:52,553 --> 02:15:54,855 BRING CLINICAL TRIALS INTO 3990 02:15:54,855 --> 02:15:59,026 COMMUNITIES AND INTO HOMES WHERE 3991 02:15:59,026 --> 02:16:00,027 THEY'RE MOST APPROPRIATE. 3992 02:16:00,027 --> 02:16:01,028 I HAVE AN EXAMPLE OF THAT COMING 3993 02:16:01,028 --> 02:16:02,263 UP AND I'LL POINT TO IT IN THE 3994 02:16:02,263 --> 02:16:04,765 NEXT SLIDE. 3995 02:16:04,765 --> 02:16:06,767 WE'RE ALSO PILOTING -- OH, NOT 3996 02:16:06,767 --> 02:16:10,738 QUITE YET. 3997 02:16:10,738 --> 02:16:12,707 WE'RE ALSO PILOTING A VIRTUAL 3998 02:16:12,707 --> 02:16:13,574 CLINICAL TRIALS OFFICE. 3999 02:16:13,574 --> 02:16:15,443 THIS IS AN INVENTION THAT CAME 4000 02:16:15,443 --> 02:16:16,711 FROM THE PANDEMIC. 4001 02:16:16,711 --> 02:16:18,446 WE CAN DO A LOT MORE VIRTUALLY 4002 02:16:18,446 --> 02:16:20,214 THAN WE PREVIOUSLY THOUGHT WAS 4003 02:16:20,214 --> 02:16:22,350 POSSIBLE. 4004 02:16:22,350 --> 02:16:23,651 INCLUDING ELIGIBILITY CRITERIA 4005 02:16:23,651 --> 02:16:26,287 FOR CLINICAL STUDIES, INCLUDING 4006 02:16:26,287 --> 02:16:28,556 DOING DATA COLLECTION. 4007 02:16:28,556 --> 02:16:29,957 IT DOESN'T NECESSARILY REQUIRE 4008 02:16:29,957 --> 02:16:31,058 SOMEONE WITH BOOTS ON THE GROUND 4009 02:16:31,058 --> 02:16:31,926 IN THAT OFFICE. 4010 02:16:31,926 --> 02:16:33,561 A LOT OF THAT CAN BE DONE 4011 02:16:33,561 --> 02:16:34,161 VIRTUALLY. 4012 02:16:34,161 --> 02:16:36,397 WE'RE ALSO LEANING HARD ON OUR 4013 02:16:36,397 --> 02:16:38,733 CLINICAL TRIALS INNOVATION UNIT 4014 02:16:38,733 --> 02:16:41,335 AS A GROUP THAT CAN HELP TO 4015 02:16:41,335 --> 02:16:43,437 SPEARHEAD CLINICAL TRIAL 4016 02:16:43,437 --> 02:16:45,039 STREAMLINING, AND I JUST WANT TO 4017 02:16:45,039 --> 02:16:47,742 GIVE A SHOUT OUT TO THE MATCH 4018 02:16:47,742 --> 02:16:47,975 STUDIES. 4019 02:16:47,975 --> 02:16:50,111 SO THE ORIGINAL MACH TRIAL WAS 4020 02:16:50,111 --> 02:16:52,880 ONE OF THE FIRST TO REALLY 4021 02:16:52,880 --> 02:16:55,950 PIONEER THE PRECISION MEDICINE 4022 02:16:55,950 --> 02:16:57,985 ONCOLOGY MATCH THE MUTATION TO 4023 02:16:57,985 --> 02:17:00,321 THE DRUG AND SEE WHAT HAPPENS. 4024 02:17:00,321 --> 02:17:03,624 IT WAS A RADICAL TRANSFORMATION 4025 02:17:03,624 --> 02:17:06,861 IN THE WAY WE DO CANCER CLINICAL 4026 02:17:06,861 --> 02:17:10,865 TRIALS, AND THE SUCCESSORS, 4027 02:17:10,865 --> 02:17:12,933 MYELOMATCH, COMBO MATCH AND 4028 02:17:12,933 --> 02:17:14,969 IMMUNOMATCH ARE ALL ON THE 4029 02:17:14,969 --> 02:17:15,636 HORIZONS, MYELOMATCH ALREADY 4030 02:17:15,636 --> 02:17:18,239 OPENED A WEEK OR TWO AGO, AND I 4031 02:17:18,239 --> 02:17:20,408 THINK HAS ALREADY ENROLLEDDITY 4032 02:17:20,408 --> 02:17:20,775 FIRST PATIENT. 4033 02:17:20,775 --> 02:17:22,243 SO THESE ARE EXAMPLES OF SOME OF 4034 02:17:22,243 --> 02:17:22,977 THE TRANSFORMATION THAT'S COMING 4035 02:17:22,977 --> 02:17:29,450 FOR THE CLINICAL RESEARCH AREA. 4036 02:17:29,450 --> 02:17:32,053 SO I THINK I'VE MAYBE ALREADY 4037 02:17:32,053 --> 02:17:33,587 BEATEN THIS QUITE A LOT, BUT 4038 02:17:33,587 --> 02:17:37,525 AGAIN, BACK IN MY ASCO 4039 02:17:37,525 --> 02:17:40,227 PRESENTATION, MOVING FORWARD 4040 02:17:40,227 --> 02:17:43,297 FASTER, WH WHAT I ASKED FOR PEOE 4041 02:17:43,297 --> 02:17:44,932 TO DO, AND BY PEOPLE, I MEAN 4042 02:17:44,932 --> 02:17:47,034 CLINICAL INVESTIGATORS, I MEAN 4043 02:17:47,034 --> 02:17:48,335 FUNDERS OF CLINICAL RESEARCH, 4044 02:17:48,335 --> 02:17:51,605 THAT'S US, BUT ALSO INDUSTRY 4045 02:17:51,605 --> 02:17:54,775 SPONSORS, OTHERS, AND THE 4046 02:17:54,775 --> 02:17:57,078 PATIENTS AND ADVOCACY GROUPS TO 4047 02:17:57,078 --> 02:17:59,213 BE IMPATIENT ABOUT THIS, AND TRY 4048 02:17:59,213 --> 02:18:00,981 TO BE IMPATIENT IN A WAY THAT 4049 02:18:00,981 --> 02:18:05,553 ALLOWS US TO MOVE THIS IN A MUCH 4050 02:18:05,553 --> 02:18:13,060 FASTER SPACE. 4051 02:18:13,060 --> 02:18:15,362 WHAT WE'RE DOING, HOW YOU MOVE 4052 02:18:15,362 --> 02:18:16,897 FASTER IS YOU LOOK AT 4053 02:18:16,897 --> 02:18:17,498 BOTTLENECKS. 4054 02:18:17,498 --> 02:18:19,700 WE'RE TAKING SCIENTIFIC 4055 02:18:19,700 --> 02:18:20,568 DISCOVERY, WE KNOW THAT WE CAN 4056 02:18:20,568 --> 02:18:22,970 ASK A QUESTION IN THE CLINICAL 4057 02:18:22,970 --> 02:18:24,538 WORK SPACE, AND WE KNOW THAT 4058 02:18:24,538 --> 02:18:25,706 THERE ARE MANY STEPS THAT HAVE 4059 02:18:25,706 --> 02:18:29,543 TO BE UNDERTAKEN. 4060 02:18:29,543 --> 02:18:30,945 SOME OF THOSE CAN BE DONE IN 4061 02:18:30,945 --> 02:18:31,479 PARALLEL. 4062 02:18:31,479 --> 02:18:32,747 SOME OF THOSE COULD BE EXCLUDED. 4063 02:18:32,747 --> 02:18:36,484 AND SOME OF THEM CAN ALLOW US TO 4064 02:18:36,484 --> 02:18:38,385 GET MORE QUICKLY INTO THE HANDS 4065 02:18:38,385 --> 02:18:39,754 OF PATIENTS BY IDENTIFYING WHERE 4066 02:18:39,754 --> 02:18:41,589 THOSE BOTTLENECKS ARE AND 4067 02:18:41,589 --> 02:18:47,161 ADDRESSING THEM HEAD-ON. 4068 02:18:47,161 --> 02:18:48,796 SO THIS IS SOME OF THE OTHER 4069 02:18:48,796 --> 02:18:50,331 STUDIES THAT I WANTED TO 4070 02:18:50,331 --> 02:18:51,565 HIGHLIGHT. 4071 02:18:51,565 --> 02:18:53,801 THAT TALK ABOUT -- THAT SPEAK TO 4072 02:18:53,801 --> 02:18:54,668 THE TRANSFORMATION OF CLINICAL 4073 02:18:54,668 --> 02:18:57,438 RESEARCH. 4074 02:18:57,438 --> 02:18:58,506 SO FIRST ON THE LEFT IS THE 4075 02:18:58,506 --> 02:18:59,640 VANGUARD STUDY. 4076 02:18:59,640 --> 02:19:01,442 WE ARE VERY INTERESTED IN HOW 4077 02:19:01,442 --> 02:19:05,446 THESE MULTI-CANCER DETEPTION DEN 4078 02:19:05,446 --> 02:19:07,148 TESTS THIS, IS A BLOOD TEST THAT 4079 02:19:07,148 --> 02:19:07,815 CAN GIVE YOU AN ASSESSMENT OF 4080 02:19:07,815 --> 02:19:09,116 YOUR RISK FOR A VARIETY OF 4081 02:19:09,116 --> 02:19:10,417 COMMON TUMORS. 4082 02:19:10,417 --> 02:19:12,086 THERE ARE LOTS OF COMPANIES THAT 4083 02:19:12,086 --> 02:19:16,056 ARE BRINGING THESE KIND OF TOOLS 4084 02:19:16,056 --> 02:19:16,957 TO MARKET AND WE DON'T KNOW, 4085 02:19:16,957 --> 02:19:18,592 WHAT WILL WE DO WHEN IT'S A 4086 02:19:18,592 --> 02:19:20,227 POSITIVE TEST AND WE DON'T FIND 4087 02:19:20,227 --> 02:19:24,598 A TUMOR TO MAMP TO. 4088 02:19:24,598 --> 02:19:26,300 SOMETIMES THAT WILL MEAN A TUMOR 4089 02:19:26,300 --> 02:19:27,468 THAT'S ON THE HORIZON, SOMETIMES 4090 02:19:27,468 --> 02:19:28,836 IT WON'T. 4091 02:19:28,836 --> 02:19:30,805 WHAT WILL IT MEAN TO GET A 4092 02:19:30,805 --> 02:19:32,206 POSITIVE TEST IN TERMS OF THE 4093 02:19:32,206 --> 02:19:35,576 FOLLOW-UP, AND DO WE KNOW HOW TO 4094 02:19:35,576 --> 02:19:36,777 REFER PATIENTS EFFECTIVELY TO 4095 02:19:36,777 --> 02:19:37,344 THE NEXT STAGE? 4096 02:19:37,344 --> 02:19:39,914 SO THIS IS A TRIAL THAT WILL 4097 02:19:39,914 --> 02:19:43,551 ADDRESS SOME OF THESE QUESTIONS, 4098 02:19:43,551 --> 02:19:44,885 AND HELP US LEARN A NEW FUTURE 4099 02:19:44,885 --> 02:19:46,253 WHERE WE HAVE ACCESS TO THESE 4100 02:19:46,253 --> 02:19:48,455 KINDS OF SCIENCE FICTION TYPE OF 4101 02:19:48,455 --> 02:19:49,890 TOOLS, BUT WE HAVE TO BE ABLE TO 4102 02:19:49,890 --> 02:19:51,158 USE THEM EFFECTIVELY. 4103 02:19:51,158 --> 02:19:53,494 SO THAT WILL BE A PART OF THE 4104 02:19:53,494 --> 02:19:56,564 UNIQUE NETWORK, SO THIS IS WORK 4105 02:19:56,564 --> 02:19:59,300 THAT HAPPENS IN THE PRIMARY CARE 4106 02:19:59,300 --> 02:20:04,972 SPACE TO LEE'S COMMENT EARLIER, 4107 02:20:04,972 --> 02:20:06,841 THIS KIND OF EARLY DETECTION 4108 02:20:06,841 --> 02:20:08,042 DOESN'T HAPPEN IN THE 4109 02:20:08,042 --> 02:20:09,076 ONCOLOGIST'S OFFICE, SO IT'S 4110 02:20:09,076 --> 02:20:10,010 IMPORTANT THAT WE PARTICIPATE 4111 02:20:10,010 --> 02:20:12,079 SIDE BY SIDE WITH OUR COLLEAGUES 4112 02:20:12,079 --> 02:20:13,380 IN PRIMARY CARE IN UNDERSTANDING 4113 02:20:13,380 --> 02:20:15,115 THESE KINDS OF ADVANCES. 4114 02:20:15,115 --> 02:20:16,150 ANOTHER ONE, AND THIS IS THE ONE 4115 02:20:16,150 --> 02:20:18,519 I REFERRED TO EARLIER, IS REALLY 4116 02:20:18,519 --> 02:20:20,387 MOVING TO PUTTING SOME OF THESE 4117 02:20:20,387 --> 02:20:22,122 STUDIES RIGHT INTO THE HANDS OF 4118 02:20:22,122 --> 02:20:23,324 PATIENTS IN THEIR HOMES. 4119 02:20:23,324 --> 02:20:24,625 THIS STUDY IS NOT IN THE HOME 4120 02:20:24,625 --> 02:20:24,892 JUST YET. 4121 02:20:24,892 --> 02:20:27,595 IT CALLED THE SHIP TRIAL. 4122 02:20:27,595 --> 02:20:30,064 IT'S SELF COLLECTION FOR HPV. 4123 02:20:30,064 --> 02:20:32,933 SO ALLOWING INDIVIDUAL TO 4124 02:20:32,933 --> 02:20:35,769 SELF-SAMPLE FOR HPV FOR CERVICAL 4125 02:20:35,769 --> 02:20:39,640 CANCER TO KNOW WHAT THEIR RISK 4126 02:20:39,640 --> 02:20:43,110 LIKELY IS, HOW MUCH THEY NEED TO 4127 02:20:43,110 --> 02:20:44,411 HAVE FURTHER TESTING TO 4128 02:20:44,411 --> 02:20:46,180 ELIMINATE THEIR RISK FOR SEVERAL 4129 02:20:46,180 --> 02:20:49,350 CANCER OR TO MAPPAGE A CERVICAL 4130 02:20:49,350 --> 02:20:52,653 CANCER IF THAT'S THE CASE. 4131 02:20:52,653 --> 02:20:53,654 THE CURRENT VERSION OF THE STUDY 4132 02:20:53,654 --> 02:20:55,189 WILL BE SELF-COLLECTION THAT 4133 02:20:55,189 --> 02:20:59,727 HAPPENS IN THE DOCTOR'S OFFICE. 4134 02:20:59,727 --> 02:21:01,128 BUT FUTURE ITERATIONS OF THE 4135 02:21:01,128 --> 02:21:02,763 STUDY WILL OFFER THIS TO BE 4136 02:21:02,763 --> 02:21:03,130 TESTED AT HOME. 4137 02:21:03,130 --> 02:21:06,934 BECAUSE WE CAN EMPOWER PATIENTS 4138 02:21:06,934 --> 02:21:08,269 TO OWN THEIR OWN HEALTHCARE. 4139 02:21:08,269 --> 02:21:09,904 AND THEN THIS HAPPENS NOT JUST 4140 02:21:09,904 --> 02:21:11,472 IN THE ECOSYSTEM OF AMERICA, BUT 4141 02:21:11,472 --> 02:21:13,173 A LOT OF THESE QUESTIONS ARE 4142 02:21:13,173 --> 02:21:13,841 GLOBAL ONES. 4143 02:21:13,841 --> 02:21:15,376 AND I JUST WANTED TO POINT OUT 4144 02:21:15,376 --> 02:21:16,911 HERE THAT WE ARE WORKING VERY 4145 02:21:16,911 --> 02:21:20,814 CLOSELY WITH GLOBAL COLLEAGUES 4146 02:21:20,814 --> 02:21:23,117 WHO HAVE -- MY COUNTERPARTS FOR 4147 02:21:23,117 --> 02:21:25,986 CANCER AROUND THE COUNTRY WITH 4148 02:21:25,986 --> 02:21:28,789 QUESTIONS LIKE HOW TO TEST FOR 4149 02:21:28,789 --> 02:21:32,393 HPV, THE EXAMPLE HERE, HPV 4150 02:21:32,393 --> 02:21:34,128 ONE-DOSE VACCINE, SO CAN YOU GET 4151 02:21:34,128 --> 02:21:37,831 THE SAME LEVEL OF PROTECTION 4152 02:21:37,831 --> 02:21:39,934 WITH A SINGLE DOSE COULD 4153 02:21:39,934 --> 02:21:41,101 RADIALLY CHANGE THE WAY THIS 4154 02:21:41,101 --> 02:21:42,670 VACCINE IS DELIVERED, AND OTHER 4155 02:21:42,670 --> 02:21:48,108 PARTNERSHIPS AROUND THE WORLD. 4156 02:21:48,108 --> 02:21:49,276 AND I'VE ALREADY MENTIONED A 4157 02:21:49,276 --> 02:21:50,544 COUPLE OF TIMES THAT ONE THING 4158 02:21:50,544 --> 02:21:51,912 WE REALLY WANT TO DO IS TO MAKE 4159 02:21:51,912 --> 02:21:53,480 SURE THAT CLINICAL RESEARCH IS 4160 02:21:53,480 --> 02:21:54,415 REACHING THE COMMUNITIES WHERE 4161 02:21:54,415 --> 02:21:55,849 PATIENTS ARE. 4162 02:21:55,849 --> 02:21:58,819 AND THIS IS A WORKING GROUP THAT 4163 02:21:58,819 --> 02:22:01,088 WE PUT TOGETHER THAT TAKES 4164 02:22:01,088 --> 02:22:03,290 ADVANTAGE OF THIS ALL OF 4165 02:22:03,290 --> 02:22:04,224 GOVERNMENT -- ACTUALLY IT'S MORE 4166 02:22:04,224 --> 02:22:05,359 THAN GOVERNMENT APPROACH. 4167 02:22:05,359 --> 02:22:10,264 THE CO-CHAIRS OF THIS GROUP ARE 4168 02:22:10,264 --> 02:22:12,866 SOMEONE FROM THE AMERICAN CANCER 4169 02:22:12,866 --> 02:22:22,743 SOCIETY, BILL DAHUT, AND RAY 4170 02:22:22,743 --> 02:22:24,578 OSAROGIABON AND OUR EXECUTIVE 4171 02:22:24,578 --> 02:22:26,513 SECRETARY, ANDREA DENICOFF, WHO 4172 02:22:26,513 --> 02:22:28,248 WORKED IN PARTNERSHIP WITH THE 4173 02:22:28,248 --> 02:22:30,317 VA TO SET UP SOME CLINICAL 4174 02:22:30,317 --> 02:22:31,418 RESEARCH THERE AS WELL. 4175 02:22:31,418 --> 02:22:36,023 THE MEMBERS COME FROM ACROSS THE 4176 02:22:36,023 --> 02:22:37,825 CONTINUUM, FROM THE VA, FROM THE 4177 02:22:37,825 --> 02:22:41,195 DEPARTMENT OF DEFENSE, FROM THE 4178 02:22:41,195 --> 02:22:42,963 INDIAN HEALTH SERVICE, FROM CMS, 4179 02:22:42,963 --> 02:22:46,166 FROM HHS, ALL TOGETHER WORKING 4180 02:22:46,166 --> 02:22:49,636 TO FIND SOLUTIONS WHERE THERE IS 4181 02:22:49,636 --> 02:22:51,505 CAPACITY IN OUR SYSTEMS TO BE 4182 02:22:51,505 --> 02:22:52,573 ABLE TO DO CLINICAL RESEARCH OR 4183 02:22:52,573 --> 02:22:53,540 WHERE THERE ARE GAPS WHERE WE 4184 02:22:53,540 --> 02:22:55,275 NEED TO FILL. 4185 02:22:55,275 --> 02:22:58,112 SO THIS GROUP IS VERY ACTIVELY 4186 02:22:58,112 --> 02:22:59,346 TAKING ON THIS PROJECT AND I'M 4187 02:22:59,346 --> 02:23:00,748 REALLY EXCITED TO SEE WHAT THEY 4188 02:23:00,748 --> 02:23:07,087 BRING FORWARD. 4189 02:23:07,087 --> 02:23:08,422 AND IN ALL OF THIS I JUST WANT 4190 02:23:08,422 --> 02:23:10,057 TO MAKE SURE YOU KNOW HOW 4191 02:23:10,057 --> 02:23:12,559 COMMITTED I AM TO HEARING FROM 4192 02:23:12,559 --> 02:23:14,528 THE COMMUNITY A COUPLE OF WAYS. 4193 02:23:14,528 --> 02:23:17,898 ONE IS WE HAVE A COUPLE OF TIMES 4194 02:23:17,898 --> 02:23:23,270 NOW PUT OUT CALLS TO ASK FOR 4195 02:23:23,270 --> 02:23:26,306 ONLINE INSIGHTS THROUGH TWITTER 4196 02:23:26,306 --> 02:23:28,409 X, THROUGH LINKEDIN, THROUGH 4197 02:23:28,409 --> 02:23:29,376 INSTAGRAM, THROUGH FACEBOOK. 4198 02:23:29,376 --> 02:23:32,646 WE'VE ASKED QUESTIONS LIKE HOW 4199 02:23:32,646 --> 02:23:34,081 CAN WE REIMAGINE CLINICAL 4200 02:23:34,081 --> 02:23:35,315 RESEARCH TO ACCELERATE PROGRESS 4201 02:23:35,315 --> 02:23:37,317 FOR PEOPLE WITH CANCER. 4202 02:23:37,317 --> 02:23:39,319 AND IT'S BEEN THRILLING TO SEE 4203 02:23:39,319 --> 02:23:41,021 THE KINDS OF RESULTS THAT WE 4204 02:23:41,021 --> 02:23:42,322 GET, EVEN FROM THIS ONLINE 4205 02:23:42,322 --> 02:23:45,526 FORUM. 4206 02:23:45,526 --> 02:23:47,861 PROBABLY AS IMPACTFUL SO FAR HAS 4207 02:23:47,861 --> 02:23:48,962 BEEN MY FACE-TO-FACE MEETINGS 4208 02:23:48,962 --> 02:23:52,032 WITH ADVOCATES, WITH TRAINEES. 4209 02:23:52,032 --> 02:23:54,968 I JUST YESTERDAY VISITED TWO 4210 02:23:54,968 --> 02:23:56,437 NCORP SITES, THESE ARE COMMUNITY 4211 02:23:56,437 --> 02:23:58,038 CLINICAL RESEARCH SITES, AND 4212 02:23:58,038 --> 02:23:59,940 ASKING QUESTIONS AND LEARNING 4213 02:23:59,940 --> 02:24:00,974 WHAT'S ON PEOPLE'S MINDS. 4214 02:24:00,974 --> 02:24:04,378 SO I WILL BE ASKING FOR THAT 4215 02:24:04,378 --> 02:24:05,345 FROM YOU AS WELL. 4216 02:24:05,345 --> 02:24:06,980 AND THEN FINALLY, ONE THING THAT 4217 02:24:06,980 --> 02:24:09,283 WE'VE INITIATED AND WILL HAPPEN 4218 02:24:09,283 --> 02:24:11,151 LATER IN JULY IS A NEW ANNUAL 4219 02:24:11,151 --> 02:24:14,254 SCIENTIFIC PRIORITIES RETREAT TO 4220 02:24:14,254 --> 02:24:17,257 BRING TOGETHER ALL OF OUR MAJOR 4221 02:24:17,257 --> 02:24:19,326 LEADERS WITHIN THE NCI, AND ALL 4222 02:24:19,326 --> 02:24:23,397 OF OUR BOARD MEMBERS -- OR BOARD 4223 02:24:23,397 --> 02:24:29,503 CHAIRS FROM THE SIX BOARDS, S TO 4224 02:24:29,503 --> 02:24:30,804 DO A DEEP DIVE IN WHERE WE NEED 4225 02:24:30,804 --> 02:24:32,639 TO BE MAKING OUR INVESTMENTS. 4226 02:24:32,639 --> 02:24:34,174 SO REALLY EXCITED TO SEE HOW 4227 02:24:34,174 --> 02:24:41,315 THIS TURNS OUT. 4228 02:24:41,315 --> 02:24:42,716 ALSO WANT TO MAKE SURE YOU KNOW 4229 02:24:42,716 --> 02:24:43,750 ABOUT THE CANCER CABINET. 4230 02:24:43,750 --> 02:24:44,985 THIS IS A COMMUNITY OF THE ALL 4231 02:24:44,985 --> 02:24:46,186 OF GOVERNMENT COMPONENT OF THE 4232 02:24:46,186 --> 02:24:47,054 CANCER MOONSHOT. 4233 02:24:47,054 --> 02:24:51,525 IT TAKES UP A VARIETY OF ISSUES. 4234 02:24:51,525 --> 02:24:54,928 YOU SAW IN THE LAST 4235 02:24:54,928 --> 02:24:56,096 PRESENTATION, THIS IS WHERE THE 4236 02:24:56,096 --> 02:24:57,564 INITIATIVE TO REALLY PUSH 4237 02:24:57,564 --> 02:24:59,099 FORWARD FOR SURVIVORSHIP CAME 4238 02:24:59,099 --> 02:25:02,169 FROM, AND WE HAVE AN UPCOMING 4239 02:25:02,169 --> 02:25:04,138 COMMUNITY CONVERSATION FOCUSING 4240 02:25:04,138 --> 02:25:05,639 ON CLINICAL TRIALS, THE TOPIC OF 4241 02:25:05,639 --> 02:25:08,375 TODAY, HOW TO BRING RESEARCH TO 4242 02:25:08,375 --> 02:25:09,910 RURAL COMMUNITIES AND OTHER 4243 02:25:09,910 --> 02:25:11,578 MEDICALLY UNDERSERVED GROUPS, SO 4244 02:25:11,578 --> 02:25:12,546 REALLY EXCITED FOR THIS WORK 4245 02:25:12,546 --> 02:25:15,482 GOING FORWARD. 4246 02:25:15,482 --> 02:25:17,885 AND SO FINALLY, WHAT CAN I -- 4247 02:25:17,885 --> 02:25:19,853 WHAT DO I NEED FROM YOU? 4248 02:25:19,853 --> 02:25:22,789 THIS IS MY QUESTIONS LIST THAT I 4249 02:25:22,789 --> 02:25:26,960 JUST HAVE TO TELL YOU WHEN WE 4250 02:25:26,960 --> 02:25:29,363 MET THE LAST TIME, I CAN'T 4251 02:25:29,363 --> 02:25:30,797 REMEMBER WHICH ONE OF YOU BUT 4252 02:25:30,797 --> 02:25:33,767 SOMEONE SAID IF YOU WANT US TO 4253 02:25:33,767 --> 02:25:35,269 TELL YOU THINGS, YOU'VE GOT TO 4254 02:25:35,269 --> 02:25:36,036 ASK US SOME QUESTIONS. 4255 02:25:36,036 --> 02:25:37,704 SO I'VE BEEN DOING THIS WITH ALL 4256 02:25:37,704 --> 02:25:38,772 OF MY BOARDS SINCE THAT 4257 02:25:38,772 --> 02:25:40,641 CONVERSATION, AND I'M HAPPY TO 4258 02:25:40,641 --> 02:25:43,377 TAKE OTHER COMMENTS BUT WHAT I 4259 02:25:43,377 --> 02:25:45,112 NEED, AS YOU CAN SEE, CLINICAL 4260 02:25:45,112 --> 02:25:46,547 STUDIES ARE TOP OF MIND. 4261 02:25:46,547 --> 02:25:48,282 AND I WOULD LOVE TO KNOW HOW WE 4262 02:25:48,282 --> 02:25:50,284 SHOULD BE BEST ENGAGING THE 4263 02:25:50,284 --> 02:25:51,451 ADVOCACY COMMUNITY FOR CLINICAL 4264 02:25:51,451 --> 02:25:54,188 STUDY INNOVATION IF WE REALLY 4265 02:25:54,188 --> 02:25:55,322 WANT TO MAKE A TRANSFORMATION 4266 02:25:55,322 --> 02:25:58,559 HAPPEN. 4267 02:25:58,559 --> 02:26:01,828 WE WANT TO MOVE FURTHER FASTER. 4268 02:26:01,828 --> 02:26:02,930 OPEN TO SUGGESTIONS ON HOW TO DO 4269 02:26:02,930 --> 02:26:03,130 THAT. 4270 02:26:03,130 --> 02:26:04,565 I'M ALSO INTERESTED IN HOW WELL 4271 02:26:04,565 --> 02:26:07,801 THE NCI DESIGNATED CANCER CENTER 4272 02:26:07,801 --> 02:26:08,902 COMMUNITY OUTREACH ENGAGEMENT 4273 02:26:08,902 --> 02:26:10,671 PROGRAM DOES IN WORKING WITH THE 4274 02:26:10,671 --> 02:26:11,038 LOCAL COMMUNITY. 4275 02:26:11,038 --> 02:26:13,040 I KNOW THAT OUR CANCER CENTERS 4276 02:26:13,040 --> 02:26:14,408 PUT A LOT OF EFFORT INTO THAT. 4277 02:26:14,408 --> 02:26:16,743 IS IT WORKING, AND HOW COULD WE 4278 02:26:16,743 --> 02:26:18,145 AMPLIFY THEIR EFFORTS? 4279 02:26:18,145 --> 02:26:19,580 AND THEN FINALLY, WHAT ISSUES 4280 02:26:19,580 --> 02:26:21,648 WOULD YOU ALL ENCOURAGE US TO 4281 02:26:21,648 --> 02:26:23,283 ADDRESS? 4282 02:26:23,283 --> 02:26:25,452 SO THOSE ARE MY QUESTIONS FOR 4283 02:26:25,452 --> 02:26:25,652 TODAY. 4284 02:26:25,652 --> 02:26:27,454 BUT HAPPY TO TURN INTO A 4285 02:26:27,454 --> 02:26:30,190 CONVERSATION AND HEAR FROM YOU. 4286 02:26:30,190 --> 02:26:33,360 SO I THINK THAT'S MY LAST SLIDE. 4287 02:26:33,360 --> 02:26:35,095 OH, NO, THERE'S MORE! 4288 02:26:35,095 --> 02:26:37,531 JUST SOME CLOSING THOUGHTS. 4289 02:26:37,531 --> 02:26:39,366 WE HAVE SOME TOUGH BUDGET 4290 02:26:39,366 --> 02:26:39,866 REALITIES. 4291 02:26:39,866 --> 02:26:41,668 WE ARE DEALING WITH. 4292 02:26:41,668 --> 02:26:43,403 WE EXPECT THAT FY 25 WILL BE THE 4293 02:26:43,403 --> 02:26:43,837 SAME. 4294 02:26:43,837 --> 02:26:46,340 BUT THERE IS NO SLOWING DOWN. 4295 02:26:46,340 --> 02:26:47,908 THERE'S SO MUCH GOOD WORK TO DO. 4296 02:26:47,908 --> 02:26:50,978 THE TIME IS REALLY PERFECT FOR 4297 02:26:50,978 --> 02:26:54,248 TRANSFORMING CLINICAL RESEARCH 4298 02:26:54,248 --> 02:26:55,582 AND UTILIZING THESE DISCOVERS 4299 02:26:55,582 --> 02:26:58,819 AND TECHNOLOGIES AND MOVING THEM 4300 02:26:58,819 --> 02:27:00,554 FORWARD, SO WE REALLY HAVE NO 4301 02:27:00,554 --> 02:27:01,488 CHOICE, WE HAVE TO MOVE FORWARD 4302 02:27:01,488 --> 02:27:02,456 AND WE WILL FIND A WAY. 4303 02:27:02,456 --> 02:27:05,325 SO I THINK THAT REALLY IS MY 4304 02:27:05,325 --> 02:27:05,659 LAST SLIDE. 4305 02:27:05,659 --> 02:27:06,827 THANK YOU. 4306 02:27:06,827 --> 02:27:08,262 AND I AM VERY HAPPY TO TAKE 4307 02:27:08,262 --> 02:27:12,332 COMMENTS AND QUESTIONS. 4308 02:27:12,332 --> 02:27:14,401 >> WELL, THANK YOU SO MUCH, 4309 02:27:14,401 --> 02:27:16,670 DR. RATHMELL, FOR THAT VERY 4310 02:27:16,670 --> 02:27:19,306 COMPREHENSIVE AND VERY EXCITING 4311 02:27:19,306 --> 02:27:19,940 UPDATE. 4312 02:27:19,940 --> 02:27:22,242 I CAN'T BELIEVE SO MUCH HAS 4313 02:27:22,242 --> 02:27:23,877 HAPPENED SINCE WE'VE SEEN YOU 4314 02:27:23,877 --> 02:27:24,177 LAST. 4315 02:27:24,177 --> 02:27:26,380 IT JUST IS ENOUGH TO MAKE YOUR 4316 02:27:26,380 --> 02:27:28,015 HEAD SPIN, AND I KNOW A LOT OF 4317 02:27:28,015 --> 02:27:29,349 PEOPLE ARE GOING TO HAVE A LOT 4318 02:27:29,349 --> 02:27:30,284 OF QUESTIONS AND WANT TO ANSWER 4319 02:27:30,284 --> 02:27:31,485 YOUR QUESTIONS. 4320 02:27:31,485 --> 02:27:32,886 BUT WHILE WE'RE WAITING FOR 4321 02:27:32,886 --> 02:27:36,123 EVERYONE TO RAISE THEIR HANDS, I 4322 02:27:36,123 --> 02:27:37,791 DID HAVE SOMETHING THAT KIND OF 4323 02:27:37,791 --> 02:27:41,828 POPPED OUT AT ME BACK FOR THE 4324 02:27:41,828 --> 02:27:44,731 SELF-COLLECTION FOR HPV TESTING. 4325 02:27:44,731 --> 02:27:47,601 IS THERE A MALE VERSION OF THE 4326 02:27:47,601 --> 02:27:48,035 TEST? 4327 02:27:48,035 --> 02:27:51,204 IT SEEMS LIKE IF WE'RE ONLY 4328 02:27:51,204 --> 02:27:53,273 COLLECTING ON HALF THE 4329 02:27:53,273 --> 02:27:56,543 POPULATION, IT'S ONLY HALF THE 4330 02:27:56,543 --> 02:27:56,777 PROBLEM. 4331 02:27:56,777 --> 02:27:58,945 >> SO THE ANSWER IS SORT OF YES 4332 02:27:58,945 --> 02:27:59,713 AND SORT OF NO. 4333 02:27:59,713 --> 02:28:01,748 SO HPV IS A PROBLEM FOR BOTH MEN 4334 02:28:01,748 --> 02:28:07,321 AND WOMEN AND THERE IS AN ANAL 4335 02:28:07,321 --> 02:28:11,024 HPV TEST THAT ANYONE CAN USE. 4336 02:28:11,024 --> 02:28:14,428 THIS ONE, THE SUBSEQUENT 4337 02:28:14,428 --> 02:28:15,829 QUESTIONS ARE REALLY SPECIFIC TO 4338 02:28:15,829 --> 02:28:16,596 CERVICAL SCREENING SO THAT'S WHY 4339 02:28:16,596 --> 02:28:18,699 IT'S A CERVICAL TEST. 4340 02:28:18,699 --> 02:28:19,533 >> OKAY. 4341 02:28:19,533 --> 02:28:21,835 THANKS. 4342 02:28:21,835 --> 02:28:23,236 AND I'LL GO AHEAD AND TALK A 4343 02:28:23,236 --> 02:28:28,709 LITTLE BIT ABOUT YOUR MIDDLE 4344 02:28:28,709 --> 02:28:31,345 QUESTION ON CANCER CENTERS AND 4345 02:28:31,345 --> 02:28:32,846 TRYING TO INCREASE COMMUNITY 4346 02:28:32,846 --> 02:28:33,814 ENGAGEMENT AND ALL THAT. 4347 02:28:33,814 --> 02:28:43,623 WHAT I'M HEARING FROM WHERE I AM 4348 02:28:43,623 --> 02:28:48,328 IS THAT CANCER CARE IS PROFIT 4349 02:28:48,328 --> 02:28:49,429 ITABLE, THERE ARE MULTIPLE 4350 02:28:49,429 --> 02:28:51,131 HEALTH SYSTEMS AND HOSPITALS IN 4351 02:28:51,131 --> 02:28:52,132 PLACE, MORE AND MORE PEOPLE ARE 4352 02:28:52,132 --> 02:28:54,868 GETTING INTO THAT DELIVERY 4353 02:28:54,868 --> 02:29:00,507 SPACE, AND MAKING IT HARDER TO 4354 02:29:00,507 --> 02:29:02,175 GET, KEEP UP THE PATIENT VOLUME. 4355 02:29:02,175 --> 02:29:04,344 BUT I KNOW THAT THERE ARE 4356 02:29:04,344 --> 02:29:06,646 EXTRAORDINARY EFFORTS HAPPENING 4357 02:29:06,646 --> 02:29:13,286 TO CONNECT WITH COMMUNITIES IN 4358 02:29:13,286 --> 02:29:14,521 THE CATCHMENT AREAS. 4359 02:29:14,521 --> 02:29:15,956 BUT IT'S LIKE THAT DOESN'T SEEM 4360 02:29:15,956 --> 02:29:19,793 LIKE A PROBLEM RESEARCH CAN FIX. 4361 02:29:19,793 --> 02:29:23,764 >> WELL, I IT IS AND IT ISN'T. 4362 02:29:23,764 --> 02:29:26,299 I CAME FROM THAT ENVIRONMENT 4363 02:29:26,299 --> 02:29:27,367 BEFORE NOW. 4364 02:29:27,367 --> 02:29:28,735 BUT IT'S ACTUALLY ONE OF THE 4365 02:29:28,735 --> 02:29:30,070 THINGS THAT I LOVE IN MY CURRENT 4366 02:29:30,070 --> 02:29:32,806 JOB, IS THAT I DON'T HAVE TO 4367 02:29:32,806 --> 02:29:34,441 WORRY ABOUT THAT TYPE OF 4368 02:29:34,441 --> 02:29:34,875 COMPETITION. 4369 02:29:34,875 --> 02:29:36,276 IT'S A DIFFERENT TYPE OF 4370 02:29:36,276 --> 02:29:38,812 COMPETITION THAT I'M GLAD TO BE 4371 02:29:38,812 --> 02:29:41,748 IN. 4372 02:29:41,748 --> 02:29:43,383 AND IT IS REALLY INTERESTING. 4373 02:29:43,383 --> 02:29:47,888 ONE OF THE SESSIONS THAT WE HAD 4374 02:29:47,888 --> 02:29:55,395 TODAY A MODEL FOR AT LEAST SOME 4375 02:29:55,395 --> 02:29:57,431 PATIENTS, YOU HAVE TWO 4376 02:29:57,431 --> 02:29:59,132 ONCOLOGISTS, THE ONE AT THE 4377 02:29:59,132 --> 02:29:59,699 ACADEMIC CENTER AND THE ONE 4378 02:29:59,699 --> 02:30:01,034 THAT'S CLOSE TO YOUR HOME AND 4379 02:30:01,034 --> 02:30:05,205 ARE THERE WAYS THAT WE CAN 4380 02:30:05,205 --> 02:30:06,640 MAXIMIZE THOSE TWO 4381 02:30:06,640 --> 02:30:07,140 RELATIONSHIPS. 4382 02:30:07,140 --> 02:30:12,179 AND YET I KNOW THAT THAT EACH 4383 02:30:12,179 --> 02:30:15,115 CENTER IS REALLY VYING FOR THOSE 4384 02:30:15,115 --> 02:30:19,486 PATIENTS FOR FOR REVENUE. 4385 02:30:19,486 --> 02:30:24,958 AND SO WE HAVE TO BE HONEST 4386 02:30:24,958 --> 02:30:26,359 ABOUT WHAT SOME OF THE VARIOUS 4387 02:30:26,359 --> 02:30:27,360 INCENTIVES AND DRIVING FORCES 4388 02:30:27,360 --> 02:30:28,728 ARE WHEN WE MAKE THESE 4389 02:30:28,728 --> 02:30:28,995 DECISIONS. 4390 02:30:28,995 --> 02:30:31,798 >> RIGHT, AND TO SPEAK TO THAT 4391 02:30:31,798 --> 02:30:36,002 TOO, CROSSING STATE LINES, ONE 4392 02:30:36,002 --> 02:30:36,903 MEDICAL ONCOLOGIST SAID TO ME, I 4393 02:30:36,903 --> 02:30:38,104 WOULD LOVE TO CONTINUE TO GIVE 4394 02:30:38,104 --> 02:30:40,173 MORE SECOND OPINIONS AND 4395 02:30:40,173 --> 02:30:44,978 TREATMENT RELATED DISCUSSIONS 4396 02:30:44,978 --> 02:30:45,812 BUT WITH THE TELEHEALTH AND SOME 4397 02:30:45,812 --> 02:30:47,747 OF THE ROLLBACK FOR PRECOVID, 4398 02:30:47,747 --> 02:30:53,053 THAT WOULD BE A WAY TO BRING 4399 02:30:53,053 --> 02:30:54,221 WORLD CLASS CANCER CARE TO 4400 02:30:54,221 --> 02:30:56,656 EVERYBODY, PERHAPS, BUT AS FAR 4401 02:30:56,656 --> 02:31:00,393 AS BRAIN POWER. 4402 02:31:00,393 --> 02:31:01,828 >> TOP OF DISCUSSION TODAY, BY 4403 02:31:01,828 --> 02:31:02,429 THE WAY. 4404 02:31:02,429 --> 02:31:03,697 >> EXCELLENT. 4405 02:31:03,697 --> 02:31:03,930 >> YES. 4406 02:31:03,930 --> 02:31:05,799 I DON'T KNOW IF WE'LL GET IT 4407 02:31:05,799 --> 02:31:08,201 DONE BUT, BOY, HAVING INTERSTATE 4408 02:31:08,201 --> 02:31:09,002 TELEHEALTH, SPECIFICALLY FOR 4409 02:31:09,002 --> 02:31:11,238 CLINICAL TRIALS BUT REALLY EVEN 4410 02:31:11,238 --> 02:31:11,471 MORE -- 4411 02:31:11,471 --> 02:31:12,772 >> THAT WAS SO MEANINGFUL ?R. 4412 02:31:12,772 --> 02:31:13,373 HIGHLY VALUABLE. 4413 02:31:13,373 --> 02:31:14,274 >> THANK YOU. 4414 02:31:14,274 --> 02:31:21,815 JACKIE, YOU HAVE YOUR HAND UP. 4415 02:31:21,815 --> 02:31:23,016 >> YES, HELLO. 4416 02:31:23,016 --> 02:31:26,086 PIGGY BACKING ABOUT WHAT ANNIE 4417 02:31:26,086 --> 02:31:28,889 WAS TALKING ABOUT, COMMUNITY 4418 02:31:28,889 --> 02:31:32,759 ENGAGEMENT FOR NCI -- I SIT ON A 4419 02:31:32,759 --> 02:31:34,895 COMMITTEE FOR MOFFITT CANCER 4420 02:31:34,895 --> 02:31:36,196 CENTER, THAT'S OUR CHARGE, IS 4421 02:31:36,196 --> 02:31:37,531 CREATING AND THEN EVALUATING THE 4422 02:31:37,531 --> 02:31:39,266 COMMUNITY ENGAGEMENT STRATEGY, 4423 02:31:39,266 --> 02:31:40,534 AND ONE OF THE THINGS THEY'VE 4424 02:31:40,534 --> 02:31:41,635 DONE WHICH I DO APPRECIATE 4425 02:31:41,635 --> 02:31:43,069 HAVING BEEN TREATED HERE AND 4426 02:31:43,069 --> 02:31:46,239 LIVING IN THE STATE IS CREATING 4427 02:31:46,239 --> 02:31:47,240 SATELLITE CENTERS THROUGHOUT THE 4428 02:31:47,240 --> 02:31:48,275 STATE SO THAT THEY REALLY ARE 4429 02:31:48,275 --> 02:31:50,877 ABLE TO REACH MORE PATIENTS. 4430 02:31:50,877 --> 02:31:53,680 I KNOW THAT WHEN I WAS A 4431 02:31:53,680 --> 02:31:54,915 PATIENT, IT WAS AN HOUR AND A 4432 02:31:54,915 --> 02:31:56,650 HALF DRIVE, AND FOR MY CLINICAL 4433 02:31:56,650 --> 02:31:59,052 TRIAL, I WOULD HAVE TO DRIVE 4434 02:31:59,052 --> 02:32:01,254 THAT FAR JUST FOR BLOOD DRAWS, 4435 02:32:01,254 --> 02:32:03,857 DRIVING AN HOUR AND A HALF AND 4436 02:32:03,857 --> 02:32:04,624 THERE WERE PEOPLE IN THE 4437 02:32:04,624 --> 02:32:06,660 CLINICAL RESEARCH UNIT WITH ME 4438 02:32:06,660 --> 02:32:07,661 WHO ASKED HOW ARE YOU ABLE TO 4439 02:32:07,661 --> 02:32:09,963 AFFORD THIS, THERE'S GAS, SOME 4440 02:32:09,963 --> 02:32:13,867 PEOPLE HAVE TOLLS, AND IT MADE 4441 02:32:13,867 --> 02:32:14,634 PARTICIPATION COST PROHIBITIVE, 4442 02:32:14,634 --> 02:32:15,802 SO THAT'S ONE THING THAT I SEE 4443 02:32:15,802 --> 02:32:19,005 AS A POSITIVE, AND ALSO MAKING 4444 02:32:19,005 --> 02:32:20,874 SURE THAT IN THOSE AREAS, THEY 4445 02:32:20,874 --> 02:32:22,509 ARE LOOKING AT WHICH CANCERS ARE 4446 02:32:22,509 --> 02:32:24,044 PREVALENT AND HAVING SPECIALISTS 4447 02:32:24,044 --> 02:32:25,745 THERE AND THEN MAKING AN EFFORT 4448 02:32:25,745 --> 02:32:28,048 TO PARTNER WITH COMMUNITY-BASED 4449 02:32:28,048 --> 02:32:29,149 ORGANIZATIONS ON THE GROUND IN 4450 02:32:29,149 --> 02:32:31,217 THOSE AREAS TO REACH THOSE 4451 02:32:31,217 --> 02:32:32,285 POPULATIONS. 4452 02:32:32,285 --> 02:32:34,721 PARTICULARLY THOSE WHO -- I 4453 02:32:34,721 --> 02:32:35,922 MEAN, IT'S FLORIDA, FLORIDA IS 4454 02:32:35,922 --> 02:32:37,457 DEFINITELY AN INTERNATIONAL 4455 02:32:37,457 --> 02:32:38,825 STATE, MAKING SURE WE HAVE 4456 02:32:38,825 --> 02:32:41,061 PEOPLE THAT SPEAK LANGUAGES AND 4457 02:32:41,061 --> 02:32:42,662 SO PEOPLE FEEL COMFORTABLE AND 4458 02:32:42,662 --> 02:32:44,197 WE MEET THEM WHERE THEY ARE AND 4459 02:32:44,197 --> 02:32:46,166 THE LAST THING, THIS IS 4460 02:32:46,166 --> 02:32:47,701 SOMETHING I'M PROUD OF AS A 4461 02:32:47,701 --> 02:32:49,769 MELANOMA SURVIVOR, IT STARTED IN 4462 02:32:49,769 --> 02:32:51,171 MELANOMA, THEY HAD -- BACK THEN 4463 02:32:51,171 --> 02:32:52,606 IT WAS CALLED THE MOLE PATROL, 4464 02:32:52,606 --> 02:32:54,574 AND IT WAS A MOBILE SKIN CANCER 4465 02:32:54,574 --> 02:32:56,343 SCREENING, AND WE WOULD GO IN 4466 02:32:56,343 --> 02:32:58,712 THE SPRING TO BASEBALL SPRIRNG 4467 02:32:58,712 --> 02:33:02,482 TRASPRINGTRAINING CAMPS AND PROE 4468 02:33:02,482 --> 02:33:02,949 AWARENESS. 4469 02:33:02,949 --> 02:33:03,917 PEOPLE HAD NEVER SEEN SOMEONE 4470 02:33:03,917 --> 02:33:05,785 THAT LOOKED LIKE ME WHO HAD 4471 02:33:05,785 --> 02:33:07,587 MELANOMA, SO I WAS ABLE TO REACH 4472 02:33:07,587 --> 02:33:08,521 PEOPLE AND SAY YES, NOT ONLY 4473 02:33:08,521 --> 02:33:09,923 BEING DARKER, CAN YOU DEVELOP 4474 02:33:09,923 --> 02:33:11,791 THIS BUT ALSO BEING YOUNGER, AS 4475 02:33:11,791 --> 02:33:13,727 I WAS 22 WHEN I WAS DIAGNOSED. 4476 02:33:13,727 --> 02:33:16,463 AND THEY HAVE CREATED OTHER 4477 02:33:16,463 --> 02:33:19,666 MOBILE CANCER SCREENING MOBILES, 4478 02:33:19,666 --> 02:33:22,469 IF YOU WILL, AND I THINK THAT'S 4479 02:33:22,469 --> 02:33:23,470 BEEN SOMETHING ELSE THAT REALLY 4480 02:33:23,470 --> 02:33:25,538 HAS BEEN A CONNECTION BECAUSE 4481 02:33:25,538 --> 02:33:26,706 FOLKS ARE SEEING THAT THIS 4482 02:33:26,706 --> 02:33:28,241 CANCER CENTER, THEY'RE SEEING 4483 02:33:28,241 --> 02:33:29,676 PRACTITIONERS AND SEEING AN 4484 02:33:29,676 --> 02:33:30,310 INVESTMENT IN THE COMMUNITY 4485 02:33:30,310 --> 02:33:31,544 BECAUSE WE'RE BRINGING 4486 02:33:31,544 --> 02:33:32,612 HEALTHCARE TO THEM INSTEAD OF 4487 02:33:32,612 --> 02:33:35,015 EXPECTING THEM TO COME OUT AS 4488 02:33:35,015 --> 02:33:36,016 WELL. 4489 02:33:36,016 --> 02:33:37,217 SO THOSE ARE JUST THREE THINGS 4490 02:33:37,217 --> 02:33:38,184 THAT I CAN -- 4491 02:33:38,184 --> 02:33:39,052 >> THAT'S REALLY GOOD. 4492 02:33:39,052 --> 02:33:40,487 THAT'S REALLY HELPFUL FOR ME AS 4493 02:33:40,487 --> 02:33:42,188 WELL AS I'M STARTING TO TALK TO 4494 02:33:42,188 --> 02:33:43,523 THE CANCER CENTERS AND HELP MAKE 4495 02:33:43,523 --> 02:33:47,227 SURE THAT THEY'RE SHARING BEST 4496 02:33:47,227 --> 02:33:49,229 PRACTICES. 4497 02:33:49,229 --> 02:33:51,064 SO I MAY PING MOFFITT TO BE ONE 4498 02:33:51,064 --> 02:33:51,898 OF THE ONES ON THE GROUP TO TALK 4499 02:33:51,898 --> 02:33:52,565 ABOUT THAT. 4500 02:33:52,565 --> 02:33:53,767 THAT'S AWESOME. 4501 02:33:53,767 --> 02:33:55,802 AND I'M ALWAYS A SUCKER FOR A 4502 02:33:55,802 --> 02:33:58,905 GOOD PUN, SO I REALLY LOVE MOLE 4503 02:33:58,905 --> 02:34:09,049 PATROL. 4504 02:34:09,482 --> 02:34:10,083 >> KRISTEN. 4505 02:34:10,083 --> 02:34:10,383 >> HI. 4506 02:34:10,383 --> 02:34:11,651 THANK YOU FOR THE OVERVIEW. 4507 02:34:11,651 --> 02:34:13,620 IT WAS INTERESTING AND I LEARNED 4508 02:34:13,620 --> 02:34:14,521 SOME AND TOOK NOTES SO I 4509 02:34:14,521 --> 02:34:15,155 APPRECIATE THAT. 4510 02:34:15,155 --> 02:34:17,624 I HAVE A FEW SOMEWHAT RAMBLING 4511 02:34:17,624 --> 02:34:19,726 THOUGHTS THAT JUST AS MY LAST 4512 02:34:19,726 --> 02:34:20,927 MEETING, THINGS THAT I AM 4513 02:34:20,927 --> 02:34:21,795 PERSONALLY PASSIONATE ABOUT THAT 4514 02:34:21,795 --> 02:34:24,397 I WOULD LOVE TO SEE MORE EFFORTS 4515 02:34:24,397 --> 02:34:26,499 AND RESOURCES PUT BEHIND. 4516 02:34:26,499 --> 02:34:28,568 SO STARTING WITH CATCHING PEOPLE 4517 02:34:28,568 --> 02:34:32,172 EARLY AND SCREENING AND EARLY 4518 02:34:32,172 --> 02:34:33,306 DETECTION, THAT'S HUGE. 4519 02:34:33,306 --> 02:34:35,709 AS CANCER SURVIVOR, I THINK 4520 02:34:35,709 --> 02:34:36,810 THERE'S TONS OF THINGS GOING ON 4521 02:34:36,810 --> 02:34:38,344 IN MY BODY THAT SOMEDAY I'LL 4522 02:34:38,344 --> 02:34:39,312 FIND OUT ABOUT. 4523 02:34:39,312 --> 02:34:40,580 IF I COULD FIND OUT EARLIER, 4524 02:34:40,580 --> 02:34:41,715 THAT WOULD BE COOL BUT AGAIN, AS 4525 02:34:41,715 --> 02:34:43,283 YOU MENTIONED, IF YOU CAN'T DO 4526 02:34:43,283 --> 02:34:44,551 ANYTHING ABOUT IT, THAT'S SCARY 4527 02:34:44,551 --> 02:34:49,923 AND FRUSTRATING. 4528 02:34:49,923 --> 02:34:51,991 AND UNDERSTANDING RISK FACTORS 4529 02:34:51,991 --> 02:34:53,393 AND THEN FIGURING OUT WHAT TO DO 4530 02:34:53,393 --> 02:34:54,761 ABOUT THEM IF THERE IS ANYTHING 4531 02:34:54,761 --> 02:34:57,530 THAT CAN BE DONE TO PREVENT MORE 4532 02:34:57,530 --> 02:34:59,699 CANCERS. 4533 02:34:59,699 --> 02:35:01,801 LIKE JACKIE, I JUST HAD TWO MEL 4534 02:35:01,801 --> 02:35:11,945 MONA TWOMELANOMA CHUNKS REMOVEDY 4535 02:35:11,945 --> 02:35:13,580 HEAD I GO KIDNEY CANCER 4536 02:35:13,580 --> 02:35:14,347 MELANOMA, WHAT ELSE IS GOING TO 4537 02:35:14,347 --> 02:35:14,581 HAPPEN. 4538 02:35:14,581 --> 02:35:16,750 I HAVE A LITTLE GROWTH ON MY 4539 02:35:16,750 --> 02:35:19,018 THYROID, THAT'S OF UNKNOWN 4540 02:35:19,018 --> 02:35:20,019 SIGNIFICANCE, SO, GREAT, WHAT'S 4541 02:35:20,019 --> 02:35:24,257 GOING ON, WHAT CAN WE DO AROUND 4542 02:35:24,257 --> 02:35:25,058 SCREENING/PREVENTION. 4543 02:35:25,058 --> 02:35:26,326 I'M PART OF THE ALL-OF-US 4544 02:35:26,326 --> 02:35:27,093 RESEARCH PROGRAM. 4545 02:35:27,093 --> 02:35:28,294 I'M PERSONALLY REALLY JAZZED 4546 02:35:28,294 --> 02:35:29,295 ABOUT THAT. 4547 02:35:29,295 --> 02:35:31,364 GETTING PEOPLE TO SHARE THEIR 4548 02:35:31,364 --> 02:35:33,199 INFORMATION SO THAT WE CAN 4549 02:35:33,199 --> 02:35:34,834 UNDERSTAND MORE SO THE POWER OF 4550 02:35:34,834 --> 02:35:36,603 DATA AND WHAT CAN THE NCI DO TO 4551 02:35:36,603 --> 02:35:40,106 KIND OF PROMOTE THAT. 4552 02:35:40,106 --> 02:35:41,441 WHEN I REGISTERED, I DID THE 4553 02:35:41,441 --> 02:35:42,842 SALIVA TEST, THERE WAS NOWHERE 4554 02:35:42,842 --> 02:35:44,144 WITHIN 50 MILES OF D.C. TO DO 4555 02:35:44,144 --> 02:35:45,145 THE BLOOD WORK. 4556 02:35:45,145 --> 02:35:48,615 THAT SEEMED WILD TO ME. 4557 02:35:48,615 --> 02:35:51,217 I REACHED OUT TO VINCE AND I 4558 02:35:51,217 --> 02:35:52,886 THINK AMY ABOUT IT, AND VINCENT 4559 02:35:52,886 --> 02:35:53,953 SENT ME ALL THE INFORMATION FOR 4560 02:35:53,953 --> 02:35:56,956 PEOPLE TO CON T CONTACT THROUGHE 4561 02:35:56,956 --> 02:35:57,490 ALL-OF-US PROGRAM WHICH I 4562 02:35:57,490 --> 02:35:59,425 HAVEN'T DONE YET, BUT THAT'S 4563 02:35:59,425 --> 02:36:01,928 JUST WILD, IN D.C. , LIKE I 4564 02:36:01,928 --> 02:36:02,996 CAN'T GO SOMEWHERE? 4565 02:36:02,996 --> 02:36:06,933 SO FORMING PARTNERSHIPS TO MAKE 4566 02:36:06,933 --> 02:36:09,469 THAT A MORE IMPACTFUL PROGRAM. 4567 02:36:09,469 --> 02:36:11,271 I'M LIKE JAZZED ABOUT IT, SO IT 4568 02:36:11,271 --> 02:36:13,306 COULD JUST BE ME BUT I FEEL LIKE 4569 02:36:13,306 --> 02:36:14,407 THERE'S A LOT OF VALUE TO THAT. 4570 02:36:14,407 --> 02:36:15,508 BUT THEN WHAT I REALLY THINK 4571 02:36:15,508 --> 02:36:19,412 COULD BE HELPFUL FOR PATIENTS IS 4572 02:36:19,412 --> 02:36:21,181 LOOKING AT -- OR HAVING MORE 4573 02:36:21,181 --> 02:36:22,148 RESEARCH AROUND PALLIATIVE CARE. 4574 02:36:22,148 --> 02:36:23,550 WE KNOW IT WORKS, WE KNOW IT 4575 02:36:23,550 --> 02:36:24,951 WORKS WELL. 4576 02:36:24,951 --> 02:36:27,387 YOU MENTIONED THAT THE 4577 02:36:27,387 --> 02:36:29,255 360 APPROACH FOR NCI BUT 4578 02:36:29,255 --> 02:36:30,757 PALLIATIVE CARE REALLY IS 360, 4579 02:36:30,757 --> 02:36:32,725 SO LOOKING AT THE WHOLE PERSON, 4580 02:36:32,725 --> 02:36:34,594 WHAT'S GOING ON WITH THEM, THEIR 4581 02:36:34,594 --> 02:36:37,096 FAMILY, HOW CAN WE DO MORE OF 4582 02:36:37,096 --> 02:36:39,299 WHAT'S GOOD, STOP DOING WHAT'S 4583 02:36:39,299 --> 02:36:41,367 BAD, FOR INDIVIDUALS. 4584 02:36:41,367 --> 02:36:45,238 BUT WE NEED MORE DATA TO HAVE 4585 02:36:45,238 --> 02:36:46,472 PEOPLE PUT RESOURCES BEHIND 4586 02:36:46,472 --> 02:36:47,707 PALLIATIVE CARE, SO I'M EXCITED 4587 02:36:47,707 --> 02:36:48,141 ABOUT THAT. 4588 02:36:48,141 --> 02:36:50,076 AND THE LAST ONE IS BIOMARKER 4589 02:36:50,076 --> 02:36:51,711 TESTING COMING FROM ONE CANCER 4590 02:36:51,711 --> 02:36:56,749 AND OTHER CANCERS, HEY, LIKE, AT 4591 02:36:56,749 --> 02:36:58,952 SOME POINT HOPEFULLY WILL FLAG 4592 02:36:58,952 --> 02:37:01,020 SOMETHING BUT WE DON'T KNOW THAT 4593 02:37:01,020 --> 02:37:02,388 NOW, BUT I KNOW WE'RE MOVING IN 4594 02:37:02,388 --> 02:37:03,089 THE RIGHT DIRECTION, BUT 4595 02:37:03,089 --> 02:37:05,592 WHATEVER WE CAN DO AROUND THAT 4596 02:37:05,592 --> 02:37:07,460 AND PRECISION MEDICINE, 4597 02:37:07,460 --> 02:37:07,994 PERSONALIZED MEDICINE. 4598 02:37:07,994 --> 02:37:10,296 SO IT WAS A LOT RAMBLING, I 4599 02:37:10,296 --> 02:37:10,563 APOLOGIZE. 4600 02:37:10,563 --> 02:37:13,433 >> I GOT THEM DOWN. 4601 02:37:13,433 --> 02:37:14,767 AWESOME. 4602 02:37:14,767 --> 02:37:17,503 THOSE ARE ALL THINGS, AND GIVES 4603 02:37:17,503 --> 02:37:19,105 ME IDEAS FOR THINGS TO BRING 4604 02:37:19,105 --> 02:37:21,975 HERE FOR YOU GUYS TO HEAR ABOUT 4605 02:37:21,975 --> 02:37:23,610 UPDATES ON AND BE ABLE TO TALK 4606 02:37:23,610 --> 02:37:27,013 TO THE PEOPLE WHO ARE LEADING 4607 02:37:27,013 --> 02:37:28,848 THINGS IN THE DETECTION AND 4608 02:37:28,848 --> 02:37:30,350 BIOMARKER AND PALLIATIVE CARE 4609 02:37:30,350 --> 02:37:31,818 RESEARCH ARENA. 4610 02:37:31,818 --> 02:37:33,786 AND MAYBE TO GET ALL-OF-US TO 4611 02:37:33,786 --> 02:37:35,421 COME UP HERE AND TALK TO YOU 4612 02:37:35,421 --> 02:37:40,460 ALL. 4613 02:37:40,460 --> 02:37:41,327 >> AND LEE? 4614 02:37:41,327 --> 02:37:42,528 >> THANKS. 4615 02:37:42,528 --> 02:37:44,597 SO I SERVE ON A COUPLE OF 4616 02:37:44,597 --> 02:37:47,100 IRBs, AND ONE OF THE THINGS 4617 02:37:47,100 --> 02:37:49,202 THAT I'VE REALLY COME TO MY 4618 02:37:49,202 --> 02:37:53,373 FOCUS IS THAT THE WHOLE CLINICAL 4619 02:37:53,373 --> 02:37:57,043 TRIAL PROCESS WAS DEVELOPED IN 4620 02:37:57,043 --> 02:38:00,680 THE CHEMOTHERAPY YEARS. 4621 02:38:00,680 --> 02:38:01,814 SO THE FACT THAT WE HAVE THE 4622 02:38:01,814 --> 02:38:03,583 THREE PHASES, THE FACT THAT YOU 4623 02:38:03,583 --> 02:38:05,685 HAVE MAXIMUM TOLERATED DOSE IN 4624 02:38:05,685 --> 02:38:07,954 PHASE ONE, I STILL SEE MAXIMUM 4625 02:38:07,954 --> 02:38:09,722 TOLERATED DOSE IN IMMUNOTHERAPY 4626 02:38:09,722 --> 02:38:10,390 AND TARGETED THERAPY TRIALS 4627 02:38:10,390 --> 02:38:13,559 WHICH DRIVES ME CRAZY TO SEE 4628 02:38:13,559 --> 02:38:15,762 THAT, BUT IT SEEMS LIKE WE HAVE 4629 02:38:15,762 --> 02:38:18,598 TO RECONSIDER THE CLINICAL TRIAL 4630 02:38:18,598 --> 02:38:20,900 PROCESS AND MAYBE HAVE A 4631 02:38:20,900 --> 02:38:22,268 SEPARATE ONE FOR IMMUNOTHERAPY, 4632 02:38:22,268 --> 02:38:24,137 FOR TARGETED THERAPIES, AND FOR 4633 02:38:24,137 --> 02:38:24,938 CHEMOTHERAPY, BECAUSE YOU KNOW 4634 02:38:24,938 --> 02:38:26,105 WITH CHEMOTHERAPY, THE MORE YOU 4635 02:38:26,105 --> 02:38:28,408 GIVE THE PATIENT UP TO THEIR 4636 02:38:28,408 --> 02:38:29,409 TOLERABLE LEVEL, THE BETTER IT 4637 02:38:29,409 --> 02:38:30,143 WILL WORK. 4638 02:38:30,143 --> 02:38:31,678 THAT'S NOT TRUE FOR 4639 02:38:31,678 --> 02:38:32,445 IMMUNOTHERAPY OR TARGETED 4640 02:38:32,445 --> 02:38:35,014 THERAPIES. 4641 02:38:35,014 --> 02:38:36,349 SO -- AND IN FACT WE SEE A LOT 4642 02:38:36,349 --> 02:38:39,519 OF ACCELERATED APPROVALS FOR 4643 02:38:39,519 --> 02:38:45,558 IMMUNOTHERAPY. 4644 02:38:45,558 --> 02:38:47,226 -- DON'T THINK NECESSARILY TSH 4645 02:38:47,226 --> 02:38:48,795 YOU CAN FIND SOME ACTION AGAINST 4646 02:38:48,795 --> 02:38:49,829 THE CANCER CELLS QUITE EARLY ON 4647 02:38:49,829 --> 02:38:51,097 IN THE PROCESS. 4648 02:38:51,097 --> 02:38:54,801 SO SEEMS LIKE WE MAYBE NEED TO 4649 02:38:54,801 --> 02:38:55,802 CONSIDER, REINVENT THE WHOLE 4650 02:38:55,802 --> 02:38:57,337 CLINICAL TRIAL PROCESS BASED ON 4651 02:38:57,337 --> 02:38:58,638 WHAT DRUGS YOU'RE ACTUALLY 4652 02:38:58,638 --> 02:39:03,643 TESTING. 4653 02:39:03,643 --> 02:39:05,611 AND ALSO THE FACT THAT MOST OF 4654 02:39:05,611 --> 02:39:06,612 THE CLINICIANS AND SCIENTISTS 4655 02:39:06,612 --> 02:39:10,516 THAT I WORK WITH WITH THE IRBs 4656 02:39:10,516 --> 02:39:11,150 STILL CONSIDER CLINICAL TRIALS 4657 02:39:11,150 --> 02:39:16,522 TO BE ALL SCIENCE, AND THEY'LL Y 4658 02:39:16,522 --> 02:39:17,790 DON'T CONSIDER THE PATIENT 4659 02:39:17,790 --> 02:39:18,091 PERSPECTIVE. 4660 02:39:18,091 --> 02:39:18,925 PATIENTS CONSIDER TO BE 4661 02:39:18,925 --> 02:39:19,993 TREATMENT, SOMETIMES THE BEST 4662 02:39:19,993 --> 02:39:21,394 TREATMENT, MAYBE THE LAST 4663 02:39:21,394 --> 02:39:23,162 POSSIBLE TREATMENT. 4664 02:39:23,162 --> 02:39:25,131 SO THEY'RE NOT REALLY SUBJECTS, 4665 02:39:25,131 --> 02:39:26,899 THEY'RE -- I ALWAYS CALL THEM 4666 02:39:26,899 --> 02:39:27,533 PARTICIPANTS. 4667 02:39:27,533 --> 02:39:29,602 SOME CALL THEM -- BUT MAYBE WE 4668 02:39:29,602 --> 02:39:30,837 HAVE TO CHANGE THE LANGUAGE SO 4669 02:39:30,837 --> 02:39:32,238 THAT WE'RE NOT REFERRING TO US 4670 02:39:32,238 --> 02:39:34,173 LIKE LAB ANIMALS, WE'RE 4671 02:39:34,173 --> 02:39:35,241 PARTICIPANTS. 4672 02:39:35,241 --> 02:39:39,545 WE'RE PARTICIPATING IN SCIENCE. 4673 02:39:39,545 --> 02:39:41,614 >> EXCELLENT. 4674 02:39:41,614 --> 02:39:42,682 >> THANKS, LEE. 4675 02:39:42,682 --> 02:39:45,651 AND I WANT TO PIGGY BACK ON THE 4676 02:39:45,651 --> 02:39:48,154 IRB PERSPECTIVE, IS THAT AS LONG 4677 02:39:48,154 --> 02:39:52,525 AS OUR HUMAN SUBJECTS PROTECTION 4678 02:39:52,525 --> 02:39:54,727 LANGUAGE INCLUDES THE WORD 4679 02:39:54,727 --> 02:39:57,630 SUBJECT, IT'S GOING TO SEEP INTO 4680 02:39:57,630 --> 02:40:00,933 PATIENT-FACING SPACES. 4681 02:40:00,933 --> 02:40:02,135 AND I KNOW THAT WOULD TAKE 4682 02:40:02,135 --> 02:40:03,870 DECADES TO UPDATE TO MORE 4683 02:40:03,870 --> 02:40:05,972 PATIENT CENTRIC LANGUAGE, BUT I 4684 02:40:05,972 --> 02:40:06,706 COMPLETELY AGREE WITH YOU ON 4685 02:40:06,706 --> 02:40:07,940 THAT LANGUAGE. 4686 02:40:07,940 --> 02:40:09,342 THANK YOU, LEE. 4687 02:40:09,342 --> 02:40:10,343 VICKIE, YOU HAVE SOMETHING TO 4688 02:40:10,343 --> 02:40:12,111 ADD? 4689 02:40:12,111 --> 02:40:13,613 >> WELL, IT'S REALLY A QUESTION 4690 02:40:13,613 --> 02:40:15,681 I THINK FOR THE GROUP RATHER 4691 02:40:15,681 --> 02:40:16,783 THAN DR. RATHMELL, ALTHOUGH I 4692 02:40:16,783 --> 02:40:21,287 APPRECIATE THE PRESENTATION. 4693 02:40:21,287 --> 02:40:23,356 AS Y'ALL KNOW, I REPRESENT 4694 02:40:23,356 --> 02:40:27,493 CHILDREN WITH CANCER, AND SO THE 4695 02:40:27,493 --> 02:40:28,928 THING ABOUT CHILDREN WITH CANCER 4696 02:40:28,928 --> 02:40:30,663 IS THAT IT'S RARE AND I KNOW 4697 02:40:30,663 --> 02:40:33,599 SEVERAL OF YOU ARE ALSO IN 4698 02:40:33,599 --> 02:40:36,669 SUBTYPES THAT ARE PRETTY RARE, 4699 02:40:36,669 --> 02:40:40,006 WE DON'T HAVE A TON OF INDUSTRY 4700 02:40:40,006 --> 02:40:41,474 CLINICAL TRIALS GOING ON, AND SO 4701 02:40:41,474 --> 02:40:44,744 WE'RE REALLY, REALLY KIND OF 4702 02:40:44,744 --> 02:40:50,283 PLOWING TOWARDS MULTI-CONTINENT, 4703 02:40:50,283 --> 02:40:50,983 MULTI-INSTITUTION TRIALS AND I 4704 02:40:50,983 --> 02:40:52,285 JUST WONDERED, IS THAT THE SAME 4705 02:40:52,285 --> 02:40:53,820 THING HAPPENING IN THE SPACES 4706 02:40:53,820 --> 02:40:57,090 THAT Y'ALL ARE IN, BECAUSE IT 4707 02:40:57,090 --> 02:41:01,260 SEEMS LIKE REALLY THE ONLY WAY 4708 02:41:01,260 --> 02:41:02,795 TO HUSBAND THE RESOURCES WE HAVE 4709 02:41:02,795 --> 02:41:06,933 IS TO EXPAND WHERE WE ENROLL 4710 02:41:06,933 --> 02:41:08,701 KIDS, WHETHER IT'S IN AUSTRALIA 4711 02:41:08,701 --> 02:41:11,637 OR CANADA OR GERMANY OR 4712 02:41:11,637 --> 02:41:14,707 WHATEVER, AS PART OF PLATFORM 4713 02:41:14,707 --> 02:41:16,476 TRIALS OR WHATNOT. 4714 02:41:16,476 --> 02:41:18,010 I'M JUST CURIOUS WHERE YOU GUYS 4715 02:41:18,010 --> 02:41:19,979 ARE IN THE ADULT SPACES. 4716 02:41:19,979 --> 02:41:22,248 >> VICKIE, IF I CAN ADDRESS 4717 02:41:22,248 --> 02:41:23,316 THAT, I AM JUST SO JEALOUS OF 4718 02:41:23,316 --> 02:41:25,751 THE CHILDHOOD CANCER RESEARCH 4719 02:41:25,751 --> 02:41:27,186 COMMUNITY BECAUSE THEY'VE BEEN 4720 02:41:27,186 --> 02:41:30,256 COLLABORATING AND WORKING 4721 02:41:30,256 --> 02:41:31,491 TOGETHER FOR A REALLY LONG TIME 4722 02:41:31,491 --> 02:41:33,192 AND ARE REALLY THE MODEL OF HOW 4723 02:41:33,192 --> 02:41:34,293 THINGS SHOULD BE DONE. 4724 02:41:34,293 --> 02:41:37,430 BUT I THINK IN CERTAIN CANCER 4725 02:41:37,430 --> 02:41:38,664 SPACES, AND I'M TALKING ABOUT 4726 02:41:38,664 --> 02:41:39,665 THE OVARIAN SIDE BECAUSE THAT'S 4727 02:41:39,665 --> 02:41:42,735 WHERE I'M MORE FAMILIAR, IT'S 4728 02:41:42,735 --> 02:41:45,438 GOTTEN TO THAT EVEN -- THE 4729 02:41:45,438 --> 02:41:46,873 SUBTYPES OF EACH ONE, WE'RE 4730 02:41:46,873 --> 02:41:49,942 GETTING MOLECULARLY BASED AND 4731 02:41:49,942 --> 02:41:52,011 PRETTY SOON THESE TRIALS ARE 4732 02:41:52,011 --> 02:41:53,012 GETTING SMALLER AND SMALLER AND 4733 02:41:53,012 --> 02:41:57,049 MORE TARGETED AND MORE FOCUS ON 4734 02:41:57,049 --> 02:41:58,684 EVEN WITHIN RARE SUBTYPES, YOU 4735 02:41:58,684 --> 02:42:01,754 KNOW, AND LIKE I THINK IN COLON 4736 02:42:01,754 --> 02:42:04,690 CANCER, IT'S -- THERE'S JUST A 4737 02:42:04,690 --> 02:42:06,225 LOT OF MOVING PIECES, AND THE 4738 02:42:06,225 --> 02:42:08,628 DRUGS THAT ARE BEING DEVELOPED 4739 02:42:08,628 --> 02:42:10,163 ARE FOR, LIKE, CANCER OF THE 4740 02:42:10,163 --> 02:42:12,031 RIGHT EYEBALL FOR PEOPLE WITH 4741 02:42:12,031 --> 02:42:12,999 HAZEL EYES. 4742 02:42:12,999 --> 02:42:15,735 AND I THINK THOSE TYPES OF 4743 02:42:15,735 --> 02:42:16,836 TRIALS ESPECIALLY, YOU KNOW, 4744 02:42:16,836 --> 02:42:18,371 WHEN THEY'RE TRYING TO -- YOU 4745 02:42:18,371 --> 02:42:20,339 KNOW, THE REGISTRATION TRIALS 4746 02:42:20,339 --> 02:42:21,574 AND THEY'RE TRYING TO GET 4747 02:42:21,574 --> 02:42:23,242 APPROVAL, IT'S GOING TO TAKE 4748 02:42:23,242 --> 02:42:25,811 GLOBAL EFFORTS AND COOPERATION 4749 02:42:25,811 --> 02:42:28,414 TO GET THINGS DONE. 4750 02:42:28,414 --> 02:42:31,851 I DON'T KNOW -- I'LL ASK OUR 4751 02:42:31,851 --> 02:42:33,352 COLLEAGUES IN THEIR CANCER 4752 02:42:33,352 --> 02:42:34,887 TYPES, HOW MANY TRIALS THEY'RE 4753 02:42:34,887 --> 02:42:36,289 SEEING FOR ALL-COMERS THESE 4754 02:42:36,289 --> 02:42:38,090 DAYS. 4755 02:42:38,090 --> 02:42:40,726 YOU KNOW, AND THE OTHER THING 4756 02:42:40,726 --> 02:42:43,696 TOO IS, I'M REALLY GLAD TO HEAR 4757 02:42:43,696 --> 02:42:46,199 THAT THERE'S THE MATCH 4758 02:42:46,199 --> 02:42:48,000 SUCCESSION HAPPENING BECAUSE WE 4759 02:42:48,000 --> 02:42:51,003 LIKE THE PLATFORM TRIALS. 4760 02:42:51,003 --> 02:42:52,538 ESPECIALLY WHEN YOU CAN PLUG IN 4761 02:42:52,538 --> 02:42:55,074 ARMS AND THINGS LIKE THAT, AND 4762 02:42:55,074 --> 02:42:59,979 USE THAT SAME LEVERAGE, YOUR 4763 02:42:59,979 --> 02:43:00,546 ADMINISTRATIVE AND THE CORE 4764 02:43:00,546 --> 02:43:01,180 THINGS THAT ARE HAPPENING AND 4765 02:43:01,180 --> 02:43:03,015 NOT HAVE TO REINVENT AND REWRITE 4766 02:43:03,015 --> 02:43:04,450 THE PROTOCOL AND GO THROUGH THE 4767 02:43:04,450 --> 02:43:07,086 PAIN OF APPROVALS. 4768 02:43:07,086 --> 02:43:09,155 SO THERE'S A LOT OF THINGS IN 4769 02:43:09,155 --> 02:43:10,256 THAT WAY. 4770 02:43:10,256 --> 02:43:12,225 BUT I'LL STOP THERE SO OTHERS 4771 02:43:12,225 --> 02:43:21,867 CAN ADDRESS VICKIE'S QUESTION. 4772 02:43:21,867 --> 02:43:23,703 >> I'LL JUMP IN THOUGH I'M NOT 4773 02:43:23,703 --> 02:43:25,037 SURE I CAN SAY IT BETTER. 4774 02:43:25,037 --> 02:43:26,472 I THINK WHAT YOU SAID IS EXACTLY 4775 02:43:26,472 --> 02:43:27,607 RIGHT, IN FACT THE PEDIATRIC 4776 02:43:27,607 --> 02:43:30,309 GROUPS HAVE REALLY LED THE WAY 4777 02:43:30,309 --> 02:43:35,214 IN HOW TO DO THIS VERY WELL. 4778 02:43:35,214 --> 02:43:37,183 STILL WITH ROOM FOR IMPROVEMENT. 4779 02:43:37,183 --> 02:43:41,621 I MET WITH THE EORTC LEADERSHIP 4780 02:43:41,621 --> 02:43:43,856 WHEN I WAS AT ASCO, SUDDENLY 4781 02:43:43,856 --> 02:43:45,057 BLANKING ON HOW THAT ACRONYM 4782 02:43:45,057 --> 02:43:48,127 WORKS BUT IT'S THE EUROPEAN 4783 02:43:48,127 --> 02:43:49,262 ONCOLOGY SOMETHING, 4784 02:43:49,262 --> 02:43:52,198 TRANSLATIONAL RESEARCH. 4785 02:43:52,198 --> 02:43:54,267 AND THEY -- WHAT THEY WANTED TO 4786 02:43:54,267 --> 02:43:55,735 TALK ABOUT WAS RARE TUMOR TYPES 4787 02:43:55,735 --> 02:43:59,005 AND HOW DO WE POOL OUR 4788 02:43:59,005 --> 02:44:00,006 RESOURCES, BECAUSE SOME OF THESE 4789 02:44:00,006 --> 02:44:03,676 DISEASES ARE SO UNCOMMON THAT IN 4790 02:44:03,676 --> 02:44:05,378 ORDER TO MAKE REAL HEADWAY, WE 4791 02:44:05,378 --> 02:44:09,849 HAVE TO BE PARTNERS ACROSS THAT 4792 02:44:09,849 --> 02:44:10,616 LARGE A SPACE. 4793 02:44:10,616 --> 02:44:12,918 I THINK THERE ARE MANY DIFFERENT 4794 02:44:12,918 --> 02:44:15,755 WAYS TO SPLIT CANCERS. 4795 02:44:15,755 --> 02:44:18,924 I LOVE IT WHEN WE CAN BRING 4796 02:44:18,924 --> 02:44:20,259 THOSE BACK TOGETHER WITH THINGS 4797 02:44:20,259 --> 02:44:21,761 LIKE IF A COMMON MUTATION CAUSES 4798 02:44:21,761 --> 02:44:24,597 A COMMON RESPONSE TO A DRUG, WE 4799 02:44:24,597 --> 02:44:26,565 KNOW THAT THAT'S NOT ALWAYS 4800 02:44:26,565 --> 02:44:28,968 TRUE, BUT THERE ARE CASES WHERE 4801 02:44:28,968 --> 02:44:31,604 THAT'S WHERE WE CAN BRING THEM 4802 02:44:31,604 --> 02:44:32,705 BACK TOGETHER, AND THERE ARE 4803 02:44:32,705 --> 02:44:39,011 CASES WHERE WE CAN WIDDLE DOWN 4804 02:44:39,011 --> 02:44:40,579 TO A RARE TYPE OR RARE SUBTYPE 4805 02:44:40,579 --> 02:44:42,648 AND THEN BE ABLE TO MAKE THAT 4806 02:44:42,648 --> 02:44:45,584 HEADWAY, BECAUSE NOW WE KNOW, 4807 02:44:45,584 --> 02:44:46,686 A-HA, THE DRIVER, AND TO PROVE 4808 02:44:46,686 --> 02:44:48,454 THAT, WE HAVE TO BRING ALL THESE 4809 02:44:48,454 --> 02:44:49,121 PEOPLE TOGETHER. 4810 02:44:49,121 --> 02:44:50,389 SO I THINK A LOT OF WHAT WILL 4811 02:44:50,389 --> 02:44:53,693 WE'RE DOING IS LEANING ON THE 4812 02:44:53,693 --> 02:44:54,593 PEDIATRIC EXPERIENCE AND TRYING 4813 02:44:54,593 --> 02:44:56,662 TO DO THAT IN THE ADULT SPACE AS 4814 02:44:56,662 --> 02:45:02,401 WELL. 4815 02:45:02,401 --> 02:45:03,669 >> LEE, DID YOU HAVE SOMETHING 4816 02:45:03,669 --> 02:45:04,337 TO ADD? 4817 02:45:04,337 --> 02:45:08,074 >> I BELIEVE THE FDA ALLOWS 4818 02:45:08,074 --> 02:45:10,843 PEOPLE AS YOUNG AT AS AGE 12 TO 4819 02:45:10,843 --> 02:45:12,011 PARTICIPATE IN ADULT CLINICAL 4820 02:45:12,011 --> 02:45:13,679 TRIALS BUT I'M ON THE EARLY 4821 02:45:13,679 --> 02:45:16,549 PHASE NCI IRB, AND I VERY SELDOM 4822 02:45:16,549 --> 02:45:18,551 SEE ANYONE UNDER THE AGE OF 18 4823 02:45:18,551 --> 02:45:23,189 ALLOWED TO PARTICIPATE. 4824 02:45:23,189 --> 02:45:24,690 SO MAYBE WE HAVE AN OPPORTUNITY 4825 02:45:24,690 --> 02:45:25,591 THERE TO AT LEAST LOWER THAT AGE 4826 02:45:25,591 --> 02:45:27,259 SO THAT PEOPLE BETWEEN 12 AND 18 4827 02:45:27,259 --> 02:45:29,729 MIGHT BE ABLE TO AT LEAST GET 4828 02:45:29,729 --> 02:45:31,330 INVOLVED IN THESE CLINICAL 4829 02:45:31,330 --> 02:45:31,564 STUDIES. 4830 02:45:31,564 --> 02:45:33,899 IT WOULD BE HELPFUL FOR THEM. 4831 02:45:33,899 --> 02:45:39,171 >> THAT'S A CONVERSATION THAT 4832 02:45:39,171 --> 02:45:40,473 EMA HAS ALREADY MADE THAT PART 4833 02:45:40,473 --> 02:45:44,076 OF THE EUROPEAN -- IT WAS 4834 02:45:44,076 --> 02:45:45,511 THROUGH -- TRIALS AND IT'S BASED 4835 02:45:45,511 --> 02:45:49,281 ON BODY MASS AND I THINK THAT 4836 02:45:49,281 --> 02:45:50,916 FDA HAS A GUIDANCE ABOUT IT BUT 4837 02:45:50,916 --> 02:45:56,622 IT HASN'T BEEN A SPECIFIC CHANGE 4838 02:45:56,622 --> 02:45:58,157 IN MANDATING, SO I THINK IT'S 4839 02:45:58,157 --> 02:46:00,826 ALLOWED BUT NOT NECESSARILY 4840 02:46:00,826 --> 02:46:05,464 REQUIRED THAT ADOLESCENTS -- 4841 02:46:05,464 --> 02:46:08,300 THAT THE BMI STANDARDS SHOULD BE 4842 02:46:08,300 --> 02:46:08,567 ENROLLED. 4843 02:46:08,567 --> 02:46:10,302 >> THESE ARE NCI-FUNDED STUDIES, 4844 02:46:10,302 --> 02:46:14,140 SO I PRESUME NCI COULD MAKE A 4845 02:46:14,140 --> 02:46:15,641 DIFFERENCE THERE, IF THAT MADE 4846 02:46:15,641 --> 02:46:17,743 SENSE, AND WHERE IT MAKES SENSE. 4847 02:46:17,743 --> 02:46:21,414 >> LEE, AND WHAT I'M SEEING AT 4848 02:46:21,414 --> 02:46:24,750 MY INSTITUTION IS THAT THE IRB 4849 02:46:24,750 --> 02:46:26,385 ALLOWS PEOPLE UNDER 18 UNDER 4850 02:46:26,385 --> 02:46:28,154 CERTAIN CONDITIONS AFTER THE 4851 02:46:28,154 --> 02:46:31,223 FIRST FEW ADULTS WHO ARE 4852 02:46:31,223 --> 02:46:34,393 ENROLLED AND THERE WERE NO 4853 02:46:34,393 --> 02:46:35,494 SAFETY SIGNALS, SO THERE'S JUST 4854 02:46:35,494 --> 02:46:37,263 A WAITING PERIOD BEFORE THEY 4855 02:46:37,263 --> 02:46:38,998 ALLOW THE PEOPLE UNDER 18 TO 4856 02:46:38,998 --> 02:46:40,199 PARTICIPATE. 4857 02:46:40,199 --> 02:46:43,068 >> I SEE IN THE ONES THAT -- I 4858 02:46:43,068 --> 02:46:46,672 REVIEW THEM, THEY'RE ALMOST ALL 4859 02:46:46,672 --> 02:46:51,143 EXCLUDED, UNDER 18 EXCLUDED, 4860 02:46:51,143 --> 02:46:54,079 PRISONERS EXCLUDED, PREGNANT 4861 02:46:54,079 --> 02:46:57,416 WOMEN EXCLUDED, MOST OF THOSE 4862 02:46:57,416 --> 02:46:59,485 MAKE SENSE, BUT FOR PEOPLE 4863 02:46:59,485 --> 02:47:01,387 BETWEEN 12 AND 18 IF POSSIBLE -- 4864 02:47:01,387 --> 02:47:03,756 >> I THINK THE IRBs HAVE TO 4865 02:47:03,756 --> 02:47:06,592 BALL ABC THE PROTECTIONS 4866 02:47:06,592 --> 02:47:09,094 UNDER -- THERE'S CRITERIA THAT'S 4867 02:47:09,094 --> 02:47:11,063 EMBEDDED IN THE NEW WAY OF 4868 02:47:11,063 --> 02:47:12,164 THINKING AND HOW TO BALANCE ALL 4869 02:47:12,164 --> 02:47:12,698 THAT. 4870 02:47:12,698 --> 02:47:15,367 AND I THINK, YOU KNOW, A LOT OF 4871 02:47:15,367 --> 02:47:17,102 PEOPLE ARE JUST TRYING TO STAY 4872 02:47:17,102 --> 02:47:17,770 OUT OF TROUBLE. 4873 02:47:17,770 --> 02:47:22,575 BULL I COMPLETELYBUT I COMPLETEU 4874 02:47:22,575 --> 02:47:24,210 THAT THERE ARE WAYS TO MAKE IT 4875 02:47:24,210 --> 02:47:24,977 HAPPEN AND MAYBE THAT'S A 4876 02:47:24,977 --> 02:47:27,513 SUGGESTION TO ADD, IS OH MAYBE 4877 02:47:27,513 --> 02:47:28,414 DB AS LONG AS THERE ARE NO 4878 02:47:28,414 --> 02:47:31,550 SAFETY SIGNALS IN THE FIRST FIVE 4879 02:47:31,550 --> 02:47:32,318 PARTICIPANTS OR WHATEVER THE 4880 02:47:32,318 --> 02:47:36,589 NUMBER IS, THEN TO OPEN UP TO 4881 02:47:36,589 --> 02:47:38,023 PEDIATRICS MAY BE A STRATEGY TO 4882 02:47:38,023 --> 02:47:38,290 CONSIDER. 4883 02:47:38,290 --> 02:47:42,828 >> RIGHT, AND YOU HAVE TO HAVE 4884 02:47:42,828 --> 02:47:43,496 GUARDIAN CONSENT, WHAT IF THE 4885 02:47:43,496 --> 02:47:44,797 PARENTS ARE DIVORCED, WHO DO YOU 4886 02:47:44,797 --> 02:47:46,465 GET TO CONSENT? 4887 02:47:46,465 --> 02:47:48,868 IT MAKES IT MUCH MORE 4888 02:47:48,868 --> 02:47:51,170 COMPLICATED, BUT IF IT WOULD BE 4889 02:47:51,170 --> 02:47:53,172 HELPFUL FOR PEOPLE 12 TO 18, WE 4890 02:47:53,172 --> 02:47:54,607 SHOULD CONSIDER HOW TO MAKE IT 4891 02:47:54,607 --> 02:47:56,475 WORK BETTER FOR THEM. 4892 02:47:56,475 --> 02:48:02,147 >> YEAH. 4893 02:48:02,147 --> 02:48:03,449 I'M HAPPY TO LOOK INTO WHERE 4894 02:48:03,449 --> 02:48:04,817 THERE MIGHT BE OPTIONS FOR 4895 02:48:04,817 --> 02:48:06,752 THINGS THAT OFFER SOME LEVEL OF 4896 02:48:06,752 --> 02:48:10,689 FLEXIBILITY SOMETIMES. 4897 02:48:10,689 --> 02:48:11,557 THAT'S A GREAT COMMENT. 4898 02:48:11,557 --> 02:48:13,526 ONE OF THE DISCUSSION POINTS 4899 02:48:13,526 --> 02:48:18,464 TODAY WAS ALSO ABOUT HOW WE 4900 02:48:18,464 --> 02:48:21,734 MANAGE LEVELS OF RISK TOLERANCE, 4901 02:48:21,734 --> 02:48:24,036 AND PARTICULARLY FOR A BOARD 4902 02:48:24,036 --> 02:48:29,208 THAT'S COMPOSED OF ADVOCATES IS 4903 02:48:29,208 --> 02:48:31,143 HOW DO WE DECIDE WHAT IS AN 4904 02:48:31,143 --> 02:48:34,313 ACCEPTABLE LEVEL OF RISK. 4905 02:48:34,313 --> 02:48:39,351 AND THERE MAY BE CIRCUMSTANCES 4906 02:48:39,351 --> 02:48:45,925 WHERE THE RISK MAY BE WARRANTED. 4907 02:48:45,925 --> 02:48:47,560 >> WELL, THANK YOU SO MUCH, 4908 02:48:47,560 --> 02:48:47,893 DR. RATHMELL. 4909 02:48:47,893 --> 02:48:49,128 WE REALLY APPRECIATE THE 4910 02:48:49,128 --> 02:48:51,297 OPPORTUNITY TO HAVE THIS REALLY 4911 02:48:51,297 --> 02:48:55,568 DEEP ROBUST DISCUSSION WITH YOU 4912 02:48:55,568 --> 02:48:57,069 AND WE CAN TALK TO YOU ABOUT 4913 02:48:57,069 --> 02:48:57,636 ANYTHING. 4914 02:48:57,636 --> 02:48:59,939 IT'S JUST, YOU KNOW, EXTREMELY 4915 02:48:59,939 --> 02:49:00,806 HELPFUL TO US. 4916 02:49:00,806 --> 02:49:03,108 BUT WE DO HAVE A LITTLE BIT OF 4917 02:49:03,108 --> 02:49:04,543 BOARD BUSINESS THAT WE HAVE TO 4918 02:49:04,543 --> 02:49:11,884 TAKE CARE OF BEFORE WE SIGN OFF. 4919 02:49:11,884 --> 02:49:13,285 SO LET'S SEE HERE. 4920 02:49:13,285 --> 02:49:14,587 SO FIRST OF ALL, WE HAVE TO 4921 02:49:14,587 --> 02:49:17,089 APPROVE THE SUMMARY FOR THE LAST 4922 02:49:17,089 --> 02:49:18,524 BOARD MEETING THAT WE HAD IN 4923 02:49:18,524 --> 02:49:19,391 MARCH. 4924 02:49:19,391 --> 02:49:21,260 THE SUMMARY WAS INCLUDED IN THE 4925 02:49:21,260 --> 02:49:22,494 BOARD MATERIALS. 4926 02:49:22,494 --> 02:49:25,331 SO I AM LOOKING FOR A MOTION TO 4927 02:49:25,331 --> 02:49:27,533 APPROVE THE BOARD MINUTES. 4928 02:49:27,533 --> 02:49:30,703 >> I HAD ONE MINOR CHANGE THAT I 4929 02:49:30,703 --> 02:49:32,071 TOLD VINCENT ABOUT BUT OTHERWISE 4930 02:49:32,071 --> 02:49:33,505 I MOVE TO APPROVE WITH THAT ONE 4931 02:49:33,505 --> 02:49:35,841 MINOR CHANGE. 4932 02:49:35,841 --> 02:49:36,742 REFERRED TO AS MR. LEE RATHER 4933 02:49:36,742 --> 02:49:38,344 THAN MR. JONES. 4934 02:49:38,344 --> 02:49:40,679 >> SO WE HAVE A MOTION TO 4935 02:49:40,679 --> 02:49:41,780 APPROVE AS AMENDED. 4936 02:49:41,780 --> 02:49:45,417 AND DO I HAVE A SECOND? 4937 02:49:45,417 --> 02:49:46,852 >> I SECOND. 4938 02:49:46,852 --> 02:49:47,486 >> THANK YOU. 4939 02:49:47,486 --> 02:49:48,220 THANK YOU. 4940 02:49:48,220 --> 02:49:48,887 OKAY. 4941 02:49:48,887 --> 02:49:52,391 SO THIS HAS BEEN MOVED AND 4942 02:49:52,391 --> 02:49:54,693 SECONDED AND WE HAVE A VOTE, ALL 4943 02:49:54,693 --> 02:49:57,429 IN FAVOR, SAY YES OR RAISE YOUR 4944 02:49:57,429 --> 02:49:57,630 HAND. 4945 02:49:57,630 --> 02:49:58,163 >> AYE. 4946 02:49:58,163 --> 02:49:59,632 >> AYE, OKAY. 4947 02:49:59,632 --> 02:50:03,235 ALL OPPOSED? 4948 02:50:03,235 --> 02:50:03,902 OKAY. 4949 02:50:03,902 --> 02:50:05,337 HEARING NONE OPPOSED, THE BOARD 4950 02:50:05,337 --> 02:50:08,240 MINUTES ARE APPROVED. 4951 02:50:08,240 --> 02:50:11,610 AND OUR NEXT MEETING WILL BE ON 4952 02:50:11,610 --> 02:50:13,278 SEPTEMBER 18TH IN PERSON. 4953 02:50:13,278 --> 02:50:14,580 WE LOOK FORWARD TO CONTINUING 4954 02:50:14,580 --> 02:50:16,749 THE DISCUSSION WITH YOU, 4955 02:50:16,749 --> 02:50:17,650 DR. RATHMELL, AS WELL AS 4956 02:50:17,650 --> 02:50:20,152 LEARNING SOME NEW THINGS. 4957 02:50:20,152 --> 02:50:21,687 AND THIS HAS BEEN JUST AN 4958 02:50:21,687 --> 02:50:23,555 AMAZING MEETING. 4959 02:50:23,555 --> 02:50:24,790 AMY, DO YOU HAVE ANYTHING TO ADD 4960 02:50:24,790 --> 02:50:25,624 AT THIS POINT? 4961 02:50:25,624 --> 02:50:27,726 >> NO, NO, THANK YOU SO MUCH, 4962 02:50:27,726 --> 02:50:30,129 ANNIE, FOR LEADING MEETING AND 4963 02:50:30,129 --> 02:50:31,130 THANK YOU ALL OF YOU FOR 4964 02:50:31,130 --> 02:50:32,231 SPENDING ALL YOUR AFTERNOON WITH 4965 02:50:32,231 --> 02:50:33,632 US. 4966 02:50:33,632 --> 02:50:35,300 AND WE ARE OBVIOUSLY VERY MUCH 4967 02:50:35,300 --> 02:50:36,735 LOOKING FORWARD TO SEEING 4968 02:50:36,735 --> 02:50:38,370 EVERYONE IN PERSON IN THE FALL. 4969 02:50:38,370 --> 02:50:40,639 AND THANK YOU TO THE ADVOCACY 4970 02:50:40,639 --> 02:50:41,740 OFFICE STAFF. 4971 02:50:41,740 --> 02:50:44,376 REALLY DOES ALL THE BEHIND THE 4972 02:50:44,376 --> 02:50:45,744 SCENES -- 4973 02:50:45,744 --> 02:50:47,279 >> BUT THIS IS THE LAST DAY FOR 4974 02:50:47,279 --> 02:50:47,680 SOME PEOPLE? 4975 02:50:47,680 --> 02:50:49,314 WE HAVE TO SAY GOODBYE TO THEM 4976 02:50:49,314 --> 02:50:50,449 AND THANK THEM. 4977 02:50:50,449 --> 02:50:52,117 >> WE DID. 4978 02:50:52,117 --> 02:50:54,453 WE WERE DOING THAT IN THE 4979 02:50:54,453 --> 02:50:55,888 BEGINNING. 4980 02:50:55,888 --> 02:50:57,089 I WAS JUST TEXTING WITH SOME OF 4981 02:50:57,089 --> 02:50:59,191 THEM, YOU KNOW, YOU MIGHT MOVE 4982 02:50:59,191 --> 02:51:02,261 OFF OF NCRA BUT YOU NEVER REALLY 4983 02:51:02,261 --> 02:51:04,029 MOVE OFF OF NCI AND WE WILL 4984 02:51:04,029 --> 02:51:05,330 OBVIOUSLY KEEP IN TOUCH AND LOOK 4985 02:51:05,330 --> 02:51:08,934 FORWARD TO PLUGGING YOU ALL INTO 4986 02:51:08,934 --> 02:51:09,168 PLACES. 4987 02:51:09,168 --> 02:51:10,569 NCI IS A BIG PLACE AND 4988 02:51:10,569 --> 02:51:11,470 COLLECTIVE PATIENT PERSPECTIVE 4989 02:51:11,470 --> 02:51:14,406 IS IMPORTANT TO EVERY NOOK AND 4990 02:51:14,406 --> 02:51:16,275 CRANNY OF THAT SPACE, SO 4991 02:51:16,275 --> 02:51:17,943 PLUGGING PEOPLE INTO OTHER 4992 02:51:17,943 --> 02:51:18,177 PLACES. 4993 02:51:18,177 --> 02:51:19,578 THANK YOU, VICKIE. 4994 02:51:19,578 --> 02:51:22,648 >> THIS ISN'T GOODBYE, PEOPLE. 4995 02:51:22,648 --> 02:51:23,849 I HATE GOODBYES, BUT WE WILL 4996 02:51:23,849 --> 02:51:24,717 CONTINUE TO BE COLLEAGUES AND 4997 02:51:24,717 --> 02:51:26,018 OUR PATHS WILL DEFINITELY CROSS. 4998 02:51:26,018 --> 02:51:28,721 AND I THANK YOU SO MUCH FOR 4999 02:51:28,721 --> 02:51:29,888 MAKING MY JOB EASY. 5000 02:51:29,888 --> 02:51:32,925 IT'S BEEN REALLY WONDERFUL. 5001 02:51:32,925 --> 02:51:35,828 AND THANK YOU, DR. RATHMELL, FOR 5002 02:51:35,828 --> 02:51:36,795 SHOWING US AROUND THE WAR OFFICE 5003 02:51:36,795 --> 02:51:36,995 THERE. 5004 02:51:36,995 --> 02:51:38,197 THAT WAS REALLY A HIGHLIGHT. 5005 02:51:38,197 --> 02:51:39,431 >> ABSOLUTELY. 5006 02:51:39,431 --> 02:51:40,833 IT'S BEEN A PLEASURE TO SIT IN 5007 02:51:40,833 --> 02:51:44,570 THIS CRAZY FANCY ROOM. 5008 02:51:44,570 --> 02:51:46,638 >> THANK YOU ALL, AND WE'LL SEE 5009 02:51:46,638 --> 02:51:47,606 YOU IN SEPTEMBER. 5010 02:51:47,606 --> 02:51:48,874 >> THANKS, EVERYBODY. 5011 02:51:48,874 --> 02:51:59,017 >> BYE.